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Acute mesenteric ischemia is considered a 
rare and fatal condition. Removal of necrotic 
bowel has been the conventional treatment 
with >80% overall mortality. This study 
shows that the disease is more common 
than appendicitis or ruptured abdominal 
aortic aneurysm in patients >75 years of age. 
Endovascular therapy was attempted in ¾ of 
patients resulting in 42% overall mortality and 
only ¹⁄³ required bowel resection. Computed 
tomography was diagnostic in 86%, but the 
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Acute  mesenteric  ischemia  (AMI)  is  generally  considered  as  a  rare  disease  with  high  mor-­‐‑
tality.  The  most  common  cause  of  AMI  is  acute  embolic  or  thrombotic  occlusion  of  the  su-­‐‑
perior   mesenteric   artery.   Until   the   late   1990s,   mesenteric   revascularization   in   AMI   was  
extremely  rare  in  Finland.  The  mainstay  of  treatment  was  bowel  resection  without  revascu-­‐‑
larization,  and  the  overall  mortality  was  more  than  80%.  
This  study  included  111  consecutive  AMI-­‐‑patients  treated  in  Kuopio  University  Hospital  
between   2009   and   2013.   The   incidence   rate   of  AMI  was   7.3/100  000   inhabitants/year   and  
increased  exponentially  with  age.  The  incidence  rate  of  AMI  caused  by  embolic  or  throm-­‐‑
botic   obstruction   of   the   superior   mesenteric   artery   was   4.5/100  000/year.   AMI   was  more  
common   than   ruptured   abdominal   aortic   aneurysm   and   a  more   common   cause   of   acute  
abdominal  pain  than  acute  appendicitis  in  patients  over  age  75  years.  
The  most  important  diagnostic  tool  in  AMI  is  contrast  enhanced  computed  tomography  
(CT).  In  this  study,  the  emergency  department  radiologist  was  able  to  detect  AMI  in  97%  of  
cases  if  the  clinician  had  mentioned  AMI  suspicion  in  the  CT  referral.  However,  AMI  suspi-­‐‑
cion  was  mentioned  in  only  31%  of  the  CT  referrals,  and  without  prior  AMI  suspicion,  the  
radiologist  was  able  to  interpret  CT  findings  correctly  in  only  81%  of  those  cases  (p=0.04).  
Furthermore,  the  risk  of  bowel  resection  was  more  than  three  times  higher  in  patients  with-­‐‑
out  AMI   suspicion  prior   to   imaging.  Thus,  detecting  AMI   in  CT   is  dependent  on   clinical  
suspicion  of  the  disease.  
The  specific  CT  findings  in  AMI  are  thromboembolic  clot  within  the  superior  mesenteric  
artery,   decreased   bowel   wall   enhancement,   and   intestinal   pneumatosis.   These   findings  
were  absent   in  one-­‐‑third  of  patients  with  AMI  caused  by  mesenteric  atherosclerosis.  Fur-­‐‑
thermore,   there  was  moderate   interobserver   variability   in   the   interpretation   of   intestinal  
CT-­‐‑findings.  However,  practically  all  patients  who  developed  AMI  upon  chronic  mesenter-­‐‑
ic   ischemia   had   at   least   some   abnormal   intestinal   CT   findings,   such   as   mesenteric   fat  
stranding  (edema),  bowel  wall  thickening,  or  bowel  lumen  dilatation  (paralysis).  While  the  
symptoms   in   acute   on   chronic   mesenteric   ischemia   can   be   insidious   and   obscure,   these  
unspecific  CT  findings  together  with  severely  calcified  superior  mesenteric  artery  and  ele-­‐‑
vated  inflammatory  markers  should  raise  the  suspicion  of  AMI.  
A   total  of  66  patients   in   this   study  had  AMI  caused  by  embolism   (38%)  or   thrombosis  
(62%).   Endovascular   therapy   (EVT)  was   attempted   in   50   of   these   patients   (mean   age   79  
years).   EVT  was   technically   successful   in   44   (88%)   patients.   Three   patients   were   treated  
with  surgical  bypass  after  failed  EVT  with  mortality   in  one  patient.  The  30-­‐‑day  mortality,  
bowel   resection,   and   EVT-­‐‑related   complication   rates   after   successful   or   failed   EVT  were  
32%,  34%,  and  10%,  respectively.  The  30-­‐‑day  mortality  of  the  sixteen  patients  treated  with-­‐‑
out   revascularization  was  75%.  However,   those  patients  had  worse  prognosis  at  baseline.  
The  overall  mortality  rate  of  all  66  patients  with  AMI  was  42%.  
In  conclusion,  AMI  should  be  suspected  especially  in  elderly  patients  with  cardiovascu-­‐‑
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liberally  in  those  patients.  Aggressive  treatment  with  mesenteric  revascularization  is  asso-­‐‑
ciated  with  significant  survival  benefit.  EVT  is  a  feasible  option  in  most  cases  of  AMI.  
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Akuuttia  mesenteriaali-­‐‑iskemiaa  (AMI)  pidetään  harvinaisena  ja  usein  kuolemaan  johtava-­‐‑
na   sydän-­‐‑   ja   verisuonisairauksien   komplikaationa.   Sen   tavallisin   aiheuttaja   on   ylemmän  
suolilievevaltimon   veritulppa   (embolia)   tai   valtimokovettumataudin   aiheuttama   tukos  
(tromboosi).  Suoliston  verenkierron  palauttamiseen  tähtäävä  toimenpide  eli  revaskularisaa-­‐‑
tio  oli  harvinaisuus  90-­‐‑luvulla  Suomessa.  Kuolioon  menneen  suolen  osan  poisto  eli   suoli-­‐‑
resektio  oli  vielä  tuolloin  käytännössä  ainoa  AMI:n  hoito.  Potilaiden  kuolleisuus  oli  yli  80%.  
Väitöskirjatutkimuksen   aineistona   olivat   Kuopion   yliopistollisessa   sairaalassa   vuosina  
2009-­‐‑2013  hoidetut  111  peräkkäistä  AMI-­‐‑potilasta.  AMI:n  ilmaantuvuudeksi  Pohjois-­‐‑Savon  
sairaanhoitopiirin  alueella  saatiin  7,3/100  000  asukasta/vuosi.  Ylemmän  suolilievevaltimon  
tukoksesta  johtuneen  AMI:n  ilmaantuvuus  oli  4,5/100  000  asukasta/vuosi.  AMI  oli  yleisem-­‐‑
pi   kuin   vatsa-­‐‑aortan  pullistuman   repeämä   (3,9/100  000/vuosi)   tai   umpilisäkkeen   tulehdus  
yli   75-­‐‑vuotiailla   sairaalapotilailla.   Kyseessä   on   siis   varsin  merkittävä   akuutin   vatsakivun  
syy  vanhuspotilailla.  
Tärkein  AMI:n  diagnostinen  työkalu  on  varjoainetehosteinen  vatsan  tietokonetomografia  
(TT).   Tutkimuksessa   havaittiin,   että   AMI-­‐‑epäily   oli   mainittu   kuvantamislähetteessä   vain  
31  %:ssa  tapauksista,  jolloin  päivystävä  radiologi  osasi  tulkita  TT-­‐‑löydökset  oikein  97  %:ssa  
tapauksista.  Mikäli  AMI-­‐‑epäilyä  ei  oltu  mainittu  TT-­‐‑lähetteessä,  vastaava  osuvuus  oli  vain  
81  %   (p=0,04)   ja   suoliresektioon   joutumisen   riski   oli   yli   kolminkertainen.  Kliinikon   epäily  
siis  johdatteli  päivystävän  radiologin  tunnistamaan  AMI:an  liittyvät  löydökset  paremmin.  
AMI:n  diagnostisia  TT-­‐‑löydöksiä  ovat  ylemmän  suolilievevaltimon  veritulppa,  huonosti  
tehostuva  suolisegmentti   ja   suolen  seinämän  kaasukuplat  eli  pneumatoosi.  Valtimokovet-­‐‑
tumataudin  aiheuttamassa  AMI:ssa  kolmasosalta  potilaista  kuitenkin  kaikki  nämä  löydök-­‐‑
set   puuttuivat.  Myös   suoliston   TT-­‐‑löydösten   tulkinta   vaihteli   kohtalaisesti   kolmen   koke-­‐‑
neen  radiologin  välillä.  Silti   lähes  kaikilta  AMI-­‐‑potilailta   löytyi   joitakin  poikkeavia  suolis-­‐‑
ton  TT-­‐‑löydöksiä,  kuten  suoliliepeen  ödeemia,  paksuuntunut  suolen  seinämä  tai   laajentu-­‐‑
nut   paralyyttinen   suoli.   Krooninen   suoli-­‐‑iskemia   voi   akutisoitua   salakavalasti   ja   oireet  
voivat  olla  epämääräisiä.  Myös  epäspesifit  TT-­‐‑löydökset  ja  kohonneet  tulehdusarvot  voivat  
auttaa  tunnistamaan  mesenteriaali-­‐‑iskemian  akutisoitumisen  potilaalla,   jolla  on  krooninen  
ylemmän  suolilievevaltimon  tukos  tai  ahtauma.  
Tutkimuksessa  oli  mukana  66  potilasta,  joilla  AMI:n  syy  oli  embolia  (38  %)  tai  tromboosi  
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AMI:a  on  syytä  epäillä  akuutin  vatsakivun  taustalla  etenkin  iäkkäillä  potilailla,  joilla  on  
valtimokovettumataudin   riskitekijöitä.  Vatsan  TT  on   silloin   tehtävä  varjoainetehosteisesti.  
Aktiivinen  pyrkimys  suoliston  revaskularisaatioon  vähentää  potilaiden  kuolleisuutta  mer-­‐‑
kittävästi.  Revaskularisaatio  on  useimmiten  toteutettavissa  suonensisäisesti.  
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1  Introduction    
"ʺAcute  mesenteric  ischemia  (AMI)  is  a  rare  and  often  fatal  condition."ʺ  This  phrase  is  com-­‐‑
monly  used  to  describe  the  disease  with  a  dreary  reputation.  In  the  early  1990s  in  Finland,  
the  overall  mortality  in  AMI  was  over  80%,  and  survival  reached  50%  only  under  the  most  
favorable   circumstances  when  aggressive   treatment  with  bowel   resection  was   considered  
feasible  (1).  However,  in  two-­‐‑thirds  of  the  cases  with  AMI,  the  only  possible  treatment  was  
comfort   care   resulting   in   100%  mortality   (with  or  without  prior   exploration  via   laparoto-­‐‑
my).   Intestinal   revascularization   was   attempted   in   rare   occasions,   and   the   results   were  
discouraging.    
There  is  another  well-­‐‑known  vascular  emergency  that  similarly  presents  with  acute  ab-­‐‑
dominal  pain,   is  deadly,  and  rare:  ruptured  abdominal  aortic  aneurysm  (RAAA).  What   is  
not   so  well  known,  however,   is   that  AMI   is  more   common   than  RAAA.  A   frequently   re-­‐‑
ferred  population  based  autopsy  study  demonstrated  that  the  incidence  of  AMI,  caused  by  
acute   occlusion   of   the   superior   mesenteric   artery   (SMA),   was   1.5   times   higher   than   the  
incidence  of  RAAA  nearly  four  decades  ago  in  Malmö,  Sweden  (2,3).  Even  so,  there  seems  
to  be  a   lack  of  such  enthusiasm  for   the  development  of  AMI   treatment  as   there   is   for   the  
management  of  RAAA.  Bowel   resection  without   revascularization   is   still   the  mainstay  of  
treatment   in   AMI   in   many   hospitals.   It   has   also   been   stated   that   there   are   no   place   for  
endovascular   interventions   in   AMI   (because   percutaneous   procedures   do   not   allow   for  
assessment  of  bowel  viability).  Nevertheless,  we  have  been  using  endovascular  approach  as  
the   primary   revascularization  method   in  AMI   for   several   years   in   our   institution.  Mean-­‐‑
while,  there  is  an  ongoing  "ʺopen  versus  endovascular"ʺ  debate  regarding  the  optimal  treat-­‐‑
ment  approach  in  AMI  (4).  A  need  to  evaluate  our  endovascular-­‐‑first  strategy,  and  also,  the  
chance   to   dispute   some   old   conceptions   of   AMI   ultimately   gave   the  motivation   for   this  
thesis.  
Traditionally,  the  etiology  of  AMI  is  defined  as  embolism,  thrombosis,  non-­‐‑occlusive,  or  
venous   ischemia.  Acute  occlusion  of   the  SMA   is  generally  accepted  as   the  most   common  
cause   of  AMI.  However,   the   etiological   categorization   of  AMI  has   not   changed   since   the  
time  when  angiography  was   the  gold  standard  diagnostic   investigation.  Today,   thanks   to  
the  modern  computed  tomography  (CT),  we  get  more  information  on  plaque  morphology  
and  bowel  injury.  Still,  it  is  impossible  to  distinguish  acute  from  chronic  thrombus  based  on  
CT  alone.  Furthermore,   there  are   those  patients  who  present  with   fulminant   intestinal   is-­‐‑
chemia   and   chronic   calcified   obstruction   of   the   mesenteric   arteries,   without   any   sign   of  
acute   thrombotic   clot   in  CT   (at   least   not   visible   to   the   eye).   Therefore,   an   elderly  patient  
presenting  with  acute  abdominal  pain  and  calcified  atherosclerotic  obstruction  of  the  SMA  
represents  a  special  challenge  for  the  clinician.  The  calcified  artery  may  be  a  mere  incidental  
finding;  we  know  that  most  patients  with  mesenteric  atherosclerosis  are  asymptomatic.  On  
the  other  hand,  the  patient  could  be  suffering  from  life-­‐‑threatening  AMI.  
The  classical  characterization  of  AMI  has  been  "ʺsevere,  poorly  localized  abdominal  pain  
that   is  out  of  proportions  to  the  physical  examination"ʺ.   In  practice,  however,   this  descrip-­‐‑
tion  seems  to  apply  only  when  AMI  is  caused  by  sudden  (embolic)  occlusion  of  previously  
unobstructed  SMA.  Patients  who  develop  AMI  upon  chronic   (atherosclerotic)  obstruction  
of  the  SMA  often  seem  to  present  with  insidious  onset  of  obscure  symptoms,  such  as  vomit-­‐‑
ing  and  diarrhea,  and  the  diagnosis  can  be  incredibly  difficult.  
In  the  contrast  enhanced  CT,  strong  signs  of  AMI  are  embolic  or  thrombotic  clot  of  the  
SMA,  unenhanced  bowel  wall  segment,  and  intestinal  pneumatosis.  CT  has  been  associated  
with   as   high   as   96-­‐‑100%   sensitivity   and   89-­‐‑98%   specificity   in   the   diagnosis   of  AMI   (5,6).  
However,  there  seems  to  be  discrepancy  between  research  and  practice.  Many  of  the  stud-­‐‑
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The  classical  characterization  of  AMI  has  been  "ʺsevere,  poorly  localized  abdominal  pain  
that   is  out  of  proportions  to  the  physical  examination"ʺ.   In  practice,  however,   this  descrip-­‐‑
tion  seems  to  apply  only  when  AMI  is  caused  by  sudden  (embolic)  occlusion  of  previously  
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of  the  SMA  often  seem  to  present  with  insidious  onset  of  obscure  symptoms,  such  as  vomit-­‐‑
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with   as   high   as   96-­‐‑100%   sensitivity   and   89-­‐‑98%   specificity   in   the   diagnosis   of  AMI   (5,6).  
However,  there  seems  to  be  discrepancy  between  research  and  practice.  Many  of  the  stud-­‐‑




prior   suspicion   of   AMI   using   optimal   imaging   protocols.   In   addition,  many   of   the   AMI  
diagnoses   in   those   studies  have  been  confirmed  by   laparotomy  or  autopsy,  which  means  
that  the  majority  of  the  study  patients  may  already  have  had  advanced  bowel  ischemia.  In  
the  daily  life  of  the  emergency  department,  AMI  is  rarely  suspected  prior  to  imaging,  and  
therefore,  CT   is  often  performed  with  suboptimal  protocol   for   the  diagnosis  of  AMI.  Fur-­‐‑
thermore,   the   intestinal   findings  are  more   subtle   in  patients  who  have  not  yet  developed  
advanced  bowel  ischemia,  and  such  findings  are  more  easily  disregarded  in  the  CT  analy-­‐‑
sis.  It  seemed  to  us  that  the  performance  of  emergency  department  radiologists  in  the  inter-­‐‑
pretation  of  CT  in  AMI  warranted  further  evaluation,  not  only  in  a  study  setting  but  also  in  
the  daily  practice.  
AMI   is  undoubtedly   a   rare  disease,   but   its   incidence   increases   exponentially  with   age.  
Therefore,  AMI  might  not  be  a   rare  condition  after  all   in  an  80-­‐‑year-­‐‑old  patient  with   risk  
factors  for  atherosclerosis  and  acute  abdominal  pain.  The  emergency  department  surgeons  
and  radiologists  occupy  a  key  position  in  the  early  detection  of  AMI.  If  they  underestimate  
or  poorly  understand   the   significance  of  AMI  as  a  potential   cause  of   the  acute  abdomen,  
there  is  a  possibility  that  AMI  is  being  widely  underdiagnosed.  
The  primary  aims  of   this   study  were   to  determine   the  current  age-­‐‑related   incidence  of  
AMI   in   patients   presenting  with   acute   abdomen,   to   evaluate   the   emergency   department  
radiologists'ʹ  performance  and  the  interobserver  variability  in  the  interpretation  of  CT  find-­‐‑
ings  in  AMI,  and  finally,  to  assess  outcomes  and  to  clarify  the  role  of  endovascular  therapy  






2    Review  of  the  literature  
2.1 MESENTERIC CIRCULATION AND COLLATERAL NETWORK 
2.1.1  Arterial  circulation  
Three  main  arteries  deliver  blood   to   the   small   and   large   intestine:   the  SMA,   celiac   artery  
(CA)  and   inferior  mesenteric  artery   (IMA).  The  collateral  network   is  extensive  and  varies  
from  person  to  person.  There  are  three  main  collateral  patterns;  those  that  exist  within  the  
same  main  vessel  distribution,  those  between  the  main  mesenteric  arteries,  and  collaterals  
between  mesenteric  and  parietal  circulation  (7).    
The   vascularization   of   the   left   colon   can   be   confusing   because   of   inconstant   collateral  
anatomy  (8).  According  to  most  authors,  a  distal  marginal  artery  of  the  colon  (also  known  
as  the  marginal  artery  of  Drummond)  is  always  present  and  connects  the  middle  colic  ar-­‐‑
tery  arising  from  the  SMA  to  the  left  colic  artery  originating  from  the  IMA  (Figures  1b  and  
2).  There  are  many  different  names  in  the  literature  for  another  arterial  arch  located  central-­‐‑
ly  to  the  marginal  artery  in  the  mesentery  connecting  the  SMA  and  the  IMA,  best  known  as  
the  arch  of  Riolan  (Figure  1b).  However,  recent  reviews  of  the  historical  literature  suggest  
that  there  is  no  evidence  for  the  presence  of  any  such  regular  collateral  structure  other  than  
the  middle   colic   artery,   the  marginal   artery,   and   the   ascending   left   colic   artery   and   their  
anastomoses  at  the  transverse  mesocolon  (9,10)  (Figure  2).    
Meandering  mesenteric  artery  is  a  commonly  used  name  to  describe  an  enlarged  tortu-­‐‑
ous  collateral  artery  connecting   the   IMA  and  the  SMA  (Figure  3).   Its  presence   indicates  a  
compensatory  response  to  an  obstruction  somewhere  in  the  mesenteric  circulation  (8,10).  If  
such  a  structure  is  unexpectedly  encountered  during,  for  example,  bowel  surgery,  ligation  
should  be  avoided  as  it  can  lead  to  disastrous  intestinal  ischemia.  
The  gastroduodenal  artery  and  the  pancreaticoduodenal  arcade  represent  the  dominant  
collateral   pathway   between   the  CA   and   the   SMA,   but   sometimes,   less   known   collaterals  
connecting  these  two  main  arteries  may  exist,  such  as  the  arc  of  Bühler  —  a  rare  embryolog-­‐‑
ical  remnant  directly  connecting  these  two  main  arteries  —  and  the  greater  omental  arcade  
(the   arc   of   Barkow)   between   the   left   and   right   gastroepiploic   arteries   (11,12)   (Figure   1a).  
Any  of  these  collaterals  may  slowly  enlarge  in  response  to  obstruction  of  CA  or  SMA.    
Even  if  all  three  main  arteries  are  chronically  occluded,  the  patient  may  still  be  asymp-­‐‑
tomatic  if  the  collaterals  from  the  parietal  circulation  have  sufficiently  developed  (13).  
  
2.1.2  Venous  circulation  
The  venous  blood  from  the  intestine  drains  via  the  superior  mesenteric  vein  (SMV),  splenic  
vein   and   inferior  mesenteric   vein   to   the  portal   vein.  Occlusion  of   the  portal   vein  usually  
results  in  cavernous  transformation  of  the  gastrohepatic  ligament,  and  pre-­‐‑existing  portal-­‐‑
systemic  anastomoses  commonly  enlarge  (Table  1).  
  
Table 1. Portal-systemic venous anastomoses (14,15). 
 
Recanalized umbilical vein  ⇒   Anterior abdominal wall (epigastric veins) 
Left gastric vein and short gastric veins  ⇒   Mediastinal veins (esophageal varices) 
Splenic vein  ⇒   Left renal vein (splenorenal varices/shunt) 
Superior and inferior mesenteric veins  ⇒   Retroperitoneal veins (ascending lumbar/azygos/hemiazygos) 
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Figure 1. Gastric (a) and bowel (b) arterial collateral network. (Used with permission of Mayo 








Figure 2. SMA and IMA anatomy and collaterals. Critical regions of collateralization: Griffith’s 
point (SMA to IMA), Sudeck’s point (IMA to internal iliac artery). SMA = superior mesenteric 
artery, IMA = inferior mesenteric artery, IC = ileocolic artery, RC = right colic artery, MC = 
middle colic artery, LC = left colic artery, SA = sigmoid arteries, SR = superior rectal artery. 
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Figure 2. SMA and IMA anatomy and collaterals. Critical regions of collateralization: Griffith’s 
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Figure 3. This is an angiographic 3-D CT reconstruction of a patient with abdominal angina due 
to proximal occlusion of the CA and SMA. The bowel is perfused via enlarged IMA (red arrow-
heads), and the meandering mesenteric artery (white arrowheads) seems to traverse alongside 
the transverse mesocolon. The SMA (white open arrowheads) is filled via retrograde flow sup-






2.2 CLINICAL PRESENTATION AND ETIOLOGY 
First,  it  is  important  to  distinguish  between  primary  and  secondary  mesenteric  ischemia;  the  
latter   is  caused  by  extrinsic  compression  of  otherwise  normal   intestinal  vessels,   for  exam-­‐‑
ple,  due  to  adhesions,  volvulus,  malignancy  etc.  Primary  mesenteric  ischemia  occurs  due  to  
"ʺintrinsic"ʺ  arterial  occlusion  such  as  acute  thromboembolism,  or  secondary  to  thrombosis  of  
the  mesenteric   veins,  mesenteric   hypoperfusion   in   aortic   dissection,  mesenteric   vasocon-­‐‑
striction,  or  low  cardiac  output  (16).  This  thesis  focuses  on  primary  mesenteric  ischemia.  
2.2.1  Acute  mesenteric  ischemia  
AMI  represents  a   life-­‐‑threatening  condition  caused  by  inadequate  blood  flow  through  the  
mesenteric   vessels   resulting   in   intestinal   ischemia   and   eventually,   bowel   necrosis   unless  
sufficient   blood   flow   is   restored.   The   etiology   of   AMI   is   divided   in   mesenteric   arterial  
thromboembolic   disease,   mesenteric   venous   thrombosis   (MVT),   non-­‐‑occlusive   (or   non-­‐‑
obstructive)  mesenteric  ischemia  (NOMI)  and  other  etiologies.  Acute  occlusion  of  the  SMA  
is  considered  the  most  common  cause  of  AMI.  The  distribution  of  etiology  in  AMI  has  been  
given  roughly  as  ⅔  thromboembolic,  ⅙  NOMI,  and  ⅙  MVT,  and  the  embolism  per  throm-­‐‑
bosis  ratio  varies  between  studies  ranging  between  0.5–1.4  (17–19).  
2.2.1.1  Embolism  
Embolic  AMI   is   characterized  by   acute   onset   of   symptoms;   the   abdominal  pain   is   severe  
and  diffuse  without  any  localization.  The  phrase  "ʺpain  out  of  proportions"ʺ  is  often  used  to  
describe  the  early  clinical  presentation  of  SMA  embolism,  however,  the  clinical  manifesta-­‐‑
tion  and  severity  of  the  disease  varies  a  great  deal  depending  on  individual  anatomy  and  
the  location  of  the  occlusion  in  the  mesenteric  arterial  tree  (20,21).  
The  common  risk  factors  for  embolic  AMI  are  atrial  fibrillation,  congestive  heart  failure,  
recent   myocardial   infarction,   and   prior   embolic   events   such   as   a   stroke   (20).   A   cardiac  
thrombus  was  demonstrated  in  the  Malmö  autopsy  study  (with  a  cohort  of  24  000  consecu-­‐‑
tive  autopsies  from  1970–1982)  in  nearly  half  of  122  subjects  with  mortality  from  SMA  em-­‐‑
bolism.  Furthermore,  68%  had  synchronous  embolism  elsewhere  in  the  abdominal  viscera,  
leg,  arm,  brain,  or  coronary  arteries  (22).  
2.2.1.2  Thrombosis  
Thrombus  usually   forms   in   the  proximal  SMA  with  superimposed  high-­‐‑grade  stenosis  or  
ruptured  atherosclerotic  plaque.  Thus,  in  most  cases,  thrombosis  is  a  complication  of  ather-­‐‑
osclerotic  vascular  disease.  Besides  atherosclerosis,  the  risk  factors  for  thrombosis  are  pro-­‐‑
longed   hypotension,   hypovolemia,   and   hypercoagulable   states   (21).   Prior   symptoms   of  
chronic  mesenteric   ischemia  (CMI)  have  been  reported   in  25–30%  of  patients  with  throm-­‐‑
botic  AMI  (18,21).  A  recent  study  of  55  patients  with  symptomatic  mesenteric  atherosclero-­‐‑
sis  referred  for  EVT,  of  whom  48  had  acute  disease,  demonstrated  that  symptoms  consistent  
with  CMI  were  found  retrospectively  in  up  to  84%  of  patients  prior  to  the  final  admission,  
and  previous  hospitalization  for  the  same  complaints  had  occurred  in  78%  (23).  Some  pa-­‐‑
tients  may  have  undergone  explorative  laparotomy,  or  cholecystectomy,  for  gastrointestinal  
issues  without  relief  of  symptoms  before  the  disease  eventually  culminates  in  AMI  (21,23).  
The  clinical  presentation  of  thrombotic  AMI  is  more  varied  than  in  the  embolic  etiology  
depending  on  the  acuteness  and  extent  of  the  arterial  obstruction,  and  on  the  compensatory  
blood   flow   from   the   collateral   arteries.   Although   many   patients   with   acute   thrombosis  
present  with  fulminant  bowel  ischemia,  a  subacute  presentation  pattern  is  also  common.  In  
slowly  progressing  atherosclerotic  disease,   the  collateral  arteries  are  often  well  developed  
and  the  bowel  is  accustomed  to  withstanding  ischemia.  It  may  take  several  days  to  weeks  






Figure 3. This is an angiographic 3-D CT reconstruction of a patient with abdominal angina due 
to proximal occlusion of the CA and SMA. The bowel is perfused via enlarged IMA (red arrow-
heads), and the meandering mesenteric artery (white arrowheads) seems to traverse alongside 
the transverse mesocolon. The SMA (white open arrowheads) is filled via retrograde flow sup-






2.2 CLINICAL PRESENTATION AND ETIOLOGY 
First,  it  is  important  to  distinguish  between  primary  and  secondary  mesenteric  ischemia;  the  
latter   is  caused  by  extrinsic  compression  of  otherwise  normal   intestinal  vessels,   for  exam-­‐‑
ple,  due  to  adhesions,  volvulus,  malignancy  etc.  Primary  mesenteric  ischemia  occurs  due  to  
"ʺintrinsic"ʺ  arterial  occlusion  such  as  acute  thromboembolism,  or  secondary  to  thrombosis  of  
the  mesenteric   veins,  mesenteric   hypoperfusion   in   aortic   dissection,  mesenteric   vasocon-­‐‑
striction,  or  low  cardiac  output  (16).  This  thesis  focuses  on  primary  mesenteric  ischemia.  
2.2.1  Acute  mesenteric  ischemia  
AMI  represents  a   life-­‐‑threatening  condition  caused  by  inadequate  blood  flow  through  the  
mesenteric   vessels   resulting   in   intestinal   ischemia   and   eventually,   bowel   necrosis   unless  
sufficient   blood   flow   is   restored.   The   etiology   of   AMI   is   divided   in   mesenteric   arterial  
thromboembolic   disease,   mesenteric   venous   thrombosis   (MVT),   non-­‐‑occlusive   (or   non-­‐‑
obstructive)  mesenteric  ischemia  (NOMI)  and  other  etiologies.  Acute  occlusion  of  the  SMA  
is  considered  the  most  common  cause  of  AMI.  The  distribution  of  etiology  in  AMI  has  been  
given  roughly  as  ⅔  thromboembolic,  ⅙  NOMI,  and  ⅙  MVT,  and  the  embolism  per  throm-­‐‑
bosis  ratio  varies  between  studies  ranging  between  0.5–1.4  (17–19).  
2.2.1.1  Embolism  
Embolic  AMI   is   characterized  by   acute   onset   of   symptoms;   the   abdominal  pain   is   severe  
and  diffuse  without  any  localization.  The  phrase  "ʺpain  out  of  proportions"ʺ  is  often  used  to  
describe  the  early  clinical  presentation  of  SMA  embolism,  however,  the  clinical  manifesta-­‐‑
tion  and  severity  of  the  disease  varies  a  great  deal  depending  on  individual  anatomy  and  
the  location  of  the  occlusion  in  the  mesenteric  arterial  tree  (20,21).  
The  common  risk  factors  for  embolic  AMI  are  atrial  fibrillation,  congestive  heart  failure,  
recent   myocardial   infarction,   and   prior   embolic   events   such   as   a   stroke   (20).   A   cardiac  
thrombus  was  demonstrated  in  the  Malmö  autopsy  study  (with  a  cohort  of  24  000  consecu-­‐‑
tive  autopsies  from  1970–1982)  in  nearly  half  of  122  subjects  with  mortality  from  SMA  em-­‐‑
bolism.  Furthermore,  68%  had  synchronous  embolism  elsewhere  in  the  abdominal  viscera,  
leg,  arm,  brain,  or  coronary  arteries  (22).  
2.2.1.2  Thrombosis  
Thrombus  usually   forms   in   the  proximal  SMA  with  superimposed  high-­‐‑grade  stenosis  or  
ruptured  atherosclerotic  plaque.  Thus,  in  most  cases,  thrombosis  is  a  complication  of  ather-­‐‑
osclerotic  vascular  disease.  Besides  atherosclerosis,  the  risk  factors  for  thrombosis  are  pro-­‐‑
longed   hypotension,   hypovolemia,   and   hypercoagulable   states   (21).   Prior   symptoms   of  
chronic  mesenteric   ischemia  (CMI)  have  been  reported   in  25–30%  of  patients  with  throm-­‐‑
botic  AMI  (18,21).  A  recent  study  of  55  patients  with  symptomatic  mesenteric  atherosclero-­‐‑
sis  referred  for  EVT,  of  whom  48  had  acute  disease,  demonstrated  that  symptoms  consistent  
with  CMI  were  found  retrospectively  in  up  to  84%  of  patients  prior  to  the  final  admission,  
and  previous  hospitalization  for  the  same  complaints  had  occurred  in  78%  (23).  Some  pa-­‐‑
tients  may  have  undergone  explorative  laparotomy,  or  cholecystectomy,  for  gastrointestinal  
issues  without  relief  of  symptoms  before  the  disease  eventually  culminates  in  AMI  (21,23).  
The  clinical  presentation  of  thrombotic  AMI  is  more  varied  than  in  the  embolic  etiology  
depending  on  the  acuteness  and  extent  of  the  arterial  obstruction,  and  on  the  compensatory  
blood   flow   from   the   collateral   arteries.   Although   many   patients   with   acute   thrombosis  
present  with  fulminant  bowel  ischemia,  a  subacute  presentation  pattern  is  also  common.  In  
slowly  progressing  atherosclerotic  disease,   the  collateral  arteries  are  often  well  developed  
and  the  bowel  is  accustomed  to  withstanding  ischemia.  It  may  take  several  days  to  weeks  




nosed  and  treated  (20).  It  has  been  suggested  that  because  of  this  slower  progression  of  the  
disease,  the  prognosis  of  AMI  may  be  better  in  patients  with  thrombotic  than  with  embolic  
etiology  (21).    
Thus,  a  significant  number  of  AMI  patients  develop  acute  intestinal  ischemia  upon  CMI,  
which   is   often   referred   to   as   acute   on   chronic   mesenteric   ischemia   (AOCMI).  However,   the  
frequency  with  which  CMI  becomes  acute  (presumably  by  thrombosis)  remains  unknown  
(23,24).  
2.2.1.3  Non-­‐‑occlusive  mesenteric  ischemia  
NOMI   can   be   described   as   hypoperfusion   of   the   intestine  without   occlusion   of   the  main  
mesenteric  arteries.  A  variety  of  clinical  conditions  can  trigger  NOMI,  for  example,  cardiac  
failure,  hypovolemia,  sepsis,  and  hypotension  following  dialysis  or  major  surgery.  In  addi-­‐‑
tion,   the  use  of  extracorporeal  circulation,   intra-­‐‑aortic  blood  pump,  and  administration  of  
drugs   that   can   cause   vasoconstriction   in   the   splanchnic   vessels   (e.g.   norepinephrine   or  
vasopressin)  may   contribute   to   the   development   of  NOMI   (21,25).   Other   risk   factors   for  
NOMI  include  atherosclerosis,  diabetes  mellitus,  and  renal  insufficiency  (25).  
Early  signs  of  NOMI  are  nonspecific  and  easily  missed,  as  the  clinical  presentation  is  of-­‐‑
ten  dominated  by  the  symptoms  of  the  underlying  acute  condition.  NOMI  should  be  sus-­‐‑
pected   in  patients  with   low  flow  state  or   shock  who  develop  abdominal  pain,   in  patients  
receiving  vasoconstrictor  substances  who  develop  abdominal  pain,  and  in  patients  who  are  
unusually  ill  after  cardiac  surgery,  aortic  surgery,  open  revascularization  for  CMI,  or  other  
major  abdominal  surgery  (24,26).  
In  the  Malmö  autopsy  study  including  62  patients  with  fatal  NOMI,  40%  had  stenosis  of  
the   SMA;  mesenteric   artery   stenosis  was   found   to   be   the   only   causative   factor   of   bowel  
infarction   in  28%  of   those  with  SMA  stenosis   (27).   In  another  prospective  study  of  63  pa-­‐‑
tients  with  angiography-­‐‑verified  NOMI  after  cardiac  or  major   thoracic  vessel  surgery,   the  
degree  of  SMA  vasoconstriction   in  angiography  showed  significant   correlation  with  peri-­‐‑
operative  mortality  (the  rate  of  SMA  stenosis  was  not  reported)  (25).  
2.2.1.4  Mesenteric  venous  thrombosis  
MVT  is  defined  as   thrombosis  of   the  SMV  with  or  without   thrombosis  of   the  portal  vein,  
the  splenic  vein,  and  the  inferior  mesenteric  vein.  MVT  accounts  for  about  3-­‐‑15%  of  all  cases  
of  mesenteric   ischemia.  MVT  may   arise   due   to   other   conditions,   such   as  malignancy,   in-­‐‑
flammatory  bowel  disease,   trauma,  pancreatitis,  heritable  thrombophilia,  or  any  other  hy-­‐‑
percoagulable   state   (secondary  MVT).   In   about   20–50%   of   cases,   the   underlying   cause   is  
unknown  (primary  MVT).  In  acute  occlusion  of  the  SMV,  mild  intestinal  edema  may  grad-­‐‑
ually  develop   into   arterial   spasm  and   transmural   bowel   infarction  within  days   to  weeks.  
Subacute  form  of  MVT  develops  gradually  within  several  weeks  and  the  pain  is  often  less  
severe,   and   there  may   be   a   history   of   (bloody)   diarrhea.   In   chronic  MVT,   complications  
such  as  portal  hypertension  and  hypersplenism  may  develop  several  months  after  the  acute  
event   (21,28).  With   treatment   or   during   the   natural   course   of   the   disease,   the   SMV  may  
either  recanalize  or  obliterate.  
In  a  review  of  15  studies  performed  between  1922-­‐‑1999,  the  bowel  resection  rate  in  MVT  
ranged  from  8–100%,  but  most  commonly  the  rate  was  between  ⅓  to  ⅔,  and  the  mortality  
rate  varied  between  9–59%  (28).  Historically,  the  diagnosis  of  MVT  was  often  established  in  
laparotomy,  and  presumably,  many  cases  with  mild  self-­‐‑limited  disease  were  never  diag-­‐‑
nosed.   Today,   owing   to   liberal   use   of   CT   in   acute   abdominal   pain,   the   diagnosis   can   be  
established  earlier,  and  with  adequate  anticoagulation  treatment,  venous   intestinal   infarc-­‐‑
tion   may   be   avoided.   In   a   recent   retrospective   analysis   of   102   consecutive   cases   with  
portomesenteric  venous  thrombosis,  only  two  patients  required  bowel  resection  (29).  How-­‐‑
ever,   in   that   study,   patients   with   isolated   portal   vein   thrombosis   and   those   with   SMV  
thrombosis  were  not   analysed   separately,   and  ⅓  of  patients  had   chronic   thrombosis.  Ve-­‐‑
nous   mesenteric   ischemia   rarely   develops   unless   the   peripheral   veins   of   the   mesentery  




out  extension  of  the  thrombus  to  the  SMV  rarely  causes  bowel  infarction  (28).  The  Malmö  
autopsy  cohort  included  239  patients  with  isolated  portal  vein  thrombosis,  of  whom  none  
had   developed   intestinal   infarction,   while   29   out   of   31   autopsy   subjects   with  MVT   had  
bowel   necrosis   (30).   In   conclusion,  MVT   seems   to   carry   a   significant   risk   of   developing  
venous  mesenteric  ischemia,  while  isolated  portal  vein  thrombosis  does  not.  
2.2.2  Chronic  mesenteric  ischemia  
The  etiology  of  CMI   is  mesenteric  atherosclerosis   in   the  vast  majority  of   cases.  Other  un-­‐‑
common  etiologies  associated  with  CMI  are  fibromuscular  dysplasia,  Buerger'ʹs  disease,  and  
aortic  dissection.  Elderly  women  present   for   treatment  more  commonly  than  men  (24,31).  
The  classic  symptoms  of  "ʺabdominal  angina"ʺ  are  postprandial  abdominal  pain,  weight  loss,  
and  fear  of  eating;  this  triad  is  present  in  22-­‐‑50%  of  patients  with  CMI  (31,32).  However,  the  
pattern   of   the   symptoms   can   be   quite   variable;   the   pain   is   not   always   clearly   related   to  
eating,  some  patients  complain  of  diarrhea,  vomiting,  or  constipation,  and  not  all  patients  
lose  weight.   It   is  clear,   though,   that  CMI  patients  do  reduce   food   intake  significantly  and  
the  majority  of  patients  have  other   cardiovascular  diseases   (24,31).   In   the   study  of  55  pa-­‐‑
tients  with  symptomatic  mesenteric  atherosclerosis  referred  for  EVT,  pathologic  endoscopic  
findings   were   surprisingly   common,   found   in   73%   of   investigated   patients;   the   typical  
findings   were   right-­‐‑sided   colitis/ulcers,   duodenitis,   antral   gastritis,   and  Helicobater   pylori  
negative  duodenal/antral  ulcers/erosions  (23).  In  general,  CMI  poses  no  imminent  threat  to  
life,  but  the  disease  may  eventually  culminate  in  acute  ischemia  (i.e.  AOCMI).  
2.2.3  Ischemic  colitis  
Ischemic   colitis   can   be   divided   in   left-­‐‑sided   and   right-­‐‑sided   disease.   Left-­‐‑sided   ischemic  
colitis  usually  presents  with  abdominal  pain  and  bloody  diarrhea,  and  is  either  idiopathic  
or  associated  with  occlusion  of  the  IMA,  colonic  obstruction,  or  hypoperfusion  of  the  colon  
due  to,  for  example,  cardiac  diseases,  dehydration,  or  abdominal  aortic  surgery  (16,33,34).  
In  most   cases,   acute   isolated   left-­‐‑sided   ischemic   colitis   can  be   treated   conservatively,   and  
relief  of  symptoms  occur  within  days  to  weeks  (33,34).  However,  colon  gangrene,  stricture,  
and  other  complications  can  develop.  Up  to  20%  of  patients  with  ischemic  colitis  ultimately  
require  surgery,  in  which  case  the  mortality  rate  is  high,  almost  40%  (35).  
In  a  recent  single-­‐‑center  study  including  58  patients  with  acute  right-­‐‑sided  ischemic  coli-­‐‑
tis  who  required  urgent  surgery  but  had  no  feasible  option  for  vascular  intervention,  SMA  
atherosclerosis  was  found  in  more  than  half  (36).  Thus,  right-­‐‑sided  ischemic  colitis  is  often  
associated  with  SMA  obstruction,  and  mortality  and  the  severity  of   illness   is  significantly  
higher   than   in   the   left-­‐‑sided   disease.   Therefore,   many   authors   currently   recognize   that  
right-­‐‑sided  ischemic  colitis  should  be  considered  as  AMI  or  CMI,  depending  on  the  severity  
and  acuteness  of  the  disease,  and  treated  accordingly  (34,35).    
2.2.4  Other  etiologies  
There  are  a  variety  of  non-­‐‑atherosclerotic   causes  of  mesenteric  arterial  disease   such  as   fi-­‐‑
bromuscular  dysplasia,  neurofibromatosis,  aortic  coarctation,  and  numerous  different  vas-­‐‑
culitides,  but  those  are  all  extremely  rare  causes  of  AMI  (37,38).  For  example,  in  a  24-­‐‑year  
review  of  7  514  patients  evaluated  for  vasculitis   in   the  Mayo  Clinics,  only  120   (1.6%)  pre-­‐‑
sented  symptoms  of  mesenteric   ischemia,  and  mere  15  patients  underwent  open  or  endo-­‐‑
vascular  treatment  for  occlusive  mesenteric  vasculitis  (38).    
A  few  special  AMI-­‐‑related  conditions  are  covered  in  the  following  subsections.  
2.2.4.1  Aortic  dissection  
Occasionally,  intestinal  ischemia  develops  secondary  to  aortic  dissection.  The  treatment  of  
AMI  due   to   aortic   dissection  differs   essentially   from   the  management   of  AMI   caused   by  
other  etiologies,  and  therefore,  aortic  dissection  represents  its  own  distinct  etiological  cate-­‐‑




nosed  and  treated  (20).  It  has  been  suggested  that  because  of  this  slower  progression  of  the  
disease,  the  prognosis  of  AMI  may  be  better  in  patients  with  thrombotic  than  with  embolic  
etiology  (21).    
Thus,  a  significant  number  of  AMI  patients  develop  acute  intestinal  ischemia  upon  CMI,  
which   is   often   referred   to   as   acute   on   chronic   mesenteric   ischemia   (AOCMI).  However,   the  
frequency  with  which  CMI  becomes  acute  (presumably  by  thrombosis)  remains  unknown  
(23,24).  
2.2.1.3  Non-­‐‑occlusive  mesenteric  ischemia  
NOMI   can   be   described   as   hypoperfusion   of   the   intestine  without   occlusion   of   the  main  
mesenteric  arteries.  A  variety  of  clinical  conditions  can  trigger  NOMI,  for  example,  cardiac  
failure,  hypovolemia,  sepsis,  and  hypotension  following  dialysis  or  major  surgery.  In  addi-­‐‑
tion,   the  use  of  extracorporeal  circulation,   intra-­‐‑aortic  blood  pump,  and  administration  of  
drugs   that   can   cause   vasoconstriction   in   the   splanchnic   vessels   (e.g.   norepinephrine   or  
vasopressin)  may   contribute   to   the   development   of  NOMI   (21,25).   Other   risk   factors   for  
NOMI  include  atherosclerosis,  diabetes  mellitus,  and  renal  insufficiency  (25).  
Early  signs  of  NOMI  are  nonspecific  and  easily  missed,  as  the  clinical  presentation  is  of-­‐‑
ten  dominated  by  the  symptoms  of  the  underlying  acute  condition.  NOMI  should  be  sus-­‐‑
pected   in  patients  with   low  flow  state  or   shock  who  develop  abdominal  pain,   in  patients  
receiving  vasoconstrictor  substances  who  develop  abdominal  pain,  and  in  patients  who  are  
unusually  ill  after  cardiac  surgery,  aortic  surgery,  open  revascularization  for  CMI,  or  other  
major  abdominal  surgery  (24,26).  
In  the  Malmö  autopsy  study  including  62  patients  with  fatal  NOMI,  40%  had  stenosis  of  
the   SMA;  mesenteric   artery   stenosis  was   found   to   be   the   only   causative   factor   of   bowel  
infarction   in  28%  of   those  with  SMA  stenosis   (27).   In  another  prospective  study  of  63  pa-­‐‑
tients  with  angiography-­‐‑verified  NOMI  after  cardiac  or  major   thoracic  vessel  surgery,   the  
degree  of  SMA  vasoconstriction   in  angiography  showed  significant   correlation  with  peri-­‐‑
operative  mortality  (the  rate  of  SMA  stenosis  was  not  reported)  (25).  
2.2.1.4  Mesenteric  venous  thrombosis  
MVT  is  defined  as   thrombosis  of   the  SMV  with  or  without   thrombosis  of   the  portal  vein,  
the  splenic  vein,  and  the  inferior  mesenteric  vein.  MVT  accounts  for  about  3-­‐‑15%  of  all  cases  
of  mesenteric   ischemia.  MVT  may   arise   due   to   other   conditions,   such   as  malignancy,   in-­‐‑
flammatory  bowel  disease,   trauma,  pancreatitis,  heritable  thrombophilia,  or  any  other  hy-­‐‑
percoagulable   state   (secondary  MVT).   In   about   20–50%   of   cases,   the   underlying   cause   is  
unknown  (primary  MVT).  In  acute  occlusion  of  the  SMV,  mild  intestinal  edema  may  grad-­‐‑
ually  develop   into   arterial   spasm  and   transmural   bowel   infarction  within  days   to  weeks.  
Subacute  form  of  MVT  develops  gradually  within  several  weeks  and  the  pain  is  often  less  
severe,   and   there  may   be   a   history   of   (bloody)   diarrhea.   In   chronic  MVT,   complications  
such  as  portal  hypertension  and  hypersplenism  may  develop  several  months  after  the  acute  
event   (21,28).  With   treatment   or   during   the   natural   course   of   the   disease,   the   SMV  may  
either  recanalize  or  obliterate.  
In  a  review  of  15  studies  performed  between  1922-­‐‑1999,  the  bowel  resection  rate  in  MVT  
ranged  from  8–100%,  but  most  commonly  the  rate  was  between  ⅓  to  ⅔,  and  the  mortality  
rate  varied  between  9–59%  (28).  Historically,  the  diagnosis  of  MVT  was  often  established  in  
laparotomy,  and  presumably,  many  cases  with  mild  self-­‐‑limited  disease  were  never  diag-­‐‑
nosed.   Today,   owing   to   liberal   use   of   CT   in   acute   abdominal   pain,   the   diagnosis   can   be  
established  earlier,  and  with  adequate  anticoagulation  treatment,  venous   intestinal   infarc-­‐‑
tion   may   be   avoided.   In   a   recent   retrospective   analysis   of   102   consecutive   cases   with  
portomesenteric  venous  thrombosis,  only  two  patients  required  bowel  resection  (29).  How-­‐‑
ever,   in   that   study,   patients   with   isolated   portal   vein   thrombosis   and   those   with   SMV  
thrombosis  were  not   analysed   separately,   and  ⅓  of  patients  had   chronic   thrombosis.  Ve-­‐‑
nous   mesenteric   ischemia   rarely   develops   unless   the   peripheral   veins   of   the   mesentery  




out  extension  of  the  thrombus  to  the  SMV  rarely  causes  bowel  infarction  (28).  The  Malmö  
autopsy  cohort  included  239  patients  with  isolated  portal  vein  thrombosis,  of  whom  none  
had   developed   intestinal   infarction,   while   29   out   of   31   autopsy   subjects   with  MVT   had  
bowel   necrosis   (30).   In   conclusion,  MVT   seems   to   carry   a   significant   risk   of   developing  
venous  mesenteric  ischemia,  while  isolated  portal  vein  thrombosis  does  not.  
2.2.2  Chronic  mesenteric  ischemia  
The  etiology  of  CMI   is  mesenteric  atherosclerosis   in   the  vast  majority  of   cases.  Other  un-­‐‑
common  etiologies  associated  with  CMI  are  fibromuscular  dysplasia,  Buerger'ʹs  disease,  and  
aortic  dissection.  Elderly  women  present   for   treatment  more  commonly  than  men  (24,31).  
The  classic  symptoms  of  "ʺabdominal  angina"ʺ  are  postprandial  abdominal  pain,  weight  loss,  
and  fear  of  eating;  this  triad  is  present  in  22-­‐‑50%  of  patients  with  CMI  (31,32).  However,  the  
pattern   of   the   symptoms   can   be   quite   variable;   the   pain   is   not   always   clearly   related   to  
eating,  some  patients  complain  of  diarrhea,  vomiting,  or  constipation,  and  not  all  patients  
lose  weight.   It   is  clear,   though,   that  CMI  patients  do  reduce   food   intake  significantly  and  
the  majority  of  patients  have  other   cardiovascular  diseases   (24,31).   In   the   study  of  55  pa-­‐‑
tients  with  symptomatic  mesenteric  atherosclerosis  referred  for  EVT,  pathologic  endoscopic  
findings   were   surprisingly   common,   found   in   73%   of   investigated   patients;   the   typical  
findings   were   right-­‐‑sided   colitis/ulcers,   duodenitis,   antral   gastritis,   and  Helicobater   pylori  
negative  duodenal/antral  ulcers/erosions  (23).  In  general,  CMI  poses  no  imminent  threat  to  
life,  but  the  disease  may  eventually  culminate  in  acute  ischemia  (i.e.  AOCMI).  
2.2.3  Ischemic  colitis  
Ischemic   colitis   can   be   divided   in   left-­‐‑sided   and   right-­‐‑sided   disease.   Left-­‐‑sided   ischemic  
colitis  usually  presents  with  abdominal  pain  and  bloody  diarrhea,  and  is  either  idiopathic  
or  associated  with  occlusion  of  the  IMA,  colonic  obstruction,  or  hypoperfusion  of  the  colon  
due  to,  for  example,  cardiac  diseases,  dehydration,  or  abdominal  aortic  surgery  (16,33,34).  
In  most   cases,   acute   isolated   left-­‐‑sided   ischemic   colitis   can  be   treated   conservatively,   and  
relief  of  symptoms  occur  within  days  to  weeks  (33,34).  However,  colon  gangrene,  stricture,  
and  other  complications  can  develop.  Up  to  20%  of  patients  with  ischemic  colitis  ultimately  
require  surgery,  in  which  case  the  mortality  rate  is  high,  almost  40%  (35).  
In  a  recent  single-­‐‑center  study  including  58  patients  with  acute  right-­‐‑sided  ischemic  coli-­‐‑
tis  who  required  urgent  surgery  but  had  no  feasible  option  for  vascular  intervention,  SMA  
atherosclerosis  was  found  in  more  than  half  (36).  Thus,  right-­‐‑sided  ischemic  colitis  is  often  
associated  with  SMA  obstruction,  and  mortality  and  the  severity  of   illness   is  significantly  
higher   than   in   the   left-­‐‑sided   disease.   Therefore,   many   authors   currently   recognize   that  
right-­‐‑sided  ischemic  colitis  should  be  considered  as  AMI  or  CMI,  depending  on  the  severity  
and  acuteness  of  the  disease,  and  treated  accordingly  (34,35).    
2.2.4  Other  etiologies  
There  are  a  variety  of  non-­‐‑atherosclerotic   causes  of  mesenteric  arterial  disease   such  as   fi-­‐‑
bromuscular  dysplasia,  neurofibromatosis,  aortic  coarctation,  and  numerous  different  vas-­‐‑
culitides,  but  those  are  all  extremely  rare  causes  of  AMI  (37,38).  For  example,  in  a  24-­‐‑year  
review  of  7  514  patients  evaluated  for  vasculitis   in   the  Mayo  Clinics,  only  120   (1.6%)  pre-­‐‑
sented  symptoms  of  mesenteric   ischemia,  and  mere  15  patients  underwent  open  or  endo-­‐‑
vascular  treatment  for  occlusive  mesenteric  vasculitis  (38).    
A  few  special  AMI-­‐‑related  conditions  are  covered  in  the  following  subsections.  
2.2.4.1  Aortic  dissection  
Occasionally,  intestinal  ischemia  develops  secondary  to  aortic  dissection.  The  treatment  of  
AMI  due   to   aortic   dissection  differs   essentially   from   the  management   of  AMI   caused   by  
other  etiologies,  and  therefore,  aortic  dissection  represents  its  own  distinct  etiological  cate-­‐‑




aortic  dissections  were  complicated  by  visceral  ischemia  in  3.7%  and  7.1%  of  cases,  respec-­‐‑
tively,  and  the  mortality  rates  respectively  were  63.2%  and  30.8%  with  AMI,  and  23.8%  and  
9.1%  without  AMI  (39,40).  
Mesenteric  ischemia  can  develop  during  the  course  of  acute  aortic  dissection  by  several  
mechanisms,  occlusive  and  non-­‐‑occlusive.  These  include  hypotension  due  to  tamponade  or  
bleeding,  diversion  of  the  flow  to  the  false  lumen,  coverage  of  the  ostium  of  the  mesenteric  
arteries  by   intimal   flap,  or  extension  of   the  dissection   to   the  mesenteric  arteries,   in  which  
case,  thrombosis  of  the  mesenteric  artery  may  occur.  The  treatment  options  for  mesenteric  
hypoperfusion  in  type  B  dissection  include  endovascular  stenting  of   the  descending  aorta  
(to  divert  blood  flow  to  the  true  lumen),  endovascular  or  open  surgical  fenestration  of  the  
intimal  flap,  and  direct  stenting  of  the  mesenteric  arteries  involved  (40).  Type  A  dissection  
requires  surgical  or  hybrid   treatment,  however,   the  prognosis  of   immediate  central  aortic  
repair  is  extremely  poor  in  patients  with  AMI.  Therefore,  the  alternative  strategy  is  to  try  to  
establish  bowel  perfusion  by  percutaneous   interventions,  whenever  possible,   followed  by  
surgical  aortic  repair  (41).  
2.2.4.2  Isolated  superior  mesenteric  artery  dissection  
Isolated   spontaneous   dissection   can   occur   in   any   visceral   artery,   most   frequently   in   the  
SMA.  The  natural   course   of   isolated   SMA  dissection   is   variable;   it   can  be   self-­‐‑limited,   or  
progress   to   thrombosis   of   the   false   lumen,   narrowing   or   obliteration   of   the   true   lumen,  
rupture   through   the  adventitia,  or   formation  of  aneurysm.  AMI   is  a   serious   complication  
due  to  occlusion  of  the  dissected  SMA.  Most  patients  present  with  sudden  onset  of  severe  
abdominal  or  back  pain,  which  is  caused  by  the  dissection  itself.  Another  type  of  abdominal  
pain  develops  later  if  the  disease  advances  to  intestinal  ischemia,  or  rupture  and  mesenteric  
hematoma.  The  diagnosis  is  usually  established  in  CT  (42).  
A   recent   review  of   cases   reported   in   the   literature   included   495   patients  with   isolated  
SMA  dissection,  of  whom  86%  were  male,  and  the  average  age  was  53  years  for  males  and  
59   years   for   females   (42).   Approximately   two-­‐‑thirds   were   treated  with  medical   therapy,  
which   failed   in  13%   (persistent   abdominal  pain,   evidence  of  bowel   ischemia,  or  develop-­‐‑
ment  of  aneurysm).  Careful  observation  and  medical  therapy  is  sufficient  in  asymptomatic  
cases,   although  every  patient   should  be   evaluated   individually.   SMA  stenosis   alone  does  
not   justify   invasive   treatment;   narrowing   of   the   true   lumen  may   improve   spontaneously  
after   the  acute   stage  of   the  dissection   (43).  The   role  of  anticoagulation   remains  uncertain,  
but  it  is  commonly  used  in  the  conservative  treatment.  Patients  with  persistent  abdominal  
pain  and  compromised  intestinal  perfusion  should  be  considered  for  endovascular  or  sur-­‐‑
gical  repair.  Endovascular  stenting  may  be  successful  in  focal  proximal  lesions,  while  direct  
surgical   intimectomy  with  patch  angioplasty,  or  bypass  grafting  may  be   the  only   feasible  
options  in  obstruction  of  a  long  arterial  segment  with  branches  (42,43).  The  same  treatment  
strategy  applies  to  isolated  celiac  artery  dissection  as  well  (44).  
2.2.4.3  Celiac  artery  compression  syndrome  
CA   compression   syndrome,   a.k.a.  median   arcuate   ligament   syndrome   (MALS),  was   first  
described   in   1963   by   Pekka-­‐‑Tapani  Harjola   (45).  MALS   is   a   rare   disorder   resulting   from  
compression   of   the   celiac   trunk   by   the   left   and   the   right   diaphragmatic   crura,   thus,   the  
median  arcuate  ligament,  crossing  anterior  to  the  aorta  (37).  Compression  of  the  CA  by  the  
median  arcuate  ligament  is  usually  a  mere  incidental  finding;  it  was  detected  in  21  patients  
in  a  retrospective  review  of  CT  scans  performed  in  744  patients.  Only  3  of  the  21  patients  
with  CA  compression  had  symptoms,  hence,  the  actual  syndrome  (46).    
The  symptoms  of  MALS  include  postprandial  abdominal  pain,  nausea,  vomiting,  weight  
loss,  bloating,  and  pain  triggered  by  exercise.  MALS  is  often  a  diagnosis  of  exclusion.  De-­‐‑
spite  many  theories,  the  pathophysiology  of  MALS  remains  unknown.  Intermittent  foregut  
ischemia  may  play   a  part.   This   assumption  was   supported  by   a   study  of   gastric   exercise  




tion  of  maximal   gradient   between  gastric   and   arterial   blood  pCO2   levels   in  patients  who  
were  free  of  complaints  after  the  treatment  (47).  Other  theories  consider  the  role  of  ganglion  
nerve  involvement  in  the  pain  syndrome;  temporary  celiac  ganglion  block  often  improves  
symptoms   in  MALS,  and  therefore,  may  also  help   to   identify  patients  who  would  benefit  
from  surgical  treatment  (37).  The  surgical  treatment  options  are  celiac  axis  decompression  
(open   or   laparoscopic)  with   subsequent   endovascular   stenting   of   residual   stenosis   of   the  
CA  when  necessary  (48,49),  or  celiac  decompression  and  reconstruction  by  primary  reanas-­‐‑
tomosis  or  interposition  bypass  grafting  (50).  
CA  compression  alone  is  unlikely  to  cause  AMI.  However,  if  compression  of  the  CA  by  
the  median  arcuate  ligament  contributes  to  the  development  of  acute  intestinal  ischemia,  it  
is  essential  to  recognize  that  purely  endovascular  treatment  without  prior  decompression  of  
the  CA  will  lead  to  stent  compression  or  fracture,  and  therefore,  is  not  recommended  (51).  
2.2.4.4  Cardiac  surgery  
In  a  recent  review  of  acute  intestinal  ischemia  after  cardiac  surgery,  the  researchers  report-­‐‑
ed  0.3%  prevalence  of  AMI  after  nearly  174  000  cardiac  operations  based  on  18  publications  
between  years  1987-­‐‑2012  (52).  Thus,  AMI  is  a  rare  complication  of  cardiac  surgery.  Howev-­‐‑
er,   underdiagnosis  may   occur;  NOMI,   determined   by   angiography   and   clinical   findings,  
was   detected   in   9%   of   865   consecutive   patients   undergoing   elective   cardiac   surgery   in   a  
prospective   study   (53).  Major   risk   factors   for  AMI  after   cardiac  operations   are  prolonged  
cardiopulmonary  bypass,  prolonged  mechanical  ventilation,  intra-­‐‑aortic  balloon  pump,  use  
of  vasopressors  and  inotropes,  peripheral  arterial  disease,  and  old  age.  The  cause  of  AMI  is  
usually  non-­‐‑occlusive  hypoperfusion   and  mesenteric   vasoconstriction,   and   the  diagnostic  
and  treatment  options  are  basically  the  same  as  in  other  NOMI  situations.  However,  those  
options  are  limited  by  the  patient’s  critical  condition  in  the  postoperative  setting.  The  diag-­‐‑
nosis  is  often  delayed,  and  the  prognosis  is  poor;  the  in-­‐‑hospital  mortality  averages  around  
75%  (range  50–100%)  (52).  
2.2.4.5  Aortoiliac  surgery  
The  estimated  incidence  of  transmural  bowel  necrosis  after  aortoiliac  surgery  was  2.8%  in  a  
study  of  2930  aortoiliac  operations  recorded  in  The  Swedish  Vascular  Registry  (Swedvasc)  
(54).  Among  412  patients  operated  for  RAAA,  the  incidence  of  bowel  gangrene  was  7.3%.  
The  ischemic  lesion  was  in  the  left  colon  in  95%  of  all  cases.  The  following  independent  risk  
factors   for   intestinal   ischemia  after  aortoiliac  surgery  were   identified:  preoperative  shock,  
emergency   surgery,   type  of   the  hospital,   renal   insufficiency,   age,   aortobifemoral  grafting,  
ligation  of   the  hypogastric   arteries,   cross-­‐‑clamping   time,   and  operating   time   (55).   IMA   is  
often  diseased  or  ligated  during  aortoiliac  surgery  making  the  left  colon  prone  to  ischemic  
injury.  
Abdominal  pain  and  early  passage  of  bloody  stools  (within  24  hours  after  the  operation)  
are  considered  the  classical  symptoms  of  colon  ischemia  after  aortoiliac  surgery.  However,  
the  clinical  presentation  is  often  obscure.  In  the  Swedvasc  study,  merely  12%  had  peritonitis  
or  intensive  abdominal  pain,  and  only  a  quarter  of  the  patients  presented  with  early  bloody  
stools  (54).  Sometimes,  the  only  signs  are  unexplained  hemodynamic  instability  and  oligu-­‐‑
ria.  The  diagnosis  is  made  in  sigmoidoscopy  or  ultimately  in  relaparotomy.  
2.2.4.6  Abdominal  compartment  syndrome  
It  has  been   suggested   that   abdominal   compartment   syndrome  may  be   the  most   common  
cause   of   intestinal   hypoperfusion   in  modern  medicine   (26).   In   two  prospective   studies,   a  
third  of   all   patients   treated   in  mixed   (surgical   and  non-­‐‑surgical)   intensive   care  units  had  
intra-­‐‑abdominal  hypertension,  defined  as   intra-­‐‑abdominal  pressure  >12  mmHg  (56,57).   In  
one  of  the  two  studies,  11  (13%)  out  of  96  patients  with  intra-­‐‑abdominal  hypertension  had  
abdominal   compartment   syndrome,  defined  as   intra-­‐‑abdominal  pressure  >25  mmHg  plus  




aortic  dissections  were  complicated  by  visceral  ischemia  in  3.7%  and  7.1%  of  cases,  respec-­‐‑
tively,  and  the  mortality  rates  respectively  were  63.2%  and  30.8%  with  AMI,  and  23.8%  and  
9.1%  without  AMI  (39,40).  
Mesenteric  ischemia  can  develop  during  the  course  of  acute  aortic  dissection  by  several  
mechanisms,  occlusive  and  non-­‐‑occlusive.  These  include  hypotension  due  to  tamponade  or  
bleeding,  diversion  of  the  flow  to  the  false  lumen,  coverage  of  the  ostium  of  the  mesenteric  
arteries  by   intimal   flap,  or  extension  of   the  dissection   to   the  mesenteric  arteries,   in  which  
case,  thrombosis  of  the  mesenteric  artery  may  occur.  The  treatment  options  for  mesenteric  
hypoperfusion  in  type  B  dissection  include  endovascular  stenting  of   the  descending  aorta  
(to  divert  blood  flow  to  the  true  lumen),  endovascular  or  open  surgical  fenestration  of  the  
intimal  flap,  and  direct  stenting  of  the  mesenteric  arteries  involved  (40).  Type  A  dissection  
requires  surgical  or  hybrid   treatment,  however,   the  prognosis  of   immediate  central  aortic  
repair  is  extremely  poor  in  patients  with  AMI.  Therefore,  the  alternative  strategy  is  to  try  to  
establish  bowel  perfusion  by  percutaneous   interventions,  whenever  possible,   followed  by  
surgical  aortic  repair  (41).  
2.2.4.2  Isolated  superior  mesenteric  artery  dissection  
Isolated   spontaneous   dissection   can   occur   in   any   visceral   artery,   most   frequently   in   the  
SMA.  The  natural   course   of   isolated   SMA  dissection   is   variable;   it   can  be   self-­‐‑limited,   or  
progress   to   thrombosis   of   the   false   lumen,   narrowing   or   obliteration   of   the   true   lumen,  
rupture   through   the  adventitia,  or   formation  of  aneurysm.  AMI   is  a   serious   complication  
due  to  occlusion  of  the  dissected  SMA.  Most  patients  present  with  sudden  onset  of  severe  
abdominal  or  back  pain,  which  is  caused  by  the  dissection  itself.  Another  type  of  abdominal  
pain  develops  later  if  the  disease  advances  to  intestinal  ischemia,  or  rupture  and  mesenteric  
hematoma.  The  diagnosis  is  usually  established  in  CT  (42).  
A   recent   review  of   cases   reported   in   the   literature   included   495   patients  with   isolated  
SMA  dissection,  of  whom  86%  were  male,  and  the  average  age  was  53  years  for  males  and  
59   years   for   females   (42).   Approximately   two-­‐‑thirds   were   treated  with  medical   therapy,  
which   failed   in  13%   (persistent   abdominal  pain,   evidence  of  bowel   ischemia,  or  develop-­‐‑
ment  of  aneurysm).  Careful  observation  and  medical  therapy  is  sufficient  in  asymptomatic  
cases,   although  every  patient   should  be   evaluated   individually.   SMA  stenosis   alone  does  
not   justify   invasive   treatment;   narrowing   of   the   true   lumen  may   improve   spontaneously  
after   the  acute   stage  of   the  dissection   (43).  The   role  of  anticoagulation   remains  uncertain,  
but  it  is  commonly  used  in  the  conservative  treatment.  Patients  with  persistent  abdominal  
pain  and  compromised  intestinal  perfusion  should  be  considered  for  endovascular  or  sur-­‐‑
gical  repair.  Endovascular  stenting  may  be  successful  in  focal  proximal  lesions,  while  direct  
surgical   intimectomy  with  patch  angioplasty,  or  bypass  grafting  may  be   the  only   feasible  
options  in  obstruction  of  a  long  arterial  segment  with  branches  (42,43).  The  same  treatment  
strategy  applies  to  isolated  celiac  artery  dissection  as  well  (44).  
2.2.4.3  Celiac  artery  compression  syndrome  
CA   compression   syndrome,   a.k.a.  median   arcuate   ligament   syndrome   (MALS),  was   first  
described   in   1963   by   Pekka-­‐‑Tapani  Harjola   (45).  MALS   is   a   rare   disorder   resulting   from  
compression   of   the   celiac   trunk   by   the   left   and   the   right   diaphragmatic   crura,   thus,   the  
median  arcuate  ligament,  crossing  anterior  to  the  aorta  (37).  Compression  of  the  CA  by  the  
median  arcuate  ligament  is  usually  a  mere  incidental  finding;  it  was  detected  in  21  patients  
in  a  retrospective  review  of  CT  scans  performed  in  744  patients.  Only  3  of  the  21  patients  
with  CA  compression  had  symptoms,  hence,  the  actual  syndrome  (46).    
The  symptoms  of  MALS  include  postprandial  abdominal  pain,  nausea,  vomiting,  weight  
loss,  bloating,  and  pain  triggered  by  exercise.  MALS  is  often  a  diagnosis  of  exclusion.  De-­‐‑
spite  many  theories,  the  pathophysiology  of  MALS  remains  unknown.  Intermittent  foregut  
ischemia  may  play   a  part.   This   assumption  was   supported  by   a   study  of   gastric   exercise  




tion  of  maximal   gradient   between  gastric   and   arterial   blood  pCO2   levels   in  patients  who  
were  free  of  complaints  after  the  treatment  (47).  Other  theories  consider  the  role  of  ganglion  
nerve  involvement  in  the  pain  syndrome;  temporary  celiac  ganglion  block  often  improves  
symptoms   in  MALS,  and  therefore,  may  also  help   to   identify  patients  who  would  benefit  
from  surgical  treatment  (37).  The  surgical  treatment  options  are  celiac  axis  decompression  
(open   or   laparoscopic)  with   subsequent   endovascular   stenting   of   residual   stenosis   of   the  
CA  when  necessary  (48,49),  or  celiac  decompression  and  reconstruction  by  primary  reanas-­‐‑
tomosis  or  interposition  bypass  grafting  (50).  
CA  compression  alone  is  unlikely  to  cause  AMI.  However,  if  compression  of  the  CA  by  
the  median  arcuate  ligament  contributes  to  the  development  of  acute  intestinal  ischemia,  it  
is  essential  to  recognize  that  purely  endovascular  treatment  without  prior  decompression  of  
the  CA  will  lead  to  stent  compression  or  fracture,  and  therefore,  is  not  recommended  (51).  
2.2.4.4  Cardiac  surgery  
In  a  recent  review  of  acute  intestinal  ischemia  after  cardiac  surgery,  the  researchers  report-­‐‑
ed  0.3%  prevalence  of  AMI  after  nearly  174  000  cardiac  operations  based  on  18  publications  
between  years  1987-­‐‑2012  (52).  Thus,  AMI  is  a  rare  complication  of  cardiac  surgery.  Howev-­‐‑
er,   underdiagnosis  may   occur;  NOMI,   determined   by   angiography   and   clinical   findings,  
was   detected   in   9%   of   865   consecutive   patients   undergoing   elective   cardiac   surgery   in   a  
prospective   study   (53).  Major   risk   factors   for  AMI  after   cardiac  operations   are  prolonged  
cardiopulmonary  bypass,  prolonged  mechanical  ventilation,  intra-­‐‑aortic  balloon  pump,  use  
of  vasopressors  and  inotropes,  peripheral  arterial  disease,  and  old  age.  The  cause  of  AMI  is  
usually  non-­‐‑occlusive  hypoperfusion   and  mesenteric   vasoconstriction,   and   the  diagnostic  
and  treatment  options  are  basically  the  same  as  in  other  NOMI  situations.  However,  those  
options  are  limited  by  the  patient’s  critical  condition  in  the  postoperative  setting.  The  diag-­‐‑
nosis  is  often  delayed,  and  the  prognosis  is  poor;  the  in-­‐‑hospital  mortality  averages  around  
75%  (range  50–100%)  (52).  
2.2.4.5  Aortoiliac  surgery  
The  estimated  incidence  of  transmural  bowel  necrosis  after  aortoiliac  surgery  was  2.8%  in  a  
study  of  2930  aortoiliac  operations  recorded  in  The  Swedish  Vascular  Registry  (Swedvasc)  
(54).  Among  412  patients  operated  for  RAAA,  the  incidence  of  bowel  gangrene  was  7.3%.  
The  ischemic  lesion  was  in  the  left  colon  in  95%  of  all  cases.  The  following  independent  risk  
factors   for   intestinal   ischemia  after  aortoiliac  surgery  were   identified:  preoperative  shock,  
emergency   surgery,   type  of   the  hospital,   renal   insufficiency,   age,   aortobifemoral  grafting,  
ligation  of   the  hypogastric   arteries,   cross-­‐‑clamping   time,   and  operating   time   (55).   IMA   is  
often  diseased  or  ligated  during  aortoiliac  surgery  making  the  left  colon  prone  to  ischemic  
injury.  
Abdominal  pain  and  early  passage  of  bloody  stools  (within  24  hours  after  the  operation)  
are  considered  the  classical  symptoms  of  colon  ischemia  after  aortoiliac  surgery.  However,  
the  clinical  presentation  is  often  obscure.  In  the  Swedvasc  study,  merely  12%  had  peritonitis  
or  intensive  abdominal  pain,  and  only  a  quarter  of  the  patients  presented  with  early  bloody  
stools  (54).  Sometimes,  the  only  signs  are  unexplained  hemodynamic  instability  and  oligu-­‐‑
ria.  The  diagnosis  is  made  in  sigmoidoscopy  or  ultimately  in  relaparotomy.  
2.2.4.6  Abdominal  compartment  syndrome  
It  has  been   suggested   that   abdominal   compartment   syndrome  may  be   the  most   common  
cause   of   intestinal   hypoperfusion   in  modern  medicine   (26).   In   two  prospective   studies,   a  
third  of   all   patients   treated   in  mixed   (surgical   and  non-­‐‑surgical)   intensive   care  units  had  
intra-­‐‑abdominal  hypertension,  defined  as   intra-­‐‑abdominal  pressure  >12  mmHg  (56,57).   In  
one  of  the  two  studies,  11  (13%)  out  of  96  patients  with  intra-­‐‑abdominal  hypertension  had  
abdominal   compartment   syndrome,  defined  as   intra-­‐‑abdominal  pressure  >25  mmHg  plus  




Patients  with  major  bleeding,  especially  those  with  RAAA,  are  at  risk  of  developing  ab-­‐‑
dominal   compartment   syndrome.   The   association   between   abdominal   compartment   syn-­‐‑
drome  and  colonic  ischemia  after  RAAA  repair  is  well-­‐‑known,  and  increase  in  the  survival  
has   been  demonstrated   if   the   hypoperfusion   syndrome   can   be   reversed   early   (58).  Other  
common   risk   factors   for   abdominal   compartment   syndrome   include   abdominal   surgery,  
major  trauma  or  burn,   intestinal  obstruction  or  paralysis,  severe  acute  pancreatitis,  sepsis,  
and  massive  fluid  resuscitation  (59).  
Intra-­‐‑abdominal  pressure  can  be  reduced  with  epidural  analgesia  in  patients  with  pain-­‐‑
ful  and  distended  abdomen,  or  with  sufficient  muscle  relaxation  in  patients  receiving  me-­‐‑
chanical   ventilation.   When   abdominal   compartment   syndrome   develops   despite   of   the  
conservative   treatment,   decompression   laparotomy   is   necessary.   However,   the   surgeon  
should  not  solely  rely  on   intra-­‐‑abdominal  pressure   in   the  decision  making,  and  the   intra-­‐‑
abdominal  pressure  measurement  itself  is  an  elaborate  maneuver  with  many  possible  con-­‐‑
founding   elements   (60).   The   contemporary   open   abdomen   management   is   resource   de-­‐‑
manding  but  relatively  straightforward  with  the  use  of  negative  pressure  therapy  and  pol-­‐‑





2.3.1  Asymptomatic  mesenteric  atherosclerosis  
It  is  commonly  acknowledged,  that  an  incidental  finding  of  mesenteric  artery  stenosis  is  far  
more  common  than  symptomatic  AMI  or  CMI.  However,  there  are  only  little  contemporary  
population   based   data   on   the   prevalence   of   significant   mesenteric   atherosclerosis   in   the  
population.   Twenty   years   ago,   Otso   Järvinen   and   associates   examined   the   occurrence   of  
mesenteric   atherosclerosis   in   an  unselected  Finnish  autopsy   series  of   120  patients   (61).   In  
subjects  aged  80  years  or  more,  mesenteric  artery  stenosis  was  found  in  67%,  whereas  the  
corresponding  rate  was  only  6%  among   those   less   than  40  years  of  age.  Only  one  patient  
had   bowel   necrosis   at   autopsy.   Using   duplex   ultrasound,   another   study   demonstrated  
occlusion  or  significant  (>70%)  stenosis  of  the  CA  or  SMA  in  18%  of  asymptomatic  patients  
aged  65  years  or  more,  and  in  3%  of  patients  less  than  65  years  old  (62).  More  than  half  of  
the  patients  in  both  studies  had  a  single-­‐‑vessel  disease,  which  was  more  common  in  the  CA  
than  in  the  SMA  (61,62).    
Furthermore,  a  Korean  study  of   celiac  arteriographies  and  CTs  performed   in  400  cases  
(mean   age   57   years,   range   17-­‐‑85)   referred   for   chemoembolization   of   hepatic   tumors   sug-­‐‑
gested  a  7%  prevalence  of  hemodynamically  significant  CA  stenosis  in  patients  defined  as  
asymptomatic   (63).  The  etiology  of   the  CA  stenosis  was  determined  as  extrinsic  compres-­‐‑
sion  due  to  the  median  arcuate  ligament  in  55%,  atherosclerosis  in  10%,  and  indeterminate  
in  35%.  A  recent  retrospective  analysis  of  preoperative  CT  studies  performed  in  242  Dutch  
patients   (median   age   65   years)   undergoing   colorectal   surgery   demonstrated   occlusion   or  
≥50%  stenosis  of  the  SMA  in  3%,  CA  in  21%,  and  IMA  in  25%  (64).  
There  are  two  studies  that  examined  the  clinical  course  of  asymptomatic  mesenteric  ar-­‐‑
tery  stenosis.  In  a  cohort  of  553  free-­‐‑living  elderly  patients  in  the  United  States,  97  (17.5%)  
had  obstruction  of  the  CA  or  SMA  in  duplex  ultrasound.  During  a  mean  follow-­‐‑up  of  6½  
years,  none  developed  CMI  or  AMI  (65).  In  another  study  of  aortograms  performed  in  980  
consecutive  patients,  82  (8.4%)  had  at  least  50%  stenosis  in  one  mesenteric  artery  (13).  Ten  
patients  were   lost   to   follow-­‐‑up,   and   twelve  were  not   included   in   the   analysis   because   of  
uncertain  hemodynamic   significance  of   the  disease.  The   remaining  60  patients   (mean  age  
67.5  years)  were  followed  for  1  to  6  years  (mean  2.6  years)  during  which  40%  died,  and  four  
(6%)  developed  primary  mesenteric  ischemia;  one  patient  died  of  AMI  and  three  developed  
symptoms  of  CMI.  Thirteen  (86%)  of  15  patients  with  significant  three-­‐‑vessel  disease  in  that  




In  conclusion,  based  on  the  available  historical  and  contemporary  data,  the  prevalence  of  
asymptomatic  mesenteric  artery  stenosis  ranges  between  6–29%  in  the  general  population  
and  increases  (exponentially)  with  age  (66).  The  natural  course  of  the  disease  rarely  culmi-­‐‑
nates   in  AMI,   although   patients  with   significant   disease   of   all   three  main   arteries   are   at  
considerable   risk.   In   a   single-­‐‑vessel   mesenteric   artery   obstruction,   the   CA   is   more   often  
affected  than  the  SMA.  Especially  in  younger  patients,  the  etiology  of  CA  stenosis  is  more  
often   external   compression   caused   by   the   median   arcuate   ligament   than   atherosclerosis  
(67).  
2.3.2  Acute  mesenteric  ischemia  
There  are  not  many  prior  studies  that  provide  data  on  the  epidemiology  of  AMI.  The  rele-­‐‑
vant  earlier  studies  have  been  performed  in  Sweden.  Based  on  the  Malmö  autopsy  study,  
the   incidence  of  AMI  caused  by   thromboembolic  occlusion  of   the  SMA  (diagnosed   in  au-­‐‑
topsy   or   laparotomy)   was   8.6/100  000/year   and   12.6/100  000/year   for   all   AMI   etiologies  
(2,17).  The  age-­‐‑specific   incidence  of  AMI   increased  exponentially  with  age.  The   incidence  
rate   of   fatal  NOMI  has   been   given   as   2.0/100  000  person   years   by   the   same   investigators  
(27).  The   incidence  rate  of  MVT  with   intestinal  necrosis  has  been  estimated  at  1.8/100  000  
person  years  (68).  In  addition,  two  contemporary  Swedish  studies  reported  incidence  rates  
of  5.3–5.4/100  000  person  years  for  patients  that  were  treated  for  acute  occlusion  of  the  SMA  
(69,70).    
Yet  another  Swedish  study  of  CT  performed  for  acute  abdominal  pain   in  2222  patients  
showed  the  distribution  of  diagnoses  as  follows:  nonspecific  abdominal  pain  (44%),  appen-­‐‑
dicitis   (16%),  bowel  obstruction   (9%),  diverticulitis   (8%),  gastrointestinal  perforation   (3%),  
gallstone  disease  (3%),  pancreatitis  (3%),  and  RAAA  (0.5%);  only  five  patients  (0.2%)  with  
acute  abdomen  ultimately  had  AMI  (71).  In  Finland,  mesenteric  ischemia  constituted  1%  of  
emergency  operations  in  a  three-­‐‑year  survey  performed  in  one  central  hospital  (72).  
A  few  studies  on  AMI  have  taken  advantage  of  an  administrative  database  called  the  Na-­‐‑
tional   Inpatient   Sample.   It   represents   a   20%   sample   of   hospitals   (or   hospital   discharges)  
containing  data  from  more  than  7  million  hospital  stays  and  yielding  weighted  estimates  of  
more  than  36  million  hospitalizations  each  year  in  the  United  States.  The  database  is  useful  
in   estimating   current   trends   in   rare  diseases.   Based   on   this   database,   hospitalizations   for  
AMI  declined  from  8.4  to  6.7/100  000/year  between  the  years  1995–2010.  However,  during  
this  period,  the  annual  number  of  endovascular  procedures  for  AMI  have  been  increasing  
from   roughly   0.1   to   0.2   per   100  000   persons;   the   rate   of   open   revascularizations   for  AMI  
have  stayed  unchanged  at  approximately  0.2/100  000/year  (73).  
2.3.3  Chronic  mesenteric  ischemia  
AMI   is   the  most   common   presentation   of   symptomatic  mesenteric   ischemia.   There   is   no  
data  on  the  incidence  of  CMI  (66).  This  is  mainly  due  to  the  lack  of  specific  symptoms  and  
definitive  diagnostic   tests.  Even   so,   according   to   the  National   Inpatient   Sample  database,  
the   hospitalization   rate   for   CMI   has   been   steadily   around   2.0/100  000/year   in   the  United  
States  (73).  
2.3.4  Ischemic  colitis  
Determining  the  true  incidence  of  ischemic  colitis  is  difficult,  because  the  diagnosis  is  often  
missed  and   the  disease  usually  heals  spontaneously.  Furthermore,   in  clinical  practice,   the  
diagnostic  criteria  of  ischemic  colitis  are  likely  to  vary,  and  a  prudent  clinician  will  wait  for  
the   histological   confirmation   before  making   the  diagnosis.   Therefore,   the   incidence   of   is-­‐‑
chemic  colitis   in  general  population  ranges  widely  from  4.5   to  44  cases   /100  000/year  (74).  
The   risk  of   ischemic  colitis   is   increased   in   females,   in  patients  aged  ≥65  years,  and   in  pa-­‐‑
tients  with  irritable  bowel  syndrome  or  chronic  obstructive  pulmonary  disease.  
In   a   recent   retrospective   population-­‐‑based   case-­‐‑control   study,   the   incidence   rate   of   is-­‐‑




Patients  with  major  bleeding,  especially  those  with  RAAA,  are  at  risk  of  developing  ab-­‐‑
dominal   compartment   syndrome.   The   association   between   abdominal   compartment   syn-­‐‑
drome  and  colonic  ischemia  after  RAAA  repair  is  well-­‐‑known,  and  increase  in  the  survival  
has   been  demonstrated   if   the   hypoperfusion   syndrome   can   be   reversed   early   (58).  Other  
common   risk   factors   for   abdominal   compartment   syndrome   include   abdominal   surgery,  
major  trauma  or  burn,   intestinal  obstruction  or  paralysis,  severe  acute  pancreatitis,  sepsis,  
and  massive  fluid  resuscitation  (59).  
Intra-­‐‑abdominal  pressure  can  be  reduced  with  epidural  analgesia  in  patients  with  pain-­‐‑
ful  and  distended  abdomen,  or  with  sufficient  muscle  relaxation  in  patients  receiving  me-­‐‑
chanical   ventilation.   When   abdominal   compartment   syndrome   develops   despite   of   the  
conservative   treatment,   decompression   laparotomy   is   necessary.   However,   the   surgeon  
should  not  solely  rely  on   intra-­‐‑abdominal  pressure   in   the  decision  making,  and  the   intra-­‐‑
abdominal  pressure  measurement  itself  is  an  elaborate  maneuver  with  many  possible  con-­‐‑
founding   elements   (60).   The   contemporary   open   abdomen   management   is   resource   de-­‐‑
manding  but  relatively  straightforward  with  the  use  of  negative  pressure  therapy  and  pol-­‐‑





2.3.1  Asymptomatic  mesenteric  atherosclerosis  
It  is  commonly  acknowledged,  that  an  incidental  finding  of  mesenteric  artery  stenosis  is  far  
more  common  than  symptomatic  AMI  or  CMI.  However,  there  are  only  little  contemporary  
population   based   data   on   the   prevalence   of   significant   mesenteric   atherosclerosis   in   the  
population.   Twenty   years   ago,   Otso   Järvinen   and   associates   examined   the   occurrence   of  
mesenteric   atherosclerosis   in   an  unselected  Finnish  autopsy   series  of   120  patients   (61).   In  
subjects  aged  80  years  or  more,  mesenteric  artery  stenosis  was  found  in  67%,  whereas  the  
corresponding  rate  was  only  6%  among   those   less   than  40  years  of  age.  Only  one  patient  
had   bowel   necrosis   at   autopsy.   Using   duplex   ultrasound,   another   study   demonstrated  
occlusion  or  significant  (>70%)  stenosis  of  the  CA  or  SMA  in  18%  of  asymptomatic  patients  
aged  65  years  or  more,  and  in  3%  of  patients  less  than  65  years  old  (62).  More  than  half  of  
the  patients  in  both  studies  had  a  single-­‐‑vessel  disease,  which  was  more  common  in  the  CA  
than  in  the  SMA  (61,62).    
Furthermore,  a  Korean  study  of   celiac  arteriographies  and  CTs  performed   in  400  cases  
(mean   age   57   years,   range   17-­‐‑85)   referred   for   chemoembolization   of   hepatic   tumors   sug-­‐‑
gested  a  7%  prevalence  of  hemodynamically  significant  CA  stenosis  in  patients  defined  as  
asymptomatic   (63).  The  etiology  of   the  CA  stenosis  was  determined  as  extrinsic  compres-­‐‑
sion  due  to  the  median  arcuate  ligament  in  55%,  atherosclerosis  in  10%,  and  indeterminate  
in  35%.  A  recent  retrospective  analysis  of  preoperative  CT  studies  performed  in  242  Dutch  
patients   (median   age   65   years)   undergoing   colorectal   surgery   demonstrated   occlusion   or  
≥50%  stenosis  of  the  SMA  in  3%,  CA  in  21%,  and  IMA  in  25%  (64).  
There  are  two  studies  that  examined  the  clinical  course  of  asymptomatic  mesenteric  ar-­‐‑
tery  stenosis.  In  a  cohort  of  553  free-­‐‑living  elderly  patients  in  the  United  States,  97  (17.5%)  
had  obstruction  of  the  CA  or  SMA  in  duplex  ultrasound.  During  a  mean  follow-­‐‑up  of  6½  
years,  none  developed  CMI  or  AMI  (65).  In  another  study  of  aortograms  performed  in  980  
consecutive  patients,  82  (8.4%)  had  at  least  50%  stenosis  in  one  mesenteric  artery  (13).  Ten  
patients  were   lost   to   follow-­‐‑up,   and   twelve  were  not   included   in   the   analysis   because   of  
uncertain  hemodynamic   significance  of   the  disease.  The   remaining  60  patients   (mean  age  
67.5  years)  were  followed  for  1  to  6  years  (mean  2.6  years)  during  which  40%  died,  and  four  
(6%)  developed  primary  mesenteric  ischemia;  one  patient  died  of  AMI  and  three  developed  
symptoms  of  CMI.  Thirteen  (86%)  of  15  patients  with  significant  three-­‐‑vessel  disease  in  that  




In  conclusion,  based  on  the  available  historical  and  contemporary  data,  the  prevalence  of  
asymptomatic  mesenteric  artery  stenosis  ranges  between  6–29%  in  the  general  population  
and  increases  (exponentially)  with  age  (66).  The  natural  course  of  the  disease  rarely  culmi-­‐‑
nates   in  AMI,   although   patients  with   significant   disease   of   all   three  main   arteries   are   at  
considerable   risk.   In   a   single-­‐‑vessel   mesenteric   artery   obstruction,   the   CA   is   more   often  
affected  than  the  SMA.  Especially  in  younger  patients,  the  etiology  of  CA  stenosis  is  more  
often   external   compression   caused   by   the   median   arcuate   ligament   than   atherosclerosis  
(67).  
2.3.2  Acute  mesenteric  ischemia  
There  are  not  many  prior  studies  that  provide  data  on  the  epidemiology  of  AMI.  The  rele-­‐‑
vant  earlier  studies  have  been  performed  in  Sweden.  Based  on  the  Malmö  autopsy  study,  
the   incidence  of  AMI  caused  by   thromboembolic  occlusion  of   the  SMA  (diagnosed   in  au-­‐‑
topsy   or   laparotomy)   was   8.6/100  000/year   and   12.6/100  000/year   for   all   AMI   etiologies  
(2,17).  The  age-­‐‑specific   incidence  of  AMI   increased  exponentially  with  age.  The   incidence  
rate   of   fatal  NOMI  has   been   given   as   2.0/100  000  person   years   by   the   same   investigators  
(27).  The   incidence  rate  of  MVT  with   intestinal  necrosis  has  been  estimated  at  1.8/100  000  
person  years  (68).  In  addition,  two  contemporary  Swedish  studies  reported  incidence  rates  
of  5.3–5.4/100  000  person  years  for  patients  that  were  treated  for  acute  occlusion  of  the  SMA  
(69,70).    
Yet  another  Swedish  study  of  CT  performed  for  acute  abdominal  pain   in  2222  patients  
showed  the  distribution  of  diagnoses  as  follows:  nonspecific  abdominal  pain  (44%),  appen-­‐‑
dicitis   (16%),  bowel  obstruction   (9%),  diverticulitis   (8%),  gastrointestinal  perforation   (3%),  
gallstone  disease  (3%),  pancreatitis  (3%),  and  RAAA  (0.5%);  only  five  patients  (0.2%)  with  
acute  abdomen  ultimately  had  AMI  (71).  In  Finland,  mesenteric  ischemia  constituted  1%  of  
emergency  operations  in  a  three-­‐‑year  survey  performed  in  one  central  hospital  (72).  
A  few  studies  on  AMI  have  taken  advantage  of  an  administrative  database  called  the  Na-­‐‑
tional   Inpatient   Sample.   It   represents   a   20%   sample   of   hospitals   (or   hospital   discharges)  
containing  data  from  more  than  7  million  hospital  stays  and  yielding  weighted  estimates  of  
more  than  36  million  hospitalizations  each  year  in  the  United  States.  The  database  is  useful  
in   estimating   current   trends   in   rare  diseases.   Based   on   this   database,   hospitalizations   for  
AMI  declined  from  8.4  to  6.7/100  000/year  between  the  years  1995–2010.  However,  during  
this  period,  the  annual  number  of  endovascular  procedures  for  AMI  have  been  increasing  
from   roughly   0.1   to   0.2   per   100  000   persons;   the   rate   of   open   revascularizations   for  AMI  
have  stayed  unchanged  at  approximately  0.2/100  000/year  (73).  
2.3.3  Chronic  mesenteric  ischemia  
AMI   is   the  most   common   presentation   of   symptomatic  mesenteric   ischemia.   There   is   no  
data  on  the  incidence  of  CMI  (66).  This  is  mainly  due  to  the  lack  of  specific  symptoms  and  
definitive  diagnostic   tests.  Even   so,   according   to   the  National   Inpatient   Sample  database,  
the   hospitalization   rate   for   CMI   has   been   steadily   around   2.0/100  000/year   in   the  United  
States  (73).  
2.3.4  Ischemic  colitis  
Determining  the  true  incidence  of  ischemic  colitis  is  difficult,  because  the  diagnosis  is  often  
missed  and   the  disease  usually  heals  spontaneously.  Furthermore,   in  clinical  practice,   the  
diagnostic  criteria  of  ischemic  colitis  are  likely  to  vary,  and  a  prudent  clinician  will  wait  for  
the   histological   confirmation   before  making   the  diagnosis.   Therefore,   the   incidence   of   is-­‐‑
chemic  colitis   in  general  population  ranges  widely  from  4.5   to  44  cases   /100  000/year  (74).  
The   risk  of   ischemic  colitis   is   increased   in   females,   in  patients  aged  ≥65  years,  and   in  pa-­‐‑
tients  with  irritable  bowel  syndrome  or  chronic  obstructive  pulmonary  disease.  
In   a   recent   retrospective   population-­‐‑based   case-­‐‑control   study,   the   incidence   rate   of   is-­‐‑




2009  (75).  The  odds  for  ischemic  colitis  were  significantly  higher  in  patients  with  atheroscle-­‐‑
rotic  vascular  disease.  Right-­‐‑sided   ischemic   colitis   and  concomitant   ischemia  of   the   small  





2.4.1  Clinical  evaluation  
As  discussed  previously,  the  clinical  presentation  of  AMI  varies  from  abrupt  onset  of  severe  
abdominal  pain  to  slowly  progressing  subacute  disease  depending  on  the  etiology  (occlu-­‐‑
sive  versus  non-­‐‑occlusive,  arterial  versus  venous)  and  the  pattern  of  the  arterial  obstruction  
(acute  thromboembolism  versus  chronic  arterial  obstruction).  In  some  patients,  the  clinical  
signs  and  symptoms  are  very  subtle  and  obscure  in  the  early  stage  of   ischemia.  The  most  
common  co-­‐‑morbidities,  and  clinical  symptoms  and  signs  according   to  a  meta-­‐‑analysis  of  
23  studies  with  1  970  patients  with  AMI  are  presented  in  Table  2  (76).  
Establishing  the  diagnosis  of  AMI  requires  high  index  of  suspicion  and  knowledge  of  the  
limitations  of  the  diagnostic  imaging  and  laboratory  examinations.  For  example,  the  accu-­‐‑
racy  of  CT  should  not  be  overestimated.  Moreover,  known  pitfalls  at  admission  are  refer-­‐‑
ring  a  patient  with  AMI  to   the  cardiologist  or   internist  due  to  elevated  troponin  test,  and  
making  an   incorrect  diagnosis  due   to  elevate  pancreas  amylase  or  abnormal   liver   test;  all  
these  abnormal  laboratory  tests  are  relatively  common  in  AMI  (77).  
  
  
Table 2. The most common co-morbidities, and clinical symptoms and signs in AMI (76). 
 
Characteristics Prevalence/sensitivity range 
Co-morbidities 
  Atrial fibrillation 8-79% 
 Coronary artery disease 13-75% 
 Chronic heart failure 6-58% 
 Hypercoagulable state 2-29% 
Clinical symptoms and signs  
 Acute abdominal pain 60-100% 
 Diffuse abdominal tenderness 54-90% 
 Abdominal distention 18-54% 
 Peritoneal sings 13-65% 
 Nausea/vomiting 39-93% 
 Diarrhea/rectal bleeding 12-48% 
  
2.4.2  Biomarkers  
Classically,  patients  with  AMI  have  leukocytosis,  metabolic  acidosis,  elevated  D-­‐‑dimer,  and  
elevated   serum   lactate.  However,   these   laboratory   tests   are   highly  unspecific   and  do  not  
exclude  the  possibility  of  AMI  when  negative  (78).  A  biomarker  capable  of  detecting  early  
mesenteric   hypoperfusion   would   be   of   great   clinical   value,   such   as   the   troponin   test   in  




ers  are  not  specific  for  AMI.  There  are  some  promising  blood  tests  that  have  been  studied  
on  patients  with  suspected  AMI;  these  are  D-­‐‑dimer,  D-­‐‑lactate,  α-­‐‑glutathione  S-­‐‑transferase,  
and  intestinal  fatty  acid  binding  protein  (FABP)  (79).  
The  traditional  inflammatory  markers  taken  from  all  patients  with  acute  abdomen  in  Fin-­‐‑
land  are  white  blood  cell  (WBC)  count  and  C-­‐‑reactive  protein  (CRP).  Lactate,  lactate  dehy-­‐‑
drogenase,  D-­‐‑dimer,  procalcitonin  and  arterial  blood  samples  are  not  obtained  routinely  in  
surgical  acute  care  units  in  Finland.  
2.4.2.1  Conventional  inflammatory  markers  
The  WBC  count  and  CRP  are  usually  elevated  in  AMI.  However,  WBC  count  was  found  to  
be  negative  in  approximately  6–20%  of  AMI  cases,  and  CRP  in  15–25%  (69,77,80).  Logically  
thinking,  the  inflammatory  markers  may  be  negative  in  the  early  phase  of  intestinal  ische-­‐‑
mia,  for  example,  in  a  sudden  embolic  occlusion  of  the  SMA.  WBC  count  is  elevated  earlier  
in  the  embolic  AMI,  while  CRP  tends  to  be  higher  in  patients  with  thrombotic  etiology  (77).  
Recently,   it   has   been   postulated   that   neutrophil/lymphocyte   ratio   could   play   a   role   in  
various   ischemic   conditions   such   as   cardiac   events,  where   high   neutrophil   counts   reflect  
inflammation  and  low  lymphocytes  reflect  poor  general  health  and  physiologic  stress  (81).  
Although  WBC  differential  is  not  routinely  screened,  it  could  be  easily  integrated  as  a  part  
of   the  complete  blood  count   that   is  performed  on  all  patients  with  acute  abdominal  pain.  
The  sensitivity  and  specificity  of  neutrophil/lymphocyte  level  greater  than  4.5  for  AMI  were  
77%   and   72%,   respectively,   according   to   one   recent   study,   but   no   data   whatsoever   was  
disclosed  on  the  patient  outcome  or  how  the  diagnosis  of  AMI  was  established  (82).  Anoth-­‐‑
er  study  of  70  laparotomy-­‐‑verified  AMI  patients  (of  whom  62  underwent  bowel  resection)  
suggested  much  higher  cut-­‐‑off  value  of  9.9  for  neutrophil/lymphocyte  ratio  with  74%  sensi-­‐‑
tivity   and   83%   specificity   (83).   In   the   same   study,   the   suggested   cut-­‐‑off   value   for  WBC  
count  was  14.4  x  109/L  achieving  only  57%  sensitivity  and  69%  specificity.  
Procalcitonin  has  been  investigated  in  clinical  practice  by  three  groups  in  a  total  of  659  
patients  with  intestinal  ischemia  (84).  The  sensitivity  ranged  between  72-­‐‑100%  and  specifici-­‐‑
ty  between  68-­‐‑91%.  However,  the  etiology  in  more  than  ⅔  of  those  patients  was  small  bow-­‐‑
el  obstruction  as  opposed  to  primary  mesenteric  ischemia.  In  a  study  of  93  patients  under-­‐‑
going   aortic   surgery,   postoperative   serum  procalcitonin   (with   cut-­‐‑off   value   of   2.0   ng/ml)  
had   a   100%   negative   predictive   value   for   colon   ischemia,   and   100%   sensitivity   and   84%  
specificity,  although  only  four  patients  in  that  study  suffered  ischemic  colitis  (85).  In  anoth-­‐‑
er  prospective  study  of  865  patients  undergoing  cardiac  surgery  (see  paragraph  2.2.4.4.),  78  
patients   had  NOMI   and   significantly   higher   procalcitonin   levels   than   those  who  did   not  
develop  NOMI  postoperatively;   in  contrast,  CRP  was  marginally   lower  while  WBC  count  
was   slightly   higher   in   the  NOMI   than   in   the   non-­‐‑NOMI   group   (53).   A   drawback   of   the  
study  was   that   although   the   in-­‐‑hospital  mortality  was   significantly   higher   in   the  NOMI  
group  (22%  versus  1%),  no  data  on  the  cause  of  death  was  given  and  none  of  the  patients  
were  reported  undergoing  laparotomy,  either,  which  would  have  proved  the  diagnosis  of  
NOMI.  
2.4.2.2  Lactate  and  acid-­‐‑base  balance  
Lactate  has  been   linked   to  AMI   for  decades,  but  only  recently  have   the  conjugated   forms  
been  studied  as  possible  biomarkers  for  AMI.  L-­‐‑lactate  is  produced  by  all  human  cells  espe-­‐‑
cially  when  perfusion  and  oxygen  delivery  is  restricted  (86).  Early  elevation  of  L-­‐‑lactate  in  
AMI  is  not  detected,  since  the  liver  is  capable  of  clearing  large  amounts  of  L-­‐‑lactate  released  
by  the  gut  to  the  portal  circulation  (87).  When  detectable,  elevated  lactate  in  AMI  is  associ-­‐‑
ated  with  severe  splanchnic  hypoperfusion  and  metabolic  acidosis,  and  transmural  infarc-­‐‑
tion  may  already  have  been  initiated  (79,86).  A  recent  study  of  lactate  measurements  in  91  
patients   with   bowel   resection   performed   due   to   AMI   demonstrated   significantly   higher  
lactate  levels  and  lower  pH  when  measured  <6  hours  versus  >6  hours  before  surgery  (88).  
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drogenase,  D-­‐‑dimer,  procalcitonin  and  arterial  blood  samples  are  not  obtained  routinely  in  
surgical  acute  care  units  in  Finland.  
2.4.2.1  Conventional  inflammatory  markers  
The  WBC  count  and  CRP  are  usually  elevated  in  AMI.  However,  WBC  count  was  found  to  
be  negative  in  approximately  6–20%  of  AMI  cases,  and  CRP  in  15–25%  (69,77,80).  Logically  
thinking,  the  inflammatory  markers  may  be  negative  in  the  early  phase  of  intestinal  ische-­‐‑
mia,  for  example,  in  a  sudden  embolic  occlusion  of  the  SMA.  WBC  count  is  elevated  earlier  
in  the  embolic  AMI,  while  CRP  tends  to  be  higher  in  patients  with  thrombotic  etiology  (77).  
Recently,   it   has   been   postulated   that   neutrophil/lymphocyte   ratio   could   play   a   role   in  
various   ischemic   conditions   such   as   cardiac   events,  where   high   neutrophil   counts   reflect  
inflammation  and  low  lymphocytes  reflect  poor  general  health  and  physiologic  stress  (81).  
Although  WBC  differential  is  not  routinely  screened,  it  could  be  easily  integrated  as  a  part  
of   the  complete  blood  count   that   is  performed  on  all  patients  with  acute  abdominal  pain.  
The  sensitivity  and  specificity  of  neutrophil/lymphocyte  level  greater  than  4.5  for  AMI  were  
77%   and   72%,   respectively,   according   to   one   recent   study,   but   no   data   whatsoever   was  
disclosed  on  the  patient  outcome  or  how  the  diagnosis  of  AMI  was  established  (82).  Anoth-­‐‑
er  study  of  70  laparotomy-­‐‑verified  AMI  patients  (of  whom  62  underwent  bowel  resection)  
suggested  much  higher  cut-­‐‑off  value  of  9.9  for  neutrophil/lymphocyte  ratio  with  74%  sensi-­‐‑
tivity   and   83%   specificity   (83).   In   the   same   study,   the   suggested   cut-­‐‑off   value   for  WBC  
count  was  14.4  x  109/L  achieving  only  57%  sensitivity  and  69%  specificity.  
Procalcitonin  has  been  investigated  in  clinical  practice  by  three  groups  in  a  total  of  659  
patients  with  intestinal  ischemia  (84).  The  sensitivity  ranged  between  72-­‐‑100%  and  specifici-­‐‑
ty  between  68-­‐‑91%.  However,  the  etiology  in  more  than  ⅔  of  those  patients  was  small  bow-­‐‑
el  obstruction  as  opposed  to  primary  mesenteric  ischemia.  In  a  study  of  93  patients  under-­‐‑
going   aortic   surgery,   postoperative   serum  procalcitonin   (with   cut-­‐‑off   value   of   2.0   ng/ml)  
had   a   100%   negative   predictive   value   for   colon   ischemia,   and   100%   sensitivity   and   84%  
specificity,  although  only  four  patients  in  that  study  suffered  ischemic  colitis  (85).  In  anoth-­‐‑
er  prospective  study  of  865  patients  undergoing  cardiac  surgery  (see  paragraph  2.2.4.4.),  78  
patients   had  NOMI   and   significantly   higher   procalcitonin   levels   than   those  who  did   not  
develop  NOMI  postoperatively;   in  contrast,  CRP  was  marginally   lower  while  WBC  count  
was   slightly   higher   in   the  NOMI   than   in   the   non-­‐‑NOMI   group   (53).   A   drawback   of   the  
study  was   that   although   the   in-­‐‑hospital  mortality  was   significantly   higher   in   the  NOMI  
group  (22%  versus  1%),  no  data  on  the  cause  of  death  was  given  and  none  of  the  patients  
were  reported  undergoing  laparotomy,  either,  which  would  have  proved  the  diagnosis  of  
NOMI.  
2.4.2.2  Lactate  and  acid-­‐‑base  balance  
Lactate  has  been   linked   to  AMI   for  decades,  but  only  recently  have   the  conjugated   forms  
been  studied  as  possible  biomarkers  for  AMI.  L-­‐‑lactate  is  produced  by  all  human  cells  espe-­‐‑
cially  when  perfusion  and  oxygen  delivery  is  restricted  (86).  Early  elevation  of  L-­‐‑lactate  in  
AMI  is  not  detected,  since  the  liver  is  capable  of  clearing  large  amounts  of  L-­‐‑lactate  released  
by  the  gut  to  the  portal  circulation  (87).  When  detectable,  elevated  lactate  in  AMI  is  associ-­‐‑
ated  with  severe  splanchnic  hypoperfusion  and  metabolic  acidosis,  and  transmural  infarc-­‐‑
tion  may  already  have  been  initiated  (79,86).  A  recent  study  of  lactate  measurements  in  91  
patients   with   bowel   resection   performed   due   to   AMI   demonstrated   significantly   higher  
lactate  levels  and  lower  pH  when  measured  <6  hours  versus  >6  hours  before  surgery  (88).  




sis),  the  probability  of  bowel  infraction  already  being  developed  is  high.  Therefore,  normal  
lactate   and   acid-­‐‑base   balance   cannot   be   used   to   exclude   AMI.   Indeed,   in   a   prospective  
study  of  patients  with  acute  thromboembolic  occlusion  of  the  SMA,  five  of  twelve  patients  
with  arterial  blood  gas  analysis  available  had  in  fact  alkalosis,  while  only  three  had  acido-­‐‑
sis.  Alkalosis  was  explained  by  vomiting,  which  may  be  caused  by  paralytic   ileus  in  AMI  
(69).  
The  D-­‐‑isomerase  of   lactate   is   found  in  the   intestinal   lumen  produced  by  anaerobic  me-­‐‑
tabolism  of   the   coliform  bacterial   flora.  D-­‐‑lactate   is  metabolized  very   slowly  by   the   liver,  
and   elevated   levels   might   indicate   increased   permeability   and   bacterial   translocation  
through   the   gut   wall   occurring   in   intestinal   ischemia   (79,86).   However,   D-­‐‑lactate   is   not  
specific  for  AMI,  and  the  reliability  of  D-­‐‑lactate  assays  has  been  impaired  by  interference  of  
L-­‐‑lactate   and   L-­‐‑lactate   dehydrogenase   (79).   Currently,   the   assessment   of   D-­‐‑lactate   is   not  
available  in  clinical  laboratories  in  Finland.  
2.4.2.3  D-­‐‑dimer  
D-­‐‑dimer  is  a  marker  of  fibrinolysis  and  used  for  screening  of  variety  of  thrombotic  condi-­‐‑
tions.   In  AMI,  D-­‐‑dimer  may  be  elevated  due  to  major  acute  thromboembolism  within  the  
mesenteric  arteries,  or  due  to  ischemic  damage  of  the  intestinal  wall  where  the  fibrinolysis  
supposedly   occur   in   the   small   arteries   and   veins   of   the   submucosal   layer   (79).   A   recent  
review  evaluating  D-­‐‑dimer  as  a  marker  for  AMI  reported  pooled  sensitivity  of  96%  but  only  
40%  specificity  (76).  Thus,  a  negative  D-­‐‑dimer  might  be  helpful  in  excluding  AMI.  Howev-­‐‑
er,  the  current  data  is  insufficient  in  order  to  recommend  routine  use  of  D-­‐‑dimer  screening  
in  patients  with   acute   abdomen.   Furthermore,   there   is   variability   in   the   characteristics   of  
different  commercial  D-­‐‑dimer  assays,  and  therefore,  one  study  results  are  not  directly  ap-­‐‑
plicable  in  another  hospital  (79).  Lowering  the  cut-­‐‑off  value  of  D-­‐‑dimer  increases  sensitivity  
at  the  cost  of  decreased  specificity.  
2.4.2.4  FABP  and  α-­‐‑glutathione  S-­‐‑transferase  
Intestinal  FABP  is  found  in  cells  on  the  luminal  side  of  the  intestinal  villi,  which  is  the  first  
site  of  destruction  in  AMI.  Intestinal  FABP  is  released  in  the  circulation  and  quickly  cleared  
through  the  kidneys  into  the  urine  (half-­‐‑time  of  11  minutes)  (78).  The  pooled  sensitivity  for  
FABP  in  AMI  has  been  given  as  70%  with  93%  specificity  (76).  A  recent  study  on  patients  
with  suspected  intestinal  ischemia  showed  significantly  higher  plasma  and  urine  concentra-­‐‑
tions  of  intestinal  FABP  and  liver  FABP  in  patients  with  proven  ischemia.  The  highest  sen-­‐‑
sitivity  (90%)  and  specificity  (89%)  was  associated  with  urine  intestinal  FABP  (89).  Another  
interesting  study  of  perioperative  intestinal  FABP  concentrations  in  96  patients  undergoing  
open  or  endovascular  repair  for  various  types  of  aortic  aneurysms  showed  increased  levels  
in  patients  undergoing  open  repair,  and  further,  high  levels  of  intestinal  FABP  at  the  end  of  
surgery  had  100%  sensitivity  and  98%  specificity   for   identification  of  patients  who  devel-­‐‑
oped  intestinal  necrosis  as  a  complication  postoperatively  (n=4)  (90).  
Another   potential   early  marker   of   AMI   is   α-­‐‑glutathione   S-­‐‑transferase,   a   family   of   en-­‐‑
zymes  highly  active  in  the  liver  and  mucosa  of  the  small   intestine.  These  enzymes  are  re-­‐‑
leased  following  cell  membrane  damage  (78).  In  a  meta-­‐‑analysis,  the  pooled  sensitivity  and  
specificity  for  α-­‐‑glutathione  S-­‐‑transferase  in  detecting  AMI  were  68%  and  85%,  respectively  
(76).   It   remains   to  be  seen   if   future  research  will  confirm  the  utility  of  some  of   these  new  
biochemical  markers.  
2.4.3  Imaging  
CT,  or  more  precisely,  CT  angiography   (CTA)  has   replaced   conventional   angiography  as  
the  gold  standard  diagnostic  imaging  modality  in  AMI.  The  utility  of  plain  abdominal  radi-­‐‑
ography  in  AMI  is  limited;  the  signs  to  look  for  in  the  abdominal  or  chest  X-­‐‑ray  are  intesti-­‐‑
nal   paralysis,   intraperitoneal   free   gas,   and   portal   venous   gas.   Magnetic   resonance   angi-­‐‑




SMA  and  the  CA,  but  it  has  limited  value  in  the  evaluation  of  distal  occlusions  in  the  mes-­‐‑
entery.  Magnetic   resonance   imaging   is   also   time   consuming   and   impractical   in   the   acute  
setting  (91).  Duplex  ultrasound  is  being  used  for  screening  purposes  for  CMI,  and  for  fol-­‐‑
low-­‐‑up  imaging  after  mesenteric  revascularization  (although  less  so  in  Finland  as  far  as  we  
know)  (34).  
2.4.3.1  Duplex  ultrasound  
Visualizing   the  mesenteric   vessels  with  duplex   ultrasound   is   technically   challenging   and  
may  be  impossible  in  AMI  due  to  extensive  gas  within  the  bowel  loops.  Ultrasound  is  not  
recommended  for  the  initial  evaluation  of  patients  with  suspected  AMI,  because  it   is  time  
consuming   and   of   limited  diagnostic   value   (92).   In   the   screening   of  CMI,   the  ultrasound  
assessment  is  performed  during  fasting  by  searching  for  luminal  narrowing  and  atheroscle-­‐‑
rotic  plaques   followed  by  color  Doppler  analysis.  The  sample  volume   (1.5  mm)   is  passed  
slowly  from  the  aorta  to  the  target  vessel  searching  for  elevated  peak  systolic  or  end  dias-­‐‑
tolic   velocities.   Peak   systolic   velocity   cut-­‐‑off   value   of   275   cm/s   has   been  widely   used   for  
hemodynamically   significant   SMA   stenosis   and   200   cm/s   for   CA   stenosis   (92).   A   recent  
study   with   currently   the   largest   number   of   mesenteric   duplex   ultrasound   versus   angi-­‐‑
ography  correlations  of  153  patients  with  suspected  CMI  showed  that  specifically,  the  peak  
systolic  velocity  was  the  best  variable  for  detecting  ≥50%  and  ≥70%  stenoses  of  the  SMA  or  
CA.   The  most   accurate   cut-­‐‑off   values   for   ≥50%   and   ≥70%   SMA   stenoses  were   ≥295   cm/s  
(87%   sensitivity,   89%   specificity)   and  ≥400   cm/s   (72%   sensitivity,   93%   specificity),   respec-­‐‑
tively.   The   corresponding   values   for   ≥50%   and   ≥70%   CA   stenoses   were   ≥240   cm/s   (87%  
sensitivity,  83%  specificity)  and  ≥320  cm/s  (80%  sensitivity,  89%  specificity)  (93).  
The  cut-­‐‑off  values  for  significant  stenosis  presented  above  apply  only  to  native  arteries.  
It  is  known  that  peak  systolic  velocity  remains  higher  after  successful  stenting  of  the  SMA  
than   the   threshold  of  275  cm/s.  Therefore,  duplex  ultrasound  examination  should  be  per-­‐‑
formed  early  after  stenting  to  establish  a  baseline  for  future  surveillance.  An  increase  above  
baseline  or  a  peak  systolic  velocity  of  ≥500  cm/s  within  the  stented  SMA  is  suspicious  for  in-­‐‑
stent  restenosis  (94).  
When  assessing  the  dynamics  of  the  mesenteric  circulation,  it  is  important  to  remember  
that   the  blood   flow   in   the  mesentery   is   susceptible   to  significant  variation.   In   fasting,  ap-­‐‑
proximately   20%  of   the   cardiac   output   flows   through   the  mesenteric   arteries;   the  CA   re-­‐‑
ceives  800  ml/min  and  the  SMA  has  a  basal  flow  of  500  ml/min.  Postprandially,  the  CA  flow  
increases  approximately  30%  while   the  SMA  flow  increases  by  more   than  150%  (66).  Fur-­‐‑
thermore,  increased  velocity  in  an  unobstructed  mesenteric  artery  may  be  consequence  of  a  
concomitant  obstruction  elsewhere   in   the   splanchnic   circulation.  A  hemodynamically   sig-­‐‑
nificant   stenosis   in   either   CA   or   SMA   has   been   shown   to   increase   flow   velocities   in   the  
other  unaffected  artery  especially  when  significant  collaterals  have  developed  (95).  
In  MALS,  the  positional  changes  in  the  CA  peak  systolic  velocity  could  be  identified  with  
duplex  ultrasound  examination.  A  maximum  velocity  of  ≥350  cm/s  in  combination  with  CA  
deflection  angle  higher   than  50°  during  expiration  has  been  proposed  as   an   indicator   for  
CA  compression  by  the  median  arcuate  ligament  (96).  
2.4.3.2  Digital  subtraction  angiography  
Digital  subtraction  angiography  (DSA)  is  an  invasive  procedure  and  more  commonly  used  
to  perform  endovascular  therapeutic  procedures  than   just  for  plain  diagnostics.  However,  
DSA   is   still   in  many  ways   superior   to   the  CTA   in   detailed   and   dynamic   imaging   of   the  
mesenteric  anatomy  and  collaterals.  A  thorough  visceral  angiographic  examination  consists  
of   a   non-­‐‑selective   anterior-­‐‑posterior   aortic   angiography,   a   lateral   aortography   preferably  
during   maximal   inspiration   and   expiration   (for   detection   of   MALS),   and   selective   angi-­‐‑
ography  of  all  three  mesenteric  arteries  (34).  In  AMI  however,  DSA  is  not  worth  performing  
in  this  meticulous  manner  when  CTA,  which  has  usually  been  obtained  prior  to  the  inter-­‐‑




sis),  the  probability  of  bowel  infraction  already  being  developed  is  high.  Therefore,  normal  
lactate   and   acid-­‐‑base   balance   cannot   be   used   to   exclude   AMI.   Indeed,   in   a   prospective  
study  of  patients  with  acute  thromboembolic  occlusion  of  the  SMA,  five  of  twelve  patients  
with  arterial  blood  gas  analysis  available  had  in  fact  alkalosis,  while  only  three  had  acido-­‐‑
sis.  Alkalosis  was  explained  by  vomiting,  which  may  be  caused  by  paralytic   ileus  in  AMI  
(69).  
The  D-­‐‑isomerase  of   lactate   is   found  in  the   intestinal   lumen  produced  by  anaerobic  me-­‐‑
tabolism  of   the   coliform  bacterial   flora.  D-­‐‑lactate   is  metabolized  very   slowly  by   the   liver,  
and   elevated   levels   might   indicate   increased   permeability   and   bacterial   translocation  
through   the   gut   wall   occurring   in   intestinal   ischemia   (79,86).   However,   D-­‐‑lactate   is   not  
specific  for  AMI,  and  the  reliability  of  D-­‐‑lactate  assays  has  been  impaired  by  interference  of  
L-­‐‑lactate   and   L-­‐‑lactate   dehydrogenase   (79).   Currently,   the   assessment   of   D-­‐‑lactate   is   not  
available  in  clinical  laboratories  in  Finland.  
2.4.2.3  D-­‐‑dimer  
D-­‐‑dimer  is  a  marker  of  fibrinolysis  and  used  for  screening  of  variety  of  thrombotic  condi-­‐‑
tions.   In  AMI,  D-­‐‑dimer  may  be  elevated  due  to  major  acute  thromboembolism  within  the  
mesenteric  arteries,  or  due  to  ischemic  damage  of  the  intestinal  wall  where  the  fibrinolysis  
supposedly   occur   in   the   small   arteries   and   veins   of   the   submucosal   layer   (79).   A   recent  
review  evaluating  D-­‐‑dimer  as  a  marker  for  AMI  reported  pooled  sensitivity  of  96%  but  only  
40%  specificity  (76).  Thus,  a  negative  D-­‐‑dimer  might  be  helpful  in  excluding  AMI.  Howev-­‐‑
er,  the  current  data  is  insufficient  in  order  to  recommend  routine  use  of  D-­‐‑dimer  screening  
in  patients  with   acute   abdomen.   Furthermore,   there   is   variability   in   the   characteristics   of  
different  commercial  D-­‐‑dimer  assays,  and  therefore,  one  study  results  are  not  directly  ap-­‐‑
plicable  in  another  hospital  (79).  Lowering  the  cut-­‐‑off  value  of  D-­‐‑dimer  increases  sensitivity  
at  the  cost  of  decreased  specificity.  
2.4.2.4  FABP  and  α-­‐‑glutathione  S-­‐‑transferase  
Intestinal  FABP  is  found  in  cells  on  the  luminal  side  of  the  intestinal  villi,  which  is  the  first  
site  of  destruction  in  AMI.  Intestinal  FABP  is  released  in  the  circulation  and  quickly  cleared  
through  the  kidneys  into  the  urine  (half-­‐‑time  of  11  minutes)  (78).  The  pooled  sensitivity  for  
FABP  in  AMI  has  been  given  as  70%  with  93%  specificity  (76).  A  recent  study  on  patients  
with  suspected  intestinal  ischemia  showed  significantly  higher  plasma  and  urine  concentra-­‐‑
tions  of  intestinal  FABP  and  liver  FABP  in  patients  with  proven  ischemia.  The  highest  sen-­‐‑
sitivity  (90%)  and  specificity  (89%)  was  associated  with  urine  intestinal  FABP  (89).  Another  
interesting  study  of  perioperative  intestinal  FABP  concentrations  in  96  patients  undergoing  
open  or  endovascular  repair  for  various  types  of  aortic  aneurysms  showed  increased  levels  
in  patients  undergoing  open  repair,  and  further,  high  levels  of  intestinal  FABP  at  the  end  of  
surgery  had  100%  sensitivity  and  98%  specificity   for   identification  of  patients  who  devel-­‐‑
oped  intestinal  necrosis  as  a  complication  postoperatively  (n=4)  (90).  
Another   potential   early  marker   of   AMI   is   α-­‐‑glutathione   S-­‐‑transferase,   a   family   of   en-­‐‑
zymes  highly  active  in  the  liver  and  mucosa  of  the  small   intestine.  These  enzymes  are  re-­‐‑
leased  following  cell  membrane  damage  (78).  In  a  meta-­‐‑analysis,  the  pooled  sensitivity  and  
specificity  for  α-­‐‑glutathione  S-­‐‑transferase  in  detecting  AMI  were  68%  and  85%,  respectively  
(76).   It   remains   to  be  seen   if   future  research  will  confirm  the  utility  of  some  of   these  new  
biochemical  markers.  
2.4.3  Imaging  
CT,  or  more  precisely,  CT  angiography   (CTA)  has   replaced   conventional   angiography  as  
the  gold  standard  diagnostic  imaging  modality  in  AMI.  The  utility  of  plain  abdominal  radi-­‐‑
ography  in  AMI  is  limited;  the  signs  to  look  for  in  the  abdominal  or  chest  X-­‐‑ray  are  intesti-­‐‑
nal   paralysis,   intraperitoneal   free   gas,   and   portal   venous   gas.   Magnetic   resonance   angi-­‐‑




SMA  and  the  CA,  but  it  has  limited  value  in  the  evaluation  of  distal  occlusions  in  the  mes-­‐‑
entery.  Magnetic   resonance   imaging   is   also   time   consuming   and   impractical   in   the   acute  
setting  (91).  Duplex  ultrasound  is  being  used  for  screening  purposes  for  CMI,  and  for  fol-­‐‑
low-­‐‑up  imaging  after  mesenteric  revascularization  (although  less  so  in  Finland  as  far  as  we  
know)  (34).  
2.4.3.1  Duplex  ultrasound  
Visualizing   the  mesenteric   vessels  with  duplex   ultrasound   is   technically   challenging   and  
may  be  impossible  in  AMI  due  to  extensive  gas  within  the  bowel  loops.  Ultrasound  is  not  
recommended  for  the  initial  evaluation  of  patients  with  suspected  AMI,  because  it   is  time  
consuming   and   of   limited  diagnostic   value   (92).   In   the   screening   of  CMI,   the  ultrasound  
assessment  is  performed  during  fasting  by  searching  for  luminal  narrowing  and  atheroscle-­‐‑
rotic  plaques   followed  by  color  Doppler  analysis.  The  sample  volume   (1.5  mm)   is  passed  
slowly  from  the  aorta  to  the  target  vessel  searching  for  elevated  peak  systolic  or  end  dias-­‐‑
tolic   velocities.   Peak   systolic   velocity   cut-­‐‑off   value   of   275   cm/s   has   been  widely   used   for  
hemodynamically   significant   SMA   stenosis   and   200   cm/s   for   CA   stenosis   (92).   A   recent  
study   with   currently   the   largest   number   of   mesenteric   duplex   ultrasound   versus   angi-­‐‑
ography  correlations  of  153  patients  with  suspected  CMI  showed  that  specifically,  the  peak  
systolic  velocity  was  the  best  variable  for  detecting  ≥50%  and  ≥70%  stenoses  of  the  SMA  or  
CA.   The  most   accurate   cut-­‐‑off   values   for   ≥50%   and   ≥70%   SMA   stenoses  were   ≥295   cm/s  
(87%   sensitivity,   89%   specificity)   and  ≥400   cm/s   (72%   sensitivity,   93%   specificity),   respec-­‐‑
tively.   The   corresponding   values   for   ≥50%   and   ≥70%   CA   stenoses   were   ≥240   cm/s   (87%  
sensitivity,  83%  specificity)  and  ≥320  cm/s  (80%  sensitivity,  89%  specificity)  (93).  
The  cut-­‐‑off  values  for  significant  stenosis  presented  above  apply  only  to  native  arteries.  
It  is  known  that  peak  systolic  velocity  remains  higher  after  successful  stenting  of  the  SMA  
than   the   threshold  of  275  cm/s.  Therefore,  duplex  ultrasound  examination  should  be  per-­‐‑
formed  early  after  stenting  to  establish  a  baseline  for  future  surveillance.  An  increase  above  
baseline  or  a  peak  systolic  velocity  of  ≥500  cm/s  within  the  stented  SMA  is  suspicious  for  in-­‐‑
stent  restenosis  (94).  
When  assessing  the  dynamics  of  the  mesenteric  circulation,  it  is  important  to  remember  
that   the  blood   flow   in   the  mesentery   is   susceptible   to  significant  variation.   In   fasting,  ap-­‐‑
proximately   20%  of   the   cardiac   output   flows   through   the  mesenteric   arteries;   the  CA   re-­‐‑
ceives  800  ml/min  and  the  SMA  has  a  basal  flow  of  500  ml/min.  Postprandially,  the  CA  flow  
increases  approximately  30%  while   the  SMA  flow  increases  by  more   than  150%  (66).  Fur-­‐‑
thermore,  increased  velocity  in  an  unobstructed  mesenteric  artery  may  be  consequence  of  a  
concomitant  obstruction  elsewhere   in   the   splanchnic   circulation.  A  hemodynamically   sig-­‐‑
nificant   stenosis   in   either   CA   or   SMA   has   been   shown   to   increase   flow   velocities   in   the  
other  unaffected  artery  especially  when  significant  collaterals  have  developed  (95).  
In  MALS,  the  positional  changes  in  the  CA  peak  systolic  velocity  could  be  identified  with  
duplex  ultrasound  examination.  A  maximum  velocity  of  ≥350  cm/s  in  combination  with  CA  
deflection  angle  higher   than  50°  during  expiration  has  been  proposed  as   an   indicator   for  
CA  compression  by  the  median  arcuate  ligament  (96).  
2.4.3.2  Digital  subtraction  angiography  
Digital  subtraction  angiography  (DSA)  is  an  invasive  procedure  and  more  commonly  used  
to  perform  endovascular  therapeutic  procedures  than   just  for  plain  diagnostics.  However,  
DSA   is   still   in  many  ways   superior   to   the  CTA   in   detailed   and   dynamic   imaging   of   the  
mesenteric  anatomy  and  collaterals.  A  thorough  visceral  angiographic  examination  consists  
of   a   non-­‐‑selective   anterior-­‐‑posterior   aortic   angiography,   a   lateral   aortography   preferably  
during   maximal   inspiration   and   expiration   (for   detection   of   MALS),   and   selective   angi-­‐‑
ography  of  all  three  mesenteric  arteries  (34).  In  AMI  however,  DSA  is  not  worth  performing  
in  this  meticulous  manner  when  CTA,  which  has  usually  been  obtained  prior  to  the  inter-­‐‑




2.4.3.3  Computed  tomography  
2.4.3.3.1  Diagnostic  accuracy  
Contrast  enhanced  CT  with  modern  multidetector  devices  has  proved  to  be  the  method  of  
choice   for  detecting  vascular  pathology  and  associated   intestinal  changes   in  AMI.  The  re-­‐‑
cent  studies  on  the  diagnostic  accuracy  of  CT  in  primary  AMI  are  presented  in  Table  3.  The  
quality  of  these  studies  has  been  previously  assessed  using  the  Quality  Assessment  of  Di-­‐‑
agnostic  Accuracy  Studies   tool   in   two   systematic   reviews   (76,97).  The   information  of   our  
interest  is  gathered  from  each  individual  study  (thus,  not  directly  from  the  meta-­‐‑analyses).  
It   is   noteworthy,   that   these   studies   were   performed   almost   exclusively   on   patients   with  
clinical   suspicion  of  AMI  prior   to   the   imaging,  and   the   laparotomy  rates  were  high   (sug-­‐‑
gesting  that  high  proportion  of  study  patients  had  advanced  bowel  ischemia).  Furthermore,  
all  CTs  were  performed  in  optimal  (i.e.  biphasic)  contrast  enhanced  protocols  for  the  detec-­‐‑
tion  of  AMI.  The  sensitivity  and  specificity  of  CT  in  these  studies  ranged  between  89–100%.  
  
  
Table 3. Recent studies on the diagnostic accuracy of biphasic CT in patients with clinically 
suspected primary AMI (cases with secondary AMI have been excluded from this table). 
 









Kirkpatrick 2003 (5) 100% 89% 62 26/26 Prospective 25 (96%) 
Zandrino 2006 (98) 92% 100% unknown b 24/26 Retrospective b 24 (92%) 
Aschoff 2009 (6) 96% 98% 79 27/28 Retrospective 27 (96%) 
Ofer 2009 (99) 89% 97% 91 16/18 Retrospective 13 (72%) 
Akyildiz 2009 (100) 93% 89% 47 26/28 Prospective 28 (100%) 
Barmase 2011 (101) 100% 100% 31 16/16 Prospective 11 (69%) 
Yikilimaz 2011 (102) 100% 100% 200 50/50 Prospective 50 (100%) 
TP = No. of true positive cases / TP+FN = No. of all true positive and false negative cases 
a In this table, advanced bowel ischemia was defined as cases with laparotomy or autopsy proof of AMI, or 
withdrawal of active treatment resulting in rapid death. For the rest, the diagnosis of AMI was confirmed 
by clinical presentation and other findings (suggesting reversible bowel ischemia). 
b This was a case-control study with 24 surgically and two angiographically verified AMI cases and 34 
surgically proven non-AMI control cases.  
  
2.4.3.3.2  Imaging  technique  
Contrast  agent  is  used  to  highlight  (i.e.,  enhance)  specific  tissues  such  as  blood  vessels  and  
bowel  wall  during  the  abdominal  CT.  Contrast  enhanced  CT  performed  in  both  arterial  and  
portal  venous  phases  (biphasic  protocol)  is  currently  recommended  as  the  first-­‐‑line  imaging  
technique   in  AMI   (92).  The  venous  phase   is   required   for   the  assessment  of   intestinal  and  
solid  organ  perfusion  pattern  and  other  pathology  of  the  abdomen,  and  the  arterial  phase  
enables  more  accurate  detection  of  vascular  pathology  (103).  A  single-­‐‑phase  image  acquisi-­‐‑
tion   with   biphasic   contrast   medium   injection   is   called   the   "ʺsplit-­‐‑bolus"ʺ   protocol,   which  
enables  diagnostic  enhancement  of  arteries,  veins,  parenchymal  organs,  and  bowel  wall  in  a  
single  series  of  images.  However,  in  most  cases  of  unknown  etiology,  the  routine  CT  of  the  
acute  abdomen  will  be  performed   in  venous  phase  alone,  because   in  practice,  AMI   is  not  




Triphasic   CT   (constituting   of   unenhanced,   arterial,   and   venous   phases)   has   also   been  
suggested  as  the  standard  imaging  protocol  in  AMI.  The  reasons  for  obtaining  unenhanced  
CT  are  detection  of   submucosal   hemorrhage   and   assessment   of   bowel  wall   enhancement  
comparing  unenhanced  and  contrast  enhanced  images.  However,  submucosal  hemorrhage  
has   low   sensitivity   for  AMI   and  poor   interobserver   agreement.   Furthermore,   considering  
the  larger  radiation  dose  in  triphasic  imaging  and  the  fact  that  abnormal  enhancement  can  
be  assessed  by  using  normally  enhancing  bowel  as  an   internal   reference,  obtaining  unen-­‐‑
hanced  CT  is  not  required  for  the  diagnosis  of  AMI  (105).  
Acute  renal  insufficiency  has  been  reported  in  52–72%  of  patients  with  acute  SMA  occlu-­‐‑
sion  prior  to  imaging  (70,106).  The  typical  amount  of  non-­‐‑ionic  iodinated  contrast  material  
required  for  the  abdominal  CT  is  120  ml  (103).  It  may  be  necessary  to  reduce  the  amount  of  
contrast  medium   in   patients  with   chronic   renal   insufficiency.  However,   performing   only  
unenhanced  CT  because  of  the  fear  of  contrast  induced  nephropathy  will  risk  delaying  the  
diagnosis,  and  the  patient'ʹs  prognosis  will  be  worse  if  the  patient  is,  indeed,  suffering  from  
AMI   (107).   Besides,   it   seems   that   contrast   induced   nephropathy   in   patients  with  AMI   is  
extremely  uncommon  (106).  
2.4.3.3.3  Signs  of  bowel  ischemia  
The  CT  findings  of  AMI  are   listed  in  Table  4.  Decreased  or  absent  bowel  wall  enhancement   is  
probably  the  most  specific  finding  in  acute  intestinal   ischemia  (96%  specificity),  but  it  has  
been   reported  having  a   low  sensitivity   (18–62%)   (108).   Increased   enhancement  of   the  bowel  
wall  (33%  sensitivity,  71%  specificity)  is  caused  by  local  hyperemia  and  hyperperfusion,  for  
example,  during  reperfusion  conditions  following  occlusive  AMI  or  NOMI  (108).  Impaired  
venous   drainage   of   contrast   medium   in  MVT  may   also   cause   hyperenhancement   of   the  
bowel  wall  (103).  
The  normal  bowel  wall  thickness  in  CT  ranges  from  3  to  5  mm,  but  it  is  strongly  depend-­‐‑
ent  on  the  degree  of  bowel  distention  or  contraction.  Bowel  wall  thickening  is  the  most  com-­‐‑
mon  but   also   the   least   specific   finding   in  AMI   associated   often  with   ischemic   colitis   and  
reversible  intestinal  ischemia  (108).  It  is  caused  by  edema  or  inflammation  in  the  submuco-­‐‑
sal   layer.  Hemorrhage  may  also   appear   as  hyperattenuation  of   the  bowel  wall.   If   absent,  
bowel  wall  thickening  does  not  exclude  AMI,  and  in  case  of  transmural  infarction,  the  bow-­‐‑
el  wall  may  become  paper  thin  (103).  
Pneumatosis  intestinalis  and  portomesenteric  venous  gas  have  been  reported  in  6–28%  and  3–
14%  of   cases  with  AMI,   respectively.  The   specificity  of   these   findings   approach  100%   for  
acute   intestinal   ischemia,  but  pneumatosis  does  not  yet  prove   irreversible  bowel  damage  
(108).  The  concomitant  presence  of  pneumatosis  and  portomesenteric  gas  exhibit  83%  speci-­‐‑
ficity  but  only  17%  sensitivity  for  transmural  bowel  infarction  (109).    
Luminal  dilatation   is  a  common  but  unspecific  CT  finding  in  AMI  and  may  result  either  
from   intestinal  paralysis   or   from   transmural   bowel  necrosis.  The  dilated  bowel   loops   are  
often  filled  with  gas  and  fluid.  Bowel  dilatation  has  been  reported  in  approximately  half  of  
AMI  patients  (107).  Mesenteric   fat  stranding  and  ascites  are  nonspecific  findings  reported  in  
68–69%  and  49–88%  of  AMI  patients,  respectively  (108).  Intra-­‐‑abdominal  free  gas  is  a  sign  of  
intestinal  perforation  or  associated  with  extensive  pneumatosis.  
Arterial  embolus  or  thrombus,  or  MVT  are  not  direct  signs  of  bowel  ischemia  but  represent  
the  etiology  in  AMI.  Embolus  or  thrombus  within  mesenteric  artery  suggests  an  acute  arte-­‐‑
rial   occlusion.  Mesenteric   atherosclerosis   without   sign   of   thrombotic   occlusion   may   be   an  
incidental   finding  or   associated  with  CMI.  However,  CMI  may   eventually   become  acute,  
and   thrombotic   clot  may   not   always   be   visible   in  CT.   Intraluminal   filling   defect   and   en-­‐‑
gorgement  of   the  SMV,  venous  collaterals  and  mesenteric   fat   stranding  are   indications  of  
acute  MVT  (103).  In  NOMI,  the  vascular  findings  are  usually  absent.  In  some  cases,  irregu-­‐‑
lar  narrowing  (vasospasm)  of  the  SMA,  IMA,  and  mesenteric  arterial  arcades  may  be  visible  
in  CT  but  are  difficult  to  detect  (110).  Diminutive  aorta  and  inferior  vena  cava  in  CT  may  
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comparing  unenhanced  and  contrast  enhanced  images.  However,  submucosal  hemorrhage  
has   low   sensitivity   for  AMI   and  poor   interobserver   agreement.   Furthermore,   considering  
the  larger  radiation  dose  in  triphasic  imaging  and  the  fact  that  abnormal  enhancement  can  
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sion  prior  to  imaging  (70,106).  The  typical  amount  of  non-­‐‑ionic  iodinated  contrast  material  
required  for  the  abdominal  CT  is  120  ml  (103).  It  may  be  necessary  to  reduce  the  amount  of  
contrast  medium   in   patients  with   chronic   renal   insufficiency.  However,   performing   only  
unenhanced  CT  because  of  the  fear  of  contrast  induced  nephropathy  will  risk  delaying  the  
diagnosis,  and  the  patient'ʹs  prognosis  will  be  worse  if  the  patient  is,  indeed,  suffering  from  
AMI   (107).   Besides,   it   seems   that   contrast   induced   nephropathy   in   patients  with  AMI   is  
extremely  uncommon  (106).  
2.4.3.3.3  Signs  of  bowel  ischemia  
The  CT  findings  of  AMI  are   listed  in  Table  4.  Decreased  or  absent  bowel  wall  enhancement   is  
probably  the  most  specific  finding  in  acute  intestinal   ischemia  (96%  specificity),  but  it  has  
been   reported  having  a   low  sensitivity   (18–62%)   (108).   Increased   enhancement  of   the  bowel  
wall  (33%  sensitivity,  71%  specificity)  is  caused  by  local  hyperemia  and  hyperperfusion,  for  
example,  during  reperfusion  conditions  following  occlusive  AMI  or  NOMI  (108).  Impaired  
venous   drainage   of   contrast   medium   in  MVT  may   also   cause   hyperenhancement   of   the  
bowel  wall  (103).  
The  normal  bowel  wall  thickness  in  CT  ranges  from  3  to  5  mm,  but  it  is  strongly  depend-­‐‑
ent  on  the  degree  of  bowel  distention  or  contraction.  Bowel  wall  thickening  is  the  most  com-­‐‑
mon  but   also   the   least   specific   finding   in  AMI   associated   often  with   ischemic   colitis   and  
reversible  intestinal  ischemia  (108).  It  is  caused  by  edema  or  inflammation  in  the  submuco-­‐‑
sal   layer.  Hemorrhage  may  also   appear   as  hyperattenuation  of   the  bowel  wall.   If   absent,  
bowel  wall  thickening  does  not  exclude  AMI,  and  in  case  of  transmural  infarction,  the  bow-­‐‑
el  wall  may  become  paper  thin  (103).  
Pneumatosis  intestinalis  and  portomesenteric  venous  gas  have  been  reported  in  6–28%  and  3–
14%  of   cases  with  AMI,   respectively.  The   specificity  of   these   findings   approach  100%   for  
acute   intestinal   ischemia,  but  pneumatosis  does  not  yet  prove   irreversible  bowel  damage  
(108).  The  concomitant  presence  of  pneumatosis  and  portomesenteric  gas  exhibit  83%  speci-­‐‑
ficity  but  only  17%  sensitivity  for  transmural  bowel  infarction  (109).    
Luminal  dilatation   is  a  common  but  unspecific  CT  finding  in  AMI  and  may  result  either  
from   intestinal  paralysis   or   from   transmural   bowel  necrosis.  The  dilated  bowel   loops   are  
often  filled  with  gas  and  fluid.  Bowel  dilatation  has  been  reported  in  approximately  half  of  
AMI  patients  (107).  Mesenteric   fat  stranding  and  ascites  are  nonspecific  findings  reported  in  
68–69%  and  49–88%  of  AMI  patients,  respectively  (108).  Intra-­‐‑abdominal  free  gas  is  a  sign  of  
intestinal  perforation  or  associated  with  extensive  pneumatosis.  
Arterial  embolus  or  thrombus,  or  MVT  are  not  direct  signs  of  bowel  ischemia  but  represent  
the  etiology  in  AMI.  Embolus  or  thrombus  within  mesenteric  artery  suggests  an  acute  arte-­‐‑
rial   occlusion.  Mesenteric   atherosclerosis   without   sign   of   thrombotic   occlusion   may   be   an  
incidental   finding  or   associated  with  CMI.  However,  CMI  may   eventually   become  acute,  
and   thrombotic   clot  may   not   always   be   visible   in  CT.   Intraluminal   filling   defect   and   en-­‐‑
gorgement  of   the  SMV,  venous  collaterals  and  mesenteric   fat   stranding  are   indications  of  
acute  MVT  (103).  In  NOMI,  the  vascular  findings  are  usually  absent.  In  some  cases,  irregu-­‐‑
lar  narrowing  (vasospasm)  of  the  SMA,  IMA,  and  mesenteric  arterial  arcades  may  be  visible  
in  CT  but  are  difficult  to  detect  (110).  Diminutive  aorta  and  inferior  vena  cava  in  CT  may  




In  the  Malmö  autopsy  study,  synchronous  embolism  (arm,  leg,  brain,  abdominal  viscera)  
was   found   in  68%  of  patients  with  SMA  embolism  but   in  none  of   the  patients  with  SMA  
thrombosis   (22).  Synchronous  emboli  within  the  visceral  arteries  are  not  always  visible   in  
the  abdominal  CT,  but  may  be  detected  as  a  solid  organ  infarction  in  the  kidneys,  spleen  or  
liver.  Solid  organ  infarctions  have  been  detected  in  15–36%  of  patients  with  AMI,  however,  
not  exclusively  in  patients  with  embolism  but  also  in  patients  with  thrombosis  (5,6,102).  
Ultimately,  the  diagnosis  of  AMI  is  established  by  evaluating  the  patient'ʹs  clinical  condi-­‐‑
tion,   the   laboratory   findings,   and   the   vascular   CT   findings   together   with   the   associated  
intestinal  CT  findings.  
  
  
Table 4. Computed tomography findings in AMI (103,108). 
  
Vascular findings − Arterial embolus (oval shaped clot in a previously unaffected artery) 
− Arterial thrombus (clot with superimposed calcified lesion) 
− Mesenteric atherosclerosis 
− Mesenteric venous thrombosis 
− Portomesenteric venous gas 
Intestinal findings − Abnormal bowel wall enhancement (decreased, increased) 
− Bowel wall thickening (edema, hyperdense hemorrhage) 
− Luminal dilatation (paralysis, transmural bowel necrosis) 
− Pneumatosis intestinalis 
Other intra-abdominal 
findings 
− Mesenteric fat stranding (edema) 
− Ascites 
− Free gas 




Järvinen  and  associates  reported  the  following  outcomes  of  214  AMI  patients  (median  age  
75  years)  treated  between  1972–1990  in  Tampere  University  Hospital,  Finland:  bowel  resec-­‐‑
tion  without  revascularization  was  performed  in  69  (32%)  patients  with  34  survivors  (51%  
mortality),   and   revascularization   was   attempted   in   15   (7%)   patients   with   two   survivors  
(87%   mortality).   Explorative   laparotomy   was   the   only   intervention   in   87   (41%)   patients  
with  two  survivors,  and  43  (20%)  patients  received  only  comfort  care  with  100%  mortality.  
Thus,  only  16%  of  patients  with  AMI  could  be  saved  with  bowel   resection  alone   (1).  Ma-­‐‑
mode  and  co-­‐‑workers  reported  similar  result  of  57  AMI  patients  (mean  age  68  years)  treat-­‐‑
ed  between  1987–1993  with  35%  bowel  resection  rate,  18%  revascularization  rate,  and  81%  
overall   mortality   rate   (111).   It   seems   that   in   those   days,   intestinal   revascularization   was  
performed  sparingly,  and  the  results  gave  a  dismal  picture  of  the  procedure.  
Endean'ʹs  group  reported  the  results  of  43  patients  with  occlusive  AMI  treated  between  
1993–2000  with  slightly  more  encouraging  results  (18).  Surgery  was  performed  in  all  except  
one  patient;  laparotomy  alone  in  13,  bowel  resection  alone  in  12,  and  open  revascularization  




The  modern  management  of  occlusive  AMI  aims  at  rapid  revascularization  and  resection  of  
necrotic  bowel,  when  necessary.  The  treatment  strategy  depends,  besides  on  the  etiology  of  
AMI,  also  on  the  local  resources,  i.e.,  whether  a  hybrid  or  semi-­‐‑hybrid  (defined  as  conven-­‐‑
tional  operating  theatre  with  mobile  C-­‐‑arm  and  carbon  table  top)  operating  room  is  availa-­‐‑
ble,  and  whether  you  have  the  personnel  capable  of  performing  demanding  endovascular  
interventions  and  vascular  surgery.  Another  crucial  factor   in  the  treatment  is  whether  the  
patient  is  stable  or  in  septic  peritonitis  (112).  An  algorithm  for  the  treatment  of  AMI  is  pre-­‐‑
sented  in  Figure  4.  It  can  be  applied  regardless  of  whether  a  hybrid  operating  room  is  avail-­‐‑





Figure 4. Surgical algorithm for the management of AMI patients with obstruction of the SMA; 




Table 5. Hybrid or semi-hybrid operating room strategy for treating stable AMI patients, 
adapted and simplified from Björck 2015 (4). 
 
1. Endovascular therapy (aspiration, stenting, etc.) under local anesthesia 
2a. If EVT successful, re-evaluation of the abdomen 
 - if symptoms persist ⇒ laparotomy 
 - if symptoms resolve ⇒ close surveillance 
2b. If EVT unsuccessful, laparotomy 
 - hybrid stenting 
 - surgical revascularization 
3. Completion angiography (followed by adjunctive endovascular procedures when necessary) 
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adapted and simplified from Björck 2015 (4). 
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A  list  of  studies  published  in  the  21st  century  involving  more  than  20  AMI  patients  treat-­‐‑
ed  with  open,  hybrid,  or  endovascular  revascularization  (gathered  by  performing  PubMed  
search  for  publications  in  English  language)  is  presented  in  Table  6.    
Since  many  AMI  patients  are  fragile  and  elderly  people  with  poor  long-­‐‑term  survival  ex-­‐‑
pectancy,  it  has  to  be  individually  considered  whether  the  patient  will  actually  benefit  from  
aggressive  treatment  efforts  or   if   the  patient  should  be  treated  with  only  comfort  care  de-­‐‑
spite  all  the  modern  treatment  capabilities.  
2.5.1  Embolism  
Acute  SMA  embolism  can  be  treated  with  open  surgical  embolectomy  or  with  endovascular  
approach.  The  surgical  approach  to  the  SMA  is  performed  via  upper  midline  incision.  The  
SMA  is  exposed  below  the  transverse  mesocolon,  and  balloon  embolectomy  with  no.  2  or  3  
Fogarty  catheter  is  performed  through  a  transverse  arteriotomy  (113).  
In  the  past,  intra-­‐‑arterial  thrombolysis  was  the  primary  mode  of  EVT  in  SMA  embolism  
(114,115).  The  development  of   catheters   suitable   for   endovascular   aspiration  has   reduced  
the   need   for   thrombolysis,   and   today,   thrombolysis   has   been   superseded   by  mechanical  
aspiration  (116).  However,  catheter-­‐‑directed  continuous  infusion  of  thrombolytic  agent  can  
still  be  used  as  an  adjunct  to  clear  out  residual  thrombi  or  distal  embolization  after  endo-­‐‑
vascular  mechanical  aspiration.  
In  a  septic  patient  with  peritonitis,  laparotomy  is  the  primary  intervention  and  surgical  
embolectomy  is  the  fastest  way  to  achieve  intestinal  reperfusion  during  emergency  laparot-­‐‑
omy  (112).  In  stable  patients,  endovascular  mechanical  aspiration  has  been  technically  suc-­‐‑
cessful   in   73–100%  of   cases  with   10–86%  bowel   resection   rate   and  mortality   rate   ranging  
between  10–33%  (116).  These  results  compare  favorably  or  at  least  equally  with  the  30–49%  
mortality  rate  reported  for  open  embolectomy  in  AMI  (117,118).  If  EVT  is  successful  and  the  
symptoms   resolve   quickly,   laparotomy   can   be   avoided   in  more   than   half   of   the   patients  
with  SMA  embolism   (116).  However,   if   the  abdominal  pain  persists  after   technically   suc-­‐‑
cessful  EVT,  laparotomy  should  be  performed  without  delay.  Failure  to  resect  irreversibly  
damaged  bowel  will  lead  to  sepsis  and  even  larger  bowel  necrosis  (Figure  5).  
2.5.2  Thrombosis  
The  surgical  approaches  to  revascularization  in  thrombotic  (atherosclerotic)  occlusion  of  the  
SMA  are  antegrade  bypass,  retrograde  bypass,   thromboendarterectomy,  SMA  reimplanta-­‐‑
tion,  and  hybrid  open  mesenteric  stenting  (119).  According  to  the  National  Inpatient  Sam-­‐‑
ple  database,  the  mode  of  open  revascularization  for  AMI  in  the  United  State  during  1988-­‐‑
2006  was  embolectomy  in  49%,  bypass  in  44%,  and  endarterectomy  in  7%  (118).  The  corre-­‐‑
sponding  mortality  rates  were  49%,  28%,  and  38%,  respectively.  
Patients  with  AMI  are  critically  ill,  and  therefore,  the  procedure  time  has  to  be  as  short  as  
possible.  In  emergency  conditions,  retrograde  bypass  to  the  SMA  with  a  prosthetic  graft  is  
the  fastest  to  perform.  An  iliac  artery  to  SMA  bypass  using  a  C-­‐‑shaped  prosthetic  graft  has  
been  shown   to  perform  as  well  as  an  antegrade  bypass   in  CMI   (120).  Bypass   to   the  SMA  
alone  is  strongly  preferred  in  AMI  as  opposed  to  multi-­‐‑vessel  bypass  grafting.  Most  authors  
prefer  autologous  vein  in  AMI  due  to  the  fear  of  bacterial  contamination  of  the  abdomen,  
while  synthetic  grafts  seem  to  work  very  well  in  CMI  due  to  the  larger  diameter  of  the  graft  
and  the  excellent  outflow  of  the  SMA  (119,120).  
The  endovascular  approach   to   the   treatment  of   thrombotic  AMI   is  percutaneous   trans-­‐‑
luminal  angioplasty  (PTA)  with  stenting  (PTA/S)  through  femoral  or  brachial  access.  In  case  
of  calcified  total  occlusion  (instead  of  partial  stenosis  with  soft  thrombotic  component),  the  
brachial  access   is  preferred  owing   to  more   favorable  angle  of   the  SMA.  There  are   institu-­‐‑
tional   variations   in   the   PTA/S   techniques   and   instrumentation.   Balloon   expandable   bare  




Table 6. Studies published in the 21st century with more than 20 AMI patients treated with 
open, hybrid or endovascular revascularization for AMI. Bowel resection and mortality rates are 





























1990-2002 Open 22 72 50% 73% 132 Single-center 
Edwards (123) 1990-2000 Open 43 68 65% 53% 76 Single-center 
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23744 b NIS database 
(unweighted) 
Acosta (127) 2005-2008 EVT 21 73 32% 14% unknown Single-center 
Björnsson 
(114) 
1997-2009 EVT 34 c 78 24% 26% unknown 12 hospitals 
Jia (128) 2005-2012 EVT 21 71 24% 10% 28 Single-center 
Yun (117) 2003-2011 Open 25 d 74 56% 30% 32 d Single-center 
Raupach (116) 2003-2014 EVT 37 d 76 41% 27% unknown Single-center 
Newton (129) 2005-2008 Open 142 66 34% 30% unknown 211 hospitals 






50 52% 7% 58 Single-center 











a These are not actual numbers of patients but estimates from the National Inpatient Sample (NIS) data-
base, which contains a 20% sample of hospital stays in approximately 1000 hospitals in the United States. 
The given numbers represent weighted estimates for the entire population. 
b A total of 3976 patients were reported having only bowel resection, and 19089 patients did not receive 
any intervention. Therefore, the overall revascularization rate was less than 3%. 
c This study included only patients treated with intra-arterial thrombolysis with or without adjunctive 
endovascular procedures. 
d These studies included only patients with SMA embolism treated with open embolectomy (Yun), or me-
chanical aspiration with or without adjunctive endovascular procedures (Raupach). 





A  list  of  studies  published  in  the  21st  century  involving  more  than  20  AMI  patients  treat-­‐‑
ed  with  open,  hybrid,  or  endovascular  revascularization  (gathered  by  performing  PubMed  
search  for  publications  in  English  language)  is  presented  in  Table  6.    
Since  many  AMI  patients  are  fragile  and  elderly  people  with  poor  long-­‐‑term  survival  ex-­‐‑
pectancy,  it  has  to  be  individually  considered  whether  the  patient  will  actually  benefit  from  
aggressive  treatment  efforts  or   if   the  patient  should  be  treated  with  only  comfort  care  de-­‐‑
spite  all  the  modern  treatment  capabilities.  
2.5.1  Embolism  
Acute  SMA  embolism  can  be  treated  with  open  surgical  embolectomy  or  with  endovascular  
approach.  The  surgical  approach  to  the  SMA  is  performed  via  upper  midline  incision.  The  
SMA  is  exposed  below  the  transverse  mesocolon,  and  balloon  embolectomy  with  no.  2  or  3  
Fogarty  catheter  is  performed  through  a  transverse  arteriotomy  (113).  
In  the  past,  intra-­‐‑arterial  thrombolysis  was  the  primary  mode  of  EVT  in  SMA  embolism  
(114,115).  The  development  of   catheters   suitable   for   endovascular   aspiration  has   reduced  
the   need   for   thrombolysis,   and   today,   thrombolysis   has   been   superseded   by  mechanical  
aspiration  (116).  However,  catheter-­‐‑directed  continuous  infusion  of  thrombolytic  agent  can  
still  be  used  as  an  adjunct  to  clear  out  residual  thrombi  or  distal  embolization  after  endo-­‐‑
vascular  mechanical  aspiration.  
In  a  septic  patient  with  peritonitis,  laparotomy  is  the  primary  intervention  and  surgical  
embolectomy  is  the  fastest  way  to  achieve  intestinal  reperfusion  during  emergency  laparot-­‐‑
omy  (112).  In  stable  patients,  endovascular  mechanical  aspiration  has  been  technically  suc-­‐‑
cessful   in   73–100%  of   cases  with   10–86%  bowel   resection   rate   and  mortality   rate   ranging  
between  10–33%  (116).  These  results  compare  favorably  or  at  least  equally  with  the  30–49%  
mortality  rate  reported  for  open  embolectomy  in  AMI  (117,118).  If  EVT  is  successful  and  the  
symptoms   resolve   quickly,   laparotomy   can   be   avoided   in  more   than   half   of   the   patients  
with  SMA  embolism   (116).  However,   if   the  abdominal  pain  persists  after   technically   suc-­‐‑
cessful  EVT,  laparotomy  should  be  performed  without  delay.  Failure  to  resect  irreversibly  
damaged  bowel  will  lead  to  sepsis  and  even  larger  bowel  necrosis  (Figure  5).  
2.5.2  Thrombosis  
The  surgical  approaches  to  revascularization  in  thrombotic  (atherosclerotic)  occlusion  of  the  
SMA  are  antegrade  bypass,  retrograde  bypass,   thromboendarterectomy,  SMA  reimplanta-­‐‑
tion,  and  hybrid  open  mesenteric  stenting  (119).  According  to  the  National  Inpatient  Sam-­‐‑
ple  database,  the  mode  of  open  revascularization  for  AMI  in  the  United  State  during  1988-­‐‑
2006  was  embolectomy  in  49%,  bypass  in  44%,  and  endarterectomy  in  7%  (118).  The  corre-­‐‑
sponding  mortality  rates  were  49%,  28%,  and  38%,  respectively.  
Patients  with  AMI  are  critically  ill,  and  therefore,  the  procedure  time  has  to  be  as  short  as  
possible.  In  emergency  conditions,  retrograde  bypass  to  the  SMA  with  a  prosthetic  graft  is  
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been  shown   to  perform  as  well  as  an  antegrade  bypass   in  CMI   (120).  Bypass   to   the  SMA  
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brachial  access   is  preferred  owing   to  more   favorable  angle  of   the  SMA.  There  are   institu-­‐‑
tional   variations   in   the   PTA/S   techniques   and   instrumentation.   Balloon   expandable   bare  
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base, which contains a 20% sample of hospital stays in approximately 1000 hospitals in the United States. 
The given numbers represent weighted estimates for the entire population. 
b A total of 3976 patients were reported having only bowel resection, and 19089 patients did not receive 
any intervention. Therefore, the overall revascularization rate was less than 3%. 
c This study included only patients treated with intra-arterial thrombolysis with or without adjunctive 
endovascular procedures. 
d These studies included only patients with SMA embolism treated with open embolectomy (Yun), or me-
chanical aspiration with or without adjunctive endovascular procedures (Raupach). 






Figure 5. (a) A patient with acute embolic occlusion of the SMA (white open arrowhead) was 
treated with aspiration via brachial access (b) with excellent primary result (c). However, the 
abdominal pain persisted, and laparotomy was not performed until 12 hours after reperfusion 
when the patient was already in profound septic shock. Almost entire small bowel was necrotic. 
There was a good pulse in the SMA trunk but not in the mesentery. Thus, subsequent NOMI had 
developed due to vasospasm of the arteries (white arrowheads) and failure to resect damaged 
bowel on time. When damage control bowel resection was finally performed, the patient was left 
with only 20 cm of proximal jejunum, 10 cm additional jejunal segment and 15-20 cm of termi-
nal ileum, and the colon. Anastomoses were performed in second look, and ultimately, the 
patient survived with transitory short bowel syndrome. 
  
  
Recently,   a   study   comparing   bare  metal   stent   (n=164)   and   covered   stent   (n=61)   in   the  
treatment  of  CMI  showed  superior  primary  patency  and  freedom  from  recurrence  and  re-­‐‑
intervention  for  the  covered  stent  (132).  However,  there  are  not  yet  any  publications  regard-­‐‑
ing   the  use  of   SMA  stent  grafts   in  AMI   setting.   Furthermore,   stent  grafting  may  provide  
technical   disadvantages   and   limitations   over   conventional   stenting.   For   example,   in   the  
referred  study,  long  lesions  with  side-­‐‑branches  were  more  likely  to  be  treated  by  bare  metal  
stent,  and  thus,  the  study  groups  were  not  randomized.  
The  potential  complications  in  PTA/S  are  access-­‐‑related  problems  (in  2–15%),  inadvertent  
subintimal   recanalization,   dissection   of   the   SMA   (Figure   6),   and  perforation   of   the   distal  




mesenteric   hematoma,   thrombotic   occlusion   or   later   formation   of   a   false   aneurysm.   The  
guidewire  should  be  positioned  in  the  main  trunk  (i.e.  ileocolic  branch)  of  the  SMA  as  op-­‐‑
posed  to  distal  jejunal  branches,  which  are  more  prone  to  perforation.  Distal  embolization  is  
reported  in  8%  of  patients  treated  with  PTA/S  of  the  SMA  (133).  
As  an  alternative  to  percutaneous  procedure  or  if  the  endovascular  antegrade  recanaliza-­‐‑
tion  of  the  SMA  fails,  it  is  possible  to  utilize  retrograde  "ʺhybrid"ʺ  recanalization  of  the  SMA  
via   laparotomy   and   exposure   of   the   SMA   below   the   transverse  mesocolon.   The   SMA   is  
punctured   directly,   and   the   lesion   is   crossed   with   a   long   0.035"ʺ   hydrophilic   guidewire,  
which  is  snared  in  the  aorta  with  a  snare  passed  through  a  brachial  or  femoral  access.  From  
the   femoral  or  brachial   artery,   a   7  French   sheath   is  placed  over   the   through-­‐‑and-­‐‑through  
wire  to  the  SMA,  and  stenting  is  performed  in  an  antegrade  fashion  (131,134).   In  the  con-­‐‑
ventional   antegrade   recanalization   technique,   it  may  be  difficult   to   get   sufficient   support  
for  the  guidewire  to  be  able  to  pass  through  a  tight  stenosis  or  total  occlusion  of  the  SMA;  
this  is  not  an  issue  in  the  hybrid  technique.  If  the  patient  is  going  to  need  laparotomy  any-­‐‑
way,   risky   bypass   surgery   in   a   patient  with   peritonitis   could   be   avoided  with   this   tech-­‐‑
nique.  Further  advantages  of   the  hybrid  stenting  are   that   the  distal  SMA  and  major  side-­‐‑
branches  may  be  clamped  or  occluded  using  elastic  vessel   loops  to  avoid  distal  emboliza-­‐‑
tion,  and   in  case  of  a  major   thrombosis,  open  removal  of   the   thrombus  can  be  performed  
prior  to  the  stenting  (112).  
2.5.3  Non-­‐‑occlusive  mesenteric  ischemia  
NOMI  is  caused  by  mesenteric  hypoperfusion  as  a  result  of  a  low  flow-­‐‑state  and  vasocon-­‐‑
striction  of  the  mesenteric  vessels.  NOMI  has  been  associated  with  high  mortality  ranging  
from   approximately   70%   in   those   treated   with   bowel   resection   to   90%   in   those   without  
resection  (135).  This  may  be  true  in  the  obvious  presentations  of  NOMI,  which  are  intestinal  
infarction  and  ischemic  colitis.  However,  in  the  early  stage  of  NOMI,  surgery  is  not  a  thera-­‐‑
peutic  option.  The  treatment  of  the  underlying  cause  (e.g.,  cardiac  failure  or  sepsis)  has  to  
be  started  as  soon  as  possible,  and  further   treatment  goal   is   the  return  of  adequate  blood  
flow   to   the   intestine.   Patients  with   suspected  NOMI   are   initially   treated  with   aggressive  
fluid  resuscitation,  correction  of  anemia  and  electrolyte  imbalances,  antibiotics,  and  admin-­‐‑
istration  of  low  molecular  weight  heparin  (LMWH).  Laparotomy  is  performed  when  bowel  
infarction   is   suspected.  Alpha-­‐‑adrenergic   drugs   (norepinephrine)   should   be   avoided,   alt-­‐‑
hough  it  may  be  impossible  in  the  hypotensive  critically  ill  patient  (136).  
Some  authors  state  that  DSA,  CT,  and  ultrasound  are  not  useful  in  NOMI,  while  others  
encourage  the  use  of  CT  to  look  for  signs  of  intestinal  ischemia  and  to  rule  out  other  causes  
of  AMI  (such  as  the  occlusive  etiology)  (136,137).  DSA  is  an  invasive  procedure  and  diffi-­‐‑
cult  to  perform  on  intensive  care  patients.  However,  a  novel  study  showed  significant  cor-­‐‑
relation  of  mortality  and  the  level  of  vasospasm  seen  in  DSA  in  patients  with  NOMI  (25).  
Other  DSA  signs  that  associated  with  increased  mortality  were  reflux  of  contrast  medium  
into   the   aorta   and   delayed   portal   vein   filling   reflecting   increased   vasoconstriction   in   the  
mesentery.  Thus,  DSA  could  be  used  as  a  diagnostic  procedure,  and  even  further,  as  a  ther-­‐‑
apeutic  intervention  in  NOMI.    
Continuous  intra-­‐‑arterial  infusion  of  vasodilator  drugs  (usually  papaverine)  directly  into  
the  SMA  has  been  used  for  the  treatment  of  the  vasospasm  in  NOMI,  although  there  is  no  
strong  evidence  to  support  the  efficacy  of  the  therapy.  Papaverine  is  administrated  as  a  60  
mg  bolus  followed  by  infusion  (30–60  mg/h)  with  repeated  angiograms  obtained  every  24  
hours  (91).  Boley  and  associates  demonstrated  a  40%  mortality  rate  in  patients  with  NOMI  
by  performing  laparotomy  only  in  those  who  did  not  respond  to  treatment  with  papaverine  
(138).  Another   interesting   experimental   treatment  modality   is   intravenous   administration  
of  prostaglandin  E1  or  the  prostacyclin  analogue  iloprost  to  improve  the  hepato-­‐‑splanchnic  
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infarction   is   suspected.  Alpha-­‐‑adrenergic   drugs   (norepinephrine)   should   be   avoided,   alt-­‐‑
hough  it  may  be  impossible  in  the  hypotensive  critically  ill  patient  (136).  
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of  AMI  (such  as  the  occlusive  etiology)  (136,137).  DSA  is  an  invasive  procedure  and  diffi-­‐‑
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Other  DSA  signs  that  associated  with  increased  mortality  were  reflux  of  contrast  medium  
into   the   aorta   and   delayed   portal   vein   filling   reflecting   increased   vasoconstriction   in   the  
mesentery.  Thus,  DSA  could  be  used  as  a  diagnostic  procedure,  and  even  further,  as  a  ther-­‐‑
apeutic  intervention  in  NOMI.    
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the  SMA  has  been  used  for  the  treatment  of  the  vasospasm  in  NOMI,  although  there  is  no  
strong  evidence  to  support  the  efficacy  of  the  therapy.  Papaverine  is  administrated  as  a  60  
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hours  (91).  Boley  and  associates  demonstrated  a  40%  mortality  rate  in  patients  with  NOMI  
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of  prostaglandin  E1  or  the  prostacyclin  analogue  iloprost  to  improve  the  hepato-­‐‑splanchnic  







Figure 6. (a) A patient with CMI had a short thrombotic plaque in the proximal SMA (open white 
arrowhead). This looks like a simple task to treat with stenting. (b) The SMA lesion was crossed 
with a hydrophilic guidewire via right brachial access. (c) After balloon predilatation, DSA re-
vealed the dreaded complication, a long dissection of the SMA (white arrowheads) with the tip 
of the catheter supposedly in the false lumen (black arrowhead). Thus, the guidewire was inad-
vertently in the subintimal layer (b). Fortunately, the dissection was not flow-limiting and the 
patient was treated with only dual antiplatelet therapy and "watchful waiting". After a year, the 
false lumen had thrombosed causing residual stenosis of the proximal SMA, which was treated 
with PTA/S. 
  
2.5.4  Mesenteric  venous  thrombosis  
The   key   to   the   treatment   of   MVT   is   early   diagnosis.   Systemic   anticoagulation   prevents  
progression  of  the  thrombosis  and  is  associated  with  lower  mortality  and  higher  recanaliza-­‐‑
tion   rate   of   the   thrombosed  veins.   The   treatment   time  with  warfarin   is   usually  up   to   six  
months.   However,   lifelong   anticoagulation   is   recommended   for   patients   with   persistent  
hypercoagulable  state,  and  it  may  be  considered  even  to  those  with  idiopathic  MVT  (28).  
LMWH  can  be  started  immediately  to  patients  with  mild  symptoms  and  without  signs  of  
acute   intestinal   ischemia.  If   there  are  signs  of  progressing  bowel   ischemia  such  as  moder-­‐‑
ate-­‐‑to-­‐‑severe  abdominal  pain  or  significant  bowel  edema  in  CT,  the  initial  treatment  should  
be  started  with  continuous  infusion  of  unfractionated  heparin  instead  of  LMWH.  The  effect  




surgery.   In   case   of   severe   abdominal   pain   and   suspected   bowel   infarction   or   developing  
abdominal  compartment  syndrome,   laparotomy  and  often  extensive  resection  of  unviable  
bowel  is  needed  (28,113).  
Several  methods   for   endovascular  direct   thrombolysis   or  mechanical   thrombectomy  of  
the  MVT  have  been  developed  in  recent  years  (113).  These  include  indirect  thrombolysis  via  
the  SMA,  and  percutaneous  transhepatic  or  surgically  inserted  catheter-­‐‑directed  thrombo-­‐‑
lysis.  Transjugular   intrahepatic  portosystemic  shunting  has  been  used  to   increase  outflow  
in  the  portal  vein  and  to  facilitate  access  for  direct  mechanical  thrombectomy  and  thrombo-­‐‑
lysis  of  MVT.  
Di  Minno  and  coworkers  compared  a  group  of  18  MVT  patients  treated  with  percutane-­‐‑
ous  transhepatic  thrombolysis  to  a  group  of  14  patients  treated  with  anticoagulation  alone  
(141).  Flow  was  restored  in  16/18  patients  in  the  treatment  group.  The  mortality  rates  were  
17%  versus  14%,  bowel  resection  rates  6%  versus  36%,  and  the  rates  of  late  portal  hyperten-­‐‑
sion   11%   versus   50%   in   the   treatment   versus   control   group,   respectively.   In   contrast,   in  
another   series   of   20   patients   treated  with   transcatheter   thrombolysis   (including   four   pa-­‐‑
tients  with   liver   transplant),  none  of   the  patients  required  bowel  resection,  but  up  to  60%  
developed  major  complications   (142).  Thus,   there  are   risks   involved   in   the   invasive   treat-­‐‑
ment  of  MVT,  and  currently,  there  are  not  enough  evidence  to  support  wide-­‐‑spread  use  of  
this  technique  in  MVT  except  for  selected  cases.  
2.5.5  Bowel  viability  and  damage  control  surgery  
In  some  patients,  laparotomy  has  to  be  performed  on  the  basis  of  clinical  assessment  alone  
if  irreversible  bowel  damage  is  suspected.  Grey  and  smelly  bowel  is  frankly  ischemic,  while  
loss  of  peristalsis  and  mild  discoloration  are  more  subtle  ischemic  changes.  In  case  of  mas-­‐‑
sive   bowel   necrosis,   it   has   to   be  decided  whether   the  patient   can   actually   survive   before  
racing   into  extreme  resection.  The  survival   in  short  bowel  syndrome   is  dependent  on   the  
patient'ʹs   age,   and   length   and   anatomy  of   the   remaining   bowel.   The  prognosis   is   poor,   if  
entire  colon  is  removed  and  the  remaining  short  bowel  is  less  than  100  cm.  However,  if  the  
colon   and   terminal   ileum   are   preserved,   even   as   short   as   30   cm   of   short   bowel  may   be  
enough  for  the  patient  to  survive  (143).  
It  can  be  extremely  difficult  to  assess  which  part  of  the  bowel  is  salvageable  and  which  is  
not.  If  an  active  treatment  path  has  been  chosen,  it  is  preferred  to  perform  revascularization  
first,  unless   there   is  uncontrollable  spillage  of   intestine  content   in  the  abdomen.  Reassess-­‐‑
ment  of  the  bowel  viability  should  be  done  20-­‐‑30  minutes  after  successful  revascularization,  
after  which  the  resection  of  unviable  bowel,  if  necessary,  is  performed  sparingly  (144).  It  is  
not  recommended  to  perform  primary  anastomosis  in  case  of  peritonitis,  if  several  anasto-­‐‑
moses  are  required,  or  if  there  is  any  doubt  that  the  ischemic  bowel  damage  might  progress  
after   revascularization.  Damage  control  principles  may  be  used   liberally   (112).  The  bowel  
resections  are  performed  quickly  with  staples,  and  the  dissection  of  the  mesentery  should  
be  kept  close  to  the  bowel  to  spare  the  marginal  collateral  vessels.  The  abdomen  is  left  open  
in  patients  with  planned  second  look,  and  a  vacuum  dressing  is  applied.  The  abdomen  is  
re-­‐‑entered   24-­‐‑48   hours   after   the   initial   laparotomy   to   determine   whether   further   bowel  
resection  is  needed.  At  this  stage,  the  decision  to  perform  anastomoses  or  stomas  is  made  
based  on  the  patients  overall  condition  (144).  
Laparoscopy  has  not  been  of  great  diagnostic  value  in  the  initial  evaluation  of  bowel  is-­‐‑
chemia   in  AMI,  however,   it   could  have   a   role   in   assessing  bowel  vitality   after   successful  
endovascular  revascularization  (145).  
2.5.6  Medical  management  and  follow-­‐‑up  
The   initial  management   of  AMI   should   be   started  with   fluid   resuscitation   before   the  CT  
scan.  Electrolyte  imbalances  (usually  hyperkalemia)  and  anemia  should  be  corrected.  Bowel  
ischemia  causes  bacterial  translocation  through  the  bowel  wall  and  broad-­‐‑spectrum  antibi-­‐‑






Figure 6. (a) A patient with CMI had a short thrombotic plaque in the proximal SMA (open white 
arrowhead). This looks like a simple task to treat with stenting. (b) The SMA lesion was crossed 
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patient'ʹs   age,   and   length   and   anatomy  of   the   remaining   bowel.   The  prognosis   is   poor,   if  
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not  recommended  to  perform  primary  anastomosis  in  case  of  peritonitis,  if  several  anasto-­‐‑
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re-­‐‑entered   24-­‐‑48   hours   after   the   initial   laparotomy   to   determine   whether   further   bowel  
resection  is  needed.  At  this  stage,  the  decision  to  perform  anastomoses  or  stomas  is  made  
based  on  the  patients  overall  condition  (144).  
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scan.  Electrolyte  imbalances  (usually  hyperkalemia)  and  anemia  should  be  corrected.  Bowel  
ischemia  causes  bacterial  translocation  through  the  bowel  wall  and  broad-­‐‑spectrum  antibi-­‐‑




tions,  LMWH  should  be  started  to  inhibit  further  development  of  thrombosis.  If  vasopres-­‐‑
sors  are  required,  dobutamine  should  be  preferred  to  norepinephrine  (20).  
Post-­‐‑procedural  medical  management   include   anticoagulation   in   patients  with   arterial  
embolism  or  MVT  for  a  minimum  of  six  months,  or  lifelong  depending  on  the  underlying  
cause.  The  post-­‐‑procedure  medication  after  EVT  for  AMI  caused  by  atherosclerotic  vascular  
disease  is  comparable  to  that  of  other  peripheral  vascular  interventions  including  acetylsal-­‐‑
icylic  acid,  clopidogrel  and  statin  (24).  It  is  generally  accepted  that  dual  antiplatelet  therapy  
should  be  continued  for  a  minimum  of  6–8  weeks  after  SMA  stenting,  although  early  stent  
thrombosis  in  such  a  high-­‐‑flow  artery  is  rare.  
The  long-­‐‑term  patency  is  generally  known  to  be  significantly  lower  after  PTA/S  than  af-­‐‑
ter  surgical  bypass  of  the  SMA.  According  to  a  review  of  studies  with  patients  undergoing  
open  (n=1163)  or  endovascular   (n=776)  repair   for  CMI  between  1990  and  2009,  1-­‐‑year  pri-­‐‑
mary  patency  rates  were  91%  and  74%  in  open  and  endovascular  revascularization,  respec-­‐‑
tively   (146).  Approximately   30%  of  CMI  patients   treated  with  EVT   required   a   secondary  
procedure  during  two-­‐‑year  mean  follow-­‐‑up  time.  This  mandates  close  surveillance  of  AMI  
patients  treated  with  PTA/S,  at  least  of  those  with  significant  long-­‐‑term  survival  expectan-­‐‑
cy.  One  suggested  follow-­‐‑up  protocol  included  clinical  examination  and  duplex  ultrasound  
every  6  months  during  the  first  year  and  annually  thereafter  (133).  However,  the  evaluation  
of  in-­‐‑stent  restenosis  with  duplex  ultrasound  is  demanding  and  subject  to  error  (see  para-­‐‑
graph  2.4.3.1),  and  therefore,  CTA  might  be  preferred,  at  least  in  case  symptoms  recur.  The  
recurrence   of   symptoms   after   PTA/S   almost   invariably   means   re-­‐‑stenosis,   which   can   be  






3    The  aims  of  the  study  
The  overall  aims  of  this  study  were  to  evaluate  the  significance  of  AMI  as  a  cause  of  acute  
abdomen   in   adult   patients,   to   assess   the   accuracy   of   routine   abdominal   CT   in   detecting  
AMI,  and  furthermore,  to  evaluate  the  feasibility  and  outcome  of  EVT  as  the  primary  revas-­‐‑
cularization  method  in  AMI.  
  
The  specific  aims  were:  
  
1. To  determine  the  age-­‐‑specific  incidence  of  AMI  among  patients  admitted  to  hospital  
for  acute  abdominal  pain  
2. To  evaluate   the  emergency  department   radiologists'ʹ   ability   to  detect  AMI   in  CT  of  
the  acute  abdomen  in  the  clinical  setting  and  to  identify  factors  affecting  the  radiolo-­‐‑
gists'ʹ  performance  
3. To   study   the   utility   of   CT   findings   in   detecting   patients  who   develop   acute   upon  
chronic  mesenteric  ischemia  
4. To  evaluate  interobserver  agreement  on  the  interpretation  of  vascular  and  intestinal  
CT  findings  in  patients  with  symptomatic  mesenteric  atherosclerosis  
5. To   determined   the   technical   success   rate,   bowel   resection   rate,   complications,   and  





tions,  LMWH  should  be  started  to  inhibit  further  development  of  thrombosis.  If  vasopres-­‐‑
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3    The  aims  of  the  study  
The  overall  aims  of  this  study  were  to  evaluate  the  significance  of  AMI  as  a  cause  of  acute  
abdomen   in   adult   patients,   to   assess   the   accuracy   of   routine   abdominal   CT   in   detecting  
AMI,  and  furthermore,  to  evaluate  the  feasibility  and  outcome  of  EVT  as  the  primary  revas-­‐‑
cularization  method  in  AMI.  
  
The  specific  aims  were:  
  
1. To  determine  the  age-­‐‑specific  incidence  of  AMI  among  patients  admitted  to  hospital  
for  acute  abdominal  pain  
2. To  evaluate   the  emergency  department   radiologists'ʹ   ability   to  detect  AMI   in  CT  of  
the  acute  abdomen  in  the  clinical  setting  and  to  identify  factors  affecting  the  radiolo-­‐‑
gists'ʹ  performance  
3. To   study   the   utility   of   CT   findings   in   detecting   patients  who   develop   acute   upon  
chronic  mesenteric  ischemia  
4. To  evaluate  interobserver  agreement  on  the  interpretation  of  vascular  and  intestinal  
CT  findings  in  patients  with  symptomatic  mesenteric  atherosclerosis  
5. To   determined   the   technical   success   rate,   bowel   resection   rate,   complications,   and  








4    Patients  and  methods  
4.1 STUDY DESIGN AND PATIENTS 
This  thesis  is  based  on  a  retrospective  study,  which  was  approved  by  the  local  ethics  com-­‐‑
mittee  of  Kuopio  University  Hospital.  Formal   informed  consent  was  not  required   for   this  
type  of  study.  Our  institution  serves  as  a  tertiary  referral  hospital  for  five  health  care  dis-­‐‑
tricts   and   solely  provides   secondary   care   for   a  well-­‐‑defined  population  of   approximately  
248  000   inhabitants   in  Kuopio  university  hospital   area   in  Finland.  All  patients  with  acute  
abdomen  are   referred  or  directly   transferred   to   the  emergency  department  of  our   institu-­‐‑
tion.  Thus,  we  see  nearly  all  patients  with  acute  abdominal  pain  from  this  population.    
4.1.1  Screening  methods  for  study  patients  
A  thorough  search  of  the  hospital  electronic  medical  record,  and  surgical  and  endovascular  
databases  was  performed  to   find  all  consecutive  patients   treated  for  AMI  during  a  5-­‐‑year  
study  period  from  January  2009  to  December  2013.    
It  was  presumed  that  not  all  patients  with  AMI  were  assigned  the  appropriate   interna-­‐‑
tional  classification  of  disease  10  (ICD-­‐‑10)  code  (K55.0,  acute  vascular  disorder  of  intestine).  
Therefore,  a  meticulous  screening  of  approximately  750  hits  with  multiple  associated  ICD-­‐‑
10   codes   (K55.0,   K55.1,   K55.8,   K55.9,   I74.8,   I82.88,   I81,   K65.0,   K63.1,   K63.8,   I71.00,   I71.01,  
I71.09,  I71.4,  I71.3)  for  various  conditions  (such  as  peritonitis)  was  carried  out.  All  patients  
with  AMI  were  manually  identified.  
For   the  purpose  of   comparing   the   incidence  of  AMI  with  other  diagnoses  of   the   acute  
abdomen,  we  screened  for  patients  admitted  for  acute  appendicitis,  acute  pancreatitis,  acute  
cholecystitis  and  RAAA  during  the  study  period.  It  was  presumed  that  all  appendectomies  
within   the   study   population   were   performed   at   our   institution.   The   number   of   patients  
with  acute  appendicitis  is  equivalent  to  the  number  of  appendectomies  performed  with  the  
diagnosis  of  appendicitis  (K35-­‐‑K37).  These  cases  were  identified  from  a  search  of  the  opera-­‐‑
tive   database,   and   cases   of   prophylactic   appendectomy   were   excluded.   Cases   involving  
admission   for  RAAA   (I71.3)  were   identified   from  a   search  of   the   operative  database   and  
electronic  medical   records,   including   cases   treated  with  open  or   endovascular   surgery  or  
with   only   palliative   care.   The   numbers   of   hospitalization   for   acute   pancreatitis   (K85.*   or  
K86.00)   and   acute   cholecystitis   (K80.*,  K81.0)  were   searched   for   a   2-­‐‑year  period   covering  
2009  and  2010.  
4.1.2  Overall  study  design  
A  total  of  136  patients  with  primary  mesenteric  ischemia  were  detected,  of  whom  111  had  
AMI  and  25  were  determined  as  CMI.  This  study  focused  on  patients  admitted  to  the  acute  
care  unit  for  acute  abdomen.  Therefore,  patients  who  developed  AMI  either  during  inten-­‐‑
sive  care  for  other  diseases  or  directly  related  to  major  surgery  (e.g.,  aortic  or  cardiac  sur-­‐‑
gery)  were  not  searched  nor  included  in  the  further  analyses.  All  publications  were  based  
on  the  same  patient  material.    
The  flow  chart  of  the  studies  I-­‐‑III  is  presented  in  Figure  7.  Study  I  was  a  research  on  the  
hospital   incidence  of  AMI  within  our  health   care  district.   Study   II  was  an  analysis  of   the  
emergency  department  radiologists'ʹ  ability  to  detect  AMI,  and  the  CT  findings  were  exam-­‐‑
ined  and  categorized  according  to  the  etiology  of  AMI.  In  study  III,  the  feasibility  and  out-­‐‑
come  of  EVT   in  occlusive  AMI  was  evaluated.  Finally,   interobserver  variability   in   the  CT  
interpretation  of  vascular  and  intestinal  findings  in  patients  with  symptomatic  mesenteric  
atherosclerosis,  and  the  utility  of  CT  findings  in  detecting  those  who  develop  AOCMI,  was  







4    Patients  and  methods  
4.1 STUDY DESIGN AND PATIENTS 
This  thesis  is  based  on  a  retrospective  study,  which  was  approved  by  the  local  ethics  com-­‐‑
mittee  of  Kuopio  University  Hospital.  Formal   informed  consent  was  not  required   for   this  
type  of  study.  Our  institution  serves  as  a  tertiary  referral  hospital  for  five  health  care  dis-­‐‑
tricts   and   solely  provides   secondary   care   for   a  well-­‐‑defined  population  of   approximately  
248  000   inhabitants   in  Kuopio  university  hospital   area   in  Finland.  All  patients  with  acute  
abdomen  are   referred  or  directly   transferred   to   the  emergency  department  of  our   institu-­‐‑
tion.  Thus,  we  see  nearly  all  patients  with  acute  abdominal  pain  from  this  population.    
4.1.1  Screening  methods  for  study  patients  
A  thorough  search  of  the  hospital  electronic  medical  record,  and  surgical  and  endovascular  
databases  was  performed  to   find  all  consecutive  patients   treated  for  AMI  during  a  5-­‐‑year  
study  period  from  January  2009  to  December  2013.    
It  was  presumed  that  not  all  patients  with  AMI  were  assigned  the  appropriate   interna-­‐‑
tional  classification  of  disease  10  (ICD-­‐‑10)  code  (K55.0,  acute  vascular  disorder  of  intestine).  
Therefore,  a  meticulous  screening  of  approximately  750  hits  with  multiple  associated  ICD-­‐‑
10   codes   (K55.0,   K55.1,   K55.8,   K55.9,   I74.8,   I82.88,   I81,   K65.0,   K63.1,   K63.8,   I71.00,   I71.01,  
I71.09,  I71.4,  I71.3)  for  various  conditions  (such  as  peritonitis)  was  carried  out.  All  patients  
with  AMI  were  manually  identified.  
For   the  purpose  of   comparing   the   incidence  of  AMI  with  other  diagnoses  of   the   acute  
abdomen,  we  screened  for  patients  admitted  for  acute  appendicitis,  acute  pancreatitis,  acute  
cholecystitis  and  RAAA  during  the  study  period.  It  was  presumed  that  all  appendectomies  
within   the   study   population   were   performed   at   our   institution.   The   number   of   patients  
with  acute  appendicitis  is  equivalent  to  the  number  of  appendectomies  performed  with  the  
diagnosis  of  appendicitis  (K35-­‐‑K37).  These  cases  were  identified  from  a  search  of  the  opera-­‐‑
tive   database,   and   cases   of   prophylactic   appendectomy   were   excluded.   Cases   involving  
admission   for  RAAA   (I71.3)  were   identified   from  a   search  of   the   operative  database   and  
electronic  medical   records,   including   cases   treated  with  open  or   endovascular   surgery  or  
with   only   palliative   care.   The   numbers   of   hospitalization   for   acute   pancreatitis   (K85.*   or  
K86.00)   and   acute   cholecystitis   (K80.*,  K81.0)  were   searched   for   a   2-­‐‑year  period   covering  
2009  and  2010.  
4.1.2  Overall  study  design  
A  total  of  136  patients  with  primary  mesenteric  ischemia  were  detected,  of  whom  111  had  
AMI  and  25  were  determined  as  CMI.  This  study  focused  on  patients  admitted  to  the  acute  
care  unit  for  acute  abdomen.  Therefore,  patients  who  developed  AMI  either  during  inten-­‐‑
sive  care  for  other  diseases  or  directly  related  to  major  surgery  (e.g.,  aortic  or  cardiac  sur-­‐‑
gery)  were  not  searched  nor  included  in  the  further  analyses.  All  publications  were  based  
on  the  same  patient  material.    
The  flow  chart  of  the  studies  I-­‐‑III  is  presented  in  Figure  7.  Study  I  was  a  research  on  the  
hospital   incidence  of  AMI  within  our  health   care  district.   Study   II  was  an  analysis  of   the  
emergency  department  radiologists'ʹ  ability  to  detect  AMI,  and  the  CT  findings  were  exam-­‐‑
ined  and  categorized  according  to  the  etiology  of  AMI.  In  study  III,  the  feasibility  and  out-­‐‑
come  of  EVT   in  occlusive  AMI  was  evaluated.  Finally,   interobserver  variability   in   the  CT  
interpretation  of  vascular  and  intestinal  findings  in  patients  with  symptomatic  mesenteric  
atherosclerosis,  and  the  utility  of  CT  findings  in  detecting  those  who  develop  AOCMI,  was  







Figure 7. Flow chart of the patients in studies I-III. Arrows with dashed line represent excluded 
patients in each study. * = Two patients had tumor infiltration of the SMA; one patient had 
aortic dissection with acute intestinal ischemia at presentation. 
  
4.1.3  Determination  of  AMI  and  etiology  in  general  
The  verification  of  AMI  diagnosis  and  the  determination  of  etiology  were  based  on  clinical  
data,   imaging,   surgery,   and  autopsy,  when  available.  A   team  consisting  of   an  abdominal  
radiologist,  interventional  radiologist,  and  a  specialist  in  vascular  and  gastrointestinal  sur-­‐‑
gery  reanalysed  the  CT  and  DSA  images  of  all  screened  patients.    
Embolism  was  defined  as  a  pathognomonic  clot  surrounded  by  contrast  material  in  a  non-­‐‑
calcified  arterial   segment  of   the  SMA.  A  very  acute  onset  of   symptoms,  atrial   fibrillation,  
findings  of  cardiac   thrombi   in  CT,  and   the  presence  of  other  synchronous  embolic  events  
(i.e.   solid   abdominal   organ   infarction,   stroke,   or   limb   embolism)   were   also   indicative   of  
embolic  etiology.  
Thrombosis  was  defined  as  a)  a  thrombotic  occlusion  with  superimposed  calcified  stenosis  
of  the  SMA,  or  b)  a  chronic  occlusion  or  severe  stenosis  (70-­‐‑99%)  of  the  SMA,  together  with  
significant  atherosclerotic  obstruction  of  the  CA  or  IMA  in  a  patient  with  acute  episode  of  
prolonged  symptoms  and  other  findings  consistent  with  the  diagnosis  of  AMI.  (In  the  orig-­‐‑





NOMI  (as  non-­‐‑obstructive  mesenteric  ischemia)  was  defined  as  severe  hypoperfusion  of  
the  intestine  or  fulminant  ischemic  colitis  without  significant  obstruction  of  the  SMA.  
MVT  was  defined  as  acute  abdominal  pain  and  related  symptoms   together  with  major  
thrombosis   of   the   SMV   and   surrounding  mesenteric   edema   indicating   acute   thrombosis.  
Patients  with  isolated  portal  vein  thrombosis  were  not  included.  
Venous  mesenteric  ischemia  was  defined  as  acute  or  subacute  MVT  with  CT  findings  sug-­‐‑
gesting  intestinal  ischemia  (such  as  bowel  wall  thickening  with  ascites  or  abnormal  bowel  
wall  enhancement)  or  advanced  intestinal  injury  requiring  bowel  resection.  
4.1.4  Determination  of  AMI  in  study  II  
CT  was  obtained  in  95  AMI  patients  before  treatment  (Figure  7).  The  etiology  of  AMI  was  
determined   as   embolism   in   24,   thrombosis   in   37   (including   39   events),  NOMI   in   25,   and  
MVT   in   nine   patients.   The  definitive   diagnosis   of  AMI  was   confirmed   by   laparotomy  or  
autopsy  in  11  patients  in  the  embolism  group.  The  embolic  occlusion  of  the  SMA  was  con-­‐‑
firmed  by  CT  in  22  cases,  while  two  patients  had  distal  embolus  of  the  SMA  treated  with  
bowel   resection;   besides   intestinal   necrosis   and   histological   confirmation   of   thrombosed  
arteries  of   the  mesentery,  both  patients  had  atrial   fibrillation  and  synchronous  splenic   in-­‐‑
farction  consistent  with  the  embolic  etiology.  The  diagnosis  of  AMI  was  confirmed  by  lapa-­‐‑
rotomy  or  autopsy  in  19  patients  in  the  thrombosis  group  and  in  14  patients  in  the  NOMI  
group.  For  the  rest,  the  diagnosis  of  AMI  was  confirmed  by  one  of  the  following  features:  
acute  thrombotic  occlusion  of  the  SMA  in  CT  (n=6  in  the  thrombosis  group),  intestinal  CT  
findings  specific   for  AMI  (n=6  in  the  thrombosis  group,  n=5  in  the  NOMI  group),  or  non-­‐‑
specific  intestinal  CT  findings  (n=8  in  the  thrombosis  group,  n=6  in  the  NOMI  group).  All  
patients  had  acute   clinical  presentation  pattern   consistent  with   the  diagnosis  of  AMI  and  
appropriate   response   to   treatment.  All  patients  with  MVT  were  diagnosed  with  CT;  only  
one  required  laparotomy.  
4.1.5  Determination  of  AMI  in  study  III  
A  total  of  66  patients  with  embolic  or  thrombotic  AMI  were  eligible  for  the  study  III.  The  
clinical  diagnosis  was   confirmed  by   laparotomy   in   29   (44%)  patients,  CT   in   36   (54%)  pa-­‐‑
tients,   and  autopsy  alone   in  one   (2%)  patient.  Altogether,  CT  was  performed   in  61   (92%)  
patients  in  the  study  III.  
4.1.6  Patients  and  study  groups  in  study  IV  
The  fourth  study  constituted  a  substudy  of  the  136  initial  patients  focusing  on  patients  who  
developed  acute  upon  CMI.  Patients  with  intermittent  CMI  were  used  as  a  control  group.  
The   inclusion  criteria  were  a)   symptomatic  arterial  AMI  or  CMI,  b)   contrast  enhanced  CT  
obtained  before  treatment,  and  c)  significant  (>50%)  obstruction  of  the  SMA  caused  by  ath-­‐‑
erosclerotic  vascular  disease  based  on  CT  findings  and  verified  by  DSA.  Thus,  patients  with  
embolic  AMI,  NOMI  or  MVT  were  excluded   from   this   study,  as  were  also   those  without  
DSA  imaging.    
A   total   of   47  patients  met   the   inclusion   criteria   and  were   categorized  as  AOCMI   (case  
group)  or  CMI  (control  group)  by  a  specialist  in  gastrointestinal  and  vascular  surgery  based  
on  all  available   information  on   the  patient'ʹs  clinical  presentation,   treatment  and  outcome.  
The  basic  criteria  for  the  two  study  groups  were:  
  
AOCMI  (n=27)  
− Fulminant  disease  or  persistent  symptoms  consistent  with  the  clinical  presentation  of  
acute  intestinal  ischemia    
− Significantly  elevated  CRP  or  WBC  count  
− Intestinal  ischemia  verified  by  laparotomy  (n=13),  or  emergency  revascularization  re-­‐‑
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aortic dissection with acute intestinal ischemia at presentation. 
  
4.1.3  Determination  of  AMI  and  etiology  in  general  
The  verification  of  AMI  diagnosis  and  the  determination  of  etiology  were  based  on  clinical  
data,   imaging,   surgery,   and  autopsy,  when  available.  A   team  consisting  of   an  abdominal  
radiologist,  interventional  radiologist,  and  a  specialist  in  vascular  and  gastrointestinal  sur-­‐‑
gery  reanalysed  the  CT  and  DSA  images  of  all  screened  patients.    
Embolism  was  defined  as  a  pathognomonic  clot  surrounded  by  contrast  material  in  a  non-­‐‑
calcified  arterial   segment  of   the  SMA.  A  very  acute  onset  of   symptoms,  atrial   fibrillation,  
findings  of  cardiac   thrombi   in  CT,  and   the  presence  of  other  synchronous  embolic  events  
(i.e.   solid   abdominal   organ   infarction,   stroke,   or   limb   embolism)   were   also   indicative   of  
embolic  etiology.  
Thrombosis  was  defined  as  a)  a  thrombotic  occlusion  with  superimposed  calcified  stenosis  
of  the  SMA,  or  b)  a  chronic  occlusion  or  severe  stenosis  (70-­‐‑99%)  of  the  SMA,  together  with  
significant  atherosclerotic  obstruction  of  the  CA  or  IMA  in  a  patient  with  acute  episode  of  
prolonged  symptoms  and  other  findings  consistent  with  the  diagnosis  of  AMI.  (In  the  orig-­‐‑





NOMI  (as  non-­‐‑obstructive  mesenteric  ischemia)  was  defined  as  severe  hypoperfusion  of  
the  intestine  or  fulminant  ischemic  colitis  without  significant  obstruction  of  the  SMA.  
MVT  was  defined  as  acute  abdominal  pain  and  related  symptoms   together  with  major  
thrombosis   of   the   SMV   and   surrounding  mesenteric   edema   indicating   acute   thrombosis.  
Patients  with  isolated  portal  vein  thrombosis  were  not  included.  
Venous  mesenteric  ischemia  was  defined  as  acute  or  subacute  MVT  with  CT  findings  sug-­‐‑
gesting  intestinal  ischemia  (such  as  bowel  wall  thickening  with  ascites  or  abnormal  bowel  
wall  enhancement)  or  advanced  intestinal  injury  requiring  bowel  resection.  
4.1.4  Determination  of  AMI  in  study  II  
CT  was  obtained  in  95  AMI  patients  before  treatment  (Figure  7).  The  etiology  of  AMI  was  
determined   as   embolism   in   24,   thrombosis   in   37   (including   39   events),  NOMI   in   25,   and  
MVT   in   nine   patients.   The  definitive   diagnosis   of  AMI  was   confirmed   by   laparotomy  or  
autopsy  in  11  patients  in  the  embolism  group.  The  embolic  occlusion  of  the  SMA  was  con-­‐‑
firmed  by  CT  in  22  cases,  while  two  patients  had  distal  embolus  of  the  SMA  treated  with  
bowel   resection;   besides   intestinal   necrosis   and   histological   confirmation   of   thrombosed  
arteries  of   the  mesentery,  both  patients  had  atrial   fibrillation  and  synchronous  splenic   in-­‐‑
farction  consistent  with  the  embolic  etiology.  The  diagnosis  of  AMI  was  confirmed  by  lapa-­‐‑
rotomy  or  autopsy  in  19  patients  in  the  thrombosis  group  and  in  14  patients  in  the  NOMI  
group.  For  the  rest,  the  diagnosis  of  AMI  was  confirmed  by  one  of  the  following  features:  
acute  thrombotic  occlusion  of  the  SMA  in  CT  (n=6  in  the  thrombosis  group),  intestinal  CT  
findings  specific   for  AMI  (n=6  in  the  thrombosis  group,  n=5  in  the  NOMI  group),  or  non-­‐‑
specific  intestinal  CT  findings  (n=8  in  the  thrombosis  group,  n=6  in  the  NOMI  group).  All  
patients  had  acute   clinical  presentation  pattern   consistent  with   the  diagnosis  of  AMI  and  
appropriate   response   to   treatment.  All  patients  with  MVT  were  diagnosed  with  CT;  only  
one  required  laparotomy.  
4.1.5  Determination  of  AMI  in  study  III  
A  total  of  66  patients  with  embolic  or  thrombotic  AMI  were  eligible  for  the  study  III.  The  
clinical  diagnosis  was   confirmed  by   laparotomy   in   29   (44%)  patients,  CT   in   36   (54%)  pa-­‐‑
tients,   and  autopsy  alone   in  one   (2%)  patient.  Altogether,  CT  was  performed   in  61   (92%)  
patients  in  the  study  III.  
4.1.6  Patients  and  study  groups  in  study  IV  
The  fourth  study  constituted  a  substudy  of  the  136  initial  patients  focusing  on  patients  who  
developed  acute  upon  CMI.  Patients  with  intermittent  CMI  were  used  as  a  control  group.  
The   inclusion  criteria  were  a)   symptomatic  arterial  AMI  or  CMI,  b)   contrast  enhanced  CT  
obtained  before  treatment,  and  c)  significant  (>50%)  obstruction  of  the  SMA  caused  by  ath-­‐‑
erosclerotic  vascular  disease  based  on  CT  findings  and  verified  by  DSA.  Thus,  patients  with  
embolic  AMI,  NOMI  or  MVT  were  excluded   from   this   study,  as  were  also   those  without  
DSA  imaging.    
A   total   of   47  patients  met   the   inclusion   criteria   and  were   categorized  as  AOCMI   (case  
group)  or  CMI  (control  group)  by  a  specialist  in  gastrointestinal  and  vascular  surgery  based  
on  all  available   information  on   the  patient'ʹs  clinical  presentation,   treatment  and  outcome.  
The  basic  criteria  for  the  two  study  groups  were:  
  
AOCMI  (n=27)  
− Fulminant  disease  or  persistent  symptoms  consistent  with  the  clinical  presentation  of  
acute  intestinal  ischemia    
− Significantly  elevated  CRP  or  WBC  count  
− Intestinal  ischemia  verified  by  laparotomy  (n=13),  or  emergency  revascularization  re-­‐‑






− Intermittent  symptoms  consistent  with  CMI:  disabling  postprandial  pain,   food   intol-­‐‑
erance,  and  avoidance  of  eating,  with  or  without  weight  loss  
− Spontaneous  resolution  of  acute  symptoms  (if  any)  
− Interventions  performed  electively  
4.1.7  Data  acquisition  
The  population  data  were   retrieved   from   the  Official   Statistics   authority   and   categorized  
into  nine   age  groups   (10–19,   20–29   ...   >90);   these  data  were  used   to   calculate   age-­‐‑specific  
incidence  rates  for  AMI  and  the  reference  diagnoses.  The  number  of  emergency  CT  studies  
of   the  abdomen  was  retrieved  from  the  radiology   information  system.  Comorbidities  and  
clinical  data  were  retrieved  from  the  electronic  medical  records.  The  duration  of  the  endo-­‐‑
vascular   procedure  was   calculated   using   the   time   stamps   of   the   first   and   the   last   angio-­‐‑
gram;  an  extra  15  minutes  was  added  for  the  estimated  time  spent  on  cannulation.    
4.1.8  Definitions  of  study  parameters  
Clinical  presentation,  duration  of   symptoms,   laboratory  values,   and  simultaneous  cardio-­‐‑
vascular  events  were  recorded  at  the  time  of  diagnosis,  which  was  usually  the  equivalent  of  
the   time   of   the   first   CT   examination.   Chronic   renal   insufficiency  was   defined   as   plasma  
creatinine  >130  µμmol/l  (1.5  mg/dl)  prior  to  hospitalization.  Acute  kidney  injury  was  defined  
as  plasma  creatinine  >130  µμmol/l  in  patients  with  previously  normal  renal  function,  or  >20%  
increase  of  plasma  creatinine  in  patients  with  chronic  renal  insufficiency  (115).  Synchronous  
ischemic   event   was   defined   as   preoperative   stroke,   acute   limb   ischemia,   or   CT   signs   of  
embolism  or  infarction  in  the  spleen,  liver,  or  kidney.  Diagnostic  delays  were  recorded,  and  
the  time  of  admission  was  defined  as  the  time  of  initial  presentation  to  any  hospital,  before  
transfer   to   our   tertiary   center.  Early  mortality  was  defined  as  death  within   30  days   from  
admission  or  during  hospitalization.  
4.1.9  Measures  of  outcome  
EVT  failure  was  defined  as  the  failure  to  recanalize  the  SMA,  significant  recoil  after  PTA/S,  
flow-­‐‑limiting  dissection  of  the  SMA,  or  failure  of  mechanical  thrombectomy  and  thrombo-­‐‑
lysis.  A  residual  occlusion  in  a  small  branch  of  the  SMA  was  not  considered  a  failure  if  flow  
to  the  main  stem  of  SMA  was  restored.  Technical  success  of  EVT  was  defined  as  return  of  
bowel  perfusion  with  or  without  need  for  bowel  resection.  Perioperative  and  postoperative  
complications  were   recorded;   bleeding   complications   included   only   events   that   required  
blood  transfusion  or  surgical   intervention.  The  late  mortality  was  monitored  using  an  au-­‐‑




4.2 DIAGNOSTIC IMAGING 
4.2.1  CT  imaging  protocols  
CT  protocols  were  categorized  as  unenhanced,  CTA,  portal  venous  phase,  biphasic  (defined  
as  CTA  +  portal  venous  phase,  with  or  without  an  unenhanced  phase),  and  split-­‐‑bolus.  In  
study  II,  CT  imaging  was  performed  using  a  64-­‐‑slice  MDCT  system  in  96  AMI  events  (So-­‐‑
matom  Definition  AS64;  Siemens  Medical  Systems   in  89  events  and  Toshiba  Aquilion  64;  
Toshiba   Medical   Systems   in   seven   events).   One   patient   was   examined   with   a   16-­‐‑slice  
MDCT  (Sensation  16;  Siemens  Medical  Systems).    
4.2.2  Image  analysis  
The  CT  examinations  were  evaluated  retrospectively,  blindly,  and  independently  by  three  




of  experience  in  abdominal  radiology.  Observer  C  was  an  interventional  radiologist  with  11  
years  of  experience  in  vascular  interventional  radiology.  The  observers  were  told  to  look  for  
mesenteric  ischemia,  but  they  were  blinded  to  the  diagnosis,  other  imaging,  and  all  clinical  
information.  Observer  A  scrutinized  the  initial  CT  examinations  of  all  patients  in  studies  I-­‐‑
III.  Observers  B  and  C  were   involved   in   the   interobserver  variability   test   in  study  IV.  All  
DSA   images   were   analysed   by   the   observer   C   independently   and   blinded   from   the   CT  
analysis  with  year  and  a  half  between  the  analyses.  
The  CT  findings  were  evaluated  according  to  a  predefined  scheme.  The  SMA  obstruction  
was  graded  as  100%  occlusion,  70-­‐‑99%,  50-­‐‑70%,  <50%  or  no  stenosis,  and  characterized  as  
embolic,   thrombotic   (with   superimposed   calcified   stenosis),   or   chronic   calcified   lesion.  A  
similar   grading   was   used   for   CA   and   IMA   obstruction.   A   hemodynamically   significant  
stenosis   of   the  CA  was   defined   as   ≥70%   based   on  CT   interpretation,  whereas   significant  
stenosis  of   the   IMA  was  defined  roughly  as  ≥50%.  The   following   intestinal   findings  were  
registered:  bowel  wall  enhancement,  bowel  wall  thickening,  bowel  lumen  dilatation,  mes-­‐‑
enteric  fat  stranding,  pneumatosis,  venous  gas,  ascites,  and  pneumoperitoneum  (108).  Small  
bowel  diameter  >2.5  cm  and  colon  diameter  >6  cm  (>9  cm  in  cecum)  were  considered  ab-­‐‑
normal  signs  of  intestinal  paralysis  (5,6).  Decreased  bowel  wall  enhancement,  pneumatosis,  
and  SMA  thromboembolsim  were  regarded  as  AMI-­‐‑specific  CT  findings.    
4.2.3  CT  referral  and  report  analysis  
The   referring  clinician'ʹs  primary  suspicion  of  AMI  was   registered.  The  on-­‐‑call   radiologist  
evaluated  all  CT  studies   in   the  24/7  emergency  setting.  The   radiologist’s   interpretation  of  
the  CT  findings  was  evaluated  from  the   initial   radiology  reports  and  considered  correct   if  
the  vascular  and  intestinal  findings  were  adequately  reported  and  a  diagnosis  of  AMI  was  
proposed  or  suspected.   If   the  radiologist  had  suspected  AMI  but   failed   to  report  some  of  
the  CT  findings,  or  if  the  radiologist  had  adequately  reported  all  relevant  findings  but  did  
not  propose  the  diagnosis  of  AMI,  then  the  CT  report  was  still  considered  essentially  cor-­‐‑
rect.  If  the  radiologist  missed  the  relevant  findings  and  failed  to  suspect  AMI,  the  CT  report  




4.3.1  Treatment  strategies  
There  was  no  predefined  treatment  algorithm  in  this  study.  In  cases  of  occlusive  AMI,  the  
decision   to   perform   a   laparotomy   first,   consult   an   interventional   radiologist,   or   treat   the  
patient   conservatively  was   the   responsibility   of   the   on-­‐‑call   gastrointestinal   surgeon.   The  
primary   intervention   was   defined   as   EVT   first   or   laparotomy   first.   Laparotomy   was   per-­‐‑
formed  after   initial  EVT,   if  necessary.  Unviable  bowel  was   resected  with  primary  anasto-­‐‑
mosis,  except  in  cases  with  massive  unresectable  necrosis  of  the  intestine.  Open  revascular-­‐‑
ization  was  not  used  as   the  primary   treatment   approach  during   the   study  period;   it  was  
performed  selectively  after   failure  of  EVT.  Relaparotomy  was  performed  as  a  planned  se-­‐‑
cond  look  or  on  demand.  
NOMI  patients  were  primarily  treated  with  conservative  treatment,  and  laparotomy  was  
performed  in  cases  of  advanced  peritoneal  signs  and  symptoms.  
Patients  with  acute  MVT  were  started  on  LMWH  or  continuous  infusion  of  unfractionat-­‐‑
ed   heparin   at   admission.   Percutaneous   transhepatic   catheter-­‐‑directed   thrombolysis   was  
considered  for  patients  with  extensive  portomesenteric  venous  thrombosis  and  bowel  ede-­‐‑
ma.   Laparotomy  was   performed   in   case   of   suspected   intestinal   necrosis.  Anticoagulation  






− Intermittent  symptoms  consistent  with  CMI:  disabling  postprandial  pain,   food   intol-­‐‑
erance,  and  avoidance  of  eating,  with  or  without  weight  loss  
− Spontaneous  resolution  of  acute  symptoms  (if  any)  
− Interventions  performed  electively  
4.1.7  Data  acquisition  
The  population  data  were   retrieved   from   the  Official   Statistics   authority   and   categorized  
into  nine   age  groups   (10–19,   20–29   ...   >90);   these  data  were  used   to   calculate   age-­‐‑specific  
incidence  rates  for  AMI  and  the  reference  diagnoses.  The  number  of  emergency  CT  studies  
of   the  abdomen  was  retrieved  from  the  radiology   information  system.  Comorbidities  and  
clinical  data  were  retrieved  from  the  electronic  medical  records.  The  duration  of  the  endo-­‐‑
vascular   procedure  was   calculated   using   the   time   stamps   of   the   first   and   the   last   angio-­‐‑
gram;  an  extra  15  minutes  was  added  for  the  estimated  time  spent  on  cannulation.    
4.1.8  Definitions  of  study  parameters  
Clinical  presentation,  duration  of   symptoms,   laboratory  values,   and  simultaneous  cardio-­‐‑
vascular  events  were  recorded  at  the  time  of  diagnosis,  which  was  usually  the  equivalent  of  
the   time   of   the   first   CT   examination.   Chronic   renal   insufficiency  was   defined   as   plasma  
creatinine  >130  µμmol/l  (1.5  mg/dl)  prior  to  hospitalization.  Acute  kidney  injury  was  defined  
as  plasma  creatinine  >130  µμmol/l  in  patients  with  previously  normal  renal  function,  or  >20%  
increase  of  plasma  creatinine  in  patients  with  chronic  renal  insufficiency  (115).  Synchronous  
ischemic   event   was   defined   as   preoperative   stroke,   acute   limb   ischemia,   or   CT   signs   of  
embolism  or  infarction  in  the  spleen,  liver,  or  kidney.  Diagnostic  delays  were  recorded,  and  
the  time  of  admission  was  defined  as  the  time  of  initial  presentation  to  any  hospital,  before  
transfer   to   our   tertiary   center.  Early  mortality  was  defined  as  death  within   30  days   from  
admission  or  during  hospitalization.  
4.1.9  Measures  of  outcome  
EVT  failure  was  defined  as  the  failure  to  recanalize  the  SMA,  significant  recoil  after  PTA/S,  
flow-­‐‑limiting  dissection  of  the  SMA,  or  failure  of  mechanical  thrombectomy  and  thrombo-­‐‑
lysis.  A  residual  occlusion  in  a  small  branch  of  the  SMA  was  not  considered  a  failure  if  flow  
to  the  main  stem  of  SMA  was  restored.  Technical  success  of  EVT  was  defined  as  return  of  
bowel  perfusion  with  or  without  need  for  bowel  resection.  Perioperative  and  postoperative  
complications  were   recorded;   bleeding   complications   included   only   events   that   required  
blood  transfusion  or  surgical   intervention.  The  late  mortality  was  monitored  using  an  au-­‐‑




4.2 DIAGNOSTIC IMAGING 
4.2.1  CT  imaging  protocols  
CT  protocols  were  categorized  as  unenhanced,  CTA,  portal  venous  phase,  biphasic  (defined  
as  CTA  +  portal  venous  phase,  with  or  without  an  unenhanced  phase),  and  split-­‐‑bolus.  In  
study  II,  CT  imaging  was  performed  using  a  64-­‐‑slice  MDCT  system  in  96  AMI  events  (So-­‐‑
matom  Definition  AS64;  Siemens  Medical  Systems   in  89  events  and  Toshiba  Aquilion  64;  
Toshiba   Medical   Systems   in   seven   events).   One   patient   was   examined   with   a   16-­‐‑slice  
MDCT  (Sensation  16;  Siemens  Medical  Systems).    
4.2.2  Image  analysis  
The  CT  examinations  were  evaluated  retrospectively,  blindly,  and  independently  by  three  




of  experience  in  abdominal  radiology.  Observer  C  was  an  interventional  radiologist  with  11  
years  of  experience  in  vascular  interventional  radiology.  The  observers  were  told  to  look  for  
mesenteric  ischemia,  but  they  were  blinded  to  the  diagnosis,  other  imaging,  and  all  clinical  
information.  Observer  A  scrutinized  the  initial  CT  examinations  of  all  patients  in  studies  I-­‐‑
III.  Observers  B  and  C  were   involved   in   the   interobserver  variability   test   in  study  IV.  All  
DSA   images   were   analysed   by   the   observer   C   independently   and   blinded   from   the   CT  
analysis  with  year  and  a  half  between  the  analyses.  
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4.3.1  Treatment  strategies  
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cond  look  or  on  demand.  
NOMI  patients  were  primarily  treated  with  conservative  treatment,  and  laparotomy  was  
performed  in  cases  of  advanced  peritoneal  signs  and  symptoms.  
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CMI   patients   were   usually   examined   electively   at   the   outpatient   clinic,   or   discharged  
from  the  hospital  after  spontaneous  resolution  of  symptoms.  EVT  was  the  primary  revascu-­‐‑
larization  modality  for  patients  with  CMI.  
4.3.2  EVT  technique  
The  primary  endovascular  technique  for  the  treatment  of  embolism  was  mechanical  throm-­‐‑
bectomy.  Embolus  and  massive  thrombosis  were  aspirated  using  a  6  French  guiding  cathe-­‐‑
ter.  Adjunctive  PTA  with  optional  stenting  of  the  underlying  lesion  was  performed,  if  nec-­‐‑
essary.   Catheter-­‐‑directed   thrombolysis  with   urokinase  was   utilized   if  mechanical   throm-­‐‑
bectomy  did  not  resolve  the  thrombus.  Primary  PTA/S  was  used  for  calcified  lesions  if  there  




Ninety-­‐‑five  patients  had  97  AMI  events  (three  separate  AMI  events  in  one  patient)  with  CT  
examination  prior  to  treatment.  The  demographics,  clinical  data,  diagnostic  and  therapeutic  
measures  of  those  95  patients  (retrieved  from  study  II)  are  presented  in  Tables  7  and  8.  
  
  
Table 7. Demographics of 95 patients with AMI (from study II). 
 
Demographics/comorbidities Embolism Thrombosis NOMI MVT p 
Number of AMI patients 24 (25) 37 (39) 25 (26) 9 (10)  
Age, years 79 ± 11 78 ± 9 76 ± 10 53 ± 11 0.04 
Gender, male 9 (38) 15 (41) 13 (52) 8 (89) <0.01 
Hypertension 12 (50) 28 (76) 17 (68) 3 (33) <0.05 
Hyperlipidemia 7 (29) 15 (41) 11 (44) 0 (0) 0.07 
Obesity (BMI ≥30 kg/m2) 6 (25) 5 (14) 6 (24) 4 (44) 0.29 
Diabetes mellitus 6 (25) 17 (46) 4 (16) 0 (0) 0.03 
Chronic renal insufficiency 1 (4) 2 (5) 1 (4) 0 (0) 0.99 
Coronary artery disease 14 (58) 17 (46) 10 (40) 0 (0) 0.02 
Peripheral arterial disease 4 (17) 17 (46) 3 (12) 0 (0) <0.01 
Stroke/transitory ischemic attack 8 (33) 10 (27) 8 (32) 0 (0) 0.21 
Atrial fibrillation 17 (71) 9 (24) 6 (24) 0 (0) <0.01 
Chronic heart failure 2 (8) 7 (19) 6 (24) 0 (0) 0.29 
Warfarin 7 (29) 6 (16) 3 (12) 0 (0) 0.26 
Acetylsalicylic acid 12 (50) 26 (70) 13 (52) 0 (0) <0.01 
Clopidogrel 1 (4) 4 (11) 1 (4) 0 (0) 0.76 
Statin 13 (54) 24 (65) 11 (40) 0 (0) <0.01 





Table 8. Clinical data, and diagnostic and therapeutic measures of 95 patients with 97 AMI 
events (from study II). 
 
Clinical characteristics Embolism Thrombosis NOMI MVT p 
Number of AMI events 24 (25) 39 (40) 25 (26) 9 (9)  
Duration of symptoms <24 h 15 (63) 7 (18) 9 (36) 0 (0) <0.01 
Acute myocardial infarction 3 (13) 2 (5) 0 (0) 0 (0) 0.23 
Acute kidney injury 0 (0) 5 (13) 10 (40) 0 (0) <0.01 
Metabolic acidosis a 6 (25) 5 (13) 13 (52) 0 (0) <0.01 
Laboratory values      
 WBC count, 109/l 12.8 (10-17) 16.2 (12-20) 10.9 (8-16) 10.6 (9-12) <0.01 
 CRP, mg/l 121 (11-235) 168 (100-207) 114 (11-218) 117 (67-170) 0.58 
 Plasma creatinine, µmol/l 91 (62-106) 69 (59-113) 96 (71-192) 71 (60-79) 0.06 
Delays (hours)      
 from admission to CT 3.9 (2-10) 5.6 (2-30) 5.0 (1-26) 5.4 (3-24) 0.52 
 from admission to diagnosis 4.6 (3-18) 5.6 (2-34) 14.1 (2-35) 5.4 (3-24) 0.91 
 from diagnosis to treatment 3.4 (2-5) 3.5 (2-23) 3.7 (3-6) - 0.53 
Diagnostic procedures      
 Laparotomy or autopsy 11 (45) 19 (49) 14 (56) 1 (11)  
 DSA 18 (75) 31 (79) 0 (0) 0 (0)  
 Unenhanced CT 0 (0) 2 (5) 3 (12) 0 (0)  
 Contrast enhanced CT 24 (100) 37 (95) 22 (88) 9 (100)  
 CTA 10 (42) 14 (36) 13 (52) 0 (0)  
 CT in venous phase alone 14 (58) 23 (59) 9 (36) 9 (100)  
Treatment      
 Endovascular therapy 18 (75) 31 (79) 0 (0) 1 (11)  
 Laparotomy 8 (33) 18 (46) 14 (56) 1 (11)  
 Bowel resection 7 (29) 14 (36) 12 (48) 1 (11)  
 Unresectable bowel necrosis 0 (0) 2 (5) 2 (8) 0 (0)  
 Surgical revascularization 0 (0) 2 (5) - -  
 Conservative treatment 3 (13) 4 (10) 11 (44) 8 (89)  
Data are presented as n (%) or median (interquartile range). 
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4.5 STATISTICAL ANALYSIS 
All  statistics  were  calculated  using  SPSS  22.0.  Continuous  variables  were  expressed  as  mean  
±   standard  deviation  or  median  and   interquartile   range.   Fisher’s   exact   test   or  χ²   test  was  
used   to   compare  nominal  data.  Regarding  nonparametric  data,   the  Mann-­‐‑Whitney  U   test  
was  used  to  compare  two  groups  and  the  Kruskal-­‐‑Wallis  one-­‐‑way  analysis  of  variance  for  
comparison  of  more  than  two  groups.  Univariate  analysis  of  risk  factors  was  performed  on  
independent   CT   findings   and   baseline   variables;   associations   with   mortality   and   bowel  
resection  rates  were  examined;  odds  ratio  was  used   to  reflect  odds  of   the  outcome  event.  
Long-­‐‑term   survival   was   illustrated   using   the   Kaplan-­‐‑Meier  method.   Cox   regression  was  
used  for  age-­‐‑adjusted  survival  analysis.  Spearman'ʹs  correlation  coefficients  were  calculated  
to  analyse  the  correlation  of  the  SMA  stenosis  grade  assessed  by  CT  versus  DSA.  The  kappa  
statistics  was  used  to  test  interobserver  agreement;  values  0.0  -­‐‑  0.2  were  considered  slight,  
0.2  -­‐‑  0.4  fair,  0.4  -­‐‑  0.6  moderate,  0.6  -­‐‑  0.8  substantial,  and  0.8  -­‐‑  1.0  near  perfect  agreement.  P  






5    Results  and  discussion  
5.1 STUDY I  
5.1.1  The  incidence  of  AMI  
A   crude   incidence   rate   is   an   abstract   concept   for   a   clinician   treating   patients  with   acute  
abdomen  on  a  daily  basis.  The  probability  of  AMI  being  the  cause  of  acute  abdominal  pain  
in  a  previously  healthy  60-­‐‑year  old  patient   is  entirely  different   than   in  an  80-­‐‑year  old  pa-­‐‑
tient  with  cardiovascular  risk  factors.  Therefore,  in  this  study,  the  incidence  of  AMI  is  pre-­‐‑
sented  as  age-­‐‑specific  rates  and  in  context  with  other  diagnoses  of  the  acute  abdomen.  
The  annual  incidence  rates  of  AMI  (including  all  etiologies)  and  occlusive  AMI  (includ-­‐‑
ing  embolism  and  thrombosis)  were  7.3  and  4.5/100,000  inhabitants,  respectively  (Table  9).  
In  patients  with  age  ≥75  years,  the  corresponding  incidence  rates  were  48.3  and  34.1/100,000  
person   years.   The   incidence   of  AMI   increased   exponentially  with   age   and   surpassed   the  
age-­‐‑specific   incidence  of   acute  appendicitis   at   75  years,   and   the  overall   incidence  of  AMI  
was  higher  than  RAAA  (Figure  8).  It  has  been  previously  demonstrated  that  acute  cholecys-­‐‑
titis  is  the  most  common  cause  for  emergency  abdominal  surgery  in  patients  aged  >65  years  
in   Finland   (72).   This   study   shows   that   acute   cholecystitis   has   a   similar   exponential   age-­‐‑
specific   incidence  curve  as  AMI.  Acute  pancreatitis,  on  the  other  hand,  showed  a  double-­‐‑
peaked   age-­‐‑specific   incidence   curve.   The   first   peak   is   due   to   alcohol   related  pancreatitis,  
and  the  second  peak  correlates  with  the  high  occurrence  of  gallstones  in  the  elderly.  Thus,  
acute  pancreatitis  was  slightly  more  common  in  the  elderly  than  AMI.  
The  incidence  of  AMI  at  our  hospital  area  is  in  line  with  the  incidence  rates  reported  in  
the  previous   contemporary   studies   (mentioned  previously   in   2.3.2)   (69,70).  However,   the  
high  incidence  of  AMI  over  three  decades  ago,  reported  in  the  Malmö  autopsy  study,  has  
not  been  traced  to  current  low  autopsy  rates  (2).  A  total  of  7796  urgent  abdominal  CTs  were  
performed  in  our  hospital  during  the  5-­‐‑year  study  period;  AMI  was  present   in  82  (1%)  of  
those  cases,  which  is  also  in  line  with  the  previous  study  on  CT  of  the  acute  abdomen  (see  
also  2.3.2)  (71).  
  
  
Table 9. Incidence rates of AMI and the references diagnoses during the study period (including 
all ages). 
 





AMI (all etiologies) 7.3 4.5–11.5 
 Occlusive AMI 4.5 2.5–8.1 
 NOMI 2.0 0.8–4.8 
 Venous mesenteric ischemia 0.5 - 
 Other etiologies 0.2 - 
Acute appendicitis 87.4 76.7–99.9 
RAAA 3.9 2.1–7.3 
Acute pancreatitis 45.6 37.9–54.8 
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was  higher  than  RAAA  (Figure  8).  It  has  been  previously  demonstrated  that  acute  cholecys-­‐‑
titis  is  the  most  common  cause  for  emergency  abdominal  surgery  in  patients  aged  >65  years  
in   Finland   (72).   This   study   shows   that   acute   cholecystitis   has   a   similar   exponential   age-­‐‑
specific   incidence  curve  as  AMI.  Acute  pancreatitis,  on  the  other  hand,  showed  a  double-­‐‑
peaked   age-­‐‑specific   incidence   curve.   The   first   peak   is   due   to   alcohol   related  pancreatitis,  
and  the  second  peak  correlates  with  the  high  occurrence  of  gallstones  in  the  elderly.  Thus,  
acute  pancreatitis  was  slightly  more  common  in  the  elderly  than  AMI.  
The  incidence  of  AMI  at  our  hospital  area  is  in  line  with  the  incidence  rates  reported  in  
the  previous   contemporary   studies   (mentioned  previously   in   2.3.2)   (69,70).  However,   the  
high  incidence  of  AMI  over  three  decades  ago,  reported  in  the  Malmö  autopsy  study,  has  
not  been  traced  to  current  low  autopsy  rates  (2).  A  total  of  7796  urgent  abdominal  CTs  were  
performed  in  our  hospital  during  the  5-­‐‑year  study  period;  AMI  was  present   in  82  (1%)  of  
those  cases,  which  is  also  in  line  with  the  previous  study  on  CT  of  the  acute  abdomen  (see  
also  2.3.2)  (71).  
  
  
Table 9. Incidence rates of AMI and the references diagnoses during the study period (including 
all ages). 
 





AMI (all etiologies) 7.3 4.5–11.5 
 Occlusive AMI 4.5 2.5–8.1 
 NOMI 2.0 0.8–4.8 
 Venous mesenteric ischemia 0.5 - 
 Other etiologies 0.2 - 
Acute appendicitis 87.4 76.7–99.9 
RAAA 3.9 2.1–7.3 
Acute pancreatitis 45.6 37.9–54.8 






Figure 8. The age-specific incidence rates of AMI and the reference diagnoses. 
  
5.1.2  Clinical  implications  
The   study   I   demonstrates   a   high   probability   of   AMI   in   elderly   patients   hospitalized   for  
acute  abdomen.  The  results  of  this  study  should  encourage  liberal  use  of  contrast  enhanced  
CT  in  elderly  patients  with  acute  abdominal  pain.  Furthermore,  the  biphasic  protocol  might  
be  preferred  especially   in  patients  with  known  risk   factors   for  atherosclerosis.  The  risk  of  
radiation-­‐‑induced  cancer  is  not  so  much  of  an  issue  in  elderly  patients,  and  moreover,  this  
risk  should  be  balanced  with  the  risk  of  fatal  delay  in  the  treatment  of  AMI.  
  
  
5.2 STUDY II  
5.2.1  Radiologists'ʹ  diagnostic  performance  
The  referring  clinician  had  suspected  AMI  in  only  30  cases  (31%)  prior  to  imaging,  and  the  
imaging  was  performed  in  portal  venous  phase  alone  in  the  majority  of  cases  (57%).  Only  
10%  of   the  CT  examinations  were  biphasic  and   the  split-­‐‑bolus  protocol  was  used   in  25%.  
Five   (5%)  CTs  were   unenhanced,   and   three   (3%)  were   performed   in   angiographic   phase  
alone.   Whether   the   CT   protocol   was   optimal   for   AMI   (biphasic   or   split-­‐‑bolus)   or   non-­‐‑
optimal  did  not  have  any  significant  effect  on  the  CT  report  correctness  in  our  study.  Even  
three  of  the  five  unenhanced  CT  examinations  were  diagnostic.    
The   initial   radiology   report  was   correct   in   97%   of   cases  where   the   clinician   had  men-­‐‑
tioned  AMI  suspicion  in  the  referral;  if  not,  the  corresponding  rate  was  significantly  lower  
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sensitivity.   Patients  without   suspicion   of   AMI   prior   to   CT  were  more   prone   to   undergo  
bowel  resection  (odds  ratio  3.38;  95%  confidence  interval  1.15–9.91),  but  the  clinical  suspi-­‐‑
cion  of  AMI  did  not  associate  with  mortality.  Previously,  Wadman  and  associates  had  simi-­‐‑
lar  results  in  their  retrospective  study  of  67  patients  with  acute  SMA  occlusion  of  whom  36  
had  contrast  enhanced  multidetector  CT  examination  (107).  In  their  study,  clinical  suspicion  
of  AMI  was  noted  in  half  of  the  patients  prior  to  CT;  the  overall  sensitivity  of  contrast  en-­‐‑
hanced  CT  according  to  the  initial  radiology  reports  was  67%,  whereas  in  cases  with  clinical  
AMI  suspicion,  the  rate  of  correct  CT  diagnosis  was  higher,  78%  (p=0.06).  
These  findings  contradict  the  previous  studies  with  markedly  higher  sensitivity  rates  for  
CT  in  AMI  (5,6,99,100,101,102)  (Table  3,  Page  18).  Even  though  those  studies  were  consid-­‐‑
ered  to  have  low  risk  of  patient  selection  bias  according  to  the  recent  systematic  review  (76),  
it  is  justified  to  suspect  that  those  studies  might  overestimate  the  accuracy  of  CT  in  detect-­‐‑
ing  AMI  in  the  clinical  practice,  because  the  studies  were  performed  on  patients  with  clini-­‐‑
cally  suspected  AMI.  For  example,  if  clinical  suspicion  of  AMI  had  been  used  as  a  selection  
criterion   in   the   current   study,  more   than   two-­‐‑thirds  of   the  AMI  patients  would  not  have  
been  even  included  in  the  first  place.  Hence,  the  results  of  our  and  Wadman'ʹs  study  reflect  
the  everyday  life  in  the  emergency  department  where  AMI  is  often  found  unexpectedly  in  
the  routine  abdominal  CT.  
Besides  our  and  Wadman'ʹs  study,  there  is  at  least  one  other  previous  study  by  Wiesner  
&  co-­‐‑workers  that  was  performed  in  a  clinical  setting  on  291  patients  with  unclear  acute  or  
subacute  abdomen;  similar  to  our  retrospective  study,  this  prospective  study  reported  sen-­‐‑
sitivity  of  CT  in  AMI  based  on  the  reports  of  the  emergency  department  radiologist  (104).  
The   sensitivity   rates   reported   in   these   three   studies   (Table   10)  were   lower   than   in   those  
studies   that   included   only   clinically   suspected  AMI   patients   (Table   3,   Page   18).   Further-­‐‑
more,  by  looking  at  the  laparotomy  rates  of  the  studies  in  Table  3,  it  would  seem  that  many  
of   those  study  patients  had  advanced  bowel   ischemia  –  a  factor,  which  possibly  made  in-­‐‑
terpretation  of  the  CT  findings  easier.  Similarly,  a  concern  regarding  previous  retrospective  
case-­‐‑control   studies   of   CT   accuracy   in   AMI   (98,147)   is   that   those   studies   were   also   per-­‐‑
formed  on  surgically  confirmed  AMI  patients  (likely  having  severe  bowel  ischemia).  
Another   factor   (besides  prior   clinical   suspicion)   that  did  affect   the   radiologist'ʹs  perfor-­‐‑
mance  in  our  study  was  the  background  of  his/her  education.  The  rate  of  correct  CT  inter-­‐‑
pretation  in  AMI  was  significantly  higher  for  body  imaging  specialists,  vascular   interven-­‐‑
tional   radiologists   and   residents   than   for   those   from   other   subspecialties   (e.g.   neuro-­‐‑   or  
musculoskeletal   radiology)   (p<0.01).   It   is   not   surprising,   because   the   former   are   involved  
with  abdominal  CT  interpretation  on  a  regular  basis.  
  
  
Table 10. Studies on the diagnostic accuracy of CT in AMI performed in patients with unclear 
acute or subacute abdomen in the clinical routine (based on the duty radiologist's report). 
 











Wiesner 2004 (104) 81% 97% 4/291 (1%) 1% 13/16 14 (88%) 
Wadman 2010 (107) 67% - 23/50 (46%) 14% 24/46 24 (52%) 
Current study 86% - 30/97 (31%) 35% b 83/97 45 (46%) 
TP = No. of true positive cases / TP+FN = No. of all true positive and false negative cases 
a In this table, advanced bowel ischemia was defined as cases with laparotomy or autopsy proof of AMI, or 
withdrawal of active treatment resulting in rapid death. For the rest, the diagnosis of AMI was confirmed 
by clinical presentation and other findings (suggesting reversible bowel ischemia). 





5.2.2  Vascular  CT  findings  
The  vascular  findings  in  92  AMI  events  with  contrast  enhanced  CT  are  presented  in  Table  
11.  Embolus  was  detectable  in  CT  in  all  except  the  two  cases  of  distal  emboli.  Thrombosis,  
by   the  definition  of   soft   thrombotic   clot,  was  visible   in  CT   in  only  46%  of  patients   in   the  
thrombosis  group.  In  the  rest,  the  morphology  of  the  SMA  lesion  was  chronic  and  calcified  
based  on  the  CT.  This  is  somewhat  controversial  because  "ʺacute  occlusion  of  the  SMA"ʺ  has  
been   the  watershed  definition  of  occlusive  versus  non-­‐‑occlusive  AMI   in   the   literature   for  
ages.  The  findings  of  our  study  suggest  that  half  of  the  patients  with  AMI  due  to  atheroscle-­‐‑
rotic  disease  may  have  chronic  rather   than  acute  occlusion  of   the  SMA,  or  even  open  but  
stenotic  SMA  with  concomitant  disease  of  the  CA  and  IMA.  Some  might  argue,  that  these  
patients   should  be   categorized  as  CMI.  This  would  be   imprudent,   because   these  patients  
had  developed   life-­‐‑threatening  acute   intestinal   ischemia   (upon  CMI),  and  more   than  one-­‐‑
third  of  patients  without  CT  visualized   thrombotic  clot  developed  bowel  necrosis  despite  
emergency  revascularization.  The  clinical  presentation  pattern  of  CMI  is  generally  accepted  
as  postprandial  abdominal  pain  (with  various  other  symptoms),  which  poses  no  imminent  
threat  to  life.  However,  if  abdominal  pain  persists  after  meal,  the  patient  may  have  already  
gone  into  irreversible  state  of  acute  ischemia.  
It   is  plausible,   though,  that  many  of  the  AMI  patients  with  seemingly  chronic  SMA  oc-­‐‑
clusion  had   in   fact   experienced   "ʺmicrothrombosis"ʺ  within  ultrathin   lumen  of   a  very   tight  
stenosis.  This  microthrombus  might  not  be  visible  in  CT,  but  it  is  sometimes  revealed  dur-­‐‑
ing  angiography  when  a  total  SMA  occlusion  is  recanalized  with  guidewire,  after  which  a  
narrow  but  open  lumen  is  visualised.  Also,  poking  the  proximal  SMA  with  a  Fogarty  embo-­‐‑
lectomy  catheter   in  open   surgery  may   sometimes  open  a  narrow   thrombosed   lumen  of   a  
tight   stenosis,   after  which   a  minimal   flow   from   the   SMA   is   noticed.  Nevertheless,   some  
patients  who  develop  fulminant  AOCMI  have  a  long  heavily  calcified  occlusion  of  the  SMA  
in  CT  (i.e.,  an  occlusion  that  has  evidently  been  there  for  years)  without  any  evidence  what-­‐‑
soever  of  an  acute  thromboembolic  event.  In  such  cases,  there  may  be  other  factors  contrib-­‐‑
uting  to  the  development  of  AOCMI  than  those  related  to  the  blood  vessels  of  the  mesen-­‐‑
tery,  for  example,  hypovolemia,  anemia,  or  low  cardiac  output.    
Incidentally,  there  were  two  patients  in  the  "ʺvisible  thrombosis"ʺ  group  of  this  study,  who  
had  an  earlier  CT,  which  demonstrated  that  the  thrombosis  was  in  fact  a  chronic  thrombus.  
Nonetheless,  both  patients  developed  acute  intestinal  necrosis.   In  the  past,   the  categoriza-­‐‑
tion  of  etiology  as  embolism  or  thrombosis  was  based  on  conventional  angiography.  Owing  
to   the  modern   CT,   there   is   now  more   information   available   on   the   plaque  morphology.  
Even  so,  it  is  still  impossible  to  distinguish  acute  thrombus  from  chronic  thrombosis  based  
on  CT  findings  alone.  Even  the  differentiation  of  embolic  versus  thrombotic  obstruction  is  
sometimes  very  difficult  based  on  imaging  alone.  
To  summarize,  the  patient'ʹs  clinical  presentation  should  primarily  define  whether  the  pa-­‐‑
tient  is  suffering  from  AMI  or  CMI,  not  the  presentation  pattern  of  the  arterial  obstruction  
(acute   versus   chronic).   Regarding  AMI   patients  with   open   but   stenotic   SMA,   those  with  
hemodynamically   insignificant   stenosis  may  be   categorized  as  NOMI,  but   those  with  70–
99%  stenosis  of  the  SMA  and  concomitant  disease  of  CA/IMA  do  not  fit  well  into  the  NOMI  
category;  these  patients  require  urgent  revascularization,  and  it  would  be  more  practical  to  
categorize  them  as  obstructive  AMI.  Understanding  the  risk  of  getting  into  a  semantic  argu-­‐‑
ment,  perhaps  the  term  non-­‐‑occlusive  mesenteric  ischemia  should  be  omitted  because  there  
is  not  much  difference  between  99%  stenosis  and  100%  occlusion  of  the  SMA;  if  the  patient  
presents  with  AMI,   revascularization   is  needed   in  both   situations.  Maybe,   the   terms  non-­‐‑
obstructive   mesenteric   ischemia   or  mesenteric   hypoperfusion   syndrome   should   be   preferred   to  
describe  NOMI.  
5.2.3  Intestinal  CT  findings  
Wadman   and   co-­‐‑workers   found   intestinal   CT   findings   (specific   or   unspecific)   in   50%   of  




abnormal  intestinal  findings  in  up  to  95%  of  CT  examinations  (Table  12).  However,  many  of  
these  findings  were  unspecific,  such  as  bowel  lumen  dilatation,  bowel  wall  thickening  and  
mesenteric  fat  stranding.  Independently,  these  unspecific  findings  cannot  be  considered  as  
diagnostic.   All   CT   findings   need   to   be   considered   as   a  whole   and   together  with   clinical  
findings.  Any  of  these  abnormal  intestinal  findings  together  with  significant  SMA  obstruc-­‐‑
tion  should  alert  the  clinician  and  the  radiologist  about  the  possibility  of  AMI.  
For  the  emergency  department  radiologist,  the  subtle  intestinal  findings  were  more  diffi-­‐‑
cult   to   detect   than   the   more   prominent   vascular   findings.   The   interobserver   variability  





Table 11. Vascular findings in contrast enhanced CT in 92 AMI events. Cases with unenhanced 
CT alone were excluded from this table (2 thrombosis and 3 NOMI events). 
 
 









SMA embolus location     
Proximal SMA root 7 (29) 0 (0) 0 (0) 0 (0) 
SMA main stem 15 (63) 0 (0) 0 (0) 0 (0) 
Not visible (distal small branch) 2 (8) 0 (0) 0 (0) 0 (0) 
Atherosclerotic changes     
Visible thrombosis 0 (0) 17 (46) 1 (5) 0 (0) 
SMA total occlusion 0 (0)  23 (62)  0 (0) 0 (0) 
SMA 70-99% stenosis 0 (0)  14 (38) 0 (0) 0 (0) 
SMA 50-70% stenosis 0 (0) 0 (0) 2 (9) 0 (0) 
CA total occlusion 0 (0) 8 (22) 2 (9) 0 (0) 
CA 70-99% stenosis 1 (4)  9 (24) 1 (5) 0 (0) 
Obstruction site     
SMA alone 16 (67) 4 (11) 0 (0) 0 (0) 
SMA+CA 1 (4) 8 (22) 1 (5) 0 (0) 
SMA+IMA 7 (29) 6 (16) 0 (0) 0 (0) 
SMA+CA+IMA 0 (0) 19 (51) 1 (5) 0 (0) 
CA+IMA 0 (0) 0 (0) 2 (9) 0 (0) 
SMV (major thrombosis) 0 (0) 0 (0) 0 (0) 9 (100) 
SMV + portal/splenic vein thrombosis 0 (0) 0 (0) 0 (0) 8 (89) 
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threat  to  life.  However,  if  abdominal  pain  persists  after  meal,  the  patient  may  have  already  
gone  into  irreversible  state  of  acute  ischemia.  
It   is  plausible,   though,  that  many  of  the  AMI  patients  with  seemingly  chronic  SMA  oc-­‐‑
clusion  had   in   fact   experienced   "ʺmicrothrombosis"ʺ  within  ultrathin   lumen  of   a  very   tight  
stenosis.  This  microthrombus  might  not  be  visible  in  CT,  but  it  is  sometimes  revealed  dur-­‐‑
ing  angiography  when  a  total  SMA  occlusion  is  recanalized  with  guidewire,  after  which  a  
narrow  but  open  lumen  is  visualised.  Also,  poking  the  proximal  SMA  with  a  Fogarty  embo-­‐‑
lectomy  catheter   in  open   surgery  may   sometimes  open  a  narrow   thrombosed   lumen  of   a  
tight   stenosis,   after  which   a  minimal   flow   from   the   SMA   is   noticed.  Nevertheless,   some  
patients  who  develop  fulminant  AOCMI  have  a  long  heavily  calcified  occlusion  of  the  SMA  
in  CT  (i.e.,  an  occlusion  that  has  evidently  been  there  for  years)  without  any  evidence  what-­‐‑
soever  of  an  acute  thromboembolic  event.  In  such  cases,  there  may  be  other  factors  contrib-­‐‑
uting  to  the  development  of  AOCMI  than  those  related  to  the  blood  vessels  of  the  mesen-­‐‑
tery,  for  example,  hypovolemia,  anemia,  or  low  cardiac  output.    
Incidentally,  there  were  two  patients  in  the  "ʺvisible  thrombosis"ʺ  group  of  this  study,  who  
had  an  earlier  CT,  which  demonstrated  that  the  thrombosis  was  in  fact  a  chronic  thrombus.  
Nonetheless,  both  patients  developed  acute  intestinal  necrosis.   In  the  past,   the  categoriza-­‐‑
tion  of  etiology  as  embolism  or  thrombosis  was  based  on  conventional  angiography.  Owing  
to   the  modern   CT,   there   is   now  more   information   available   on   the   plaque  morphology.  
Even  so,  it  is  still  impossible  to  distinguish  acute  thrombus  from  chronic  thrombosis  based  
on  CT  findings  alone.  Even  the  differentiation  of  embolic  versus  thrombotic  obstruction  is  
sometimes  very  difficult  based  on  imaging  alone.  
To  summarize,  the  patient'ʹs  clinical  presentation  should  primarily  define  whether  the  pa-­‐‑
tient  is  suffering  from  AMI  or  CMI,  not  the  presentation  pattern  of  the  arterial  obstruction  
(acute   versus   chronic).   Regarding  AMI   patients  with   open   but   stenotic   SMA,   those  with  
hemodynamically   insignificant   stenosis  may  be   categorized  as  NOMI,  but   those  with  70–
99%  stenosis  of  the  SMA  and  concomitant  disease  of  CA/IMA  do  not  fit  well  into  the  NOMI  
category;  these  patients  require  urgent  revascularization,  and  it  would  be  more  practical  to  
categorize  them  as  obstructive  AMI.  Understanding  the  risk  of  getting  into  a  semantic  argu-­‐‑
ment,  perhaps  the  term  non-­‐‑occlusive  mesenteric  ischemia  should  be  omitted  because  there  
is  not  much  difference  between  99%  stenosis  and  100%  occlusion  of  the  SMA;  if  the  patient  
presents  with  AMI,   revascularization   is  needed   in  both   situations.  Maybe,   the   terms  non-­‐‑
obstructive   mesenteric   ischemia   or  mesenteric   hypoperfusion   syndrome   should   be   preferred   to  
describe  NOMI.  
5.2.3  Intestinal  CT  findings  
Wadman   and   co-­‐‑workers   found   intestinal   CT   findings   (specific   or   unspecific)   in   50%   of  




abnormal  intestinal  findings  in  up  to  95%  of  CT  examinations  (Table  12).  However,  many  of  
these  findings  were  unspecific,  such  as  bowel  lumen  dilatation,  bowel  wall  thickening  and  
mesenteric  fat  stranding.  Independently,  these  unspecific  findings  cannot  be  considered  as  
diagnostic.   All   CT   findings   need   to   be   considered   as   a  whole   and   together  with   clinical  
findings.  Any  of  these  abnormal  intestinal  findings  together  with  significant  SMA  obstruc-­‐‑
tion  should  alert  the  clinician  and  the  radiologist  about  the  possibility  of  AMI.  
For  the  emergency  department  radiologist,  the  subtle  intestinal  findings  were  more  diffi-­‐‑
cult   to   detect   than   the   more   prominent   vascular   findings.   The   interobserver   variability  





Table 11. Vascular findings in contrast enhanced CT in 92 AMI events. Cases with unenhanced 
CT alone were excluded from this table (2 thrombosis and 3 NOMI events). 
 
 









SMA embolus location     
Proximal SMA root 7 (29) 0 (0) 0 (0) 0 (0) 
SMA main stem 15 (63) 0 (0) 0 (0) 0 (0) 
Not visible (distal small branch) 2 (8) 0 (0) 0 (0) 0 (0) 
Atherosclerotic changes     
Visible thrombosis 0 (0) 17 (46) 1 (5) 0 (0) 
SMA total occlusion 0 (0)  23 (62)  0 (0) 0 (0) 
SMA 70-99% stenosis 0 (0)  14 (38) 0 (0) 0 (0) 
SMA 50-70% stenosis 0 (0) 0 (0) 2 (9) 0 (0) 
CA total occlusion 0 (0) 8 (22) 2 (9) 0 (0) 
CA 70-99% stenosis 1 (4)  9 (24) 1 (5) 0 (0) 
Obstruction site     
SMA alone 16 (67) 4 (11) 0 (0) 0 (0) 
SMA+CA 1 (4) 8 (22) 1 (5) 0 (0) 
SMA+IMA 7 (29) 6 (16) 0 (0) 0 (0) 
SMA+CA+IMA 0 (0) 19 (51) 1 (5) 0 (0) 
CA+IMA 0 (0) 0 (0) 2 (9) 0 (0) 
SMV (major thrombosis) 0 (0) 0 (0) 0 (0) 9 (100) 
SMV + portal/splenic vein thrombosis 0 (0) 0 (0) 0 (0) 8 (89) 
















Intestinal findings     
Any abnormal intestinal finding 22 (92) 39 (100) 25 (100) 6 (67) 
Intestinal pneumatosis 6 (25) 15 (39) 10 (40) 0 (0) 
Portomesenteric venous gas 1 (4) 7 (18) 6 (24) 0 (0) 
Bowel wall enhancement a     
Abnormal 18 (82) 21 (58) 12 (55) 3 (33) 
Absent or decreased 10 (46) 8 (22) 5 (23) 2 (22) 
Increased 3 (14) 6 (17) 5 (23) 0 (0) 
Decreased and increased 5 (23) 7 (19) 2 (9) 1 (11) 
Pneumatosis, venous gas, or abnormal en-
hancement (AMI-specific intestinal findings) 
19 (79) 25 (64) 16 (64) 3 (33) 
Bowel lumen dilatation/paralysis 18 (75) 34 (87) 17 (68) 5 (56) 
Bowel wall thickening 14 (58) 28 (72) 20 (80) 5 (56) 
Isolated left-sided ischemic colitis 0 (0) 0 (0) 3 (12) 0 (0) 
Isolated right-sided or ischemic pancolitis 0 (0) 3 (8) 8 (32) 0 (0) 
Mesenteric and peritoneal findings     
Mesenteric fat stranding 22 (92) 36 (92) 24 (96) 9 (100) 
Free peritoneal fluid 7 (29) 15 (39) 14 (56) 6 (67) 
Free peritoneal gas 0 (0) 2 (5) 0 (0) 0 (0) 
Solid organ findings     
Infarction/perfusion defect 14 (58) 5 (14) 0 (0) 0 (0) 
Spleen 8  4 0 0 
Kidney/kidneys 7 0 0 0 
Liver 0 4 0 0 
Multiple organ 1 3 0 0 
Data are presented as n (%). 
 
a Calculated for 89 events. Cases with CT in unenhanced or angiographic phase alone were excluded (2 







5.3 STUDY III  
5.3.1  Treatment  pathways  
EVT  was  attempted  in  50  patients  (mean  age  79±9  years)  out  of  66  patients  with  occlusive  
AMI  (Figure  9).  The  excluded  16  patients  were  treated  without  revascularization  as  follows:  
  
No  intervention  (n=7)  
− Five  elderly  patients  were  treated  with  only  comfort  care  and  died  within  1-­‐‑3  days.  
− One  young  survivor  had  a  distal  suboccluding  embolism  of  the  SMA  without  signs  
of  advanced  ischemia,  but  with  multiple  synchronous  embolism  and  acute  myocar-­‐‑
dial  infarction;  the  patient  was  later  diagnosed  with  metastatic  lung  cancer.  
− One   elderly   patient   with   thrombotic   occlusion   of   the   SMA   and   CA  was  misdiag-­‐‑
nosed  as  cholecystitis  and  treated  conservatively;  the  patient  survived  nonetheless.    
  
Laparotomy  first  (n=9)  
− Five  patients  had  unresectable,  massive  bowel  necrosis  and  died  after  laparotomy.  
− Two  patients   had   embolic   occlusion   in   the  distal   branches   of   the   SMA.  Both  were  
treated  with  bowel  resection  alone;  one  survived.  
− One  patient  with  necrotizing  ischemic  colitis  and  septic  shock  survived  with  subtotal  
colectomy.  A  thrombotic  occlusion  of  the  SMA  and  chronic  occlusion  of  the  IMA  was  
discovered  in  retrospect.  
− One  patient  with  peritonitis  was  treated  with  initial  small  bowel  resection.  Postoper-­‐‑
ative  CT  revealed  a  partial   thrombosis  of   the  SMA  and  CA,  and  a   large  metastatic  





Figure 9. Flow chart demonstrating the treatment pathways of 66 patients with occlusive AMI. A 
total of 50 patients received attempt at EVT. Bypass was performed selectively in three patients 
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total of 50 patients received attempt at EVT. Bypass was performed selectively in three patients 





5.3.2  Results  of  EVT  
Mechanical  thrombectomy  was  used  to  treat  17  patients  with  embolism,  and  three  patients  
with   thrombotic  occlusion.  Primary  PTA/S  was  performed   in  29  patients  with   thrombotic  
obstruction  and  one  patient  with  embolism  (Table  13).  EVT  was  technically  successful  in  44  
(88%)  patients.  EVT  was  used  in  72%  and  78%  of  patients  with  embolism  and  thrombosis,  
respectively;   the   corresponding   technical   success   rates  were   94%   and   84%.   Five   patients  
(10%)  had  EVT-­‐‑related  complication  with  mortality  (unrelated  to  the  complication)  in  one  
case.  A  total  of  20  patients  (40  %)  treated  with  EVT  required  laparotomy,  and  bowel  resec-­‐‑
tion  was  performed  in  17  (34  %)  patients  (Figure  9).  Six  patients  required  relaparotomy,  and  
two  patients  had  several  laparotomies.    
The  30-­‐‑day  mortality   rate  after   successful  or   failed  EVT  was  32%   (n=16/50),  while  75%  
(n=12/16)  of   the  excluded  patients  without  attempted  revascularization  died  (two  patients  
survived  with  bowel  resection  alone,  and  two  survived  with  only  conservative  treatment).  
The  overall  mortality  of  all  patients  with  AMI  in  study  III  was  42%  (n=28/66).  
The  mean  procedure   time   for  mechanical   thrombectomy  was  95±39  minutes  and  81±44  
minutes  for  PTA/S,  which  are  acceptable  if  the  delay  until  the  beginning  of  the  procedure  is  
not  too  long.  Having  said  that,  the  delay  from  diagnosis  to  treatment  varied  significantly  in  
this   study   (median   4.4   h,   interquartile   range   2-­‐‑22   h).   This   variation  was   partly   owing   to  
logistical   reasons,   especially   for  nine  patients   referred   from  other  hospitals.   Furthermore,  
60%  of  the  EVT  procedures  were  performed  during  out-­‐‑of-­‐‑office  hours.  
5.3.2.1  Technical  failures  in  mechanical  thrombectomy  
There  was  only  one  failure  to  resolve  an  embolus  with  aspiration  and  thrombolysis  because  
of   dissection   and   re-­‐‑thrombosis   of   the   SMA;   the   patient   survived   with   bowel   resection.  
Although   it   did   not   constitute   a   technical   failure   according   to   the  definition,   six   patients  
had  residual  emboli,  distal  embolization,  or  dissection  of  a  distal  SMA  branch.  Some  might  
argue   that   residual  distal  emboli   constitute  a   failure  especially  since   three  of   six   such  pa-­‐‑
tients   in   this   study  died.  Moreover,  distal   embolization   could  have  been  avoided  by  per-­‐‑
forming  open  embolectomy.  However,  owing  to  the  presence  of  a  rich  mesenteric  collateral  
network,   peripheral   residual   occlusion   rarely   deteriorated   perfusion   in   the   mesentery.  
Furthermore,   survival  was  dependent  on  many   factors,   such  as   the  patient’s   condition   in  
general.  The  chance  of  avoiding  laparotomy  in  an  elderly  high-­‐‑risk  patient  by  performing  
endovascular  embolectomy  is  very  attractive.  
5.3.2.2  Technical  failures  in  PTA/S  
Failure  was  more  common  in  PTA/S  (Table  13).  One  procedure  had  to  be  interrupted  after  
predilatation  of  the  SMA  due  to  patient'ʹs  noncooperation;  the  patient  was  unfit  for  surgery  
and  died.  Recanalization  of  the  SMA  was  unsuccessful  in  four  patients;  surgical  bypass  was  
performed  after  failure  of  EVT  in  three  of  these  patients,  one  of  whom  did  not  survive.  A  
long   and   heavily   calcified   occlusion   may   bring   difficulties   during   recanalization   of   the  
target   vessel.   To   avoid   wasting   time   on   futile   attempts   at   EVT,   open   revascularization  
should  be  considered  as  primary  treatment  for  those  cases.    
Two  patients  received  endovascular  treatment  of  only  CA  and  IMA  lesions  after  failure  
to  recanalize  the  occluded  SMA.  It  can  be  questioned  whether  this  was  a  rational  approach.  
A  meticulous  investigation  of  the  collateral  blood  flow  to  the  intestine  should  be  performed  
during  angiography.  If  sufficient  collateral  arteries  have  not  developed,  then  the  treatment  
of  CA/IMA  may  not  improve  the  patient’s  condition  without  revascularization  of  the  SMA.  
Brachial   access   was   preferred   for   mechanical   thrombectomy   (61%)   and   PTA/S   (78%).  
Brachial  access  failed  in  three  of  37  attempts  (8%)  and  femoral  access  in  three  of  17  attempts  
(18%).  Failed  femoral  access  was  successfully  converted  to  brachial  access  in  two  cases,  and  




Table 13. Endovascular procedures, technical failures, EVT procedure-related complications, and 










Mechanical thrombectomy (SMA) 
 Technical failure 
 Adjunctive stenting 














 Technical failure 
 PTA without stenting (SMA) 
 PTA/S (SMA alone) 
 PTA/S (SMA+CA) 




















 Failure to access the SMA 
 Failure due to non-cooperation 













EVT related complications 
 Bleeding from brachial artery 
 Bleeding from femoral artery 
 SMA distal branch dissection 
 IMA dissection and perforation 



















Need for surgery 
 Laparotomy 
 Bowel resection 













Mortality 16 (32) 7 (39) 9 (28) 
All data are presented as n (%). 
a One of the two patients required distal coil embolization due to perforation of the IMA. The patient re-
quired also SMA bypass with bowel resection. However, the patient died in the intensive care unit later on. 
The other patient had right-sided ischemic colitis and survived with bowel resection (without revasculariza-
tion of the SMA). 
b Includes two failures to access any of the targeted vessels, and the two PTA/S procedures of CA/IMA with 
failure to access the SMA. Brachial access was primarily attempted in all four cases; conversion to femoral 
access was also tried in one case. 
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The  mean  procedure   time   for  mechanical   thrombectomy  was  95±39  minutes  and  81±44  
minutes  for  PTA/S,  which  are  acceptable  if  the  delay  until  the  beginning  of  the  procedure  is  
not  too  long.  Having  said  that,  the  delay  from  diagnosis  to  treatment  varied  significantly  in  
this   study   (median   4.4   h,   interquartile   range   2-­‐‑22   h).   This   variation  was   partly   owing   to  
logistical   reasons,   especially   for  nine  patients   referred   from  other  hospitals.   Furthermore,  
60%  of  the  EVT  procedures  were  performed  during  out-­‐‑of-­‐‑office  hours.  
5.3.2.1  Technical  failures  in  mechanical  thrombectomy  
There  was  only  one  failure  to  resolve  an  embolus  with  aspiration  and  thrombolysis  because  
of   dissection   and   re-­‐‑thrombosis   of   the   SMA;   the   patient   survived   with   bowel   resection.  
Although   it   did   not   constitute   a   technical   failure   according   to   the  definition,   six   patients  
had  residual  emboli,  distal  embolization,  or  dissection  of  a  distal  SMA  branch.  Some  might  
argue   that   residual  distal  emboli   constitute  a   failure  especially  since   three  of   six   such  pa-­‐‑
tients   in   this   study  died.  Moreover,  distal   embolization   could  have  been  avoided  by  per-­‐‑
forming  open  embolectomy.  However,  owing  to  the  presence  of  a  rich  mesenteric  collateral  
network,   peripheral   residual   occlusion   rarely   deteriorated   perfusion   in   the   mesentery.  
Furthermore,   survival  was  dependent  on  many   factors,   such  as   the  patient’s   condition   in  
general.  The  chance  of  avoiding  laparotomy  in  an  elderly  high-­‐‑risk  patient  by  performing  
endovascular  embolectomy  is  very  attractive.  
5.3.2.2  Technical  failures  in  PTA/S  
Failure  was  more  common  in  PTA/S  (Table  13).  One  procedure  had  to  be  interrupted  after  
predilatation  of  the  SMA  due  to  patient'ʹs  noncooperation;  the  patient  was  unfit  for  surgery  
and  died.  Recanalization  of  the  SMA  was  unsuccessful  in  four  patients;  surgical  bypass  was  
performed  after  failure  of  EVT  in  three  of  these  patients,  one  of  whom  did  not  survive.  A  
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target   vessel.   To   avoid   wasting   time   on   futile   attempts   at   EVT,   open   revascularization  
should  be  considered  as  primary  treatment  for  those  cases.    
Two  patients  received  endovascular  treatment  of  only  CA  and  IMA  lesions  after  failure  
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A  meticulous  investigation  of  the  collateral  blood  flow  to  the  intestine  should  be  performed  
during  angiography.  If  sufficient  collateral  arteries  have  not  developed,  then  the  treatment  
of  CA/IMA  may  not  improve  the  patient’s  condition  without  revascularization  of  the  SMA.  
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Brachial  access  failed  in  three  of  37  attempts  (8%)  and  femoral  access  in  three  of  17  attempts  
(18%).  Failed  femoral  access  was  successfully  converted  to  brachial  access  in  two  cases,  and  




Table 13. Endovascular procedures, technical failures, EVT procedure-related complications, and 










Mechanical thrombectomy (SMA) 
 Technical failure 
 Adjunctive stenting 














 Technical failure 
 PTA without stenting (SMA) 
 PTA/S (SMA alone) 
 PTA/S (SMA+CA) 




















 Failure to access the SMA 
 Failure due to non-cooperation 













EVT related complications 
 Bleeding from brachial artery 
 Bleeding from femoral artery 
 SMA distal branch dissection 
 IMA dissection and perforation 



















Need for surgery 
 Laparotomy 
 Bowel resection 













Mortality 16 (32) 7 (39) 9 (28) 
All data are presented as n (%). 
a One of the two patients required distal coil embolization due to perforation of the IMA. The patient re-
quired also SMA bypass with bowel resection. However, the patient died in the intensive care unit later on. 
The other patient had right-sided ischemic colitis and survived with bowel resection (without revasculariza-
tion of the SMA). 
b Includes two failures to access any of the targeted vessels, and the two PTA/S procedures of CA/IMA with 
failure to access the SMA. Brachial access was primarily attempted in all four cases; conversion to femoral 
access was also tried in one case. 




5.3.3  Conclusions  regarding  role  of  EVT  in  AMI  
The  32%  mortality  and  34%  bowel  resection  rates  compare  favorably  to  many  of  the  previ-­‐‑
ous  studies  presented  in  Table  6,  Page  23.  One  major  difference  between  this  study  and,  for  
example,   the  Arthurs'ʹ  study  is  that  the  primary  mode  of  EVT  was  thrombolysis   in  half  of  
the  patients  in  Arthurs'ʹ  study,  whereas  thrombolysis  was  used  as  an  adjunctive  in  only  8%  
of  our  study  patients  (115).  This  represents  a  paradigm  shift  in  the  endovascular  treatment  
approach  for  thromboembolic  occlusion  of  the  SMA  owing  to  the  introduction  of  catheters  
suitable  for  embolus/thrombus  aspiration.  
Arthurs  and  associates  used  EVT  as  the  preferred  treatment  modality  in  81%  of  all  con-­‐‑
secutive  patients  during  a  9-­‐‑year  study  period.  They  treated  the  other  19%  with  open  revas-­‐‑
cularization  constituting  a  total  of  100%  revascularization  rate.  However,   the  mean  age  of  
their  study  patients  was  only  63  years  compared  to  the  79-­‐‑year  mean  age  in  this  study.  The  
fact   that   the  mean  age  was  so   low,  as  well  as   in  many  other  studies   in  Table  6,  raises   the  
question  of  patient  selection  bias.  Furthermore,   it  seems  improbable   that  100%  of  all  AMI  
patients  could  have  been  treated  with  revascularization.  In  contrast,  in  Beaulieu'ʹs  study  of  
23744   patients   recorded   in   the  National   Inpatient   Sample   database,   the   revascularization  
rate  was  less  than  3%  indicating  that  those  patients  constituted  a  highly  select  group  (126).  
Outcome  of  EVT  or  any  other   treatment  modality   in  AMI  depends  significantly  on   the  
patient   selection.   If   only   low-­‐‑risk   patients   with   mild   peritoneal   signs   are   being   treated,  
obviously,  the  results  are  much  better  than  if  all  patients  with  high  risk  factors  for  mortality  
and   advanced   bowel   ischemia   were   treated.   Hence,   when   publishing   results   of   EVT   in  
AMI,  it  is  imperative  that  all  patients  diagnosed  with  obstructive  AMI  are  reported.  If  this  
is   not   done,   the   results   may   only   represent   the   selection   criteria   for   the   treatment.   The  
strength  of  the  present  study  is  that  the  treatment  approaches  and  the  results  of  all  consecu-­‐‑
tive  AMI  patients  with  obstructive  etiology  are  disclosed;  this  minimizes  the  patient  selec-­‐‑
tion  bias  that  is  inevitably  involved  with  this  type  of  retrospective  single-­‐‑center  studies.  
There  is  no  need  for  further  debate,  whether  there  is  any  role  for  EVT  in  the  treatment  of  
AMI.   EVT   in   AMI   is   definitely   an   option.   However,   it   is   not   recommendable   that   EVT  
should  be  the  first  treatment  modality  in  all  situations.  The  success  of  EVT  is  dependent  on  
the   available   local   resources   and   the   experience   of   the   endovascular   interventionist.   In  
hospitals,  where  EVT  is  not  an  option,  AMI  patients  should  be  treated  with  damage  control  
principles  and  transferred  to  a  dedicated  vascular  unit  unless  surgical  revascularization  can  
be   performed   on   site.   Furthermore,   there   are   cases  when   open   surgical   revascularization  
should  be  preferred  as  primary  approach,  such  as  SMA  embolism  with  peritonitis,  or  heavi-­‐‑
ly  calcified  and  lengthy  total  occlusion  of  the  SMA.  
All  endovascular  procedures   in  the  current  study  were  performed  in  an  angio  suite.   In  
2015,  we   introduced  a  carbon  fiber   table  and  a  mobile  C-­‐‑arm  designed  for  vascular   inter-­‐‑
ventions  into  our  surgical  operating  room.  A  semi-­‐‑hybrid  or  fully  hybrid  operating  theatre  




5.4 STUDY IV  
5.4.1  Reliability  of  vascular  CT  findings  
There  was  a  strong  correlation  between  assessments  of  the  SMA  stenosis  degree  in  CT  and  
DSA;   the   Spearman'ʹs   correlation   coefficients  were   0.61,   0.58,   and  0.66   for   observers  A,  B,  
and  C,   respectively   (P<0.001),   and   the   corresponding  kappa  values  were  0.57   (moderate),  
0.38  (fair),  and  0.67  (substantial).  Observer  C  (the  interventional  radiologist)  was  the  most  
accurate   in  assessing   the  SMA  stenosis  degree.  Observers  A  and  C  had  substantial  agree-­‐‑
ment  on  the  SMA  stenosis  grade  (k=0.72)  and  lesion  morphology  (k=0.70),  while  observer  B  
had  fair  to  moderate  agreement  with  A  and  C.  There  was  more  interobserver  variability  in  






Figure 10. Interobserver agreement on the vascular CT findings in 47 patients with symptomatic 
mesenteric atherosclerosis. 
  
5.4.2  Interpretation  of  intestinal  CT  findings  
The  interobserver  agreement  on  the  presence  of  abnormal  bowel  wall  enhancement  pattern  
ranged   from   moderate   to   substantial   (Figure   11).   Observers   A   and   C   had   substantial  
agreement  (k=0.66)  on  the  presence  of  at   least  one  AMI-­‐‑specific  CT  finding  (i.e.  decreased  
bowel   wall   enhancement,   intestinal   pneumatosis,   or   SMA   thrombosis)   in   approximately  
two-­‐‑thirds  of  the  patients  with  AOCMI;  observer  B  had  a  tendency  to  categorize  the  plaque  
morphology  more  often  as  thrombotic  than  A  or  C.  Observer  A  detected  unspecific  intesti-­‐‑
nal  findings  more  often  than  B  and  C.  Observers  B  and  C  were  in  moderate  agreement  with  
A  on  bowel  wall  thickening  and  luminal  dilatation,  but  agreed  only  fairly  regarding  mesen-­‐‑
teric   fat   stranding.  Observer  A   found  pneumatosis   or   venous  gas   in   eight   (30%)  AOCMI  
patients   in   substantial   agreement  with  observer  C,  while  B   reported  pneumatosis   in  only  
two  of  those  patients  constituting  a  fair  agreement.  
Only  half  of  the  patients  with  AOCMI  had  a  clearly  visible  thrombosis  of  the  SMA  in  CT;  
this  was  noted  also   in   study   II.  Moreover,  one-­‐‑third  of   the  patients  with  AOCMI  did  not  
show  any  AMI-­‐‑specific  CT   findings   in   study   IV.  Thus,  AOCMI   cannot   be   excluded   even  
when  all  the  AMI-­‐‑specific  signs  are  absent.  However,  all  patients  with  AOCMI  had  at  least  
some   level   of   intestinal   abnormality   (specific   or   unspecific)   in   their  CTs   according   to   the  
experienced   abdominal   radiologist   A,   and   there   was   substantial   agreement   among   the  
other  observers  as  well.  The  most  frequent  findings  in  AOCMI  were  mesenteric  fat  strand-­‐‑
ing  (96%),  bowel  lumen  dilatation  (93%),  and  bowel  wall  thickening  (70%).  Those  are  high-­‐‑
ly  unspecific  findings  that  are  seen  in  many  other  diagnoses  of  the  acute  abdomen  (5,6).  For  
example,  bowel  wall  thickening  is  found  in  inflammatory,  infectious,  or  malignant  diseases  
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Figure 10. Interobserver agreement on the vascular CT findings in 47 patients with symptomatic 
mesenteric atherosclerosis. 
  
5.4.2  Interpretation  of  intestinal  CT  findings  
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example,  bowel  wall  thickening  is  found  in  inflammatory,  infectious,  or  malignant  diseases  




enteric   arteries   and   appropriate   clinical   presentation,   the   possibility   of   AMI   needs   to   be  
considered  (for  example,  see  Figure  4  in  the  original  publication  no.  IV).    
In   the  CMI  group,  only   few  patients  had  abnormal   intestinal   findings,   and   those  were  
mostly  related  to  chronic  ischemic  colitis.  It  might  be  safe  to  conclude  that  in  the  absence  of  
any  intestinal  CT  abnormality  whatsoever,  AOCMI  is  unlikely.  However,  clinicians  need  to  
be  aware  of  the  interobserver  variability  in  the  CT  interpretation,  and  not  forget  that  some  





Figure 11. Interobserver agreement on the intestinal CT findings in 47 patients with sympto-




5.4.3  Diagnostic  signs  of  AOCMI  
Based   on   the   experience   gained   during   this   study,   a   pattern   for   the   development   of   CT  
signs   and   laboratory   findings   from  CMI   to   reversible   (subacute)   to   irreversible   intestinal  
ischemia   is  hypothesized   in  Figure  12.  AOCMI  patients  with  symptoms   for  more   than  24  
hours  had   significantly  higher  CRP   levels   than   those  with   shorter  duration  of   symptoms  
(p=0.04).  The  pattern  of  the  SMA  obstruction  (thrombotic  versus  calcified)  did  not  associate  
with  the  duration  of  symptoms  or  the  need  for  bowel  resection.  The  most  AMI-­‐‑specific  CT  
signs  are  decreased  or  absent  bowel  wall  enhancement  and  pneumatosis  (including  gas  in  
the  portal  vein  or  SMV).  However,  there  is  moderate  interobserver  variability  in  assessing  
these  findings;  this  was  also  noticed  in  a  previous  retrospective  study  of  biphasic  CT  exam-­‐‑





Figure 12. A suggested pattern for the development of CT signs and laboratory findings in 
AOCMI. The first phase (blue) represents intermittent CMI or chronic ischemic colitis. The se-
cond "subacute" phase (orange) represents persistent symptoms and possibly reversible intes-
tinal ischemia (with revascularization or sometimes with only conservative management). The 
last phase (red) is for advanced bowel ischemia requiring revascularization usually with con-
comitant bowel resection. 
  
 
5.5 BASELINE FACTORS ASSOCIATED WITH OUTCOME  
A   univariate   analysis   of   independent   baseline   factors   associated  with   outcome  was   per-­‐‑
formed  in  studies  II-­‐‑IV.  The  risk  factors  for  mortality  and  bowel  resection  are  presented  in  
Table   14.   In  patients   treated  with  EVT   (in   study   III),   those  who  had   symptoms   for  more  
than  three  days  had  better  outcome  than  those  with  shorter  duration  of  symptoms.  Thus,  
patients  with  slowly  developing  AOCMI  and  normal  bowel  wall  enhancement  have  a  good  
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fluid  resuscitation,  correction  of  anemia,  and  antibiotics.   In   those  cases,   the  revasculariza-­‐‑
tion   could  be  postponed,   for   example,   to   the  next  morning.  However,   those  patients  will  












(AOCMI + CMI) 
Baseline factor OR 95% CI OR 95% CI OR b 95% CI 
Outcome = 30-day mortality       
Abnormal bowel wall enhancement 4.00 1.35-11.89 - - - - 
Decreased bowel wall enhancement - - - - 29.17 2.88-295.34 
Pneumatosis 3.96 1.58-9.93 - - - - 
Visible thrombotic clot 8.00 a 1.40-45.76 - - 24.29 2.44-241.26 
Base deficit >5 mmol/l 3.00 1.15-7.85 - - - - 
Age - - 1.10 1.01-1.19 - - 
Elevated troponin T (>50 ng/l) - - 4.29 1.12-16.31 - - 
Paralytic ileus - - 8.04 1.72-37.59 - - 
Base deficit >2.5 mmol/l - - 12.76 3.08-52.82 - - 
Elevated lactate (≥1.33 mmol/l) - - 14.64 2.82-75.95 - - 
Outcome = bowel resection       
Decreased bowel wall enhancement - - - - 7.44 1.63-33.91 
Pneumatosis - - - - 9.17 1.72-48.94 
Base deficit >5 mmol/l 4.20 1.59-11.09 - - - - 
No clinical suspicion of AMI prior to CT 3.38 1.15-9.91 - - - - 
Outcome = 30-day survival       
Symptoms >3 days - - 15.00 1.78-126.60 - - 
Normal bowel wall enhancement - - 11.05 1.30-93.82 - - 
OR = odds ratio, CI = confidence interval 
  
a among 32 patients with atherosclerotic etiology of AMI 
b among 47 patients with symptomatic mesenteric atherosclerosis 
  
  
5.6 LONG-TERM SURVIVAL 
The   aggressive   treatment   strategy  with  mesenteric   revascularization  has   a   significant   im-­‐‑
pact   on   the   early   survival   of  AMI   patients.  However,   the   expected   long-­‐‑term   survival   is  
poor  (Figure  13,  left  curve).  Patients  with  AMI  are  elderly  people  with  numerous  risk  fac-­‐‑
tors  for  atherosclerosis  and  mortality.  This  can  be  demonstrated  by  comparing  AMI  survi-­‐‑




13,  right  curves).  The  age-­‐‑adjusted  risk  of  death  (hazard  ratio)  was  1.8  times  higher  in  AMI  
survivors   (95%   confidence   interval   1.1-­‐‑3.1,   p=0.032).  Only  one  patient  had   recurrent  AMI  
after  EVT  during  the  follow-­‐‑up  period.    
EVT   is  a   tempting  alternative   to  open  surgery   for   the  elderly  and   fragile  AMI  patients  






Figure 13. Left: Kaplan-Meier cumulative survival estimate of the 50 patients treated with EVT 
(from study III). Right: Age-adjusted Cox regression long-term survival estimates for AMI and 
acute cholecystitis (ACC) survivors with age of 65 years or more (from study I). 
 
  
5.7 FUTURE DEVELOPMENTS 
We   have   already   seen   the   shift   from   thrombolysis   to   mechanical   thrombectomy   in   the  
endovascular  treatment  of  AMI.  While  6  French  carotid  distal  access  guiding  catheters  and  
coronary  guiding  catheters  are  currently  favoured  for  SMA  embolectomy  at  our  institution,  
dedicated  aspiration  catheters  for  visceral  and  peripheral  artery  thrombectomy  have  recent-­‐‑
ly  become  available.   In  addition,   early  experience  with  motorized  vacuum  aspiration  has  
been  promising.  Although  the  endovascular  technique  will  undoubtedly  continue  to  devel-­‐‑
op,  even  more  important  discovery  would  be  a  better  diagnostic  tool  for  the  early  detection  
of  AMI.  For  now,  CT   is   fairly   accurate   in  detecting   advanced   intestinal   ischemia,   but  we  
should  aim  for  the  detection  of  AMI  before   irreversible  bowel   injury  occurs.  A  biomarker  
specific   for  AMI  would  be  useful  especially   in  detecting  mesenteric  hypoperfusion   in  pa-­‐‑
tients  being  treated  in  the   intensive  care  unit  or  undergoing  major  surgery.  However,  de-­‐‑
veloping  a  cheap  biomarker  that  would  be  used  widely  for  screening  AMI  in  patients  with  
acute   abdominal   pain,   as   troponin   T   is   used   for   screening   acute  myocardial   ischemia   in  
patients  with   chest   pain,   does   not   seem  very   likely.  AMI   is,   after   all,   a   rare   cause   of   the  
acute  abdomen.  
CT  is  currently  being  used  widely  and  increasingly  in  patients  with  acute  abdomen.  Re-­‐‑
cently,  the  utility  of  dual-­‐‑energy  CT  in  detecting  early  ischemic  changes  on  the  bowel  wall  
was   studied   in  a   swine  model   (149).  Dual-­‐‑energy  CT  may  have  advantages  over   conven-­‐‑
tional   CT   by   increasing   visualization   of   ischemic   changes   in   the   bowel.   The   attenuation  
difference   between   ischemic   and   perfused   segments   was   significantly   greater   on   dual-­‐‑
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advantage   of   the   dual-­‐‑energy  CT   could   be   the   better   visualization   of  mesenteric   arteries  
with  lower  doses  of  contrast  medium.  A  study  comparing  56  abdominal  CTAs  performed  
with   standard   protocol   versus   48   CTAs   obtained  with   dual-­‐‑energy   protocol   using   lower  
concentration  of  the  contrast  agent  demonstrated  superior  image  quality  and  visualization  
of  the  SMA  branches  with  the  dual-­‐‑energy  protocol  (150).  Prospective  studies  are  needed  to  
evaluate,  whether  diagnostic  accuracy  in  the  early  detection  of  AMI  can  be  improved  with  




5.8 STUDY LIMITATIONS 
The   incidence  rates  presented   in   this  study  are  not  overall   incidences  of   the  disease;   they  
represent  only  the  hospital  incidence  of  those  diagnosed  and  treated  for  the  disease.  Autop-­‐‑
sy  reports  of  other  than  treated  patients  were  not  sought.  Also,  the  possibility  of  false  nega-­‐‑
tive  cases  that  were  never  suspected  of  AMI  during  hospitalization  cannot  be  ruled  out  due  
to   the   current   low   autopsy   rates.   The   sensitivity   of   CT   reported   in   this   study   should   be  
interpreted  in  this  context.  Furthermore,  false  positive  cases  were  not  sought  or  registered.  
Without  a  control  group,  it  is  not  possible  to  calculate  the  specificity  for  CT  in  AMI.  
In  study  IV,  patients  with  CMI  were  used  as  a  control  group  for  those  with  AOCMI.  This  
is  not   an   ideal   case-­‐‑control   study  design.  CMI  patients   are  not   asymptomatic,   and   some-­‐‑
times,  there  is  only  a  "ʺthin  red  line"ʺ  between  AMI  and  CMI.  Proprely  determining  the  sensi-­‐‑
tivity  and  specificity  of  CT  in  diagnosing  AOCMI  would  have  required  a  control  group  of  
patients  with  asymptomatic  SMA  obstruction  and  a  non-­‐‑ischemic  cause  of  acute  abdominal  
pain.   However,   it   was   not   possible   to   find   such   patients   retrospectively.   Using   patients  
without  SMA  obstruction  as  a  control  group  would  have  constituted  a  problem  with  blind-­‐‑
ing  the  radiologists  from  the  case-­‐‑control  grouping.  
Only  univariate  analyses  of  the  risk  factors  were  performed,  because  the  number  of  pa-­‐‑
tients  was   too   small   and   the   study   groups  were   too   heterogeneous   to   perform   adequate  
multivariate  analyses.  
There   was   no   routine   follow-­‐‑up   protocol   for   AMI   patients   during   the   study   period.  
Therefore,  there  is  no  reliable  data  on  the  restenosis  rate  after  EVT.  
Finally,  this  is  a  retrospective  single-­‐‑center  study  with  obvious  surgeon  selection  bias  in  
the  selection  of  patients  for  EVT.  Other  known  disadvantages  of  retrospective  study  design  
are   that   it   relies  on  the  accuracy  of  medical  records  and  some  important  data  may  not  be  
available.  Furthermore,  retrospective  studies  are  usually  performed  to  generate  hypothesis,  
which  should   then  be   tested  prospectively   (151).  These   limitations  are  uniform  across   the  
current   literature  on  AMI;   there   is  no   level   I   evidence   to   recommend  either  EVT  or  open  
surgery  as  the  primary  revascularization  method  in  AMI  (4).  However,  the  strength  of  this  
study  in  comparison  to  the  previous  literature  is  that  all  patients,  including  those  that  were  
not   treated  with  any   revascularization  method,  were   fully  disclosed   in  detail  minimizing  





6    Conclusions  
Based  on  this  study,  the  following  conclusions  can  be  drawn:  
The   incidence   rate   of  AMI   among  patients   hospitalized   for   acute   abdominal   pain  was  
7.3/100  000   inhabitants  per   year.   The   incidence   rates   of   occlusive   arterial  AMI   (mean   age  
79±10  years)   and  NOMI   (mean  age   76±10  years)  were   4.5   and  2.0/100  000   inhabitants  per  
year.  AMI  is  more  common  than  RAAA  or  acute  appendicitis  in  patients  over  age  75  years  
with  acute  abdomen.  
The  sensitivity  of  CT  in  detecting  AMI  is  lower  in  the  clinical  practice  than  is  commonly  
reported  in  the  literature.  Clinical  suspicion  of  AMI  prior  to  imaging  is  a  major  factor  in  the  
correct  interpretation  of  CT  findings.  Approximately  half  of  AMI  patients  with  thrombotic  
etiology  presented  with  chronic  calcified  occlusion  or  stenosis  of  the  SMA,  without  a  clearly  
visible  thrombotic  clot  in  CT.  
In   this   study,   one-­‐‑third   of   patients   who   developed   AOCMI   did   not   show   any   AMI-­‐‑
specific  CT  findings.   In  contrast,  at   least  some  degree  of  abnormal   intestinal   findings  was  
detected  in  all  patients  with  AOCMI.  The  interobserver  variability  in  the  evaluation  of  the  
degree  of  SMA  obstruction  in  CT  of  patients  with  symptomatic  mesenteric  atherosclerosis  
was  negligible.  However,  the  interobserver  variability  in  the  interpretation  of  intestinal  CT  
findings  and  SMA  obstruction  morphology  (thrombotic  versus  calcified)  are  potential  pit-­‐‑
falls  in  the  early  diagnosis  of  AOCMI.  
EVT  is  feasible  as  the  primary  revascularization  method  in  a  high  proportion  of  patients  
with  obstructive  arterial  AMI  with  acceptable  complication  (10%)  and  technical  failure  rates  
(12%).  Early  revascularization  with  EVT  is  associated  with  favourable  mortality  (32%)  and  
bowel  resection  rates  (34%).  
Decreased  bowel  wall  enhancement,  pneumatosis,  visible  thrombotic  clot,  metabolic  aci-­‐‑
dosis   and  elevated   lactate   are   associated  with  negative  outcome.  Especially  patients  with  






advantage   of   the   dual-­‐‑energy  CT   could   be   the   better   visualization   of  mesenteric   arteries  
with  lower  doses  of  contrast  medium.  A  study  comparing  56  abdominal  CTAs  performed  
with   standard   protocol   versus   48   CTAs   obtained  with   dual-­‐‑energy   protocol   using   lower  
concentration  of  the  contrast  agent  demonstrated  superior  image  quality  and  visualization  
of  the  SMA  branches  with  the  dual-­‐‑energy  protocol  (150).  Prospective  studies  are  needed  to  
evaluate,  whether  diagnostic  accuracy  in  the  early  detection  of  AMI  can  be  improved  with  




5.8 STUDY LIMITATIONS 
The   incidence  rates  presented   in   this  study  are  not  overall   incidences  of   the  disease;   they  
represent  only  the  hospital  incidence  of  those  diagnosed  and  treated  for  the  disease.  Autop-­‐‑
sy  reports  of  other  than  treated  patients  were  not  sought.  Also,  the  possibility  of  false  nega-­‐‑
tive  cases  that  were  never  suspected  of  AMI  during  hospitalization  cannot  be  ruled  out  due  
to   the   current   low   autopsy   rates.   The   sensitivity   of   CT   reported   in   this   study   should   be  
interpreted  in  this  context.  Furthermore,  false  positive  cases  were  not  sought  or  registered.  
Without  a  control  group,  it  is  not  possible  to  calculate  the  specificity  for  CT  in  AMI.  
In  study  IV,  patients  with  CMI  were  used  as  a  control  group  for  those  with  AOCMI.  This  
is  not   an   ideal   case-­‐‑control   study  design.  CMI  patients   are  not   asymptomatic,   and   some-­‐‑
times,  there  is  only  a  "ʺthin  red  line"ʺ  between  AMI  and  CMI.  Proprely  determining  the  sensi-­‐‑
tivity  and  specificity  of  CT  in  diagnosing  AOCMI  would  have  required  a  control  group  of  
patients  with  asymptomatic  SMA  obstruction  and  a  non-­‐‑ischemic  cause  of  acute  abdominal  
pain.   However,   it   was   not   possible   to   find   such   patients   retrospectively.   Using   patients  
without  SMA  obstruction  as  a  control  group  would  have  constituted  a  problem  with  blind-­‐‑
ing  the  radiologists  from  the  case-­‐‑control  grouping.  
Only  univariate  analyses  of  the  risk  factors  were  performed,  because  the  number  of  pa-­‐‑
tients  was   too   small   and   the   study   groups  were   too   heterogeneous   to   perform   adequate  
multivariate  analyses.  
There   was   no   routine   follow-­‐‑up   protocol   for   AMI   patients   during   the   study   period.  
Therefore,  there  is  no  reliable  data  on  the  restenosis  rate  after  EVT.  
Finally,  this  is  a  retrospective  single-­‐‑center  study  with  obvious  surgeon  selection  bias  in  
the  selection  of  patients  for  EVT.  Other  known  disadvantages  of  retrospective  study  design  
are   that   it   relies  on  the  accuracy  of  medical  records  and  some  important  data  may  not  be  
available.  Furthermore,  retrospective  studies  are  usually  performed  to  generate  hypothesis,  
which  should   then  be   tested  prospectively   (151).  These   limitations  are  uniform  across   the  
current   literature  on  AMI;   there   is  no   level   I   evidence   to   recommend  either  EVT  or  open  
surgery  as  the  primary  revascularization  method  in  AMI  (4).  However,  the  strength  of  this  
study  in  comparison  to  the  previous  literature  is  that  all  patients,  including  those  that  were  
not   treated  with  any   revascularization  method,  were   fully  disclosed   in  detail  minimizing  





6    Conclusions  
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etiology  presented  with  chronic  calcified  occlusion  or  stenosis  of  the  SMA,  without  a  clearly  
visible  thrombotic  clot  in  CT.  
In   this   study,   one-­‐‑third   of   patients   who   developed   AOCMI   did   not   show   any   AMI-­‐‑
specific  CT  findings.   In  contrast,  at   least  some  degree  of  abnormal   intestinal   findings  was  
detected  in  all  patients  with  AOCMI.  The  interobserver  variability  in  the  evaluation  of  the  
degree  of  SMA  obstruction  in  CT  of  patients  with  symptomatic  mesenteric  atherosclerosis  
was  negligible.  However,  the  interobserver  variability  in  the  interpretation  of  intestinal  CT  
findings  and  SMA  obstruction  morphology  (thrombotic  versus  calcified)  are  potential  pit-­‐‑
falls  in  the  early  diagnosis  of  AOCMI.  
EVT  is  feasible  as  the  primary  revascularization  method  in  a  high  proportion  of  patients  
with  obstructive  arterial  AMI  with  acceptable  complication  (10%)  and  technical  failure  rates  
(12%).  Early  revascularization  with  EVT  is  associated  with  favourable  mortality  (32%)  and  
bowel  resection  rates  (34%).  
Decreased  bowel  wall  enhancement,  pneumatosis,  visible  thrombotic  clot,  metabolic  aci-­‐‑
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Abstract
Background The incidence of acute mesenteric ischemia (AMI) increases exponentially with age. The significance of AMI as a
differential diagnosis in elderly patients with acute abdomen may be underestimated.
Methods Consecutive patients hospitalized for AMI between 2009 and 2013 were retrospectively identified in a well-defined
population. Acute appendicitis, ruptured abdominal aortic aneurysm, acute pancreatitis, and acute cholecystitis were used as
reference diagnoses, and the age-specific incidence rates were calculated. In addition, long-term mortality risk was assessed for
AMI survivors.
Results The in-hospital incidence rates of AMI, acute obstructive mesenteric ischemia, and non-obstructive mesenteric ischemia
were 7.3, 4.5, and 2.0/100,000/year, respectively. AMIwas more common than ruptured abdominal aortic aneurysm, and the age-
specific incidence of AMI was higher than the incidence of acute appendicitis in patients over age 75 years with acute abdomen.
During the follow-up, the age-adjusted risk of death was 1.8 times higher in AMI survivors than in survivors of acute
cholecystitis.
Conclusion AMI may be a more common cause of acute abdomen in elderly patients than is generally thought, emphasizing the
importance of performing urgent computed tomography with contrast enhancement preferably in arterial and venous phases in
these patients.
Keywords Acute mesenteric ischemia . Incidence . Acute
abdomen . Epidemiology .Mortality
Introduction
Acute mesenteric ischemia (AMI) is generally considered a
rare cause of acute abdomen, but only limited data exist on the
epidemiology.1 The most frequently referenced study was
based on the population of Malmö, Sweden, between 1970
and 1982, with a remarkably high autopsy rate of 87 %.2 The
estimated overall incidence rate of AMI caused by acute oc-
clusion of the superior mesenteric artery (SMA) is 8.6/100,
000 person years and 12.6/100,000 for all etiologies.1 The
incidence rate of fatal non-occlusive mesenteric ischemia has
been given as 2.0/100,000 person years, and the incidence rate
of mesenteric venous thrombosis with intestinal necrosis has
been estimated at 1.8/100,000 person years.3, 4 Two contem-
porary studies reported incidence rates of 5.3–5.4/100,000
person years for patients treated for acute occlusion of the
SMA.5
, 6
In another Swedish study, the most common diagnoses in
2222 patients with acute abdominal pain, based on computed
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tomography (CT), were nonspecific abdominal pain (44 %),
appendicitis (16 %), bowel obstruction (9 %), diverticulitis
(8 %), gastrointestinal perforation (3 %), gallstone disease
(3 %), and pancreatitis (3 %); only 11 patients (0.5 %) had
AMI.7 However, the distribution of specific diagnoses in that
study was different in the elderly than in the general popula-
tion.Moreover, theMalmö study demonstrated an exponential
increase in the incidence of AMI after age 70 years.2 The age-
specific incidence rate curve in AMI is distinctly different than
in appendicitis, for example, which is considered a common
cause (98/100,000/year) of acute abdomen and has the highest
incidence in patients of ages 15–24 years.8 Thus, AMI may be
a more probable diagnosis in an elderly patient with acute
abdomen than is generally assumed.9
The purpose of this population-based study was to demon-
strate the high proportion of AMI in elderly patients admitted
to the acute care unit for acute abdomen. The age-specific
incidence rates of acute appendicitis (AA), ruptured abdomi-
nal aortic aneurysm (RAAA), acute pancreatitis (AP), and
acute cholecystitis (ACC) were used as references.
Materials and Methods
The local ethics committee approved this retrospective study.
Informed consent was waived. Our institution serves as a ter-
tiary referral hospital for five health care districts and solely
provides secondary care for a well-defined population of ap-
proximately 248,000 inhabitants (the study population) in a
university hospital area in Finland. All patients in the study
population with acute abdomen are referred or directly trans-
ferred to the acute care unit of our institution. Thus, we see
nearly all patients with acute abdominal pain from this stable
population, enabling population-based incidence estimates on
acute abdomen.
Screening Methods for Patients with AMI
A thorough search of the hospital electronic medical record
(EMR) and procedural databases (surgical and endovascular)
was performed to find all consecutive patients with AMI dur-
ing a 5-year study period from January 2009 to December
2013. It was presumed that not all patients with AMI were
assigned the appropriate international classification of disease
10 (ICD-10) code (K55.0, acute vascular disorder of intes-
tine). Therefore, a meticulous screening of approximately
750 hits with multiple AMI-associated ICD-10 codes
(K55.0, K55.1, K55.8, K55.9, I74.8, I82.88, I81, K65.0,
K63.1, K63.8, I71.00, I71.01, I71.09, I71.4, I71.3) for condi-
tions such as peritonitis was carried out, and all patients with
AMI were manually identified.
This study focuses on patients admitted to the acute care
unit for acute abdomen. Therefore, patients who developed
AMI either during intensive care for other diseases or directly
related to major surgery (e.g., aortic or cardiac surgery) were
not included. Patients with aortic dissection or isolated dissec-
tion of the SMA were excluded unless they presented with
intestinal ischemia at admission. Patients with AMI resulting
from iatrogenic injury were also excluded as were patients
with secondary intestinal ischemia (e.g., caused by strangula-
tion or volvulus). AMI patients referred from the other health
care districts were excluded (n=11). A clinical presentation
pattern of chronic mesenteric ischemia was also a criterion for
exclusion (n=25).
Determination of AMI
The diagnosis of AMI was based on clinical data, imaging,
laparotomy, and autopsy report when available. An abdominal
radiologist analyzed all CT findings in retrospect, and digital
subtraction angiography (DSA) images were analyzed by an
interventional radiologist. All data were summarized by a spe-
cialist in both gastrointestinal and vascular surgery, who con-
firmed the diagnosis of AMI and determined the etiology as
acute obstructive mesenteric ischemia (OMI), non-obstructive
mesenteric ischemia (NOMI), venous mesenteric ischemia
(VMI), or Bother .^
The diagnosis of OMI was based on three criteria: (1) ap-
propriate clinical presentation of life-threatening acute intesti-
nal ischemia with (2) arterial obstruction of the mesenteric
arteries and (3) either presence of at least some level of path-
ological intestinal findings on CT (bowel wall thickening,
abnormal bowel wall enhancement, or luminal dilatation) or
bowel necrosis in laparotomy/autopsy. The arterial obstruction
was defined as a typical thromboembolic clot or a calcified
occlusion of the SMA on CT and/or DSA. Cases with open
but severely (70–99 %) stenotic SMAwere defined as OMI if
the celiac artery and inferior mesenteric artery were also sig-
nificantly diseased and the clinical presentation and intestinal
findings clearly supported the diagnosis of acute intestinal
ischemia.10 NOMI was defined as acute intestinal ischemia
based on clinical presentation pattern and pathological intes-
tinal findings in CT (or bowel necrosis on laparotomy or au-
topsy) without significant (<70 %) obstruction of the SMA.
VMI was defined as an acute thrombosis of the superior mes-
enteric vein with CT findings suggesting intestinal ischemia
(bowel wall thickening with ascites or decreased bowel wall
enhancement) or intestinal injury requiring bowel resection.
Cases with mesenteric venous thrombosis without any signs
of intestinal ischemia other than mild symptoms were exclud-
ed. The etiology was defined as Bother^ in patients with AMI
caused by obstruction of the SMA for reasons other than
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embolism or atherosclerosis (e.g., aortic dissection, tumor in-
filtration, or external compression of the SMA).
Search Methods for the Reference Diagnoses
Because our institution is the only hospital providing acute
surgical care for the study population, it was presumed that
all appendectomies within this defined population were per-
formed at our institution. The number of AAs is therefore
equivalent to the number of appendectomies performed with
the diagnosis of AA (K35-K37); these cases were identified
from a search of the operative database, and cases of prophy-
lactic appendectomy were excluded. Cases involving admis-
sion for RAAA (I71.3) were identified from a search of the
operative database and EMRs, including cases treated with
open or endovascular surgery or with only palliative care.
The numbers of hospitalization for AP (K85.* or K86.00)
and ACC (K80.*, K81.0) were searched for a 2-year period
covering 2009 and 2010.
Study Variables and Statistical Methods
The demographic information for AMI patients was retrieved
from the EMR database, and the number of emergency CT
studies of the abdomen was retrieved from the radiology in-
formation system. Early mortality was defined as death within
30 days from admission or during hospitalization. Late mor-
tality was monitored until February 2015. Long-term survival
estimates were calculated for AMI survivors (i.e., those pa-
tients who did not suffer early mortality); ACC patients were
used as a control group. The population data were retrieved
from the Official Statistics authority and categorized into nine
age groups (10–19, 20–29 … >90); these data were used to
calculate age-specific incidence rates for AMI and the refer-
ence diagnoses. Basic calculations were performed with MS-
Excel 14, and SPSS Statistics 22 was used for statistical and
survival analyses. Continuous variables were expressed as
mean±standard deviation.
Definitions of the Epidemiological Terms
Incidence is defined as the number of new cases, such as an
acute disease, arising in the study population over a given time
period, whereas incidence rate is the number of new cases per
population at risk in a specific time period (presented as n/100,
000/year in this article unless otherwise stated). Incidence rate
for a specific age group is described as age-specific incidence
rate. Prevalence is defined as proportion of the population
having a medical condition, such as a chronic disease or a risk
factor.
Results
A total of 90 patients with AMI (mean age 76±12 years, 48 %
male) were registered. Fifty-eight (64 %) patients were at the
age of 75 years or more. The etiology was OMI in 56 (62 %),
NOMI in 25 (28 %), and VMI in six (7 %) cases. The etiology
of AMI was labeled as Bother^ in three (3 %) cases; two
patients had malignant tumor infiltration of the mesenteric
arteries, and one patient had aortic dissection with intestinal
ischemia at presentation.
Demographics and the diagnostic modalities in patients
with AMI are presented in Table 1. CT was performed in 85
(94 %) AMI patients, but only 31 (34 %) had CTangiography,
Table 1 Demographics and diagnostic modalities in patients with acute
mesenteric ischemia caused by arterial obstruction (OMI), non-







Age, mean±SD 79±10 76±10 54±12
Age ≥75 years 41 (73) 16 (64) 1 (17)
Male 24 (43) 13 (52) 6 (100)
Comorbidity
Hypertension 36 (64) 17 (68) 2 (33)
Hyperlipidemia 20 (36) 11 (44) 0
Diabetes 21 (38) 4 (16) 0
Chronic renal
insufficiencya
3 (5) 1 (4) 0
Atrial fibrillation 22 (39) 6 (24) 0
Coronary artery disease 35 (63) 10 (40) 0
Chronic heart failure 10 (18) 6 (24) 0
Peripheral arterial disease 21 (38) 3 (12) 0
Stroke or TIA 15 (27) 8 (32) 0
Medication
Warfarin 11 (20) 3 (12) 0
ASA 35 (63) 13 (52) 0
Clopidogrel 4 (7) 1 (4) 0
Statin 32 (57) 11 (44) 0
Diagnostic modalities
CT 51 (91) 25 (100) 6 (100)
CT angiography 17 (30) 12 (48) 0
DSAb 41 (73) 0 1 (17)
Laparotomy 24 (43) 14 (56) 1 (17)
Autopsy only 1 (2) 0 0
All data are presented as n (%)
SD standard deviation, TIA transitory ischemic attack,ASA acetylsalicylic
acid, CT computed tomography, DSA digital subtraction angiography
a Defined as plasma creatinine >130 μmol/L (1.5 mg/dL) prior to
hospitalization
b Endovascular therapy was used as the primary revascularization method
for patients with AMI during the study period10
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tomography (CT), were nonspecific abdominal pain (44 %),
appendicitis (16 %), bowel obstruction (9 %), diverticulitis
(8 %), gastrointestinal perforation (3 %), gallstone disease
(3 %), and pancreatitis (3 %); only 11 patients (0.5 %) had
AMI.7 However, the distribution of specific diagnoses in that
study was different in the elderly than in the general popula-
tion.Moreover, theMalmö study demonstrated an exponential
increase in the incidence of AMI after age 70 years.2 The age-
specific incidence rate curve in AMI is distinctly different than
in appendicitis, for example, which is considered a common
cause (98/100,000/year) of acute abdomen and has the highest
incidence in patients of ages 15–24 years.8 Thus, AMI may be
a more probable diagnosis in an elderly patient with acute
abdomen than is generally assumed.9
The purpose of this population-based study was to demon-
strate the high proportion of AMI in elderly patients admitted
to the acute care unit for acute abdomen. The age-specific
incidence rates of acute appendicitis (AA), ruptured abdomi-
nal aortic aneurysm (RAAA), acute pancreatitis (AP), and
acute cholecystitis (ACC) were used as references.
Materials and Methods
The local ethics committee approved this retrospective study.
Informed consent was waived. Our institution serves as a ter-
tiary referral hospital for five health care districts and solely
provides secondary care for a well-defined population of ap-
proximately 248,000 inhabitants (the study population) in a
university hospital area in Finland. All patients in the study
population with acute abdomen are referred or directly trans-
ferred to the acute care unit of our institution. Thus, we see
nearly all patients with acute abdominal pain from this stable
population, enabling population-based incidence estimates on
acute abdomen.
Screening Methods for Patients with AMI
A thorough search of the hospital electronic medical record
(EMR) and procedural databases (surgical and endovascular)
was performed to find all consecutive patients with AMI dur-
ing a 5-year study period from January 2009 to December
2013. It was presumed that not all patients with AMI were
assigned the appropriate international classification of disease
10 (ICD-10) code (K55.0, acute vascular disorder of intes-
tine). Therefore, a meticulous screening of approximately
750 hits with multiple AMI-associated ICD-10 codes
(K55.0, K55.1, K55.8, K55.9, I74.8, I82.88, I81, K65.0,
K63.1, K63.8, I71.00, I71.01, I71.09, I71.4, I71.3) for condi-
tions such as peritonitis was carried out, and all patients with
AMI were manually identified.
This study focuses on patients admitted to the acute care
unit for acute abdomen. Therefore, patients who developed
AMI either during intensive care for other diseases or directly
related to major surgery (e.g., aortic or cardiac surgery) were
not included. Patients with aortic dissection or isolated dissec-
tion of the SMA were excluded unless they presented with
intestinal ischemia at admission. Patients with AMI resulting
from iatrogenic injury were also excluded as were patients
with secondary intestinal ischemia (e.g., caused by strangula-
tion or volvulus). AMI patients referred from the other health
care districts were excluded (n=11). A clinical presentation
pattern of chronic mesenteric ischemia was also a criterion for
exclusion (n=25).
Determination of AMI
The diagnosis of AMI was based on clinical data, imaging,
laparotomy, and autopsy report when available. An abdominal
radiologist analyzed all CT findings in retrospect, and digital
subtraction angiography (DSA) images were analyzed by an
interventional radiologist. All data were summarized by a spe-
cialist in both gastrointestinal and vascular surgery, who con-
firmed the diagnosis of AMI and determined the etiology as
acute obstructive mesenteric ischemia (OMI), non-obstructive
mesenteric ischemia (NOMI), venous mesenteric ischemia
(VMI), or Bother .^
The diagnosis of OMI was based on three criteria: (1) ap-
propriate clinical presentation of life-threatening acute intesti-
nal ischemia with (2) arterial obstruction of the mesenteric
arteries and (3) either presence of at least some level of path-
ological intestinal findings on CT (bowel wall thickening,
abnormal bowel wall enhancement, or luminal dilatation) or
bowel necrosis in laparotomy/autopsy. The arterial obstruction
was defined as a typical thromboembolic clot or a calcified
occlusion of the SMA on CT and/or DSA. Cases with open
but severely (70–99 %) stenotic SMAwere defined as OMI if
the celiac artery and inferior mesenteric artery were also sig-
nificantly diseased and the clinical presentation and intestinal
findings clearly supported the diagnosis of acute intestinal
ischemia.10 NOMI was defined as acute intestinal ischemia
based on clinical presentation pattern and pathological intes-
tinal findings in CT (or bowel necrosis on laparotomy or au-
topsy) without significant (<70 %) obstruction of the SMA.
VMI was defined as an acute thrombosis of the superior mes-
enteric vein with CT findings suggesting intestinal ischemia
(bowel wall thickening with ascites or decreased bowel wall
enhancement) or intestinal injury requiring bowel resection.
Cases with mesenteric venous thrombosis without any signs
of intestinal ischemia other than mild symptoms were exclud-
ed. The etiology was defined as Bother^ in patients with AMI
caused by obstruction of the SMA for reasons other than
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embolism or atherosclerosis (e.g., aortic dissection, tumor in-
filtration, or external compression of the SMA).
Search Methods for the Reference Diagnoses
Because our institution is the only hospital providing acute
surgical care for the study population, it was presumed that
all appendectomies within this defined population were per-
formed at our institution. The number of AAs is therefore
equivalent to the number of appendectomies performed with
the diagnosis of AA (K35-K37); these cases were identified
from a search of the operative database, and cases of prophy-
lactic appendectomy were excluded. Cases involving admis-
sion for RAAA (I71.3) were identified from a search of the
operative database and EMRs, including cases treated with
open or endovascular surgery or with only palliative care.
The numbers of hospitalization for AP (K85.* or K86.00)
and ACC (K80.*, K81.0) were searched for a 2-year period
covering 2009 and 2010.
Study Variables and Statistical Methods
The demographic information for AMI patients was retrieved
from the EMR database, and the number of emergency CT
studies of the abdomen was retrieved from the radiology in-
formation system. Early mortality was defined as death within
30 days from admission or during hospitalization. Late mor-
tality was monitored until February 2015. Long-term survival
estimates were calculated for AMI survivors (i.e., those pa-
tients who did not suffer early mortality); ACC patients were
used as a control group. The population data were retrieved
from the Official Statistics authority and categorized into nine
age groups (10–19, 20–29 … >90); these data were used to
calculate age-specific incidence rates for AMI and the refer-
ence diagnoses. Basic calculations were performed with MS-
Excel 14, and SPSS Statistics 22 was used for statistical and
survival analyses. Continuous variables were expressed as
mean±standard deviation.
Definitions of the Epidemiological Terms
Incidence is defined as the number of new cases, such as an
acute disease, arising in the study population over a given time
period, whereas incidence rate is the number of new cases per
population at risk in a specific time period (presented as n/100,
000/year in this article unless otherwise stated). Incidence rate
for a specific age group is described as age-specific incidence
rate. Prevalence is defined as proportion of the population
having a medical condition, such as a chronic disease or a risk
factor.
Results
A total of 90 patients with AMI (mean age 76±12 years, 48 %
male) were registered. Fifty-eight (64 %) patients were at the
age of 75 years or more. The etiology was OMI in 56 (62 %),
NOMI in 25 (28 %), and VMI in six (7 %) cases. The etiology
of AMI was labeled as Bother^ in three (3 %) cases; two
patients had malignant tumor infiltration of the mesenteric
arteries, and one patient had aortic dissection with intestinal
ischemia at presentation.
Demographics and the diagnostic modalities in patients
with AMI are presented in Table 1. CT was performed in 85
(94 %) AMI patients, but only 31 (34 %) had CTangiography,
Table 1 Demographics and diagnostic modalities in patients with acute
mesenteric ischemia caused by arterial obstruction (OMI), non-







Age, mean±SD 79±10 76±10 54±12
Age ≥75 years 41 (73) 16 (64) 1 (17)
Male 24 (43) 13 (52) 6 (100)
Comorbidity
Hypertension 36 (64) 17 (68) 2 (33)
Hyperlipidemia 20 (36) 11 (44) 0
Diabetes 21 (38) 4 (16) 0
Chronic renal
insufficiencya
3 (5) 1 (4) 0
Atrial fibrillation 22 (39) 6 (24) 0
Coronary artery disease 35 (63) 10 (40) 0
Chronic heart failure 10 (18) 6 (24) 0
Peripheral arterial disease 21 (38) 3 (12) 0
Stroke or TIA 15 (27) 8 (32) 0
Medication
Warfarin 11 (20) 3 (12) 0
ASA 35 (63) 13 (52) 0
Clopidogrel 4 (7) 1 (4) 0
Statin 32 (57) 11 (44) 0
Diagnostic modalities
CT 51 (91) 25 (100) 6 (100)
CT angiography 17 (30) 12 (48) 0
DSAb 41 (73) 0 1 (17)
Laparotomy 24 (43) 14 (56) 1 (17)
Autopsy only 1 (2) 0 0
All data are presented as n (%)
SD standard deviation, TIA transitory ischemic attack,ASA acetylsalicylic
acid, CT computed tomography, DSA digital subtraction angiography
a Defined as plasma creatinine >130 μmol/L (1.5 mg/dL) prior to
hospitalization
b Endovascular therapy was used as the primary revascularization method
for patients with AMI during the study period10
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i.e., CT with contrast enhancement in the arterial phase. The
rate of emergency abdominal CT already showed an increas-
ing trend before 2009 and continued to increase throughout
the study period (Fig. 1). The study population was constant
during the study period, and the male-to-female ratio was
1.03. The age distribution and cardiovascular death rates of
the study population and the whole country are presented in
Fig. 2 and Table 2.
The annual incidence rates of AMI and OMI were 7.3 and
4.5/100,000 inhabitants, respectively (Table 3). In patients
with age ≥75 years, the corresponding incidence rates were
48.3 and 34.1/100,000 person years. The incidence of AMI
increased exponentially with age and surpassed the age-
specific incidence of AA at 75 years, and the overall incidence
of AMI was higher than RAAA (Fig. 3). AMI was not as
common as AP and ACC in this age group (Fig. 4). Crude
incidence rates for AA, RAAA, AP, and ACC were 87.4, 3.9,
45.6, and 55.0/100,000 person years, respectively.
Long-term survival estimates for AMI patients are present-
ed in Fig. 5. In addition, survival in patients with AMI was
compared to that of patients with ACC because of the similar
age-related incidence rate curves (Fig. 4). The early mortality
rates in all patients with AMI and ACCwere 38% (34/90) and
4 % (10/270), respectively. Although the age distribution in
patients with ACC (mean age 66±17 years) was significantly
different from that in AMI patients (mean age 76±12 years)
(P=0.000), the age distribution was the same across AMI and
ACC patients who were of the age 65 years or more (mean age
80±8 vs. 78±8 years, respectively, P=0.211). Therefore, only
patients who were ≥65 years old were included in the long-
term survival analysis. The age-adjusted risk of death was 1.8
times higher in AMI survivors (i.e., patients without early
mortality) compared to ACC survivors during the follow-up
(Fig. 6). The estimated mean survival time in AMI survivors
was 43 months (95 % confidence interval 34–52 months).
Discussion
Incidence rate is an abstract concept for a clinician treating
patients with acute abdomen on a daily basis, and the numbers
need to be put in perspective. This study shows that AMI is
not an unusual diagnosis in patients over the age of 75 years
with acute abdomen; indeed it was more common in this age
group than appendicitis and RAAA. These findings are in line
with previous reports.1, 8 It seems that AMI was not as com-
mon as AP in this age group because the age-specific inci-























Fig. 1 The annual number of emergency abdominal CTs requested by
the acute care unit (dotted line) increased after a CT system was
implemented in the emergency room area in late 2008. Unscheduled
abdominal CTs performed after admission to the ward (dashed line)
stayed constant; therefore, the total amount of urgent abdominal CT
























Fig. 2 The age distribution of the
study population in comparison to
the population of the whole
country, 2009–2013
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occurrence of gallstones in the elderly. ACC was very com-
mon in the elderly, with an exponential age-related incidence
rate curve similar to AMI.
CT with contrast enhancement in arterial and venous
phases is the Bgold standard^ protocol for AMI.11 In this study,
however, CT angiography was performed in only 36 % of the
CT examinations, indicating that AMI is often found unex-
pectedly in the routine CT for the acute abdomen, which is
usually performed in portal venous phase alone. In a previous
study of patients with acute occlusion of the SMA, there was a
tendency for a higher rate of correct CT diagnosis at first
evaluation if the suspicion of AMI had been stated in the CT
referral.12 Another study showed that one third of the relevant
findings of bowel ischemia were overlooked by the initial CT
interpretation, but secondary reading revealed most of these
findings.13 Thus, especially the emergency room physicians
and surgeons need to be aware that AMI is a relatively com-
mon cause of acute abdomen in elderly patients, and AMI
should be included in the differential diagnosis inquiry in the
CT referral when clinical suspicion arise. This will help the
on-call radiologist to choose the appropriate imaging protocol
and make a correct assessment of the radiological findings. CT
with contrast enhancement in arterial and venous phases
should be preferred in patients over the age of 75 years with
acute abdomen.
The incidence rate of RAAA was surprisingly low in this
study (3.9/100,000). An obvious reason was that patients who
died outside the hospital were not included. For comparison,
the mean incidence rate of RAAA in one Finnish cohort study
was 6.3/100,000 inhabitants between 1990 and 1997, but only
63 % (4.0/100,000) of the patients reached the hospital.14 It
was then predicted that the incidence of RAAA would in-
crease by 50 % in the next 20 years. In our study population,
no such increase has been observed.
The incidence of cardiovascular events is higher in
our study population than at the country scale.15 How-
ever, the prevalence of cardiovascular risk factors has
decreased significantly during the last three decades.16
In 2012, 28 and 18 % of men and women, respectively,
in our hospital area were smokers, 40 and 21 % respec-
tively had high diastolic blood pressure (≥90 mmHg),
and 63 and 60 % respectively had elevated serum total
cholesterol (≥5 mmol/L). These findings reflect the in-
cidence of AMI because the underlying etiology is usu-
ally atherosclerosis, atrial fibrillation, or another cardiac
event.
Table 2 Crude death rates (CDR,
n/1000 person years) between
2009 and 2013 for cardiovascular
diseases in the study population
and at the country scale according
to the Official Statistics authority
Study population Finland
N CDR N CDR
Mean population, 2009–2013 248,184 5,438,972
5-year all-cause mortality, 2009–2013 13,901 11.2 254,597 9.4
Cardiovascular diseases (I00-I425, I427-I99) 5725 4.6 100,625 3.7
Ischemic heart diseases (I20-I25) 3468 2.8 56,121 2.1
Cerebrovascular diseases (I60-I69) 1125 0.9 21,878 0.8
Other vascular diseases (I00-I15, I26-I28, I70-I99) 704 0.6 12,649 0.5
CDR crude death rate (n/1000 person/year)
Table 3 The annual population
of our hospital area (study
population) and the number of
acute mesenteric ischemia (AMI)
and other reference diagnoses
with their corresponding
incidence rates (n/100,000 person
years)
2009 2010 2011 2012 2013 Total IR 95 % CI
Population 248,182 247,943 248,130 248,233 248,430 248,184
AMI (total) 12 16 25 18 19 90 7.3 4.5–11.5
OMI 7 10 15 11 13 56 4.5 2.5–8.1
NOMI 3 5 8 5 4 25 2.0 0.8–4.8
VMI 2 1 0 2 1 6 0.5 –
Other 0 0 2 0 1 3 0.2 –
AA 213 210 241 206 215 1085 87.4 76.7–99.9
RAAA 8 11 7 15 7 48 3.9 2.1–7.3
AP 117 109 – – – 226 45.6 37.9–54.8
ACC 142 128 – – – 270 55.0 46.5–65.0
IR incidence rate, CI confidence interval, OMI obstructive mesenteric ischemia, NOMI non-obstructive mesen-
teric ischemia, VMI venous mesenteric ischemia, AA acute appendicitis, RAAA ruptured abdominal aortic aneu-
rysm, AP acute pancreatitis, ACC acute cholecystitis
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i.e., CT with contrast enhancement in the arterial phase. The
rate of emergency abdominal CT already showed an increas-
ing trend before 2009 and continued to increase throughout
the study period (Fig. 1). The study population was constant
during the study period, and the male-to-female ratio was
1.03. The age distribution and cardiovascular death rates of
the study population and the whole country are presented in
Fig. 2 and Table 2.
The annual incidence rates of AMI and OMI were 7.3 and
4.5/100,000 inhabitants, respectively (Table 3). In patients
with age ≥75 years, the corresponding incidence rates were
48.3 and 34.1/100,000 person years. The incidence of AMI
increased exponentially with age and surpassed the age-
specific incidence of AA at 75 years, and the overall incidence
of AMI was higher than RAAA (Fig. 3). AMI was not as
common as AP and ACC in this age group (Fig. 4). Crude
incidence rates for AA, RAAA, AP, and ACC were 87.4, 3.9,
45.6, and 55.0/100,000 person years, respectively.
Long-term survival estimates for AMI patients are present-
ed in Fig. 5. In addition, survival in patients with AMI was
compared to that of patients with ACC because of the similar
age-related incidence rate curves (Fig. 4). The early mortality
rates in all patients with AMI and ACCwere 38% (34/90) and
4 % (10/270), respectively. Although the age distribution in
patients with ACC (mean age 66±17 years) was significantly
different from that in AMI patients (mean age 76±12 years)
(P=0.000), the age distribution was the same across AMI and
ACC patients who were of the age 65 years or more (mean age
80±8 vs. 78±8 years, respectively, P=0.211). Therefore, only
patients who were ≥65 years old were included in the long-
term survival analysis. The age-adjusted risk of death was 1.8
times higher in AMI survivors (i.e., patients without early
mortality) compared to ACC survivors during the follow-up
(Fig. 6). The estimated mean survival time in AMI survivors
was 43 months (95 % confidence interval 34–52 months).
Discussion
Incidence rate is an abstract concept for a clinician treating
patients with acute abdomen on a daily basis, and the numbers
need to be put in perspective. This study shows that AMI is
not an unusual diagnosis in patients over the age of 75 years
with acute abdomen; indeed it was more common in this age
group than appendicitis and RAAA. These findings are in line
with previous reports.1, 8 It seems that AMI was not as com-
mon as AP in this age group because the age-specific inci-























Fig. 1 The annual number of emergency abdominal CTs requested by
the acute care unit (dotted line) increased after a CT system was
implemented in the emergency room area in late 2008. Unscheduled
abdominal CTs performed after admission to the ward (dashed line)
stayed constant; therefore, the total amount of urgent abdominal CT
























Fig. 2 The age distribution of the
study population in comparison to
the population of the whole
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occurrence of gallstones in the elderly. ACC was very com-
mon in the elderly, with an exponential age-related incidence
rate curve similar to AMI.
CT with contrast enhancement in arterial and venous
phases is the Bgold standard^ protocol for AMI.11 In this study,
however, CT angiography was performed in only 36 % of the
CT examinations, indicating that AMI is often found unex-
pectedly in the routine CT for the acute abdomen, which is
usually performed in portal venous phase alone. In a previous
study of patients with acute occlusion of the SMA, there was a
tendency for a higher rate of correct CT diagnosis at first
evaluation if the suspicion of AMI had been stated in the CT
referral.12 Another study showed that one third of the relevant
findings of bowel ischemia were overlooked by the initial CT
interpretation, but secondary reading revealed most of these
findings.13 Thus, especially the emergency room physicians
and surgeons need to be aware that AMI is a relatively com-
mon cause of acute abdomen in elderly patients, and AMI
should be included in the differential diagnosis inquiry in the
CT referral when clinical suspicion arise. This will help the
on-call radiologist to choose the appropriate imaging protocol
and make a correct assessment of the radiological findings. CT
with contrast enhancement in arterial and venous phases
should be preferred in patients over the age of 75 years with
acute abdomen.
The incidence rate of RAAA was surprisingly low in this
study (3.9/100,000). An obvious reason was that patients who
died outside the hospital were not included. For comparison,
the mean incidence rate of RAAA in one Finnish cohort study
was 6.3/100,000 inhabitants between 1990 and 1997, but only
63 % (4.0/100,000) of the patients reached the hospital.14 It
was then predicted that the incidence of RAAA would in-
crease by 50 % in the next 20 years. In our study population,
no such increase has been observed.
The incidence of cardiovascular events is higher in
our study population than at the country scale.15 How-
ever, the prevalence of cardiovascular risk factors has
decreased significantly during the last three decades.16
In 2012, 28 and 18 % of men and women, respectively,
in our hospital area were smokers, 40 and 21 % respec-
tively had high diastolic blood pressure (≥90 mmHg),
and 63 and 60 % respectively had elevated serum total
cholesterol (≥5 mmol/L). These findings reflect the in-
cidence of AMI because the underlying etiology is usu-
ally atherosclerosis, atrial fibrillation, or another cardiac
event.
Table 2 Crude death rates (CDR,
n/1000 person years) between
2009 and 2013 for cardiovascular
diseases in the study population
and at the country scale according
to the Official Statistics authority
Study population Finland
N CDR N CDR
Mean population, 2009–2013 248,184 5,438,972
5-year all-cause mortality, 2009–2013 13,901 11.2 254,597 9.4
Cardiovascular diseases (I00-I425, I427-I99) 5725 4.6 100,625 3.7
Ischemic heart diseases (I20-I25) 3468 2.8 56,121 2.1
Cerebrovascular diseases (I60-I69) 1125 0.9 21,878 0.8
Other vascular diseases (I00-I15, I26-I28, I70-I99) 704 0.6 12,649 0.5
CDR crude death rate (n/1000 person/year)
Table 3 The annual population
of our hospital area (study
population) and the number of
acute mesenteric ischemia (AMI)
and other reference diagnoses
with their corresponding
incidence rates (n/100,000 person
years)
2009 2010 2011 2012 2013 Total IR 95 % CI
Population 248,182 247,943 248,130 248,233 248,430 248,184
AMI (total) 12 16 25 18 19 90 7.3 4.5–11.5
OMI 7 10 15 11 13 56 4.5 2.5–8.1
NOMI 3 5 8 5 4 25 2.0 0.8–4.8
VMI 2 1 0 2 1 6 0.5 –
Other 0 0 2 0 1 3 0.2 –
AA 213 210 241 206 215 1085 87.4 76.7–99.9
RAAA 8 11 7 15 7 48 3.9 2.1–7.3
AP 117 109 – – – 226 45.6 37.9–54.8
ACC 142 128 – – – 270 55.0 46.5–65.0
IR incidence rate, CI confidence interval, OMI obstructive mesenteric ischemia, NOMI non-obstructive mesen-
teric ischemia, VMI venous mesenteric ischemia, AA acute appendicitis, RAAA ruptured abdominal aortic aneu-
rysm, AP acute pancreatitis, ACC acute cholecystitis
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The high incidence of AMI in Sweden more than three
decades ago has not been traced to current low autopsy rates.1
Therefore, one focus of discussion is whether or not the inci-
dence of AMI is rising as might be expected with the aging of
the population6; however, the incidence rates of other cardio-
vascular events such as acute coronary syndrome are declin-
ing in Finland.17 The incidence rates reported for AMI may
vary depending on regional differences in diagnostic and au-
topsy rates. This study, for example, applies only to hospital-
ized patients, and no conclusion can be drawn about whether
the incidence of AMI is rising or declining. However, a no-
ticeable increase in the incidence of AMI may be expected in
the next 10–15 years when the post-World War II baby
boomers reach the age of 75 years (Fig. 2).
The early mortality in AMI (38 %) was obviously much
higher than in ACC (4 %). The age-adjusted ACC group was
used as a reference for the survival analysis of the AMI pa-
tients who were 65 years old or more and who survived the
acute episode. The risk of death in AMI survivors during the
follow-up was also significantly higher compared to ACC
survivors, probably because of the high prevalence of
cardiovascular risk factors in AMI patients. Only one patient
was treated for recurrent AMI (twice) during the follow-up.
The overall mortality during the follow-up period of this study
was the highest in patients with OMI (Fig. 5). Nonetheless,
secondary prevention and follow-up for restenosis after vas-
cular interventions are necessary in patients with reasonable
life expectancy.18
The clinical presentation of AMI is often puzzling, espe-
cially in patients with chronic mesenteric atherosclerosis. For
example, an AMI patient may end up in an acute internal
medicine unit instead of a surgical unit because of simulta-
neous atrial fibrillation, cardiac failure, or myocardial infarc-
tion or because of obscure symptoms such as diarrhea and
vomiting.9, 10 We encourage a high index of suspicion of
AMI in elderly patients with acute abdomen and cardiovascu-
lar risk factors. At our institution, unscheduled and urgent CTs
were performed in the department of radiology before the
study period. A dedicated CT device was implemented in
the acute care unit in late 2008, after which the number of
emergency abdominal CT scans has increased steadily. A total



























Fig. 3 The age-specific
incidence rates of acute
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Fig. 4 The age-specific
incidence rates of hospitalizations
for acute pancreatitis (AP) and
acute cholecystitis (ACC) are
presented for 2009–2010. The
incidence of AP had a second
peak for people ages 75–85 years;
therefore, acute mesenteric
ischemia (AMI) was not as
common as AP in this age group
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during the 5-year study period; AMI was present in 82 (1 %)
of those cases, which is in line with a previous study on CTof
the acute abdomen.7 We suspect that the liberal use of abdom-
inal CT in the early diagnostics of acute abdomen in elderly
patients correlates with our high incidence of diagnosed AMI
cases.
During the screening process for this study, we learned that
the diagnosis codes in AMI patients were often incorrect. The
appropriate ICD-10 code (K55.0) was initially recorded in the
EMR for only 72 % of study patients with OMI or NOMI. In
addition, we found 29 patients for whom the diagnosis code of
acute vascular disorder of intestine (K55.0) had inadvertently
been assigned for they definitely were not AMI patients.
Therefore, epidemiological studies in AMI should not be
based solely on a computerized search of the EMR database.
Given the proliferation of studies based on administrative da-
tabases, it would be justified to make random inspections of
such databases for their accuracy in the coding of conditions
that are difficult to diagnose and have a wide spectrum of
different etiologies, such asAMI. Consequently, we performed
a thorough search for all consecutive patients with AMI during
the study period, and the definitive diagnosis of AMI was
manually confirmed for each case based on all available infor-
mation, with the imaging data analyzed by a team of specialists
in gastrointestinal/vascular imaging and interventions.
Study Limitations
The reference patients (with a diagnosis other than AMI) may
have included some incidental patients outside the studied
population, but we presume that the representation of those
patients was insignificant. Conversely, some patients with
mild disease not requiring surgical intervention and treated
with conservative therapy in primary care units may be miss-
ing (e.g., ACC patients unfit for surgery). Therefore, the inci-
dence rates of the reference diagnoses should be interpreted in
this context. Autopsy reports of those other than treated pa-
tients were not sought; therefore, the incidence rates in this
study apply only to hospitalized patients.
Conclusion
This study demonstrates a high proportion of AMI in elderly
patients hospitalized for acute abdomen. AMI is more com-
mon than AA or RAAA in patients with age of 75 years or
more with acute abdomen. The long-term mortality remains
high in AMI survivors, reflecting the high occurrence of car-
diovascular risk factors among these patients.
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Superior mesenteric artery occlusion
Bowel ischemia
Emergency radiology
a b s t r a c t
Objectives: (1) To evaluate the ability of emergency room radiologists to detect acutemesenteric ischemia
(AMI) from computed tomography (CT) images in patients with acute abdominal pain. (2) To identify
factors affecting radiologists’ performance in the CT interpretation and patient outcome.
Materials andmethods:Aretrospective studyof 95 consecutivepatients treated for 97AMIevents between
2009 and 2013 was carried out. The etiology of AMI was embolism in 24 (25%), atherosclerotic vascular
disease (ASVD) in 39 (40%), non-obstructive mesenteric ischemia (NOMI) in 25 (26%), and mesenteric
venous thrombosis (MVT) in nine (9%) cases. The protocols, referrals and initial radiology reports of the
abdominal CTswere analyzed. TheCT studieswere further scrutinized for vascular and intestinal findings.
Results: The referring clinician had suspected AMI in 30 (31%) cases prior to imaging. The crucial findings
of AMI had been stated in 97% of the radiology reports if the clinician had mentioned AMI suspicion in
the referral; if not, the corresponding rate was 81% (p=0.04). Patients without suspicion of AMI prior
to CT were more prone to undergo bowel resection. CT protocol was optimal for AMI (with contrast
enhancement in arterial and venous phases) in only 34 (35%) cases. Intestinal findingsweremore difficult
to detect than vascular findings. Vascular findings were retrospectively detectable in 92% of cases with
embolismand100% inASVDandMVT. Someevidenceof intestinal abnormalitywas retrospectively found
in the CTfindings in 92%, 100%, 100% and 67% of caseswith embolism, ASVD,NOMI andMVT, respectively.
Conclusions: AMI is underdiagnosed in the CT of the acute abdomen if there is no clinical suspicion.
© 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Acute mesenteric ischemia (AMI) represents a diagnostic chal-
lenge for the surgeons, emergency physicians and radiologists,
especially in elderly patients with acute abdomen since the inci-
dence of AMI increases exponentially with age [1]. In patients over
Abbreviations: AMI, acute mesenteric ischemia; ASVD, atherosclerotic vascular
disease; CA, celiac artery; IMA, inferior mesenteric artery; MVT, mesenteric venous
thrombosis;NOMI, non-obstructivemesenteric ischemia; PVP, portal venous phase;
SMA, superior mesenteric artery; SMV, superior mesenteric vein.
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age 75 years, AMI is more common than acute appendicitis or rup-
tured abdominal aortic aneurysm [2]. While it is known that both
timely diagnosis and rapid treatment are crucial for patient sur-
vival [3–5], there are no laboratory tests that would be diagnostic
for AMI [6]. Contrast-enhanced multidetector computed tomogra-
phy (MDCT) in the arterial and portal venous phases has proved to
be an accuratemethod for detecting vascular pathology and associ-
ated intestinal changes in AMI with a sensitivity of 89–100% and a
specificityof 90–100% [7–11].However, these studies includedonly
patients with clinically suspected AMI, and in daily clinical practice
AMI is often found unexpectedly after imaging for acute abdomi-
nal pain. Therefore, the majority of AMI patients are imaged with
suboptimal MDCT protocols, usually in the portal venous phase
alone.
The aims of this retrospective study were (1) to systematically
assess the ability of radiologists to detect AMI in a CT of the acute
http://dx.doi.org/10.1016/j.ejrad.2015.09.006
0720-048X/© 2015 Elsevier Ireland Ltd. All rights reserved.
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Conclusions: AMI is underdiagnosed in the CT of the acute abdomen if there is no clinical suspicion.
© 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Acute mesenteric ischemia (AMI) represents a diagnostic chal-
lenge for the surgeons, emergency physicians and radiologists,
especially in elderly patients with acute abdomen since the inci-
dence of AMI increases exponentially with age [1]. In patients over
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age 75 years, AMI is more common than acute appendicitis or rup-
tured abdominal aortic aneurysm [2]. While it is known that both
timely diagnosis and rapid treatment are crucial for patient sur-
vival [3–5], there are no laboratory tests that would be diagnostic
for AMI [6]. Contrast-enhanced multidetector computed tomogra-
phy (MDCT) in the arterial and portal venous phases has proved to
be an accuratemethod for detecting vascular pathology and associ-
ated intestinal changes in AMI with a sensitivity of 89–100% and a
specificityof 90–100% [7–11].However, these studies includedonly
patients with clinically suspected AMI, and in daily clinical practice
AMI is often found unexpectedly after imaging for acute abdomi-
nal pain. Therefore, the majority of AMI patients are imaged with
suboptimal MDCT protocols, usually in the portal venous phase
alone.
The aims of this retrospective study were (1) to systematically
assess the ability of radiologists to detect AMI in a CT of the acute
http://dx.doi.org/10.1016/j.ejrad.2015.09.006
0720-048X/© 2015 Elsevier Ireland Ltd. All rights reserved.
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Fig. 1. 87-year-old female with ASVD and AMI. The split-bolus injection protocol
enables diagnostic enhancement of the arteries, veins, parenchymal organs and
bowel wall in a single image acquisition. An in situ thrombus (open arrowhead,
A) is seen in the atherosclerotic SMA. The cecum and ascending colon are thick-
walled, edematous and poorly enhancing (white arrowheads, A). In a sagittal image
(B), the thrombus of the proximal SMA (arrowheads, B) is clearly visible. The on-call
radiologist interpreted the CT images correctly, although AMI was not suspected in
the referral. Percutaneous transluminal angioplasty with stenting was successfully
performed, and the patient survived. Surgery was not needed.
abdomenperformed in acute care setting, and (2) to identify factors
associatedwith amissedor delayeddiagnosis andpatient outcome.
For this purpose, we stratified the vascular and intestinal CT find-
ings of AMI subdivided into the various etiologies, and analyzed
whether the suspicion of AMI made by the referring physician had
any impact on the correct CT diagnosis, and further, we studied
which factors were associated with mortality and bowel resection
rates.
2. Materials and methods
2.1. Study design and patients
The local institutional review board approved this retrospective
study. Informed consentwaswaived. The records of all consecutive
patients treated forAMI inour tertiary care centerduringafive-year
period between 2009 and 2013 were retrieved from a meticulous
search of the hospital registries [2]. Altogether 136 patients with
mesenteric ischemiawere identified. Patients with chronicmesen-
teric ischemia (n=25), AMI secondary to iatrogenic injury (n=3),
aortic surgery or aortic dissection (n=6), or tumor infiltration of the
mesenteric arteries (n=2) were excluded. Furthermore, five AMI
patients without CT examination prior to treatmentwere excluded
and therefore 95 patients (mean age 76±12 years) with 97 AMI
events were included in the study; one patient suffered three sep-
arate AMI events during the study period.
Medical records were examined for comorbidities, medication,
clinical presentation pattern, treatment approach, and in-hospital
mortality. The duration of symptoms and laboratory values were
recordedat the timeof thefirst CTexamination. Imaging, diagnostic
and treatment delays were recorded from the electronic medical
records.
2.2. Determination and etiological categorization of AMI
All patients were admitted to the emergency room for acute
symptoms such as abdominal pain, vomiting and diarrhea. In this
study, the diagnosis of AMI was retrospectively verified by a spe-
cialist in gastrointestinal andvascular surgerybasedonall available
information: clinical data, CT findings, digital subtraction angiog-
raphy (DSA), laparotomy and autopsy report, when available. All
CT findings were re-evaluated by an experienced radiologist, and
DSA by an interventional radiologist. A consensus was sought to
determine the definitive etiology of AMI in each case. Embolism
was indicated by a clot surrounded by contrast material in a
non-calcified arterial segment of the superior mesenteric artery
(SMA). A very acute onset of symptoms, atrial fibrillation, findings
of cardiac thrombi in CT and the presence of other synchronous
embolic events (i.e. solidabdominalorgan infarction, stroke, or limb
embolism) were also indicative of embolic etiology. Atherosclerotic
vascular disease (ASVD) was defined as a) a thrombotic occlusion
with a proximal calcified stenosis of the SMA, or b) a chronic
occlusion or severe stenosis (70–99%) of the SMA, together with
atherosclerotic disease of the celiac artery (CA) and/or inferior
mesenteric artery (IMA) in a patient with acute symptoms and
otherfindings consistentwith thediagnosis of AMI.Non-obstructive
mesenteric ischemia (NOMI)was defined as severe intestinal hypop-
erfusion or fulminant ischemic colitis without an occlusion or
severe stenosis of theSMA.Mesenteric venous thrombosis (MVT)was
defined as acute abdominal pain and related symptoms together
with major thrombosis of the superior mesenteric vein (SMV) and
mesenteric edema surrounding the SMV indicating acute throm-
bosis.
2.3. CT imaging protocols
CT imaging was performed using a 64-slice MDCT system in 96
AMI events (Somatom Definition AS64; Siemens Medical Systems,
Erlangen, Germany in 89 events and Toshiba Aquilion 64; Toshiba
Medical Systems, Otawara, Japan in seven events). One patient was
examined with a 16-slice MDCT (Sensation 16; Siemens Medical
Systems, Erlangen, Germany). CT protocols were categorized as
unenhanced, CTwith angiographic phase only, portal venous phase
(PVP), multiphasic or split-bolus. The split-bolus protocol included
a single-phase image acquisition with a biphasic contrast medium
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Table 1
Demographics of 95 patients with AMI stratified by etiology.
Characteristic Etiology of AMI p
Embolism(n=24) ASVD(n=37) NOMI(n=25) MVT(n=9)
Male, n (%) 9 (38) 15 (41) 13 (52) 8 (89) 0.04
Age, mean± SD, years 79±11 78±9 76±10 53±11 <0.01
BMIa, mean± SD, kg/m2 25.9±4.6 25.1±5.7 26,6±4,5 31.4±6.0 0.01
Comorbidity, n (%)
Hypertension 12 (50) 28 (76) 17 (68) 3 (33) <0.05
Hyperlipidemia 7 (29) 15 (41) 11 (44) 0 (0) 0.07
Obesity (BMI≥30kg/m2) 6 (25) 5 (14) 6 (24) 4 (44) 0.29
Diabetes mellitus 6 (25) 17 (46) 4 (16) 0 (0) 0.03
Chronic renal insufficiencyb 1 (4) 2 (5) 1 (4) 0 (0) 0.99
Coronary artery disease 14 (58) 17 (46) 10 (40) 0 (0) 0.02
Peripheral arterial disease 4 (17) 17 (46) 3 (12) 0 (0) <0.01
Stroke or TIA 8 (33) 10 (27) 8 (32) 0 (0) 0.21
Atrial fibrillation 17 (71) 9 (24) 6 (24) 0 (0) < 0.01
Chronic heart failure 2 (8) 7 (19) 6 (24) 0 (0) 0.29
Recent major surgery (≤30d) 2 (8) 2 (5) 2 (8) 1 (11) 0.76
History of DVT or PE 0 (0) 1 (3) 1 (4) 1 (11) 0.45
Medication, n (%)
Warfarin 7 (29) 6 (16) 3 (12) 0 (0) 0.26
Acetylsalicylic acid 12 (50) 26 (70) 13 (52) 0 (0) <0.01
Clopidogrel 1 (4) 4 (11) 1 (4) 0 (0) 0.76
Statin 13 (54) 24 (65) 11 (40) 0 (0) <0.01
ASVD, atherosclerotic vascular disease; NOMI, non-obstructive mesenteric ischemia; MVT, mesenteric venous thrombosis; SD, standard deviation; BMI, body mass index;
TIA, transient ischemic attack; DVT, deep vein thrombosis; PE, pulmonary embolism.
a Information available on 90 patients.
b Defined as plasma creatinine >130mol/L (1.5mg/dL) prior to hospitalization.
injection, resulting in arterial enhancement on topof PVP in a single
series of images (Fig. 1).
2.4. CT referral, report and image analysis
The referring clinicians’ primary suspicions of mesenteric
ischemia (categorized as yes or no) were registered. The on-call
radiologist (hereafter referred to as the first reader) evaluated all
CT studies in the 24/7 emergency setting. The first reader’s inter-
pretation of the CTfindingswas evaluated from the initial radiology
reports and considered correct if the fundamental vascular and/or
intestinal findings were reported and a diagnosis of AMI was pro-
posed or suspected. If the first reader had suspected AMI but failed
to report some of the CT findings, or if the first reader had ade-
quately reported all relevant findings but did not propose the
diagnosis of AMI, then the CT report was still considered essen-
tially correct. If the first reader missed the relevant findings and
failed to suspect AMI, the CT report was defined as incorrect.
For the purposes of this study, a radiologist with 12 years of
experience in abdominal CT (hereafter referred to as the second
reader) retrospectivelyevaluatedall of theCTexaminationsaccord-
ing to a predefined scheme. The second reader was aware that all
patients had been treated for mesenteric ischemia but was blinded
to the severity of the patients’ clinical conditions, patient manage-
ment and the first reader’s report.
The presence of calcified and/or soft atherosclerotic changes,
and the degree of vessel lumen stenosis (<50%, 50–70%, 70–99%
or total occlusion) were reported separately for SMA, CA, com-
mon hepatic artery and IMA. SMA embolism or major thrombosis
was registered and considered a strong sign of AMI [8–10,12].
Extent and location of the following pathological intestinal find-
ings were registered and regarded as specific for AMI: intestinal
pneumatosis, portomesenteric venous gas, and abnormal bowel
wall enhancement. If only single-phase contrast-enhanced images
were available, normally enhancing bowel was used as an inter-
nal reference when assessing abnormal bowel wall enhancement.
The following intestinal findings were regarded as non-specific:
the presence of dilated or paralytic bowel loops (small bowel
>2.5 cm, caecum >9cm and the rest of the colon >6 cm), and bowel
wall thickening [13–17]. Other abdominal findings reported were
mesenteric fat stranding, free peritoneal fluid and free peritoneal
gas. Signs of synchronous embolism or infarction in the upper
abdominal parenchymal organs were detected and recorded.
2.5. Statistical analysis
The data analysiswas carried out using SPSS, version 22. Contin-
uous variables were expressed as mean± standard deviation (SD)
ormedianand interquartile range (IQR), andcategorical variablesas
absolute values and percentages. Fisher’s exact test or 2 test was
used to compare nominal data, and the Kruskal–Wallis one-way
analysis of variance or theMann–WhitneyU test for nonparametric
data. Univariate analysis was performed on independent CT find-
ings and baseline variables; associations with bowel resection or
in-hospital death were examined, and odds ratio (OR) was used to
reflect odds of the outcome event. P values <0.05 were considered
significant.
3. Results
The etiology of AMI was embolism in 25% (24/97), ASVD in
40% (39/97), NOMI in 26% (25/97), and MVT in 9% (9/97) of the
cases. The definitive diagnosis of AMI was confirmed by laparo-
tomy or autopsy in 11 patients in the embolism group. The embolic
occlusion of the SMA was confirmed by CT in 22 cases, while two
patients had distal embolus of the SMA treated with bowel resec-
tion; besides extensive intestinal ischemia, both patients had atrial
fibrillation and synchronous splenic infarction consistent with the
embolic etiology. The diagnosis of AMI was confirmed by laparo-
tomyor autopsy in 19 patients in theASVDgroup and in 14 patients
in theNOMI group. For the rest, the diagnosis of AMIwas confirmed
by one of the following features: acute thrombotic occlusion of the
SMA inCT (ASVDn=6), intestinal CTfindings specific forAMI (ASVD
n=6, NOMI n=5), or non-specific intestinal CT findings (ASVD n=8,
NOMI n=6). All patientswithout laparotomyor autopsy-confirmed
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Fig. 1. 87-year-old female with ASVD and AMI. The split-bolus injection protocol
enables diagnostic enhancement of the arteries, veins, parenchymal organs and
bowel wall in a single image acquisition. An in situ thrombus (open arrowhead,
A) is seen in the atherosclerotic SMA. The cecum and ascending colon are thick-
walled, edematous and poorly enhancing (white arrowheads, A). In a sagittal image
(B), the thrombus of the proximal SMA (arrowheads, B) is clearly visible. The on-call
radiologist interpreted the CT images correctly, although AMI was not suspected in
the referral. Percutaneous transluminal angioplasty with stenting was successfully
performed, and the patient survived. Surgery was not needed.
abdomenperformed in acute care setting, and (2) to identify factors
associatedwith amissedor delayeddiagnosis andpatient outcome.
For this purpose, we stratified the vascular and intestinal CT find-
ings of AMI subdivided into the various etiologies, and analyzed
whether the suspicion of AMI made by the referring physician had
any impact on the correct CT diagnosis, and further, we studied
which factors were associated with mortality and bowel resection
rates.
2. Materials and methods
2.1. Study design and patients
The local institutional review board approved this retrospective
study. Informed consentwaswaived. The records of all consecutive
patients treated forAMI inour tertiary care centerduringafive-year
period between 2009 and 2013 were retrieved from a meticulous
search of the hospital registries [2]. Altogether 136 patients with
mesenteric ischemiawere identified. Patients with chronicmesen-
teric ischemia (n=25), AMI secondary to iatrogenic injury (n=3),
aortic surgery or aortic dissection (n=6), or tumor infiltration of the
mesenteric arteries (n=2) were excluded. Furthermore, five AMI
patients without CT examination prior to treatmentwere excluded
and therefore 95 patients (mean age 76±12 years) with 97 AMI
events were included in the study; one patient suffered three sep-
arate AMI events during the study period.
Medical records were examined for comorbidities, medication,
clinical presentation pattern, treatment approach, and in-hospital
mortality. The duration of symptoms and laboratory values were
recordedat the timeof thefirst CTexamination. Imaging, diagnostic
and treatment delays were recorded from the electronic medical
records.
2.2. Determination and etiological categorization of AMI
All patients were admitted to the emergency room for acute
symptoms such as abdominal pain, vomiting and diarrhea. In this
study, the diagnosis of AMI was retrospectively verified by a spe-
cialist in gastrointestinal andvascular surgerybasedonall available
information: clinical data, CT findings, digital subtraction angiog-
raphy (DSA), laparotomy and autopsy report, when available. All
CT findings were re-evaluated by an experienced radiologist, and
DSA by an interventional radiologist. A consensus was sought to
determine the definitive etiology of AMI in each case. Embolism
was indicated by a clot surrounded by contrast material in a
non-calcified arterial segment of the superior mesenteric artery
(SMA). A very acute onset of symptoms, atrial fibrillation, findings
of cardiac thrombi in CT and the presence of other synchronous
embolic events (i.e. solidabdominalorgan infarction, stroke, or limb
embolism) were also indicative of embolic etiology. Atherosclerotic
vascular disease (ASVD) was defined as a) a thrombotic occlusion
with a proximal calcified stenosis of the SMA, or b) a chronic
occlusion or severe stenosis (70–99%) of the SMA, together with
atherosclerotic disease of the celiac artery (CA) and/or inferior
mesenteric artery (IMA) in a patient with acute symptoms and
otherfindings consistentwith thediagnosis of AMI.Non-obstructive
mesenteric ischemia (NOMI)was defined as severe intestinal hypop-
erfusion or fulminant ischemic colitis without an occlusion or
severe stenosis of theSMA.Mesenteric venous thrombosis (MVT)was
defined as acute abdominal pain and related symptoms together
with major thrombosis of the superior mesenteric vein (SMV) and
mesenteric edema surrounding the SMV indicating acute throm-
bosis.
2.3. CT imaging protocols
CT imaging was performed using a 64-slice MDCT system in 96
AMI events (Somatom Definition AS64; Siemens Medical Systems,
Erlangen, Germany in 89 events and Toshiba Aquilion 64; Toshiba
Medical Systems, Otawara, Japan in seven events). One patient was
examined with a 16-slice MDCT (Sensation 16; Siemens Medical
Systems, Erlangen, Germany). CT protocols were categorized as
unenhanced, CTwith angiographic phase only, portal venous phase
(PVP), multiphasic or split-bolus. The split-bolus protocol included
a single-phase image acquisition with a biphasic contrast medium
2446 T.T. Lehtimäki et al. / European Journal of Radiology 84 (2015) 2444–2453
Table 1
Demographics of 95 patients with AMI stratified by etiology.
Characteristic Etiology of AMI p
Embolism(n=24) ASVD(n=37) NOMI(n=25) MVT(n=9)
Male, n (%) 9 (38) 15 (41) 13 (52) 8 (89) 0.04
Age, mean± SD, years 79±11 78±9 76±10 53±11 <0.01
BMIa, mean± SD, kg/m2 25.9±4.6 25.1±5.7 26,6±4,5 31.4±6.0 0.01
Comorbidity, n (%)
Hypertension 12 (50) 28 (76) 17 (68) 3 (33) <0.05
Hyperlipidemia 7 (29) 15 (41) 11 (44) 0 (0) 0.07
Obesity (BMI≥30kg/m2) 6 (25) 5 (14) 6 (24) 4 (44) 0.29
Diabetes mellitus 6 (25) 17 (46) 4 (16) 0 (0) 0.03
Chronic renal insufficiencyb 1 (4) 2 (5) 1 (4) 0 (0) 0.99
Coronary artery disease 14 (58) 17 (46) 10 (40) 0 (0) 0.02
Peripheral arterial disease 4 (17) 17 (46) 3 (12) 0 (0) <0.01
Stroke or TIA 8 (33) 10 (27) 8 (32) 0 (0) 0.21
Atrial fibrillation 17 (71) 9 (24) 6 (24) 0 (0) < 0.01
Chronic heart failure 2 (8) 7 (19) 6 (24) 0 (0) 0.29
Recent major surgery (≤30d) 2 (8) 2 (5) 2 (8) 1 (11) 0.76
History of DVT or PE 0 (0) 1 (3) 1 (4) 1 (11) 0.45
Medication, n (%)
Warfarin 7 (29) 6 (16) 3 (12) 0 (0) 0.26
Acetylsalicylic acid 12 (50) 26 (70) 13 (52) 0 (0) <0.01
Clopidogrel 1 (4) 4 (11) 1 (4) 0 (0) 0.76
Statin 13 (54) 24 (65) 11 (40) 0 (0) <0.01
ASVD, atherosclerotic vascular disease; NOMI, non-obstructive mesenteric ischemia; MVT, mesenteric venous thrombosis; SD, standard deviation; BMI, body mass index;
TIA, transient ischemic attack; DVT, deep vein thrombosis; PE, pulmonary embolism.
a Information available on 90 patients.
b Defined as plasma creatinine >130mol/L (1.5mg/dL) prior to hospitalization.
injection, resulting in arterial enhancement on topof PVP in a single
series of images (Fig. 1).
2.4. CT referral, report and image analysis
The referring clinicians’ primary suspicions of mesenteric
ischemia (categorized as yes or no) were registered. The on-call
radiologist (hereafter referred to as the first reader) evaluated all
CT studies in the 24/7 emergency setting. The first reader’s inter-
pretation of the CTfindingswas evaluated from the initial radiology
reports and considered correct if the fundamental vascular and/or
intestinal findings were reported and a diagnosis of AMI was pro-
posed or suspected. If the first reader had suspected AMI but failed
to report some of the CT findings, or if the first reader had ade-
quately reported all relevant findings but did not propose the
diagnosis of AMI, then the CT report was still considered essen-
tially correct. If the first reader missed the relevant findings and
failed to suspect AMI, the CT report was defined as incorrect.
For the purposes of this study, a radiologist with 12 years of
experience in abdominal CT (hereafter referred to as the second
reader) retrospectivelyevaluatedall of theCTexaminationsaccord-
ing to a predefined scheme. The second reader was aware that all
patients had been treated for mesenteric ischemia but was blinded
to the severity of the patients’ clinical conditions, patient manage-
ment and the first reader’s report.
The presence of calcified and/or soft atherosclerotic changes,
and the degree of vessel lumen stenosis (<50%, 50–70%, 70–99%
or total occlusion) were reported separately for SMA, CA, com-
mon hepatic artery and IMA. SMA embolism or major thrombosis
was registered and considered a strong sign of AMI [8–10,12].
Extent and location of the following pathological intestinal find-
ings were registered and regarded as specific for AMI: intestinal
pneumatosis, portomesenteric venous gas, and abnormal bowel
wall enhancement. If only single-phase contrast-enhanced images
were available, normally enhancing bowel was used as an inter-
nal reference when assessing abnormal bowel wall enhancement.
The following intestinal findings were regarded as non-specific:
the presence of dilated or paralytic bowel loops (small bowel
>2.5 cm, caecum >9cm and the rest of the colon >6 cm), and bowel
wall thickening [13–17]. Other abdominal findings reported were
mesenteric fat stranding, free peritoneal fluid and free peritoneal
gas. Signs of synchronous embolism or infarction in the upper
abdominal parenchymal organs were detected and recorded.
2.5. Statistical analysis
The data analysiswas carried out using SPSS, version 22. Contin-
uous variables were expressed as mean± standard deviation (SD)
ormedianand interquartile range (IQR), andcategorical variablesas
absolute values and percentages. Fisher’s exact test or 2 test was
used to compare nominal data, and the Kruskal–Wallis one-way
analysis of variance or theMann–WhitneyU test for nonparametric
data. Univariate analysis was performed on independent CT find-
ings and baseline variables; associations with bowel resection or
in-hospital death were examined, and odds ratio (OR) was used to
reflect odds of the outcome event. P values <0.05 were considered
significant.
3. Results
The etiology of AMI was embolism in 25% (24/97), ASVD in
40% (39/97), NOMI in 26% (25/97), and MVT in 9% (9/97) of the
cases. The definitive diagnosis of AMI was confirmed by laparo-
tomy or autopsy in 11 patients in the embolism group. The embolic
occlusion of the SMA was confirmed by CT in 22 cases, while two
patients had distal embolus of the SMA treated with bowel resec-
tion; besides extensive intestinal ischemia, both patients had atrial
fibrillation and synchronous splenic infarction consistent with the
embolic etiology. The diagnosis of AMI was confirmed by laparo-
tomyor autopsy in 19 patients in theASVDgroup and in 14 patients
in theNOMI group. For the rest, the diagnosis of AMIwas confirmed
by one of the following features: acute thrombotic occlusion of the
SMA inCT (ASVDn=6), intestinal CTfindings specific forAMI (ASVD
n=6, NOMI n=5), or non-specific intestinal CT findings (ASVD n=8,
NOMI n=6). All patientswithout laparotomyor autopsy-confirmed
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Table 2
Clinical data at the time of CT imaging, and the treatment approach in 97 AMI events (in 95 patients) stratified by etiology.
Characteristic Etiology of AMI p
Embolism(n=24) ASVD (n=39) NOMI(n=25) MVT (n=9)
Clinical data, n (%)
Duration of symptoms <24h 15 (63) 7 (18) 9 (36) 0 (0) <0.01
Acute myocardial infarction 3 (13) 2 (5) 0 (0) 0 (0) 0.23
Acute kidney injurya 0 (0) 5 (13) 10 (40) 0 (0) <0.01
GFR >60ml/min/1.73m2 17 (71) 25 (66) 12 (48) 9 (100)
GFR 30–59 ml/min/1.73m2 7 (29) 8 (21) 7 (28) 0 (0)
GFR 15–29ml/min/1.73m2 0 (0) 4 (10) 5 (20) 0 (0)
GFR <15ml/min/1.73m2 0 (0) 1 (3) 1 (4) 0 (0)
Metabolic acidosisb 6 (25) 5 (13) 13 (52) 0 (0) <0.01
Laboratory values, median (IQR)
WBC count, 109/L 12.8 (10–17) 16.2 (12–20) 10.9 (8–16) 10.6 (9–12) <0.01
CRP, mg/L 121(11–235) 168 (100–207) 114 (11–218) 117 (67–170) 0.58
Plasma creatinine, mol/L 91 (62–106) 69 (59–113) 96 (71–192) 71 (60–79) 0.06
Delay, median (IQR), h
From admissionc to CT 3.9 (2–10) 5.6 (2–30) 5.0 (1–26) 5.4 (3–24) 0.52
From admissionc to diagnosis 4.6 (3–18) 5.6 (2–34) 14.1 (2–35) 5.4 (3–24) 0.91
From diagnosis to treatmentd 3.4 (2–5) 3.5 (2–23) 3.7 (3–6) – 0.53
Diagnostic procedures n (%)
Laparotomy or autopsy 11 (45) 19 (49) 14 (56) 1 (11)
Angiography 18 (74) 31 (79) 0 (0) 0 (0)
Unenhanced CT 0 (0) 2 (5) 3 (12) 0 (0)
CTAP 2 (8) 1 (3) 0 (0) 0 (0)
PVP 14 (58) 23 (59) 9 (36) 9 (100)
Multiphasic CT 3 (13) 4 (10) 3 (12) 0 (0)
Split-bolus CT 5 (21) 9 (23) 10 (40) 0 (0)
Treatment, n (%)
Endovascular therapye 18 (75) 31 (79) 0 (0) 1 (11)
Laparotomy 8 (33) 18 (46) 14 (56) 1 (11)
Bowel resection 7 (29) 14 (36) 12 (48) 1 (11)
Unresectable bowel necrosis 0 (0) 2 (5) 2 (8) 0 (0)
Surgical revascularization 0 (0) 2 (5) – –
Conservative treatment 3 (13) 4 (10) 11 (44) 8 (89)
In-hospital mortality, n (%) 11 (46) 12 (31) 7 (28) 0 (0) 0.08
ASVD, atherosclerotic vascular disease; NOMI, non-obstructive mesenteric ischemia; MVT, mesenteric venous thrombosis; GFR, glomerular filtration rate (calculated using
theModification of Diet in Renal Disease formula); IQR, interquartile range;WBC, white blood cell; CRP, C-reactive protein; CTAP, computed tomography angiographic phase;
PVP, portal venous phase.
a Defined as plasma creatinine >130mol/L (1.5mg/dL) in patients with previously normal renal function, or >20% increase of plasma creatinine in patients with chronic
renal insufficiency.
b Defined as base deficit >5mEq/L. Information was available in 66 events.
c Time of admission was defined as the time of initial presentation to any hospital, before transfer to our tertiary care center.
d Includes only patients treated with endovascular or surgical intervention.
e Endovascular therapy was used as the primary revascularization modality in AMI during the study period [18].
diagnosis had acute clinical presentation pattern consistent with
the diagnosis of AMI and appropriate response to treatment. In
all cases of MVT, the definitive diagnosis was confirmed by acute
thrombosis of the SMV inCT; only onepatientwithMVTunderwent
laparotomy.
3.1. Patient demographics, clinical data and treatment
approaches
The demographic data of the study patients is presented in
Table 1. Clinical data, diagnostic procedures, treatment and in-
hospitalmortality are presented in Table 2. PatientswithMVTwere
significantly younger, predominantly male, more frequently over-
weight, and had fewer cardiovascular risk factors compared to the
patient groups with arterial AMI. Atrial fibrillation was associated
with embolic etiology and peripheral arterial disease with ASVD
(p<0.01). Four (4%) patients had chronic renal insufficiency at base-
line. Regarding the clinical presentation, patients with embolism
had a shorter duration of symptoms; acute kidney injury and
metabolic acidosis were prevalent in patientswith NOMI (p<0.01).
A total of 18 (75%) patients with embolism and 31 (79%)
cases with ASVD were referred for angiography and treated with
emergency endovascular revascularization; twopatientswere con-
verted to open revascularization [18]. All MVT patients were
started on anticoagulation or continuous infusion of unfractionated
heparin at admission; one patient received transhepatic catheter-
directed thrombolysis. Eight patients (32%) with NOMI survived
without bowel resection in response to conservative treatment;
seven of them had isolated ischemic colitis, and one patient had
small bowel ischemia with chronic occlusion of the CA and IMA.
The in-hospital mortality rates for NOMI patients with small bowel
ischemia versus isolated colon ischemia were 36% (5/14) versus
18% (2/11) (p=0.332). The corresponding laparotomy rates were
86% (12/14) and 18% (2/11) (p=0.001). The laparotomy and bowel
resection rates for all study groups are presented in Table 2.
3.2. Correctness of the initial CT reports
The correctness of the first readers’ CT reports and its correla-
tionwith imagingprotocols, imagequality, first readers’ experience
and the contents of the CT referrals are shown in Table 3. When a
suspicion of AMI was expressed in the CT referral, the first reader’s
CT report was more frequently correct (97%, 29/30) than when the
suspicion was not expressed (81%, 54/67, p=0.04). The CT protocol
or the image quality had no significant effect on the correctness of
the initial CT report.
The rate of correct CT reports was significantly higher for res-
idents, body imaging specialists and angiologists in comparison
with other radiology subspecialists (p<0.01).
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Table 3
Diagnostic performance of the first CT reader arranged by etiology, imaging protocols, image quality, first reader’s experience, and clinical suspicion prior to imaging.
Total Correctness of CT report p
Correct Incorrect
All reports 97 83 (86) 14 (14)
Etiology
Embolism 24 20 (83) 4 (17)
ASVD 39 35 (90) 4 (10)
NOMI 25 19 (76) 6 (24)
MVT 9 9 (100) 0 (0)
CT protocol
Unenhanced 5 3 (60) 2(40)
CTAP 3 2 (67) 1 (33)
PVP 55 48 (87) 7 (13)
Multiphasic 10 9 (90) 1 (10)
Split-bolus 24 21 (88) 3 (13)
Optimal versus non-optimal CT protocol 0.58
Optimal (multiphasic, split-bolus)a 34 26 (76) 4 (12)
Non-optimal (PVP, CTAP, unenhanced) 63 39 (62) 10 (16)
Image quality 0.40
Diagnostic 93 79 (85) 14 (15)
Suboptimalb 4 4 (100) 0 (0)
First reader’s experience <0.01c
Resident 28 26 (93) 2 (7)
Body imaging specialist 18 17 (94) 1 (6)
Angiologist 13 12 (92) 1 (8)
Other subspecialist 38 28 (74) 10 (26)
AMI suspicion in CT referral 0.04
Yes 30 29 (97) 1 (3)
No 67 54 (81) 13 (19)
ASVD, atherosclerotic vascular disease; NOMI, non-obstructivemesenteric ischemia;MVT,mesenteric venous thrombosis; CTAP, computed tomography angiographic phase;
PVP, portal venous phase.
All data are presented as n (%).
a The optimal protocol for the diagnosis of AMIwas defined as CTwith contrast enhancement in both arterial and venous phases (i.e.multiphasic or the split-bolus protocol).
b Images with excessive respiratory motion artefacts or metal artefacts from a thoracolumbar spine fixation device were considered suboptimal.
c The rate of correct initial CT reports was significantly higher for residents, body imaging specialists and angiologists than for the other subspecialists.
In 19% (18/97) of the cases, the first reader’s findings were
defined as being essentially correct with minor shortcomings:
vascular findings of SMA embolism (n=8) or ASVD (n=3) were
correctly reported but intestinal findings were disregarded; both
vascular and intestinal findings of ASVD were correct but their
interconnection was not mentioned (n=2); SMA thrombosis was
not recognized although a suspicion of AMI was reported based on
intestinal findings (n=1). In four cases of NOMI, the essential find-
ings i.e. patency of the mesenteric vessels, intestinal pneumatosis
and/or bowel wall thickening were correctly reported; however,
the etiology was not discussed.
In 14% (14/97) of the cases, the first reader’s reports were incor-
rect; AMI was suspected in one of these CT referrals (7%). Thus,
embolic filling defects of the SMA were missed and AMI was not
suspected (n=4); vascular findings of ASVD were ignored and
bowel dilatation was interpreted as bowel obstruction (n=2), or
both vascular and intestinal findings were disregarded (n=1); AMI
was incorrectly concluded as being unlikely, although vascular and
intestinal findings consistent with ASVD and AMI were reported
(n=1); intestinal findings of NOMI were disregarded (n=2) or
reported but AMImisinterpreted as being unlikely or an alternative
diagnosis was proposed (n=4). In one of the missed NOMI cases,
cecum wall thickening raised the suspicion of a tumor (Fig. 2).
3.3. Image analysis
The CT findings, scrutinized by the second reader, are displayed
in Table 4. Vascular findingswere retrospectively detectable in 92%
of cases with embolism and 100% in ASVD and MVT. Abnormal
bowel wall enhancement (decreased, increased, or both), when
assessable, was found in 61% (54/89) of the patients, most fre-
quently in patients with SMA embolism (82%, 18/22, p<0.05).
At least some types of abnormal intestinal findings (specific
Fig. 2. 66-year-old female with NOMI and ischemic colitis. In the CT referral, AMI
was not suspected and the first reader misinterpreted the thickened colon wall
(arrowheads) to be a tumor. A right-sided hemicolectomy was carried out. The
cecumwasnecrotic consistentwith an ischemic etiology, andno signsofmalignancy
were found in the pathologic examinations.
or non-specific for AMI) were found in 95% (92/97) of all cases.
All patients within the ASVD and NOMI groups had at least some
abnormality, whereas one third of the MVT group did not exhibit
any intestinal abnormalities (p<0.01). Solid organ infarctions or
perfusion defects in contrast-enhanced CTs were found in 58%
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Table 2
Clinical data at the time of CT imaging, and the treatment approach in 97 AMI events (in 95 patients) stratified by etiology.
Characteristic Etiology of AMI p
Embolism(n=24) ASVD (n=39) NOMI(n=25) MVT (n=9)
Clinical data, n (%)
Duration of symptoms <24h 15 (63) 7 (18) 9 (36) 0 (0) <0.01
Acute myocardial infarction 3 (13) 2 (5) 0 (0) 0 (0) 0.23
Acute kidney injurya 0 (0) 5 (13) 10 (40) 0 (0) <0.01
GFR >60ml/min/1.73m2 17 (71) 25 (66) 12 (48) 9 (100)
GFR 30–59 ml/min/1.73m2 7 (29) 8 (21) 7 (28) 0 (0)
GFR 15–29ml/min/1.73m2 0 (0) 4 (10) 5 (20) 0 (0)
GFR <15ml/min/1.73m2 0 (0) 1 (3) 1 (4) 0 (0)
Metabolic acidosisb 6 (25) 5 (13) 13 (52) 0 (0) <0.01
Laboratory values, median (IQR)
WBC count, 109/L 12.8 (10–17) 16.2 (12–20) 10.9 (8–16) 10.6 (9–12) <0.01
CRP, mg/L 121(11–235) 168 (100–207) 114 (11–218) 117 (67–170) 0.58
Plasma creatinine, mol/L 91 (62–106) 69 (59–113) 96 (71–192) 71 (60–79) 0.06
Delay, median (IQR), h
From admissionc to CT 3.9 (2–10) 5.6 (2–30) 5.0 (1–26) 5.4 (3–24) 0.52
From admissionc to diagnosis 4.6 (3–18) 5.6 (2–34) 14.1 (2–35) 5.4 (3–24) 0.91
From diagnosis to treatmentd 3.4 (2–5) 3.5 (2–23) 3.7 (3–6) – 0.53
Diagnostic procedures n (%)
Laparotomy or autopsy 11 (45) 19 (49) 14 (56) 1 (11)
Angiography 18 (74) 31 (79) 0 (0) 0 (0)
Unenhanced CT 0 (0) 2 (5) 3 (12) 0 (0)
CTAP 2 (8) 1 (3) 0 (0) 0 (0)
PVP 14 (58) 23 (59) 9 (36) 9 (100)
Multiphasic CT 3 (13) 4 (10) 3 (12) 0 (0)
Split-bolus CT 5 (21) 9 (23) 10 (40) 0 (0)
Treatment, n (%)
Endovascular therapye 18 (75) 31 (79) 0 (0) 1 (11)
Laparotomy 8 (33) 18 (46) 14 (56) 1 (11)
Bowel resection 7 (29) 14 (36) 12 (48) 1 (11)
Unresectable bowel necrosis 0 (0) 2 (5) 2 (8) 0 (0)
Surgical revascularization 0 (0) 2 (5) – –
Conservative treatment 3 (13) 4 (10) 11 (44) 8 (89)
In-hospital mortality, n (%) 11 (46) 12 (31) 7 (28) 0 (0) 0.08
ASVD, atherosclerotic vascular disease; NOMI, non-obstructive mesenteric ischemia; MVT, mesenteric venous thrombosis; GFR, glomerular filtration rate (calculated using
theModification of Diet in Renal Disease formula); IQR, interquartile range;WBC, white blood cell; CRP, C-reactive protein; CTAP, computed tomography angiographic phase;
PVP, portal venous phase.
a Defined as plasma creatinine >130mol/L (1.5mg/dL) in patients with previously normal renal function, or >20% increase of plasma creatinine in patients with chronic
renal insufficiency.
b Defined as base deficit >5mEq/L. Information was available in 66 events.
c Time of admission was defined as the time of initial presentation to any hospital, before transfer to our tertiary care center.
d Includes only patients treated with endovascular or surgical intervention.
e Endovascular therapy was used as the primary revascularization modality in AMI during the study period [18].
diagnosis had acute clinical presentation pattern consistent with
the diagnosis of AMI and appropriate response to treatment. In
all cases of MVT, the definitive diagnosis was confirmed by acute
thrombosis of the SMV inCT; only onepatientwithMVTunderwent
laparotomy.
3.1. Patient demographics, clinical data and treatment
approaches
The demographic data of the study patients is presented in
Table 1. Clinical data, diagnostic procedures, treatment and in-
hospitalmortality are presented in Table 2. PatientswithMVTwere
significantly younger, predominantly male, more frequently over-
weight, and had fewer cardiovascular risk factors compared to the
patient groups with arterial AMI. Atrial fibrillation was associated
with embolic etiology and peripheral arterial disease with ASVD
(p<0.01). Four (4%) patients had chronic renal insufficiency at base-
line. Regarding the clinical presentation, patients with embolism
had a shorter duration of symptoms; acute kidney injury and
metabolic acidosis were prevalent in patientswith NOMI (p<0.01).
A total of 18 (75%) patients with embolism and 31 (79%)
cases with ASVD were referred for angiography and treated with
emergency endovascular revascularization; twopatientswere con-
verted to open revascularization [18]. All MVT patients were
started on anticoagulation or continuous infusion of unfractionated
heparin at admission; one patient received transhepatic catheter-
directed thrombolysis. Eight patients (32%) with NOMI survived
without bowel resection in response to conservative treatment;
seven of them had isolated ischemic colitis, and one patient had
small bowel ischemia with chronic occlusion of the CA and IMA.
The in-hospital mortality rates for NOMI patients with small bowel
ischemia versus isolated colon ischemia were 36% (5/14) versus
18% (2/11) (p=0.332). The corresponding laparotomy rates were
86% (12/14) and 18% (2/11) (p=0.001). The laparotomy and bowel
resection rates for all study groups are presented in Table 2.
3.2. Correctness of the initial CT reports
The correctness of the first readers’ CT reports and its correla-
tionwith imagingprotocols, imagequality, first readers’ experience
and the contents of the CT referrals are shown in Table 3. When a
suspicion of AMI was expressed in the CT referral, the first reader’s
CT report was more frequently correct (97%, 29/30) than when the
suspicion was not expressed (81%, 54/67, p=0.04). The CT protocol
or the image quality had no significant effect on the correctness of
the initial CT report.
The rate of correct CT reports was significantly higher for res-
idents, body imaging specialists and angiologists in comparison
with other radiology subspecialists (p<0.01).
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Table 3
Diagnostic performance of the first CT reader arranged by etiology, imaging protocols, image quality, first reader’s experience, and clinical suspicion prior to imaging.
Total Correctness of CT report p
Correct Incorrect
All reports 97 83 (86) 14 (14)
Etiology
Embolism 24 20 (83) 4 (17)
ASVD 39 35 (90) 4 (10)
NOMI 25 19 (76) 6 (24)
MVT 9 9 (100) 0 (0)
CT protocol
Unenhanced 5 3 (60) 2(40)
CTAP 3 2 (67) 1 (33)
PVP 55 48 (87) 7 (13)
Multiphasic 10 9 (90) 1 (10)
Split-bolus 24 21 (88) 3 (13)
Optimal versus non-optimal CT protocol 0.58
Optimal (multiphasic, split-bolus)a 34 26 (76) 4 (12)
Non-optimal (PVP, CTAP, unenhanced) 63 39 (62) 10 (16)
Image quality 0.40
Diagnostic 93 79 (85) 14 (15)
Suboptimalb 4 4 (100) 0 (0)
First reader’s experience <0.01c
Resident 28 26 (93) 2 (7)
Body imaging specialist 18 17 (94) 1 (6)
Angiologist 13 12 (92) 1 (8)
Other subspecialist 38 28 (74) 10 (26)
AMI suspicion in CT referral 0.04
Yes 30 29 (97) 1 (3)
No 67 54 (81) 13 (19)
ASVD, atherosclerotic vascular disease; NOMI, non-obstructivemesenteric ischemia;MVT,mesenteric venous thrombosis; CTAP, computed tomography angiographic phase;
PVP, portal venous phase.
All data are presented as n (%).
a The optimal protocol for the diagnosis of AMIwas defined as CTwith contrast enhancement in both arterial and venous phases (i.e.multiphasic or the split-bolus protocol).
b Images with excessive respiratory motion artefacts or metal artefacts from a thoracolumbar spine fixation device were considered suboptimal.
c The rate of correct initial CT reports was significantly higher for residents, body imaging specialists and angiologists than for the other subspecialists.
In 19% (18/97) of the cases, the first reader’s findings were
defined as being essentially correct with minor shortcomings:
vascular findings of SMA embolism (n=8) or ASVD (n=3) were
correctly reported but intestinal findings were disregarded; both
vascular and intestinal findings of ASVD were correct but their
interconnection was not mentioned (n=2); SMA thrombosis was
not recognized although a suspicion of AMI was reported based on
intestinal findings (n=1). In four cases of NOMI, the essential find-
ings i.e. patency of the mesenteric vessels, intestinal pneumatosis
and/or bowel wall thickening were correctly reported; however,
the etiology was not discussed.
In 14% (14/97) of the cases, the first reader’s reports were incor-
rect; AMI was suspected in one of these CT referrals (7%). Thus,
embolic filling defects of the SMA were missed and AMI was not
suspected (n=4); vascular findings of ASVD were ignored and
bowel dilatation was interpreted as bowel obstruction (n=2), or
both vascular and intestinal findings were disregarded (n=1); AMI
was incorrectly concluded as being unlikely, although vascular and
intestinal findings consistent with ASVD and AMI were reported
(n=1); intestinal findings of NOMI were disregarded (n=2) or
reported but AMImisinterpreted as being unlikely or an alternative
diagnosis was proposed (n=4). In one of the missed NOMI cases,
cecum wall thickening raised the suspicion of a tumor (Fig. 2).
3.3. Image analysis
The CT findings, scrutinized by the second reader, are displayed
in Table 4. Vascular findingswere retrospectively detectable in 92%
of cases with embolism and 100% in ASVD and MVT. Abnormal
bowel wall enhancement (decreased, increased, or both), when
assessable, was found in 61% (54/89) of the patients, most fre-
quently in patients with SMA embolism (82%, 18/22, p<0.05).
At least some types of abnormal intestinal findings (specific
Fig. 2. 66-year-old female with NOMI and ischemic colitis. In the CT referral, AMI
was not suspected and the first reader misinterpreted the thickened colon wall
(arrowheads) to be a tumor. A right-sided hemicolectomy was carried out. The
cecumwasnecrotic consistentwith an ischemic etiology, andno signsofmalignancy
were found in the pathologic examinations.
or non-specific for AMI) were found in 95% (92/97) of all cases.
All patients within the ASVD and NOMI groups had at least some
abnormality, whereas one third of the MVT group did not exhibit
any intestinal abnormalities (p<0.01). Solid organ infarctions or
perfusion defects in contrast-enhanced CTs were found in 58%
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Table 4
CT findings in 97 AMI events stratified by etiology.
Characteristic Etiology of AMI p
Embolism(n=24) ASVD(n=39) NOMI(n=25) MVT(n=9)
Vascular findingsa, n (%) (n=24)a (n=37)a (n=22)a (n=9)a
SMA embolus location
Proximal SMA root 7 (29) 0 (0) 0 (0) 0 (0)
SMA main stem 15 (63) 0 (0) 0 (0) 0 (0)
Not visible (distal small branch) 2 (8) 0 (0) 0 (0) 0 (0)
Atherosclerotic changes
Visible thrombosis 0 (0) 17 (46) 1 (5) 0 (0)
SMA total occlusion 0 (0) 23 (62) 0 (0) 0 (0)
SMA 70–99% stenosis 0 (0) 14 (38) 0 (0) 0 (0)
SMA 50–70% stenosis 0 (0) 0 (0) 2 (9) 0 (0)
CA/CHA total occlusion 0 (0) 8 (22) 2 (9) 0 (0)
CA/CHA 70–99% stenosis 1 (4) 9 (24) 1 (5) 0 (0)
Obstruction site
SMA alone 16 (67) 4 (11) 0 (0) 0 (0)
SMA+CA 1 (4) 8 (22) 1 (5) 0 (0)
SMA+IMA 7 (29) 6 (16) 0 (0) 0 (0)
SMA+CA+IMA 0 (0) 19 (51) 1 (5) 0 (0)
CA+IMA 0 (0) 0 (0) 2 (9) 0 (0)
SMV (major thrombosis) 0 (0) 0 (0) 0 (0) 9 (100)
SMV+PV/SV thrombosis 0 (0) 0 (0) 0 (0) 8 (89)
Intestinal findings, n (%)
Any abnormal intestinal finding 22 (92) 39 (100) 25 (100) 6 (67) < 0.01
Segmental 19 (79) 32 (82) 19 (76) 6 (67)
Diffuse 3 (13) 7 (18) 6 (24) 0 (0)
Any intestinal finding specific for AMI 19 (79) 25 (64) 16 (64) 3 (33) 0.12
Intestinal pneumatosis 6 (25) 15 (39) 10 (40) 0 (0) 0.09
Portomesenteric venous gas 1 (4) 7 (18) 6 (24) 0 (0) 0.14
Bowel wall enhancementb
Abnormal 18 (82) 21 (58) 12 (55) 3 (33) <0.05
Absent or decreased 10 (46) 8 (22) 5 (23) 2 (22)
Increased 3 (14) 6 (17) 5 (23) 0 (0)
Decreased and increased 5 (23) 7 (19) 2 (9) 1 (11)
Bowel lumen dilatation/paralysis 18 (75) 34 (87) 17 (68) 5 (56) 0.11
Bowel wall thickening 14 (58) 28 (72) 20 (80) 5 (56) 0.30
Isolated left-sided ischemic colitis 0 (0) 0 (0) 3 (12) 0 (0)
Isolated right-sided or ischemic pancolitis 0 (0) 3 (8) 8 (32) 0 (0)
Mesenteric and peritoneal findings, n (%)
Mesenteric fat stranding 22 (92) 36 (92) 24 (96) 9 (100) 0.93
Free peritoneal fluid 7 (29) 15 (39) 14 (56) 6 (67) 0.12
Free peritoneal gas 0 (0) 2 (5) 0 (0) 0 (0)
Solid organ findings, n (%)
Infarction/perfusion defect a 14 (58) 5 (14) 0 (0) 0 (0) <0.01
Spleen 8 4 0 0
Kidney/kidneys 7 0 0 0
Liver 0 4 0 0
Multiple organ 1 3 0 0
SMA=superior mesenteric artery, CA= celiac artery, CHA=common hepatic artery, IMA= inferior mesenteric artery, SMV= superior mesenteric vein, PV=portal vein,
SV= splenic vein.
a Calculated for 92 events. Unenhanced CT examinations (n=5; NOMI n=3 and ASVD n=2) were excluded.
b Calculated for 89 events. Unenhanced (n=5; NOMI n=3 and ASVD n=2) and CT angiographic (n=3; ASVD n=1 and embolism n=2) examinations in which bowel wall
enhancement could not be reliably assessed were excluded.
(14/24) of patients with embolism and 13% (5/37) of patients with
ASVD. All ASVDpatientswith infarctions or perfusion defects in the
liver and/or spleen had total occlusion of the CA consistentwith the
solid organ findings.
The definitive etiology of AMI was undecided on the basis of
contrast enhanced CT alone in two cases, the first one is illustrated
in Fig. 3. In another case, a peripheral small SMA branch embolism
was postulated by the second reader in a hemodynamically unsta-
ble patient; the definitive etiology was defined as NOMI, however,
based on the patient’s clinical presentation pattern.
3.4. Findings of AMI in the unenhanced CT examinations
Three patients with only unenhanced CT examinations had
intestinal pneumatosis, and two of them had also portomesen-
teric venous gas (Fig. 4); the diagnosis of AMI was confirmed
in laparotomy in one of these patients and percutaneous
transluminal angioplastywith stentingwasperformed for theother
two. One patient had only a non-specific intestinal paralysis and
mesenteric edema related to AMI on unenhanced CT, this diagnosis
was confirmed in laparotomy. Another patientwith non-specific CT
findings displayed considerable bowel wall thickening and edema
strictly limited to the ascending colon. The CT findings along with
thepatient’s history andclinical evaluation supported thediagnosis
of NOMI.
3.5. Independent variables associated with outcome
Abnormal bowel wall enhancement, pneumatosis, or any
intestinal CT finding specific for AMI were associated with four
to five-fold increase in the in-hospital mortality (Table 5). In sur-
vivors vs. non-survivors, abnormal enhancement was registered
in 52% (33/63) vs. 81% (22/27), pneumatosis in 22% (15/67) vs.
53% (16/30), and any specific intestinal finding in 55% (37/67) vs.
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Fig. 3. 91-year-old female with SMA embolism. Portal venous phase abdominal CT (A-B) and unenhanced cranial CT (C) images.
An unusually proximal embolic occlusion of the SMA root is seen (white arrowheads, A), as well as some calcified, although insignificant, atherosclerotic changes (open
arrowhead, A). Thick-walled ileal loops (arrowheads, B) with enhancing mucosal and serosal layers are obviously related to the SMA occlusion. As there were no other signs
of embolism in the abdomen, the embolic etiology was not definite based on abdominal CT alone. The patient had synchronous symptoms of acute stroke. Consistent with
acute cerebral infarction, obliterated sulci and a focal parenchymal hypodensity (arrowheads, C) of the left temporoparietal area were found in cranial CT. The embolic
etiology of AMI was confirmed, as the patient also had atrial fibrillation without adequate anticoagulation at baseline. Even though AMI was not initially suspected, the first
reader found and reported all relevant CT findings. The patient was treated without surgery; the embolic SMA occlusion was recanalized with endovascular treatment, and
the patient survived.
Table 5
Univariate analysis of independent variables associated with outcome (p<0.05).
Variable p OR 95% CI
Factors associated with in-hospital mortality
Abnormal bowel wall enhancement 0.01 4.00 1.35–11.89
Pneumatosis 0.01 3.96 1.58–9.93
Any intestinal finding specific for AMI 0.01 5.27 1.66–16.77
Metabolic acidosis 0.04 3.00 1.15–7.85
Visible thrombosis in CT (within the ASVD group) 0.02 8.00 1.40–45.76
Factors associated with bowel resection
Metabolic acidosis 0.01 4.20 1.59–11.09
No clinical suspicion of AMI prior to CT 0.03 3.38 1.15–9.91
OR, odds ratio; CI, confidence interval.
87% (26/30), respectively. There were no CT findings significantly
related to the bowel resection rate.With regard to the baseline risk
factors, metabolic acidosis predicted bowel resection (OR 4.20) and
in-hospital death (OR 3.00).
A clearly visible thrombosis in CT (n=17) was associated with
mortality in patientswith ASVD (OR 8.00); thrombosis was present
in 33% (9/27) of survivors and 80% (8/10) of non-survivors in the
ASVD group. Four of these cases were determined to be suffering
from chronic thrombosis based on older CTs; nevertheless, all four
patientspresentedwithacutebowelnecrosis. Twoof the remaining
13 cases presentedwith less than 24h’ duration of symptomswhile
five patients had symptoms, which had lasted for 1–3 days and six
patients for more than three days.
A suspicion of AMI was mentioned by the referring physician in
28% (19/67)of survivors and37% (11/30)ofnon-survivors (p=0.48).
If AMI was not suspected prior to the CT, the patient was signifi-
cantly more likely to undergo bowel resection (OR 3.38).
4. Discussion
The possibility of AMI was taken into consideration prior to CT
in only 31% of the study cases, and the on-call radiologist was sig-
nificantly more likely to make the correct diagnosis if AMI was
suspected in the CT referral. Patientswithout suspicion of AMI prior
to CT were significantly more prone to undergo bowel resection.
These are the main findings of the present study, and they reflect
the everyday situation in the emergency room. One might argue
that in this study, AMI may have been more likely suspected by
the clinician in patients with severe, advanced disease when the
CT findings were easier to detect and report. However, this was not
the case; the referring clinician’s suspicion of AMI did not correlate
with any increase in the in-hospital mortality or bowel resection
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Table 4
CT findings in 97 AMI events stratified by etiology.
Characteristic Etiology of AMI p
Embolism(n=24) ASVD(n=39) NOMI(n=25) MVT(n=9)
Vascular findingsa, n (%) (n=24)a (n=37)a (n=22)a (n=9)a
SMA embolus location
Proximal SMA root 7 (29) 0 (0) 0 (0) 0 (0)
SMA main stem 15 (63) 0 (0) 0 (0) 0 (0)
Not visible (distal small branch) 2 (8) 0 (0) 0 (0) 0 (0)
Atherosclerotic changes
Visible thrombosis 0 (0) 17 (46) 1 (5) 0 (0)
SMA total occlusion 0 (0) 23 (62) 0 (0) 0 (0)
SMA 70–99% stenosis 0 (0) 14 (38) 0 (0) 0 (0)
SMA 50–70% stenosis 0 (0) 0 (0) 2 (9) 0 (0)
CA/CHA total occlusion 0 (0) 8 (22) 2 (9) 0 (0)
CA/CHA 70–99% stenosis 1 (4) 9 (24) 1 (5) 0 (0)
Obstruction site
SMA alone 16 (67) 4 (11) 0 (0) 0 (0)
SMA+CA 1 (4) 8 (22) 1 (5) 0 (0)
SMA+IMA 7 (29) 6 (16) 0 (0) 0 (0)
SMA+CA+IMA 0 (0) 19 (51) 1 (5) 0 (0)
CA+IMA 0 (0) 0 (0) 2 (9) 0 (0)
SMV (major thrombosis) 0 (0) 0 (0) 0 (0) 9 (100)
SMV+PV/SV thrombosis 0 (0) 0 (0) 0 (0) 8 (89)
Intestinal findings, n (%)
Any abnormal intestinal finding 22 (92) 39 (100) 25 (100) 6 (67) < 0.01
Segmental 19 (79) 32 (82) 19 (76) 6 (67)
Diffuse 3 (13) 7 (18) 6 (24) 0 (0)
Any intestinal finding specific for AMI 19 (79) 25 (64) 16 (64) 3 (33) 0.12
Intestinal pneumatosis 6 (25) 15 (39) 10 (40) 0 (0) 0.09
Portomesenteric venous gas 1 (4) 7 (18) 6 (24) 0 (0) 0.14
Bowel wall enhancementb
Abnormal 18 (82) 21 (58) 12 (55) 3 (33) <0.05
Absent or decreased 10 (46) 8 (22) 5 (23) 2 (22)
Increased 3 (14) 6 (17) 5 (23) 0 (0)
Decreased and increased 5 (23) 7 (19) 2 (9) 1 (11)
Bowel lumen dilatation/paralysis 18 (75) 34 (87) 17 (68) 5 (56) 0.11
Bowel wall thickening 14 (58) 28 (72) 20 (80) 5 (56) 0.30
Isolated left-sided ischemic colitis 0 (0) 0 (0) 3 (12) 0 (0)
Isolated right-sided or ischemic pancolitis 0 (0) 3 (8) 8 (32) 0 (0)
Mesenteric and peritoneal findings, n (%)
Mesenteric fat stranding 22 (92) 36 (92) 24 (96) 9 (100) 0.93
Free peritoneal fluid 7 (29) 15 (39) 14 (56) 6 (67) 0.12
Free peritoneal gas 0 (0) 2 (5) 0 (0) 0 (0)
Solid organ findings, n (%)
Infarction/perfusion defect a 14 (58) 5 (14) 0 (0) 0 (0) <0.01
Spleen 8 4 0 0
Kidney/kidneys 7 0 0 0
Liver 0 4 0 0
Multiple organ 1 3 0 0
SMA=superior mesenteric artery, CA= celiac artery, CHA=common hepatic artery, IMA= inferior mesenteric artery, SMV= superior mesenteric vein, PV=portal vein,
SV= splenic vein.
a Calculated for 92 events. Unenhanced CT examinations (n=5; NOMI n=3 and ASVD n=2) were excluded.
b Calculated for 89 events. Unenhanced (n=5; NOMI n=3 and ASVD n=2) and CT angiographic (n=3; ASVD n=1 and embolism n=2) examinations in which bowel wall
enhancement could not be reliably assessed were excluded.
(14/24) of patients with embolism and 13% (5/37) of patients with
ASVD. All ASVDpatientswith infarctions or perfusion defects in the
liver and/or spleen had total occlusion of the CA consistentwith the
solid organ findings.
The definitive etiology of AMI was undecided on the basis of
contrast enhanced CT alone in two cases, the first one is illustrated
in Fig. 3. In another case, a peripheral small SMA branch embolism
was postulated by the second reader in a hemodynamically unsta-
ble patient; the definitive etiology was defined as NOMI, however,
based on the patient’s clinical presentation pattern.
3.4. Findings of AMI in the unenhanced CT examinations
Three patients with only unenhanced CT examinations had
intestinal pneumatosis, and two of them had also portomesen-
teric venous gas (Fig. 4); the diagnosis of AMI was confirmed
in laparotomy in one of these patients and percutaneous
transluminal angioplastywith stentingwasperformed for theother
two. One patient had only a non-specific intestinal paralysis and
mesenteric edema related to AMI on unenhanced CT, this diagnosis
was confirmed in laparotomy. Another patientwith non-specific CT
findings displayed considerable bowel wall thickening and edema
strictly limited to the ascending colon. The CT findings along with
thepatient’s history andclinical evaluation supported thediagnosis
of NOMI.
3.5. Independent variables associated with outcome
Abnormal bowel wall enhancement, pneumatosis, or any
intestinal CT finding specific for AMI were associated with four
to five-fold increase in the in-hospital mortality (Table 5). In sur-
vivors vs. non-survivors, abnormal enhancement was registered
in 52% (33/63) vs. 81% (22/27), pneumatosis in 22% (15/67) vs.
53% (16/30), and any specific intestinal finding in 55% (37/67) vs.
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Fig. 3. 91-year-old female with SMA embolism. Portal venous phase abdominal CT (A-B) and unenhanced cranial CT (C) images.
An unusually proximal embolic occlusion of the SMA root is seen (white arrowheads, A), as well as some calcified, although insignificant, atherosclerotic changes (open
arrowhead, A). Thick-walled ileal loops (arrowheads, B) with enhancing mucosal and serosal layers are obviously related to the SMA occlusion. As there were no other signs
of embolism in the abdomen, the embolic etiology was not definite based on abdominal CT alone. The patient had synchronous symptoms of acute stroke. Consistent with
acute cerebral infarction, obliterated sulci and a focal parenchymal hypodensity (arrowheads, C) of the left temporoparietal area were found in cranial CT. The embolic
etiology of AMI was confirmed, as the patient also had atrial fibrillation without adequate anticoagulation at baseline. Even though AMI was not initially suspected, the first
reader found and reported all relevant CT findings. The patient was treated without surgery; the embolic SMA occlusion was recanalized with endovascular treatment, and
the patient survived.
Table 5
Univariate analysis of independent variables associated with outcome (p<0.05).
Variable p OR 95% CI
Factors associated with in-hospital mortality
Abnormal bowel wall enhancement 0.01 4.00 1.35–11.89
Pneumatosis 0.01 3.96 1.58–9.93
Any intestinal finding specific for AMI 0.01 5.27 1.66–16.77
Metabolic acidosis 0.04 3.00 1.15–7.85
Visible thrombosis in CT (within the ASVD group) 0.02 8.00 1.40–45.76
Factors associated with bowel resection
Metabolic acidosis 0.01 4.20 1.59–11.09
No clinical suspicion of AMI prior to CT 0.03 3.38 1.15–9.91
OR, odds ratio; CI, confidence interval.
87% (26/30), respectively. There were no CT findings significantly
related to the bowel resection rate.With regard to the baseline risk
factors, metabolic acidosis predicted bowel resection (OR 4.20) and
in-hospital death (OR 3.00).
A clearly visible thrombosis in CT (n=17) was associated with
mortality in patientswith ASVD (OR 8.00); thrombosis was present
in 33% (9/27) of survivors and 80% (8/10) of non-survivors in the
ASVD group. Four of these cases were determined to be suffering
from chronic thrombosis based on older CTs; nevertheless, all four
patientspresentedwithacutebowelnecrosis. Twoof the remaining
13 cases presentedwith less than 24h’ duration of symptomswhile
five patients had symptoms, which had lasted for 1–3 days and six
patients for more than three days.
A suspicion of AMI was mentioned by the referring physician in
28% (19/67)of survivors and37% (11/30)ofnon-survivors (p=0.48).
If AMI was not suspected prior to the CT, the patient was signifi-
cantly more likely to undergo bowel resection (OR 3.38).
4. Discussion
The possibility of AMI was taken into consideration prior to CT
in only 31% of the study cases, and the on-call radiologist was sig-
nificantly more likely to make the correct diagnosis if AMI was
suspected in the CT referral. Patientswithout suspicion of AMI prior
to CT were significantly more prone to undergo bowel resection.
These are the main findings of the present study, and they reflect
the everyday situation in the emergency room. One might argue
that in this study, AMI may have been more likely suspected by
the clinician in patients with severe, advanced disease when the
CT findings were easier to detect and report. However, this was not
the case; the referring clinician’s suspicion of AMI did not correlate
with any increase in the in-hospital mortality or bowel resection
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rate. Similar findings have also been noted in the earlier study of
Wadman et al. Their study of 67 patients with SMA occlusion, of
whom 46 were examined with CT, also highlighted the trend of a
higher rate of correct CT diagnosis if there had been clinical suspi-
cion of AMI prior to undertaking the CT [19]. We are not aware of
any other studies dealing with this issue. In our study population,
cardiovascular diseases and diabetes were common comorbidities
in patients with embolism, ASVD and NOMI, and these risk factors
should alert the clinicians to include AMI in the differential diagno-
sis of acute abdomen. The possibility of AMI should also be clearly
stated in CT referrals in order to ensure optimal CT protocol selec-
tion and to remind the radiologist to pay particular attention to the
intestinal findings and the patency of the mesenteric vessels.
In agreementwith previous studies [20,21], the independent CT
findings which associated with increased mortality were abnor-
mal bowel wall enhancement, pneumatosis, and any CT finding
specific for AMI. All findings of AMI were correctly stated without
any shortcomings in 67% of the initial CT reports. Similar results
have been reported previously in studies with smaller study popu-
lations [19,22]; the latter study included 35 patients imaged solely
with a biphasic CT protocol. Based on the essentially correct ini-
tial CT reports with minor shortcomings in the current study, it
appears that it was easier for the radiologists to detect and inter-
pret vascular findings than the more subtle intestinal findings. The
twelve examinations with incorrect CT diagnosis were contrast-
enhanced while two were unenhanced. The residents, angiologists
and body imaging experts had a significantly higher rate of correct
CT interpretation than other radiology subspecialists, as these indi-
viduals are probably more familiar with the vascular and intestinal
pathology related to acute abdomen than for example, neuro- or
musculoskeletal radiologists.
Biphasic MDCT is considered the diagnostic modality of choice
in AMI [8–10,13,17]. The studies supporting this recommendation
were conducted in patients inwhom therewas a primary suspicion
of AMI [7–10]. However, as demonstrated in our study, AMI is often
not primarily suspected but found unexpectedly in the CT images
of patients presenting with acute abdomen.
In this study, a mere 10% of the CT examinations were purely
multiphasic, the split-bolus protocol was used in 25%, and the
majority (57%) were conducted in PVP. Nonetheless, clinically sig-
nificant arterial stenoses and/or thromboemboliwere detectable in
plain PVP studies when the images were scrutinized by the second
reader.
4.1. Caveats
An embolus of the SMA is often diagnosed based simply on a
pathognomonic clot in contrast-enhanced CT. An embolic occlu-
sion of a distal SMA branch or a mixed plaque with calcified and
non-calcified component in the root of the SMA complicates the
assessment of etiology; the clinical presentation pattern may be
the key to correct diagnosis in these cases. Acute onset of symp-
toms, atrial fibrillation, synchronous embolic events, ormyocardial
infarction (with cardiac thrombus) are all indicative of an embolic
etiology (Fig. 3).
With regard to atherosclerotic lesions of the SMA, there is no
clear-cut definition for acute versus chronic thrombotic occlusion.
A major visible thrombus in a patient with fulminant AMI may
prove to be a several-year-old chronic thrombus. Conversely, a
small, in situ thrombosis in a severely calcified lesionmay be unde-
tectable in CT, and similarly in this study, a visible thrombosis in
CT was not unequivocal of an acute occlusion. However, the diag-
nosis of acute intestinal ischemia is more relevant for the clinician
than the differential diagnosis between acute versus chronic arte-
rial occlusions. The radiologist should not too hastily exclude the
possibility of AMI due to lack of “signs of acute occlusion of the
Fig. 4. 92-year-old femalewith chronic renal failure and AMI due to atherosclerotic
occlusion of the SMA. In a coronal image of the unenhanced abdominal CT, notable
intestinal pneumatosis is seen in the ileal loops (white arrowheads, A). There are
abundant calcifications in the abdominal aorta (open arrowheads, A). In an axial
image of the lower abdomen, subtle intestinal pneumatosis (open arrowheads, B)
and subtle mesenteric venous gas (white arrowhead, B) as well as dilated, para-
lytic loops of small intestine (asterisks, B) are visible. In the CT referral, an acute
abdominal catastrophe was suspected but AMI was not mentioned specifically.
Nevertheless, the first reader reported all relevant findings and diagnosed AMI cor-
rectly. Despite technically successful percutaneous transluminal angioplasty with
stenting of the SMA performed following the CT, the patient succumbed a day after
the endovascular procedure as she was not fit for general anesthesia and operative
treatment of bowel necrosis.
SMA” if the patient has severe atherosclerosis of the mesentery.
Even subtle intestinal findings should be carefully examined and
reported; all of theAMIpatientswithatherosclerotic etiology in this
study had at least some form of abnormal bowel findings. The fact
remains that a thrombosis of the SMA in CT is no proof of an “acute
occlusion”; neither does the absence of thrombi in CT exclude the
possibility of a small acute thromboembolic event.
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Fig. 5. 57-year-old male with MVT, contrast-enhanced images in portal venous
phase. Thrombosis of the SMV is seen (arrowheads, A). Abundant mesenteric fat
stranding representing edema (asterisks, A and B), dilated small bowel loops (white
arrowheads, B) and bowel wall thickening (open arrowheads, B) related to MVT
are seen. The radiologist on-call appreciated the relevant findings related to MVT,
althoughAMIwasnot suspected in the referral. Thepatient recovered after receiving
conservative treatment with anticoagulation medication.
4.2. NOMI and MVT
As expected, NOMI was the most difficult diagnosis in this
study. All NOMI patients had abnormal bowel findings in their
CT images, confirming the diagnosis, and 56% developed bowel
necrosis. Although statistically insignificant, NOMI patients with
ischemic colitis had a lowermortality rate than thosewith ischemia
of the small intestine.
Venous intestinal infarction is a rare entity which is associ-
ated with massive thrombosis of the SMV; intestinal ischemia
rarely develops unless the peripheral veins of the mesentery are
involved [23,24]. Acute MVT often causes some level of abdominal
discomfort and symptoms that will lead to the appearance of the
patient in the acute care unit (Fig. 5). Surgical intervention is sel-
dom required and intestinal ischemia is usually self-limiting with
anticoagulation therapy. At the time of admission, only one MVT
patient in this study had developed irreversible bowel ischemia,
as the conversion from mild edema into severe ischemia or bowel
necrosis takes several days to weeks [24]. Thus, only one patient
required bowel resection (with open abdomen and primary fascial
closure after ten days). One patient with massive portomesen-
teric thrombosis was treated with transhepatic catheter-directed
thrombolysis; the portal thrombosis resolved but chronic throm-
bosis of the SMV developed. Another patient with idiopathic acute
MVT and subsequent chronic portal vein occlusion developed
severe portal hypertension and hypersplenism several years after
the acute episode.
4.3. Study limitations
Although the hospital records were thoroughly searched with
several methods to identify all consecutive AMI cases, the pos-
sibility of false negative cases that were never suspected of AMI
during hospitalization cannot be ruled out due to the current low
autopsy rates. On the other hand, in approximately half of the
study cases, the diagnosis of AMI was confirmed with laparotomy
or autopsy. For the rest, the diagnosis was confirmed by clinical
presentation and either very specific CT findings, or less specific
CT findings and a consensus of experts in vascular and abdominal
imaging, interventional radiology and surgery. If only laparotomy
or autopsywould have been used as the gold standard proof for the
diagnosis of AMI, inevitably, only patients with severe disease and
irreversible bowel ischemia would have been included. Further-
more, false positive cases were not sought or registered. Without
a control group, it is not possible to calculate the true diagnostic
accuracy and the incidence of hemodynamically significant vas-
cular stenoses or intestinal abnormalities in asymptomatic elderly
individuals remain unknown. Finally, the study groups and the CT
protocols were too heterogeneous, and the number of patients too
small, to perform an adequate multivariate analysis.
5. Conclusion
This study demonstrates that the actual CT protocols in acute
abdomen are considerably different than those considered as the
gold standard protocol in AMI. Detecting AMI in the CT for acute
abdominal pain requires a high index of suspicion by the clinician
and the emergency room radiologist.
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rate. Similar findings have also been noted in the earlier study of
Wadman et al. Their study of 67 patients with SMA occlusion, of
whom 46 were examined with CT, also highlighted the trend of a
higher rate of correct CT diagnosis if there had been clinical suspi-
cion of AMI prior to undertaking the CT [19]. We are not aware of
any other studies dealing with this issue. In our study population,
cardiovascular diseases and diabetes were common comorbidities
in patients with embolism, ASVD and NOMI, and these risk factors
should alert the clinicians to include AMI in the differential diagno-
sis of acute abdomen. The possibility of AMI should also be clearly
stated in CT referrals in order to ensure optimal CT protocol selec-
tion and to remind the radiologist to pay particular attention to the
intestinal findings and the patency of the mesenteric vessels.
In agreementwith previous studies [20,21], the independent CT
findings which associated with increased mortality were abnor-
mal bowel wall enhancement, pneumatosis, and any CT finding
specific for AMI. All findings of AMI were correctly stated without
any shortcomings in 67% of the initial CT reports. Similar results
have been reported previously in studies with smaller study popu-
lations [19,22]; the latter study included 35 patients imaged solely
with a biphasic CT protocol. Based on the essentially correct ini-
tial CT reports with minor shortcomings in the current study, it
appears that it was easier for the radiologists to detect and inter-
pret vascular findings than the more subtle intestinal findings. The
twelve examinations with incorrect CT diagnosis were contrast-
enhanced while two were unenhanced. The residents, angiologists
and body imaging experts had a significantly higher rate of correct
CT interpretation than other radiology subspecialists, as these indi-
viduals are probably more familiar with the vascular and intestinal
pathology related to acute abdomen than for example, neuro- or
musculoskeletal radiologists.
Biphasic MDCT is considered the diagnostic modality of choice
in AMI [8–10,13,17]. The studies supporting this recommendation
were conducted in patients inwhom therewas a primary suspicion
of AMI [7–10]. However, as demonstrated in our study, AMI is often
not primarily suspected but found unexpectedly in the CT images
of patients presenting with acute abdomen.
In this study, a mere 10% of the CT examinations were purely
multiphasic, the split-bolus protocol was used in 25%, and the
majority (57%) were conducted in PVP. Nonetheless, clinically sig-
nificant arterial stenoses and/or thromboemboliwere detectable in
plain PVP studies when the images were scrutinized by the second
reader.
4.1. Caveats
An embolus of the SMA is often diagnosed based simply on a
pathognomonic clot in contrast-enhanced CT. An embolic occlu-
sion of a distal SMA branch or a mixed plaque with calcified and
non-calcified component in the root of the SMA complicates the
assessment of etiology; the clinical presentation pattern may be
the key to correct diagnosis in these cases. Acute onset of symp-
toms, atrial fibrillation, synchronous embolic events, ormyocardial
infarction (with cardiac thrombus) are all indicative of an embolic
etiology (Fig. 3).
With regard to atherosclerotic lesions of the SMA, there is no
clear-cut definition for acute versus chronic thrombotic occlusion.
A major visible thrombus in a patient with fulminant AMI may
prove to be a several-year-old chronic thrombus. Conversely, a
small, in situ thrombosis in a severely calcified lesionmay be unde-
tectable in CT, and similarly in this study, a visible thrombosis in
CT was not unequivocal of an acute occlusion. However, the diag-
nosis of acute intestinal ischemia is more relevant for the clinician
than the differential diagnosis between acute versus chronic arte-
rial occlusions. The radiologist should not too hastily exclude the
possibility of AMI due to lack of “signs of acute occlusion of the
Fig. 4. 92-year-old femalewith chronic renal failure and AMI due to atherosclerotic
occlusion of the SMA. In a coronal image of the unenhanced abdominal CT, notable
intestinal pneumatosis is seen in the ileal loops (white arrowheads, A). There are
abundant calcifications in the abdominal aorta (open arrowheads, A). In an axial
image of the lower abdomen, subtle intestinal pneumatosis (open arrowheads, B)
and subtle mesenteric venous gas (white arrowhead, B) as well as dilated, para-
lytic loops of small intestine (asterisks, B) are visible. In the CT referral, an acute
abdominal catastrophe was suspected but AMI was not mentioned specifically.
Nevertheless, the first reader reported all relevant findings and diagnosed AMI cor-
rectly. Despite technically successful percutaneous transluminal angioplasty with
stenting of the SMA performed following the CT, the patient succumbed a day after
the endovascular procedure as she was not fit for general anesthesia and operative
treatment of bowel necrosis.
SMA” if the patient has severe atherosclerosis of the mesentery.
Even subtle intestinal findings should be carefully examined and
reported; all of theAMIpatientswithatherosclerotic etiology in this
study had at least some form of abnormal bowel findings. The fact
remains that a thrombosis of the SMA in CT is no proof of an “acute
occlusion”; neither does the absence of thrombi in CT exclude the
possibility of a small acute thromboembolic event.
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Fig. 5. 57-year-old male with MVT, contrast-enhanced images in portal venous
phase. Thrombosis of the SMV is seen (arrowheads, A). Abundant mesenteric fat
stranding representing edema (asterisks, A and B), dilated small bowel loops (white
arrowheads, B) and bowel wall thickening (open arrowheads, B) related to MVT
are seen. The radiologist on-call appreciated the relevant findings related to MVT,
althoughAMIwasnot suspected in the referral. Thepatient recovered after receiving
conservative treatment with anticoagulation medication.
4.2. NOMI and MVT
As expected, NOMI was the most difficult diagnosis in this
study. All NOMI patients had abnormal bowel findings in their
CT images, confirming the diagnosis, and 56% developed bowel
necrosis. Although statistically insignificant, NOMI patients with
ischemic colitis had a lowermortality rate than thosewith ischemia
of the small intestine.
Venous intestinal infarction is a rare entity which is associ-
ated with massive thrombosis of the SMV; intestinal ischemia
rarely develops unless the peripheral veins of the mesentery are
involved [23,24]. Acute MVT often causes some level of abdominal
discomfort and symptoms that will lead to the appearance of the
patient in the acute care unit (Fig. 5). Surgical intervention is sel-
dom required and intestinal ischemia is usually self-limiting with
anticoagulation therapy. At the time of admission, only one MVT
patient in this study had developed irreversible bowel ischemia,
as the conversion from mild edema into severe ischemia or bowel
necrosis takes several days to weeks [24]. Thus, only one patient
required bowel resection (with open abdomen and primary fascial
closure after ten days). One patient with massive portomesen-
teric thrombosis was treated with transhepatic catheter-directed
thrombolysis; the portal thrombosis resolved but chronic throm-
bosis of the SMV developed. Another patient with idiopathic acute
MVT and subsequent chronic portal vein occlusion developed
severe portal hypertension and hypersplenism several years after
the acute episode.
4.3. Study limitations
Although the hospital records were thoroughly searched with
several methods to identify all consecutive AMI cases, the pos-
sibility of false negative cases that were never suspected of AMI
during hospitalization cannot be ruled out due to the current low
autopsy rates. On the other hand, in approximately half of the
study cases, the diagnosis of AMI was confirmed with laparotomy
or autopsy. For the rest, the diagnosis was confirmed by clinical
presentation and either very specific CT findings, or less specific
CT findings and a consensus of experts in vascular and abdominal
imaging, interventional radiology and surgery. If only laparotomy
or autopsywould have been used as the gold standard proof for the
diagnosis of AMI, inevitably, only patients with severe disease and
irreversible bowel ischemia would have been included. Further-
more, false positive cases were not sought or registered. Without
a control group, it is not possible to calculate the true diagnostic
accuracy and the incidence of hemodynamically significant vas-
cular stenoses or intestinal abnormalities in asymptomatic elderly
individuals remain unknown. Finally, the study groups and the CT
protocols were too heterogeneous, and the number of patients too
small, to perform an adequate multivariate analysis.
5. Conclusion
This study demonstrates that the actual CT protocols in acute
abdomen are considerably different than those considered as the
gold standard protocol in AMI. Detecting AMI in the CT for acute
abdominal pain requires a high index of suspicion by the clinician
and the emergency room radiologist.
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Abstract
Purpose To evaluate endovascular therapy (EVT) as the
primary revascularization method for acute mesenteric is-
chemia (AMI).
Methods A retrospective review was performed on all
consecutive patients treated for AMI during a 5-year period
(January 2009 to December 2013). EVT was attempted in
all patients referred for emergent revascularization. Surgi-
cal revascularization was performed selectively after fail-
ure of EVT. Patient characteristics, clinical presentation,
and outcomes were studied. Failures and complications of
EVT were recorded.
Results Fifty patients, aged 79 ± 9 years (mean ± SD),
out of 66 consecutive patients with AMI secondary to
embolic or thrombotic obstruction of the superior mesen-
teric artery were referred for revascularization. The eti-
ology of AMI was embolism in 18 (36 %) and thrombosis
in 32 (64 %) patients. EVT was technically successful in
44 (88 %) patients. Mortality after successful or failed
EVT was 32 %. The rates of emergency laparotomy, bowel
resection, and EVT-related complication were 40, 34, and
10 %, respectively. Three out of six patients with failure of
EVT were treated with surgical bypass. EVT failure did not
significantly affect survival.
Conclusions EVT is feasible in most cases of AMI, with
favorable patient outcome and acceptable complication rate.
Keywords Acute mesenteric ischemia 
Endovascular revascularization  Mechanical
thrombectomy  Angioplasty  Stenting  Superior
mesenteric artery
Introduction
The modern treatment of acute mesenteric ischemia (AMI)
consists of rapid intestinal revascularization and removal of
necrotic bowel [1]. Contrast-enhanced computed tomog-
raphy (CT) is the current diagnostic modality of choice,
and, with early imaging, more patients are potential can-
didates for vascular interventions [2, 3]. Publications re-
garding the endovascular treatment of AMI, with more than
20 patients, are few [4–9] and often biased by the selection
of patients for endovascular revascularization from a very
large or unknown population [5–7].
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Our institution has been using endovascular therapy
(EVT) as the primary mode of revascularization in AMI for
several years. The objective for this study was to evaluate
the impact of EVT on the survival and need for surgery in
patients with AMI.
Materials and Methods
Study Design and Patients
This retrospective study was approved by the local ethics
committee. Formal informed consent was not required. The
records of all consecutive patients treated for AMI at our
tertiary care center from January 2009 to December 2013
were retrieved from the hospital registry and procedural
databases. The clinical diagnosis of AMI was confirmed by
CT, laparotomy, or autopsy. Patients with chronic mesen-
teric ischemia (n = 25), non-obstructive mesenteric is-
chemia (n = 25), mesenteric venous thrombosis (n = 9),
or AMI secondary to aortic surgery or dissection (n = 6)
were excluded. Patients with bowel ischemia due to ia-
trogenic injury (n = 3) or tumor infiltration of the me-
senteric arteries (n = 2) were also excluded.
Determination of Etiology
The determination of etiology was based on clinical data,
imaging, surgery, and autopsy, when available. A team
consisting of an abdominal radiologist, interventional ra-
diologist, and a specialist in vascular and gastrointestinal
surgery reanalyzed the CT and digital subtraction angiog-
raphy (DSA) findings of all screened patients. Embolism
was defined as a pathognomonic clot surrounded by con-
trast material in a non-calcified arterial segment of the
SMA, in conjunction with acute onset of symptoms and
predisposing comorbidities such as atrial fibrillation and
synchronous embolism. Thrombosis was defined as a
thrombotic occlusion of the SMA with a proximal calcified
occlusion or stenosis on CT. A subtotal occlusion or severe
stenosis ([70 %) of the SMA with concomitant obstruction
of the celiac artery (CA) and/or the inferior mesenteric
artery (IMA) was also categorized as thrombosis, if the
patient was suffering from acute episode of prolonged
symptoms consistent with the diagnosis of AMI, and there
were pathological bowel findings in CT (such as presence
of dilated or paralytic intestine, thickened bowel wall,
abnormal bowel wall enhancement, or pneumatosis).
Definition of Study Parameters
Preoperative risk factors, perioperative data, and outcomes
were retrieved from the electronic medical records
(Table 1). Clinical presentation, duration of symptoms,
laboratory values, and simultaneous cardiovascular events
were recorded at the time of diagnosis (Table 2). Acute
kidney injurywas defined as plasma creatinine[130 lmol/L
in patients with previously normal renal function, or[20 %
increase of plasma creatinine in patients with chronic renal
insufficiency [4]. Synchronous ischemic event was defined
as preoperative stroke, acute limb ischemia, or CT signs of
embolism or infarction in the spleen, liver, or kidney.
Diagnostic delays were recorded (Table 2). The time of
admission was defined as the time of initial presentation to
any hospital, before transfer to our tertiary center. The
duration of the endovascular procedure was estimated by
the time stamps of the first and the last angiogram and
should be interpreted in this context. Fluoroscopy time and
the amount of contrast medium were derived from a radi-
ology information system (Table 3).
Treatment Pathways
The primary intervention was defined as ‘‘EVT first’’ or
‘‘laparotomy first.’’ Laparotomy was performed after initial
EVT, if necessary. Unviable bowel was resected with pri-
mary anastomosis, except in cases with massive unre-
sectable necrosis of the intestine. Open revascularization
was not used as the primary treatment approach during the
study period; it was performed selectively after failure of
EVT (Fig. 1).
Endovascular Techniques
The primary endovascular technique for the treatment of
embolism was mechanical thrombectomy. Embolus and
massive thrombosis were aspirated using a 6 French
guiding catheter. Adjunctive percutaneous transluminal
angioplasty (PTA) with optional stenting (S) of the un-
derlying lesion was performed, if necessary. Catheter-di-
rected thrombolysis with urokinase was utilized if
mechanical thrombectomy did not resolve the thrombus.
Primary PTA/S was used for calcified lesions if there was
no major thrombus in the target vessel (Table 3).
Measures of Outcome
EVT failure was defined as the failure to recanalize the SMA,
significant recoil after PTA/S, flow-limiting dissection of the
SMA, or failure of mechanical thrombectomy and throm-
bolysis. A residual occlusion in a small branch of the SMA
was not considered a failure if flow to the main stem of SMA
was restored. Technical success of EVT was defined as return
of bowel perfusion with or without need for bowel resection.
Perioperative and postoperative complications were
recorded (Table 4). Bleeding complications included only
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events that required blood transfusion or surgical inter-
vention. Mortality was defined as 30-day mortality. Pa-
tients were monitored for late mortality until 30 June 2014
(Fig. 2).
Statistical Analysis
All statistical analyses were performed using SPSS
Statistics 22.0. Continuous variables were expressed as
mean ± standard deviation (SD), or median and in-
terquartile range (IQR). Fisher’s exact test or Pearson’s v2
test was used to compare nominal data, and the Mann–
Whitney U test for nonparametric data. Univariate analysis
was performed on independent variables, and odds ratio
was used to reflect odds of mortality or survival (Table 5).
p values\.05 were considered significant.
Results
Altogether, 136 patients with primary mesenteric ischemia
were retrieved from the hospital databases. Seventy pa-
tients were excluded according to the criteria described in
the methods. Sixteen out of the 66 patients with AMI
secondary to embolic or thrombotic etiology were not
referred for revascularization, and thus excluded from
further analysis. A total of 50 (76 %) patients with AMI
received an attempt at EVT (Fig. 1).
Baseline Characteristics
Risk factors were numerous in all patients (Table 1). Atrial
fibrillation, synchronous ischemic events, and shorter duration
of symptoms (\24 h) were associated with embolic etiology
(p\ .05). At presentation, 11 (61 %) patients with embolism
had atrial fibrillation without adequate anticoagulation treat-
ment (international normalized ratio\2.0). Peripheral arterial
disease, premonitory symptoms, diabetes, anemia, and ob-
struction of more than one mesenteric artery were more
common in the thrombosis group (p\ .05) (Table 2). Gen-
erally, patients with thrombosis had higher C-reactive protein
(CRP) levels at presentation, but there was no statistically
significant difference between etiological groups. However,
patientswith symptoms formore than 3 days had significantly
higher mean CRP (197 ± 70) than those with shorter dura-
tions of symptoms (116 ± 127) (p = .007).
Contrast-enhanced CT was the diagnostic modality in 49
(98 %) cases; one patient was diagnosed in laparotomy
followed by bowel resection and EVT. The diagnosis was
missed in the initial CT report in three cases of embolism
Table 1 Patient characteristics and risk factors
Variable All patients (n = 50) Embolism (n = 18) Thrombosis (n = 32) p
Age, mean ± SD (years) 79 ± 9 81 ± 10 78 ± 8 .18
Age, range (years) 58–94 59–94 58–92
Gender, male 21 (42) 5 (28) 16 (50) .15
BMI, mean ± SD (kg/m2) 25.4 ± 4.4 26.6 ± 4.5 24.6 ± 4.3 .16
Comorbidity
Hypertension 34 (68) 10 (56) 24 (75) .21
Hyperlipidemia 22 (44) 7 (39) 15 (47) .40
Diabetes mellitus 17 (34) 2 (11) 15 (47) \.05
Chronic renal insufficiencya 2 (4) 0 (0) 2 (6) .53
Atrial fibrillation 19 (38) 13 (72) 6 (19) \.05
Coronary artery disease 26 (52) 12 (67) 14 (44) .15
Previous myocardial infarction 7 (14) 4 (22) 3 (9) .23
Peripheral arterial disease 19 (38) 3 (17) 16 (50) \.05
Stroke/transitory ischemic attack 15 (30) 6 (33) 9 (28) .75
Medication
Warfarin 8 (16) 6 (33) 2 (6) \.05
Acetyl salicylic acid 32 (64) 10 (56) 22 (69) .38
Clopidogrel 4 (8) 0 (0) 4 (13) .28
Statin 30 (60) 10 (56) 20 (63) .77
All data are presented as n (%) unless otherwise stated
BMI body mass index, information was available for 45 patients
a Chronic renal insufficiency was defined as plasma creatinine[130 lmol/L (1.5 mg/dL) before admission
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and four cases of thrombosis causing additional delay in
the diagnosis (Table 2). Pathological extravascular bowel
findings related to intestinal ischemia were found
retrospectively in 48 of the 49 preoperative CT scans; one
patient with embolism had CT in only arterial phase
making the evaluation of bowel wall attenuation uncertain.
Table 2 Clinical presentation, laboratory values, findings on imaging, and diagnostic delays
All patients (n = 50) Embolism (n = 18) Thrombosis (n = 32) p
Clinical presentation
Premonitory symptomsa 8 (16) 0 (0) 8 (25) \.05
Abdominal pain 47 (94) 17 (94) 30 (94) .99
Abdominal distension 13 (26) 3 (17) 10 (31) .33
Diarrhea 24 (48) 6 (33) 18 (56) .15
Vomiting 28 (56) 12 (67) 16 (50) .37
Paralytic ileus 10 (20) 1 (6) 9 (28) .07
Gastrointestinal bleeding 7 (14) 3 (17) 4 (13) .69
Clinical features of peritonitisb 7 (14) 2 (11) 5 (15) .99
Acute kidney injury 3 (6) 0 (0) 3 (9) .54
Elevated troponin Tc 17 (34) 9 (50) 8 (25) .20
Elevated lactated 25 (50) 8 (44) 17 (53) .77
Metabolic acidosisd 16 (32) 6 (33) 10 (31) .99
Anemiae 20 (40) 3 (17) 17 (53) \.05
Acute myocardial infarction 3 (6) 2 (11) 1 (3) .29
Synchronous ischemic event 13 (26) 9 (50) 4 (13) \.05
Duration of symptoms\24 h 19 (38) 11 (61) 8 (25) \.05
Duration of symptoms 1–3 days 13 (32) 3 (17) 10 (31) .33
Duration of symptoms[3 days 18 (36) 4 (22) 14 (44) .22
Laboratory values, median (IQR)
C-reactive protein (mg/L) 149 (30–210) 69 (12–210) 164 (78–211) .17
White blood cell count, 109/L 14.3 (11–18) 12.9 (10–17) 15.9 (11–19) .15
Plasma creatinine (lmol/L) 74 (60–105) 98 (67–108) 68 (59–101) .24
Arterial lactated (mmol/L) 2.2 (1.2–5.1) 2.9 (1.2–6.0) 2.0 (1.2–4.9) .54
Vascular findings on CT and DSA
SMA total occlusion (100 %) 41 (82) 17 (94) 24 (75) .13
SMA severe stenosis (70–99 %) 8 (16) 0 (0) 8 (25)
SMA distal branch occlusion 1 (2) 1 (6) 0 (0)
CT-verified embolus/thrombus 29 (58) 18 (100) 11 (34)
SMA obstruction alone 15 (30) 12 (67) 3 (9) \.05
2- or 3-vessel diseasef 35 (70) 6 (33) 29 (91)
The delay, median (IQR) (h)
From admission to CT 3.9 (2–19) 3.8 (3–15) 2.6 (2–14) .31
From admission to diagnosis 5.2 (2–23) 3.8 (3–23) 2.6 (2–45) .59
From diagnosis to EVT 4.4 (2–22) 3.4 (2–5) 10.2 (2–31) .06
All data are presented as n (%) unless otherwise stated
a Premonitory symptoms were defined as history of symptoms consistent with chronic mesenteric ischemia (postprandial abdominal pain, weight
loss, and food intolerance)
b Based on surgeon’s interpretation of the clinical condition
c Troponin T[50 ng/L. Information was available on 41 patients
d Elevated lactate was defined as arterial lactate C1.33 mmol/L, and metabolic acidosis was defined as base deficit[2.5 mmol/L. Information
was available for 35 patients
e Hemoglobin\130 g/L in men and\115 g/L in women
f Obstruction of the CA was defined as total occlusion or severe stenosis (70–99 %) in the celiac trunk or common hepatic artery. Obstruction of
the IMA was defined as a total occlusion or significant stenosis (roughly 50–99 %)
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Endovascular Procedures and Technical Failures
EVT was attempted in 50 patients, with technical success
in 44 (88 %) (Table 3). EVT was used in 72 and 78 % of
patients with embolism and thrombosis, respectively; the
corresponding technical success rates were 94 and 84 %.
All cases were de novo lesions. Brachial access was pre-
ferred for mechanical thrombectomy (61 %) and primary
PTA/S (78 %). Brachial access failed in three of 37 at-
tempts (8 %) and femoral access in three of 17 attempts
(18 %). Failed femoral access was successfully converted
to brachial access in two cases, and vice versa in one case.
Both failed in one case.
Mechanical thrombectomy was used to treat 17 patients
with embolism, and three patients with thrombotic occlu-
sion. There was one failure (5 %) to resolve an embolus
with aspiration and thrombolysis because of dissection and
re-thrombosis of the SMA. However, the patient survived
with bowel resection. Although it did not constitute a
technical failure according to the definition, six patients
had residual emboli, distal embolization, or dissection of a
distal SMA branch; three of these patients died.
Table 3 Endovascular procedure, technical failures, EVT procedure-related complications, procedure time, and the need for surgery
Variable All patients (n = 50) Embolism (n = 18) Thrombosis (n = 32)
Mechanical thrombectomy (SMA) 20 17 3
Technical failure 1 1 0
Adjunctive stenting 3 3 3
Adjunctive thrombolysis 4 4 0
Primary PTA 30 1 29
Technical failure 5 0 5
PTA alone (SMA) 2 0 2
PTA/S (SMA alone) 20 1 19
PTA/S (SMA?CA) 3 0 3
PTA/S (CA?IMA) 2 0 2
Technical failures, n (%) 6 (12) 1 (6) 5 (16)
Failure to access the SMA 4 0 4a
Failure due to non-cooperation 1 0 1
Dissection and re-thrombosis 1 1 0
EVT-related complications, n (%) 5 (10) 2 (11) 3 (9)
Bleeding from brachial artery 1 1 –
Bleeding from femoral artery 1 – 1
SMA distal branch dissection 1 1b –
IMA dissection and perforation 1 – 1c
Stroke (right brachial access) 1 – 1
EVT-related variables
Procedure timed, mean ± SD (min) 84 ± 41 95 ± 39 81 ± 44
Fluoroscopy time, mean ± SD (min) 35 ± 21 32 ± 19 37 ± 23
Contrast dose, mean ± SD (mL) 158 ± 79 181 ± 91 147 ± 75
Need for surgery, n (%)
Laparotomy 20 (40) 5 (28) 15 (47)
Bowel resection 17 (34) 5 (28) 12 (38)
Surgical revascularization 3 (6) 0 (0) 3 (9)
All data are presented as n unless otherwise stated. There were no statistically significant differences in failure, complication, laparotomy, or
bowel resection rates between groups
a Includes two failures to access any of the targeted vessels, and the two PTA/S procedures of CA/IMA with failure to access the SMA. Brachial
access was primarily attempted in all four cases; a conversion to femoral access was also tried in one case
b Resulted in an intra-abdominal bleeding requiring embolization with coils
c Required stenting and distal embolization. The patient had also a failure to access the SMA, required bypass with bowel resection, and died in
the intensive care unit later on
d Procedure time is an estimate based on the time stamps of the first and the last angiogram, which does not include the time spent on cannulation
before the first aortogram. An extra 15 min is therefore added to the calculated difference between the time stamps
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and four cases of thrombosis causing additional delay in
the diagnosis (Table 2). Pathological extravascular bowel
findings related to intestinal ischemia were found
retrospectively in 48 of the 49 preoperative CT scans; one
patient with embolism had CT in only arterial phase
making the evaluation of bowel wall attenuation uncertain.
Table 2 Clinical presentation, laboratory values, findings on imaging, and diagnostic delays
All patients (n = 50) Embolism (n = 18) Thrombosis (n = 32) p
Clinical presentation
Premonitory symptomsa 8 (16) 0 (0) 8 (25) \.05
Abdominal pain 47 (94) 17 (94) 30 (94) .99
Abdominal distension 13 (26) 3 (17) 10 (31) .33
Diarrhea 24 (48) 6 (33) 18 (56) .15
Vomiting 28 (56) 12 (67) 16 (50) .37
Paralytic ileus 10 (20) 1 (6) 9 (28) .07
Gastrointestinal bleeding 7 (14) 3 (17) 4 (13) .69
Clinical features of peritonitisb 7 (14) 2 (11) 5 (15) .99
Acute kidney injury 3 (6) 0 (0) 3 (9) .54
Elevated troponin Tc 17 (34) 9 (50) 8 (25) .20
Elevated lactated 25 (50) 8 (44) 17 (53) .77
Metabolic acidosisd 16 (32) 6 (33) 10 (31) .99
Anemiae 20 (40) 3 (17) 17 (53) \.05
Acute myocardial infarction 3 (6) 2 (11) 1 (3) .29
Synchronous ischemic event 13 (26) 9 (50) 4 (13) \.05
Duration of symptoms\24 h 19 (38) 11 (61) 8 (25) \.05
Duration of symptoms 1–3 days 13 (32) 3 (17) 10 (31) .33
Duration of symptoms[3 days 18 (36) 4 (22) 14 (44) .22
Laboratory values, median (IQR)
C-reactive protein (mg/L) 149 (30–210) 69 (12–210) 164 (78–211) .17
White blood cell count, 109/L 14.3 (11–18) 12.9 (10–17) 15.9 (11–19) .15
Plasma creatinine (lmol/L) 74 (60–105) 98 (67–108) 68 (59–101) .24
Arterial lactated (mmol/L) 2.2 (1.2–5.1) 2.9 (1.2–6.0) 2.0 (1.2–4.9) .54
Vascular findings on CT and DSA
SMA total occlusion (100 %) 41 (82) 17 (94) 24 (75) .13
SMA severe stenosis (70–99 %) 8 (16) 0 (0) 8 (25)
SMA distal branch occlusion 1 (2) 1 (6) 0 (0)
CT-verified embolus/thrombus 29 (58) 18 (100) 11 (34)
SMA obstruction alone 15 (30) 12 (67) 3 (9) \.05
2- or 3-vessel diseasef 35 (70) 6 (33) 29 (91)
The delay, median (IQR) (h)
From admission to CT 3.9 (2–19) 3.8 (3–15) 2.6 (2–14) .31
From admission to diagnosis 5.2 (2–23) 3.8 (3–23) 2.6 (2–45) .59
From diagnosis to EVT 4.4 (2–22) 3.4 (2–5) 10.2 (2–31) .06
All data are presented as n (%) unless otherwise stated
a Premonitory symptoms were defined as history of symptoms consistent with chronic mesenteric ischemia (postprandial abdominal pain, weight
loss, and food intolerance)
b Based on surgeon’s interpretation of the clinical condition
c Troponin T[50 ng/L. Information was available on 41 patients
d Elevated lactate was defined as arterial lactate C1.33 mmol/L, and metabolic acidosis was defined as base deficit[2.5 mmol/L. Information
was available for 35 patients
e Hemoglobin\130 g/L in men and\115 g/L in women
f Obstruction of the CA was defined as total occlusion or severe stenosis (70–99 %) in the celiac trunk or common hepatic artery. Obstruction of
the IMA was defined as a total occlusion or significant stenosis (roughly 50–99 %)
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Contrast dose, mean ± SD (mL) 158 ± 79 181 ± 91 147 ± 75
Need for surgery, n (%)
Laparotomy 20 (40) 5 (28) 15 (47)
Bowel resection 17 (34) 5 (28) 12 (38)
Surgical revascularization 3 (6) 0 (0) 3 (9)
All data are presented as n unless otherwise stated. There were no statistically significant differences in failure, complication, laparotomy, or
bowel resection rates between groups
a Includes two failures to access any of the targeted vessels, and the two PTA/S procedures of CA/IMA with failure to access the SMA. Brachial
access was primarily attempted in all four cases; a conversion to femoral access was also tried in one case
b Resulted in an intra-abdominal bleeding requiring embolization with coils
c Required stenting and distal embolization. The patient had also a failure to access the SMA, required bypass with bowel resection, and died in
the intensive care unit later on
d Procedure time is an estimate based on the time stamps of the first and the last angiogram, which does not include the time spent on cannulation
before the first aortogram. An extra 15 min is therefore added to the calculated difference between the time stamps
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Primary PTA/S was performed in 29 patients with
thrombotic obstruction and one patient with embolism.
Primary PTA/S failed in five patients (17 %). There were
two failures to recanalize any of the targeted lesions. The
first patient was treated immediately with bypass surgery.
The second patient required several laparotomies, bowel
resections, and open revascularization. Both patients sur-
vived. CA and IMA were treated in two patients, which
were defined as failures because the SMA could not be
recanalized. One of the two survived with bowel resection;
however, the other patient was complicated with dissection
and distal perforation of the IMA, and died after en-
dovascular rescue of the IMA with stenting and distal
embolization, bowel resection, and bypass surgery. One
PTA/S failed owing to the patient’s inadequate coop-
eration; the patient was unfit for general anesthesia and
died the next day.
Treatment Pathways and Patient Selection
EVT was applied first in 43 patients and after laparotomy
in seven patients (Fig. 1). A total of 20 patients (40 %)
treated with EVT required laparotomy, and bowel resection
was performed in 17 (34 %) patients. Six patients required
relaparotomy, and two patients had several laparotomies.
Nine (18 %) patients were referred from other hospitals.
A total of 16 patients were treated with laparotomy first
because of clinically suspected peritonitis or CT signs of
advanced bowel necrosis (Fig. 1). Nine of these patients
were excluded from further analysis: five patients had un-
resectable bowel necrosis and died after laparotomy. Two
patients had embolization only in the distal parts of the
SMA and were treated with simple bowel resection; one of
the two survived. One patient with necrotizing ischemic
colitis and septic shock survived with subtotal colectomy; a
thrombotic occlusion of the SMA and chronic occlusion of
the IMA was discovered in retrospect. Another patient with
peritonitis was treated with initial small bowel resection;
postoperative CT revealed a partial thrombosis of the SMA
and CA, and a large metastatic mediastinal tumor; further
interventions were waived and the patient died.
Seven patients had no intervention and were excluded
(Fig. 1): five of them were elderly, sick patients who were
determinedly treated with only palliative care, and died
within 1–3 days. One young patient had a distal suboc-
cluding embolism of the SMA without signs of advanced
ischemia, but with synchronous embolism and infarction of
both kidneys, and a cardiac thrombus caused by acute
myocardial infarction; the patient was also diagnosed with
metastatic lung cancer and survived for 2 years without
surgery. One elderly patient with thrombotic occlusion of
the SMA and CA was initially misdiagnosed as cholecys-
titis and treated conservatively; fortunately, the patient
survived without further intervention.
Outcomes and Mortality
The 30-day mortality after successful or failed EVT was
32 %. EVT failed in six patients (12 %) with mortality in
two cases (33 %). Five patients (10 %) had EVT-related
complication with mortality (unrelated to the complication)
in one case. Independent factors associated with survival or
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Fig. 1 Flow chart demonstrating the treatment pathways of 66 patients with AMI. A total of 50 patients received attempt at EVT. Bypass was
performed selectively in three patients after failure of EVT
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mortality are presented in Table 5. Long-term survival
estimate of EVT patients is illustrated in Fig. 2.
Discussion
The 88 % technical success rate, 34 % bowel resection
rate, and 32 % mortality associated with EVT in the cur-
rent study are consistent with previous reports [4–9]. The
10 % procedural complication rate in endovascular inter-
ventions among patients in this study is acceptable. Patients
were older (mean age 79 ± 9 years) than in any of the
previous studies, which may contribute to the high pro-
portion of atherosclerotic etiology.
Endovascular Technical Aspects
At present, the brachial artery is our institution’s preferred
approach for both mechanical thrombectomy and PTA/S. A
long 6 French sheath is introduced into the descending
aorta, and a guiding catheter (eg, Amplatz Left 1 or Right
Judkins) is placed in the ostia of the SMA. Calcified lesions
are recanalized with a hydrophilic guidewire (.01400–.03500),
and a balloon-expandable stent is deployed. Predilatation is
frequently used. The development of dedicated aspiration
catheters has reduced the need for thrombolysis. Six French
carotid distal access guiding catheters are currently favored
for embolectomy. Early experience with motorized vacuum
aspiration has been promising.
There was only one failure in mechanical thrombectomy,
although six patients had residual distal emboli or thrombus.
Some would argue that residual distal emboli constitute a
failure especially since three of the six such patients in this
studydied.However, owing to thepresenceof a richmesenteric
collateral network, peripheral residual occlusion rarely dete-
riorated perfusion in the mesentery. The clinical outcome is
dependent on several factors, such as the extent of bowel injury
before revascularization and patient’s condition in general.
Table 4 Length of stay, perioperative and postoperative complications, and mortality
Variable All patients (n = 50) Embolism (n = 18) Thrombosis (n = 32)
Patients treated in the ICU, n (%) 10 (20) 3 (17) 7 (22)
ICU length of stay, mean ± SD (days) 3.2 ± 1.5 2.0 ± 1.0 3.7 ± 1.5
Hospital length of stay, mean ± SD (days) 9.0 ± 8.7 3.7 ± 3.1 11.9 ± 12.6
Any complication, n (%) 21 (42) 8 (44) 13 (41)
Access site bleeding 2 1 1
Intra-abdominal bleeding 1 1 0
New gastrointestinal bleeding 5 0 5
Stroke 1 0 1
New myocardial infarction 2 0 2
Heart failure 6 3 3
Acute kidney injury 4 0 4
New dialysis 1 0 1
Pneumonia 2 0 2
Pulmonary failurea 2 0 2
Pleural effusion 1 1 0
Prolonged paralytic ileus 1 0 1
Clostridium difficile enterocolitis 2 1 1
Micro-emboli (blue toe syndrome) 1 1 0
SMA stent thrombosis 1b 0 1
In-hospital death, n (%) 15c (30) 7 (39) 8 (25)
30-day mortality, n (%) 16 (32) 7 (39) 9 (28)
6-month mortality, n (%) 21 (42) 10 (56) 11 (34)
Data are presented as n unless otherwise stated. There were no statistically significant differences in mortality or complication rates between
groups
ICU intensive care unit
a Pulmonary failure was defined as requiring intubation for[72 h [4]
b The patient had a metastatic esophageal carcinoma with SMA thrombosis and synchronous pulmonary embolism. A stent thrombosis was
discovered at autopsy, after death on the sixth postoperative day
c All in-hospital deaths occurred within 30 postoperative days
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Primary PTA/S was performed in 29 patients with
thrombotic obstruction and one patient with embolism.
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mortality are presented in Table 5. Long-term survival
estimate of EVT patients is illustrated in Fig. 2.
Discussion
The 88 % technical success rate, 34 % bowel resection
rate, and 32 % mortality associated with EVT in the cur-
rent study are consistent with previous reports [4–9]. The
10 % procedural complication rate in endovascular inter-
ventions among patients in this study is acceptable. Patients
were older (mean age 79 ± 9 years) than in any of the
previous studies, which may contribute to the high pro-
portion of atherosclerotic etiology.
Endovascular Technical Aspects
At present, the brachial artery is our institution’s preferred
approach for both mechanical thrombectomy and PTA/S. A
long 6 French sheath is introduced into the descending
aorta, and a guiding catheter (eg, Amplatz Left 1 or Right
Judkins) is placed in the ostia of the SMA. Calcified lesions
are recanalized with a hydrophilic guidewire (.01400–.03500),
and a balloon-expandable stent is deployed. Predilatation is
frequently used. The development of dedicated aspiration
catheters has reduced the need for thrombolysis. Six French
carotid distal access guiding catheters are currently favored
for embolectomy. Early experience with motorized vacuum
aspiration has been promising.
There was only one failure in mechanical thrombectomy,
although six patients had residual distal emboli or thrombus.
Some would argue that residual distal emboli constitute a
failure especially since three of the six such patients in this
studydied.However, owing to thepresenceof a richmesenteric
collateral network, peripheral residual occlusion rarely dete-
riorated perfusion in the mesentery. The clinical outcome is
dependent on several factors, such as the extent of bowel injury
before revascularization and patient’s condition in general.
Table 4 Length of stay, perioperative and postoperative complications, and mortality
Variable All patients (n = 50) Embolism (n = 18) Thrombosis (n = 32)
Patients treated in the ICU, n (%) 10 (20) 3 (17) 7 (22)
ICU length of stay, mean ± SD (days) 3.2 ± 1.5 2.0 ± 1.0 3.7 ± 1.5
Hospital length of stay, mean ± SD (days) 9.0 ± 8.7 3.7 ± 3.1 11.9 ± 12.6
Any complication, n (%) 21 (42) 8 (44) 13 (41)
Access site bleeding 2 1 1
Intra-abdominal bleeding 1 1 0
New gastrointestinal bleeding 5 0 5
Stroke 1 0 1
New myocardial infarction 2 0 2
Heart failure 6 3 3
Acute kidney injury 4 0 4
New dialysis 1 0 1
Pneumonia 2 0 2
Pulmonary failurea 2 0 2
Pleural effusion 1 1 0
Prolonged paralytic ileus 1 0 1
Clostridium difficile enterocolitis 2 1 1
Micro-emboli (blue toe syndrome) 1 1 0
SMA stent thrombosis 1b 0 1
In-hospital death, n (%) 15c (30) 7 (39) 8 (25)
30-day mortality, n (%) 16 (32) 7 (39) 9 (28)
6-month mortality, n (%) 21 (42) 10 (56) 11 (34)
Data are presented as n unless otherwise stated. There were no statistically significant differences in mortality or complication rates between
groups
ICU intensive care unit
a Pulmonary failure was defined as requiring intubation for[72 h [4]
b The patient had a metastatic esophageal carcinoma with SMA thrombosis and synchronous pulmonary embolism. A stent thrombosis was
discovered at autopsy, after death on the sixth postoperative day
c All in-hospital deaths occurred within 30 postoperative days
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Failure was more common in PTA/S. A heavily calcified
occlusion may bring difficulties during recanalization of
the target vessel. To avoid wasting time on futile attempts
at EVT, open revascularization should be considered as
primary treatment for those cases. Two patients received
endovascular treatment of only CA and IMA lesions, with
failure to recanalize an occluded SMA. It is questionable
whether this is a rational approach. A meticulous investi-
gation of the collateral blood flow to the intestine should be
performed during angiography. If sufficient collateral ar-
teries have not developed, then treatment of CA or IMA
may not improve the patient’s condition without revascu-
larization of the SMA.
Diagnostic Delays and Treatment Logistics
The diagnostic delay was considerably long in some pa-
tients with thrombotic etiology, indicating that the diag-
nosis of AMI is difficult even in the era of modern imaging
techniques. The clinical presentation of AMI varies widely;
the symptoms are often obscure and non-specific, espe-
cially in patients with chronic arterial obstruction. The
diagnosis may be missed in the CT by the radiologist,
especially if the clinician fails to raise suspicion of AMI.
Owing to the diversity of clinical symptoms in AMI, 30 %
of patients in this study were first referred to a clinician
other than a surgeon, usually an internist in the acute care
unit.
All endovascular procedures in this study were per-
formed in an angiography suite. The estimated mean en-
dovascular procedure time of approximately 1.5 h in this
study is acceptable, but the delay until treatment varied.
This variation was partly owing to logistical reasons,
especially for patients referred from other hospitals. Fur-
thermore, 60 % of the endovascular procedures were per-











































Fig. 2 Kaplan–Meier cumulative survival estimate of 50 patients
treated with EVT
Table 5 Univariate analysis of independent factors associated with increased 30-day mortality or survival in 50 AMI patients treated with EVT
Baseline variables Survivor (n = 34) Non-survivor (n = 16) p OR 95 % CI
Factors associated with mortality
Age, mean ± SD (years) 77 ± 9 83 ± 7 .021 1.10 1.01–1.19
Acute myocardial infarction 0 3 .029 –
Elevated troponin T 7 10 .050 4.29 1.12–16.31
Recent major surgery 0 3 .029 –
Paralytic ileus 3 7 .007 8.04 1.72–37.59
Metabolic acidosis 5 11 .001 12.76 3.08–52.82
Elevated lactate 11 14 .001 14.64 2.82–75.95
Lactate, mean ± SD (mmol/L) 2.0 ± 1.3 5.7 ± 3.6 .001 1.93 1.20–3.13
Factors associated with survival
Symptoms[3 days 17 1 .004 15.00 1.78–126.60
Premonitory symptoms 8 0 .043 –
Normal bowel wall enhancement 15 1 .018 11.05 1.30–93.82
Data are presented as n unless otherwise stated
OR odds ratio, CI confidence interval
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wait for the endovascular team to prepare should be con-
sidered on an individual basis. Open embolectomy, surgi-
cal bypass, or hybrid stenting may be the fastest way to
achieve bowel reperfusion in some cases, when laparotomy
cannot be avoided [10]. In case of peritonitis, septic shock,
severe metabolic acidosis, or strong CT signs of bowel
necrosis, any delay in surgical treatment results in larger
bowel necrosis. Damage control laparotomy first with
subsequent open or endovascular revascularization should
be the treatment approach in those patients. There should
also be a low threshold to perform laparotomy or la-
paroscopy, if symptoms persist after successful initial EVT.
Recently, we introduced a carbon fiber table and a mobile
C-arm, designed for vascular interventions, into our sur-
gical operating room—an ideal place to treat AMI patients.
Acute, Chronic, or ‘‘Acute on Chronic’’
Acute abdomen is a diagnostic challenge on a patient with
chronic obstruction of the SMA. Some AMI patients present
with insidious rather than acute onset of symptoms, and it
may take days for the diagnosis to become self-evident as the
patient’s condition deteriorates. In this study, premonitory
symptoms and a prolonged episode of AMI seemed to favor
survival (Table 5), suggesting that these patients were in fact
suffering from ‘‘acute on chronic’’ syndrome [11]. Bowel
injury developed slowly in these patients, and even though
they had higher CRP levels at baseline, EVT was often ef-
fective several days after onset of acute symptoms.
From clinician’s perspective, there is a controversy re-
garding the definition of acute versus chronic mesenteric
ischemia in the literature; acute occlusion of the SMA and
AMI are almost synonyms, and chronic arterial occlusion
associates with chronic mesenteric ischemia. In clinical
practice, however, we often come across patients with
chronic obstruction of the mesenteric arteries who develop
fulminant acute intestinal ischemia without evidence of
acute thromboembolic event. These patients should be
categorized as AMI or ‘‘acute on chronic mesenteric is-
chemia’’ regardless of the presentation pattern of the arterial
obstruction, and treated with emergent revascularization
[11]. The clinical presentation pattern of chronic mesenteric
ischemia is generally accepted as postprandial abdominal
pain (with various other symptoms) which poses no immi-
nent threat to life, although the disease is often progressive
and may culminate in AMI [11, 12].
Historically, the categorization of etiology in AMI as em-
bolismor thrombosiswasbasedonconventional angiography.
Thanks to modern imaging, there is now more information
available on the plaque morphology. Still, it is impossible to
distinguish acute from chronic thrombosis based onCT alone.
In this study, 11 out of the 34 patients in the thrombosis group
had clearly a visible thrombus in CT (Table 2). Incidentally,
one of those 11 patients had a 2-year-oldCT available proving
that the thrombus was in fact a chronic thrombosis; nonethe-
less, the patient had acute intestinal necrosis. Another similar
case with unresectable bowel necrosis at initial laparotomy
was discovered among the excluded patients. In contrast, an
acute thrombosisof a calcifiednear total occlusionof theSMA
may be invisible in CT; only recanalization with a guidewire
























































Fig. 3 A subanalysis was performed to investigate whether a visible
major thrombosis in CT (referred here as ‘‘thrombotic obstruction’’)
was a factor in outcomes. Patients were divided into two groups
according to the treatment approach, and further, three groups
according to the presentation pattern of the arterial obstruction. There
were no statistically significant differences in mortality between
patients with ‘‘thrombotic’’ or ‘‘calcified’’ obstruction
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Failure was more common in PTA/S. A heavily calcified
occlusion may bring difficulties during recanalization of
the target vessel. To avoid wasting time on futile attempts
at EVT, open revascularization should be considered as
primary treatment for those cases. Two patients received
endovascular treatment of only CA and IMA lesions, with
failure to recanalize an occluded SMA. It is questionable
whether this is a rational approach. A meticulous investi-
gation of the collateral blood flow to the intestine should be
performed during angiography. If sufficient collateral ar-
teries have not developed, then treatment of CA or IMA
may not improve the patient’s condition without revascu-
larization of the SMA.
Diagnostic Delays and Treatment Logistics
The diagnostic delay was considerably long in some pa-
tients with thrombotic etiology, indicating that the diag-
nosis of AMI is difficult even in the era of modern imaging
techniques. The clinical presentation of AMI varies widely;
the symptoms are often obscure and non-specific, espe-
cially in patients with chronic arterial obstruction. The
diagnosis may be missed in the CT by the radiologist,
especially if the clinician fails to raise suspicion of AMI.
Owing to the diversity of clinical symptoms in AMI, 30 %
of patients in this study were first referred to a clinician
other than a surgeon, usually an internist in the acute care
unit.
All endovascular procedures in this study were per-
formed in an angiography suite. The estimated mean en-
dovascular procedure time of approximately 1.5 h in this
study is acceptable, but the delay until treatment varied.
This variation was partly owing to logistical reasons,
especially for patients referred from other hospitals. Fur-
thermore, 60 % of the endovascular procedures were per-











































Fig. 2 Kaplan–Meier cumulative survival estimate of 50 patients
treated with EVT
Table 5 Univariate analysis of independent factors associated with increased 30-day mortality or survival in 50 AMI patients treated with EVT
Baseline variables Survivor (n = 34) Non-survivor (n = 16) p OR 95 % CI
Factors associated with mortality
Age, mean ± SD (years) 77 ± 9 83 ± 7 .021 1.10 1.01–1.19
Acute myocardial infarction 0 3 .029 –
Elevated troponin T 7 10 .050 4.29 1.12–16.31
Recent major surgery 0 3 .029 –
Paralytic ileus 3 7 .007 8.04 1.72–37.59
Metabolic acidosis 5 11 .001 12.76 3.08–52.82
Elevated lactate 11 14 .001 14.64 2.82–75.95
Lactate, mean ± SD (mmol/L) 2.0 ± 1.3 5.7 ± 3.6 .001 1.93 1.20–3.13
Factors associated with survival
Symptoms[3 days 17 1 .004 15.00 1.78–126.60
Premonitory symptoms 8 0 .043 –
Normal bowel wall enhancement 15 1 .018 11.05 1.30–93.82
Data are presented as n unless otherwise stated
OR odds ratio, CI confidence interval
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wait for the endovascular team to prepare should be con-
sidered on an individual basis. Open embolectomy, surgi-
cal bypass, or hybrid stenting may be the fastest way to
achieve bowel reperfusion in some cases, when laparotomy
cannot be avoided [10]. In case of peritonitis, septic shock,
severe metabolic acidosis, or strong CT signs of bowel
necrosis, any delay in surgical treatment results in larger
bowel necrosis. Damage control laparotomy first with
subsequent open or endovascular revascularization should
be the treatment approach in those patients. There should
also be a low threshold to perform laparotomy or la-
paroscopy, if symptoms persist after successful initial EVT.
Recently, we introduced a carbon fiber table and a mobile
C-arm, designed for vascular interventions, into our sur-
gical operating room—an ideal place to treat AMI patients.
Acute, Chronic, or ‘‘Acute on Chronic’’
Acute abdomen is a diagnostic challenge on a patient with
chronic obstruction of the SMA. Some AMI patients present
with insidious rather than acute onset of symptoms, and it
may take days for the diagnosis to become self-evident as the
patient’s condition deteriorates. In this study, premonitory
symptoms and a prolonged episode of AMI seemed to favor
survival (Table 5), suggesting that these patients were in fact
suffering from ‘‘acute on chronic’’ syndrome [11]. Bowel
injury developed slowly in these patients, and even though
they had higher CRP levels at baseline, EVT was often ef-
fective several days after onset of acute symptoms.
From clinician’s perspective, there is a controversy re-
garding the definition of acute versus chronic mesenteric
ischemia in the literature; acute occlusion of the SMA and
AMI are almost synonyms, and chronic arterial occlusion
associates with chronic mesenteric ischemia. In clinical
practice, however, we often come across patients with
chronic obstruction of the mesenteric arteries who develop
fulminant acute intestinal ischemia without evidence of
acute thromboembolic event. These patients should be
categorized as AMI or ‘‘acute on chronic mesenteric is-
chemia’’ regardless of the presentation pattern of the arterial
obstruction, and treated with emergent revascularization
[11]. The clinical presentation pattern of chronic mesenteric
ischemia is generally accepted as postprandial abdominal
pain (with various other symptoms) which poses no immi-
nent threat to life, although the disease is often progressive
and may culminate in AMI [11, 12].
Historically, the categorization of etiology in AMI as em-
bolismor thrombosiswasbasedonconventional angiography.
Thanks to modern imaging, there is now more information
available on the plaque morphology. Still, it is impossible to
distinguish acute from chronic thrombosis based onCT alone.
In this study, 11 out of the 34 patients in the thrombosis group
had clearly a visible thrombus in CT (Table 2). Incidentally,
one of those 11 patients had a 2-year-oldCT available proving
that the thrombus was in fact a chronic thrombosis; nonethe-
less, the patient had acute intestinal necrosis. Another similar
case with unresectable bowel necrosis at initial laparotomy
was discovered among the excluded patients. In contrast, an
acute thrombosisof a calcifiednear total occlusionof theSMA
may be invisible in CT; only recanalization with a guidewire
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The mortality rate was higher among patients with CT-
verified embolus/thrombus than those with seemingly
chronic atherosclerotic lesion (41 vs. 19 %), but there were
no statistically significant differences in univariate analysis
when compared within all 50 patients or within 32 patients
in the thrombosis group. There were no differences in
bowel resection rates either (34 vs. 33 %) (Fig. 3). The
only independent CT finding significantly associated with
survival was normal bowel wall enhancement (Table 5).
A chronic stenosis of the SMA alone rarely causes is-
chemia; a two- or three-vessel disease increases the risk of
AMI [13]. Any CT abnormalities in the bowel wall to-
gether with severe atherosclerosis of the mesenteric arteries
should indicate a possibility of AMI. We defined a severe
stenosis of the SMA as 70–99 % which is generally ac-
cepted as hemodynamically significant. All eight patients
in Table 2 with open but stenotic SMA had synchronous
obstruction of CA/IMA, extravascular direct signs of in-
testinal ischemia in CT, and high CRP levels at baseline.
Bear in mind though, that intestinal findings in CT may be
very subtle and easily missed at early stage of AMI. The
suspicion should always be high on an elderly patient with
a history of atherosclerotic disease presenting with acute
abdominal pain.
Although plaque morphology is a factor in endovascular
technical success, a more relevant question for the clinician
is whether the patient has acute intestinal ischemia or just
worsening of symptoms of chronic intestinal ischemia.
Clinical presentation pattern and bowel findings in CT may
be useful in the differential diagnosis. While most patients
with acute on chronic syndrome benefit from urgent
revascularization, there is a risk of overtreatment, as some
patients recover with only fluid resuscitation, antibiotics,
and correction of anemia. Those patients, however, remain
at risk of developing recurrent acute ischemia [11].
Long-Term Survival
In general, patients with AMI are elderly people with nu-
merous risk factors for atherosclerosis. Regardless of the
treatment strategy, the expected long-term survival is poor
(Fig. 2). EVT is therefore a tempting alternative to open
surgery for these fragile patients.
Study Limitations
There is an obvious surgeon selection bias in all retro-
spective studies that compare EVT with other AMI treat-
ment strategies. This is a limitation of this study, as well.
The decision to perform a laparotomy first, consult an in-
terventional radiologist, or treat the patient conservatively
was the responsibility of the on-call gastrointestinal sur-
geon. Patients that were not referred for revascularization
had evidently worse prognosis at baseline. However, this
report offers a complete representation of all consecutive
patients treated for AMI during the study period.
An acute thrombosis cannot be distinguished from
chronic thrombosis based only on CT; this limitation is
uniform across all current literature on AMI. Therefore, a
team of specialists was consulted to verify the diagnosis of
AMI, and etiology, based on all available information.
Conclusions
This study adds to the literature on endovascular treatment
in AMI by demonstrating the feasibility of EVT as a pri-
mary treatment modality in a high proportion of patients.
Early EVT may reduce mortality and bowel resection rate
in patients with AMI.
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Abstract
Background We studied whether ischemia-specific computed tomography (CT) findings are consistently detectable in patients
who develop acute on chronic mesenteric ischemia (AOCMI), whereas absent in chronic mesenteric ischemia (CMI).
Methods Consecutive patients with symptomatic angiography-verified atherosclerotic obstruction of the superior mesenteric
artery (SMA)were categorized as AOCMI (n=27) or CMI (n=20). Three experienced radiologists blindly evaluated the contrast-
enhanced CTs for vascular and intestinal findings. Kappa statistics was used to test interobserver agreement.
Results Two observers had substantial agreement (k=0.66) that two thirds of AOCMI patients showed ischemia-specific CT
findings (decreased bowel wall enhancement, pneumatosis, or thrombotic SMA clot); the third observer agreed only fairly
regarding pneumatosis and thrombosis (k=0.3–0.4). All observers had substantial agreement (k=0.65–0.71) that most patients
with AOCMI had unspecific intestinal findings such as mesenteric fat stranding in up to 96 %, bowel lumen dilatation in 93 %,
and bowel wall thickening in 70 %, while only few patients with CMI had such findings (due to chronic ischemic colitis)
(P<0.001).
Conclusion One third of AOCMI patients presented without any ischemia-specific CT signs. However, any intestinal abnormal-
ity in CT together with SMAobstruction should raise suspicion of intestinal ischemia. Furthermore, clinicians need to be aware of
the interobserver variability in the CT interpretation.
Keywords Acute on chronic mesenteric ischemia .
Acute mesenteric ischemia . Chronic mesenteric ischemia .
Intestinal ischemia . Computed tomography .
Mesenteric atherosclerosis
Introduction
Acute mesenteric ischemia (AMI) is a significant cause of
acute abdomen in the elderly; it is more common than acute
appendicitis and ruptured abdominal aortic aneurysm in pa-
tients over age 75 years.1 There is no data on the epidemiology
of chronic mesenteric ischemia (CMI). Even so, asymptomat-
ic mesenteric atherosclerosis is far more common than AMI or
CMI. Significant stenosis of the celiac artery (CA) or the su-
perior mesenteric artery (SMA) was found in duplex sonog-
raphy of asymptomatic patients in 18 % of those more than
65 years old and in autopsy in 67 % of subjects aged 80 years
or more.2
,3 The clinical course of mesenteric arterial stenosis
occasionally culminates in AMI; patients with significant
three-vessel disease are at considerable risk.4
,5
In patients with acute abdominal pain, thromboembolic
occlusion of the SMA in computed tomography (CT) strongly
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suggests AMI. However, one third of patients with arterial
AMI present without visible thromboembolic clot in the CT
but with a calcified chronic lesion of the SMA.6 Therefore,
acute on chronic mesenteric ischemia (AOCMI) is one of the
most difficult diagnoses in the spectrum of acute abdomen.
The symptoms vary from fulminant peritonitis to insidious
onset of obscure symptoms such as diarrhea and vomiting.6
,7
Previous hospitalizations for various symptoms are common
in CMI patients who eventually develop irreversible state of
AMI.7 Early diagnosis is vital; urgent revascularization with
resection of necrotic bowel (if needed) can save up to 80 % of
AOCMI patients.6
,7
Thus, when the emergency room physician comes across a
patient with acute abdominal pain and atherosclerotic obstruc-
tion of the SMA in CT, the question is: BDoes this patient have
AMI, or is the SMA obstruction just an incidental finding?^
Absence of a thromboembolic clot in the CT does not exclude
the possibility of AMI, and unfortunately, there are no specific
laboratory tests that would be diagnostic.8 However, abnormal
intestinal findings such as unenhanced bowel wall and
pneumatosis in the contrast-enhanced CT are strong signs of
advanced intestinal ischemia, but at the early stage of ischemia,
the CT findings may be very subtle and unspecific; for exam-
ple, bowel lumen dilatation (as a sign of paralysis), mesenteric
fat stranding (edema), ascites, and bowel wall thickening.9
–12
The primary aims of this study were (1) to evaluate inter-
observer agreement on the intestinal and vascular CT findings
in AOCMI between three experienced radiologists and (2) to
assess the utility of those CT findings, specific or unspecific,
in detecting acute intestinal ischemia in patients with athero-
sclerotic obstruction of the SMA. Patients with CMI were
used as a control group. A secondary aim was to analyze
independent CT findings, duration of symptoms, and bowel
infarction as predictors of outcome.
Materials and Methods
Local ethics committee approved this study. Formal informed
consent was not required. The records of all consecutive pa-
tients treated for primary mesenteric ischemia at our tertiary
care center between 2009 and 2013 were meticulously
searched from the hospital databases.1 The inclusion criteria
for the current study were (1) symptomatic arterial AMI or
CMI, (2) contrast-enhanced CT obtained before treatment,
and (3) significant (>50 %) obstruction of the SMA caused
by atherosclerotic vascular disease based on CT findings and
verified by digital subtraction angiography (DSA). Patients
with embolic occlusion of the SMA (n=18) were excluded
from this study; embolism was defined as a clot without a
proximal calcified lesion usually in a patient with atrial fibril-
lation, cardiac thrombus, or other synchronous embolic event.
A total of 47 patients met the inclusion criteria and were
categorized as AOCMI (n=27) or CMI (n=20) by a specialist
in gastrointestinal and vascular surgery based on all available
information on the patient’s clinical presentation, treatment,
and outcome (Fig. 1). There were two basic criteria for the
two study groups:
Acute on Chronic Mesenteric Ischemia
(1) Fulminant disease or persistent symptoms consistent
with the clinical presentation of AMI and significantly
elevated C-reactive protein (CRP) or white blood cell
(WBC) count
(2) Intestinal ischemia verified by laparotomy or emergency
revascularization resulting in either rapid resolution of
symptoms or the development of bowel gangrene
Chronic Mesenteric Ischemia
(1) Intermittent symptoms consistent with chronic mesenter-
ic ischemia: disabling postprandial pain, food intoler-
ance, and avoidance of eating, with or without weight
loss
(2) Spontaneous resolution of acute symptoms (if any); in-
terventions performed electively
CT imaging was performed with contrast enhancement in
arterial and venous phases (CTA) or in portal venous phase
alone (CTV) using a 64-slice multidetector CT system
(Somatom Definition AS64; Siemens Medical Systems, or
Toshiba Aquilion 64; Toshiba Medical Systems). The CT ex-
aminations were evaluated retrospectively, blindly, and inde-
pendently by three experienced radiologists. Observer A had
12-year experience and observer B 5 years of experience in
abdominal radiology. Observer C was an interventional radi-
ologist with 11 years of experience in interventional
angiology. The observers were told to look for mesenteric
ischemia, but they were blinded to the diagnosis, other imag-
ing, and all clinical information.
The vascular and intestinal findings were evaluated accord-
ing to a predefined scheme. The SMA obstruction was graded
as 100% occlusion, 70–99%, 50–70%, <50% or no stenosis,
and characterized as thrombotic (with superimposed calcified
stenosis) or chronic calcified lesion. A similar grading was
used for CA and inferior mesenteric artery (IMA) obstruction.
A hemodynamically significant stenosis of the CA was de-
fined as ≥70 % based on CT interpretation, whereas signifi-
cant stenosis of the IMAwas defined roughly as ≥50 %. The
following intestinal findings were registered: bowel wall en-
hancement, bowel wall thickening, bowel lumen dilatation,
mesenteric fat stranding, pneumatosis, venous gas, ascites,
and pneumoperitoneum.9
,10 Small bowel diameter >2.5 cm
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and colon diameter >6 cm (>9 cm in cecum) was considered
abnormal sign of intestinal paralysis.11
,12 Decreased bowel
wall enhancement, pneumatosis, and SMA thrombosis were
regarded as AMI-specific CT findings. Observers B and C
were asked if they would suggest the diagnosis of AMI based
on the CT findings in each case; observer A performed the CT
analysis as a part of a previous study, for which the diagnosis
was not queried.1
,6 DSA images were analyzed by the experi-
enced interventional radiologist independently from the CT
analysis, and a similar grading was used for the SMA
obstruction.
The patient management included CT prior to intervention
in all patients with suspected AMI, except for those with sep-
tic peritonitis who needed immediate surgery and were, there-
fore, excluded from this study (n=5). After CT, the patient
was treated with laparotomy first (n=6), if there were strong
signs of bowel infarction, followed by subsequent
endovascular treatment primarily with stenting (Fig. 1). In
stable patients with AOCMI (n=21), endovascular therapy
was attempted first, followed by laparotomy if the
endovascular revascularization failed or symptoms persisted
after successful revascularization; bowel resection was per-
formed when necessary (Fig. 1). Elective endovascular
stenting was attempted in all CMI patients. Surgical bypass
was performed selectively in cases where endovascular ther-
apy failed.
Comorbidities, medication, radiology reports, treatment,
and outcomes of the study patients were derived from the
electronic medical records. The duration of symptoms and
laboratory values of ACOMI patients’ were recorded at the
time of the CT examination. The original radiology reports
were reviewed after the blinded CT analysis by the observer
A. Laparotomy and autopsy reports were studied, when avail-
able. The 30-day and long-term mortality was recorded.
All statistics were calculated using SPSS 22.0. Continuous
variables were expressed as mean±standard deviation. Fish-
er’s exact test was used to compare nominal data and the
Mann–Whitney U test or the Kruskal-Wallis test for nonpara-
metric data. Univariate analysis was performed on indepen-
dent CT findings according to observer A, and odds ratio was
used to reflect odds of the outcome event. Survival was illus-
trated using the Kaplan-Meier method. P values <0.05 were
considered significant. Spearman’s correlation coefficients
were calculated to analyze the correlation of the SMA stenosis
grade assessed by CT versus DSA. The kappa statistics (k)
was used to test interobserver agreement; values 0.0–0.2 were
considered slight, 0.2–0.4 fair, 0.4–0.6 moderate, 0.6–0.8 sub-
stantial, and 0.8–1.0 near perfect agreement.
Fig. 1 Flowchart demonstrating
the diagnostic pathways of acute
on chronic mesenteric ischemia
(AOCMI) in this study. CMI
chronic mesenteric ischemia, EVT
endovascular therapy
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suggests AMI. However, one third of patients with arterial
AMI present without visible thromboembolic clot in the CT
but with a calcified chronic lesion of the SMA.6 Therefore,
acute on chronic mesenteric ischemia (AOCMI) is one of the
most difficult diagnoses in the spectrum of acute abdomen.
The symptoms vary from fulminant peritonitis to insidious
onset of obscure symptoms such as diarrhea and vomiting.6
,7
Previous hospitalizations for various symptoms are common
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AMI.7 Early diagnosis is vital; urgent revascularization with
resection of necrotic bowel (if needed) can save up to 80 % of
AOCMI patients.6
,7
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pneumatosis in the contrast-enhanced CT are strong signs of
advanced intestinal ischemia, but at the early stage of ischemia,
the CT findings may be very subtle and unspecific; for exam-
ple, bowel lumen dilatation (as a sign of paralysis), mesenteric
fat stranding (edema), ascites, and bowel wall thickening.9
–12
The primary aims of this study were (1) to evaluate inter-
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Materials and Methods
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and outcome (Fig. 1). There were two basic criteria for the
two study groups:
Acute on Chronic Mesenteric Ischemia
(1) Fulminant disease or persistent symptoms consistent
with the clinical presentation of AMI and significantly
elevated C-reactive protein (CRP) or white blood cell
(WBC) count
(2) Intestinal ischemia verified by laparotomy or emergency
revascularization resulting in either rapid resolution of
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Baseline Characteristics of the Study Groups
The study groups were similar at baseline with respect to age
(mean age 76±8 years), sex (male 38 %), and comorbidities
(Table 1). CTAwas performed in 45% of cases. Approximate-
ly half (n=13) of the patients in the AOCMI group had
prolonged symptoms for more than 3 days, while only fifth
(n=6) had been symptomatic for less than 24 h at the time of
the CT. Prior symptoms of CMI preceding the acute episode
were reported in 22% (n=6) of patients in the AOCMI group.
All patients with AOCMI had either CRP above 100 mg/L
(74%) orWBC count above 15×109/L (89%). There were no
significant differences between the groups regarding the se-
verity of the mesenteric atherosclerosis. Based on DSA imag-
ing, SMA was occluded equally in 63 % of patients with
AOCMI and 50 % of patients with CMI, while the rest had
hemodynamically significant stenosis. Approximately half of
all patients had three-vessel disease, whereas one-vessel dis-
ease was rare especially in the AOCMI group.
Interobserver Agreement on the CT Findings
Observers A and C had substantial agreement on the SMA
stenosis grade (k=0.72) and lesion morphology (k=0.70),
while observer B had fair to moderate agreement with A and
C (Fig. 2, Table 2). The agreement on the severity of the SMA
obstruction in CT compared to DSA (the gold standard) was
moderate (k=0.57), fair (k=0.38), and substantial (k=0.67) for
observers A, B, and C, respectively. There was a strong cor-
relation between assessments of the SMA stenosis degree in
CT and DSA; the Spearman’s correlation coefficients were
0.61, 0.58, and 0.66 for observers A, B, and C, respectively
(P<0.001). Regarding hemodynamically significant CA
obstruction, observers A and B had substantial agreement
(k=0.69) but only moderate agreement (k=0.49) with C.
Agreement on the presence of significant IMA obstruction
was only fair.
The interobserver agreement on the presence of abnormal
bowel wall enhancement pattern ranged from moderate to
substantial (Fig. 3, Table 3). Observer A tended to categorize
the enhancement pattern more often as increased or mixed
pattern, while observers B and C defined the abnormal en-
hancement more often as decreased. Observer A detected un-
specific intestinal findings more often than B and C. Mesen-
teric fat stranding (96 %), bowel lumen dilatation (93 %)
(Fig. 4a), and bowel wall thickening (70 %) were common
findings in patients with AOCMI but only rarely present in
CMI (P<0.001). Observers B and C were in moderate agree-
ment with A on bowel wall thickening and luminal dilatation
but agreed only fairly regarding mesenteric fat stranding. Ob-
server A found pneumatosis or venous gas in eight (30 %)






Age 78±8 75±8 0.152
Male 13 (48) 5 (25) 0.137
Comorbidities
Hypertension 20 (74) 14 (70) 0.999
Hyperlipidemia 13 (48) 13 (65) 0.374
Diabetes mellitus 13 (48) 9 (45) 0.999
Chronic renal insufficiency 1 (4) 3 (15) 0.298
Atrial fibrillation 5 (19) 7 (35) 0.311
Coronary artery disease 13 (48) 15 (75) 0.079
Peripheral arterial disease 13 (48) 8 (40) 0.767
Cerebrovascular disease 8 (30) 5 (25) 0.999
Medication
Warfarin 2 (7) 6 (30) 0.057
Acetyl salicylic acid 21 (78) 14 (70) 0.737
Clopidogrel 4 (15) 1 (5) 0.377
Statin 19 (70) 16 (80) 0.517
Imaging protocol
CT including angiographic phase 10 (37) 11 (55) 0.250
CT in portal venous phase alone 17 (63) 9 (45)
Laboratory valuesa
CRP (mg/L) 162±113 –
WBC count (109/L) 16.6±6.9 –
CRP >100 mg/L 20 (74) –
WBC count >15×109/L 24 (89) –
CRP >100 and WBC >15 17 (63) –
CRP >100 or WBC >15 27 (100) –
SMA obstruction based on DSA
SMA total occlusion 17 (63) 10 (50) 0.551
SMA 70–99 % stenosis 10 (41) 9 (45)
SMA 50–70 % stenosis 0 (0) 1 (5)
Obstructed arteries based on DSA&CT
SMA alone 2 (7) 5 (25) 0.119
SMA+CA 8 (30) 5 (25)
SMA+IMA 3 (11) 2 (10)
SMA+CA+IMA 14 (52) 8 (40) 0.556
Solid organ perfusion defect in CT
Spleen 3 (11) 1 (5)
Liver 3 (11) 0 (0)
Data are expressed as n (%) or mean±standard deviation
AOCMI acute on chronic mesenteric ischemia, CMI chronic mesenteric
ischemia, CRP C-reactive protein, WBC white blood cell, SMA superior
mesenteric artery, DSA digital subtraction angiography, CT computed
tomography, CA celiac artery, IMA inferior mesenteric artery
a CMI patients were often examined electively, and therefore, many had
no laboratory tests taken at the time of the CT scan. Therefore, the labo-
ratory values of CMI patients were excluded
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AOCMI patients in substantial agreement with observer C,
while B reported pneumatosis in only two of those patients
(Fig. 5a) constituting a fair agreement.
Observers A and C had substantial agreement (k=0.66) on
the presence of at least one AMI-specific CT finding (i.e.,
decreased bowel wall enhancement, intestinal pneumatosis,
or SMA thrombosis) in approximately two thirds of the pa-
tients with AOCMI; observer B agreed fairly but had a ten-
dency to categorize the plaque morphology more often as
thrombotic than A or C (Fig. 3, Table 3). Altogether, there
was substantial agreement among all three observers that most
patients with AOCMI (all according to observer A) had at
least some intestinal abnormality (such as in the case present-
ed in Fig. 4), while only few patients with CMI had such
findings (P<0.001). All three observers agreed on the pres-
ence or absence of intestinal abnormality in 36 (77 %) cases.
The abnormal intestinal findings in CMI patients were located
mostly in the colon and were caused by (chronic) ischemic
colitis. The observers B and C had substantial agreement (k=
0.79) when asked, whether they would suggest the diagnosis
of AMI based on the CT findings.
Original Radiology Reports
In the AOCMI group, the original CT report (according to the
emergency room radiologist) was determined as incorrect in
four cases. The initial radiologist’s report was fully correct
(with all the relevant findings reported and diagnosis of AMI
Table 2 Vascular CT findings stratified by the three observers and the two study groups
CT finding Observer A Observer B Observer C AR
AOCMI (n=27) CMI (n=20) AOCMI (n=27) CMI (n=20) AOCMI (n=27) CMI (n=20) %
SMA stenosis grade –
100 % occlusion 15 5 17 14 17 9
70–99 % stenosis 12 13 9 3 10 10
50–70 % stenosis 0 2 1 2 0 1
<50 % or no stenosis 0 0 0 1 0 0
SMA lesion morphology 59
Calcified, chronic lesion 16 19 8 9 14 17
Thrombotic lesion 11 1 19 10 13 3
CA stenosis grade –
100 % occlusion 7 2 9 7 12 5
70–99 % stenosis 8 10 9 5 13 8
50–70 % stenosis 6 1 2 2 0 3
<50 % or no stenosis 6 7 7 6 2 4
CA 70–100 % obstructiona 15 12 18 12 25 13 70
IMA stenosis grade –
100 % occlusion 0 2 4 7 9 10
50–99 % stenosis 17 8 14 4 11 4
No significant stenosis 10 10 8 9 7 6
IMA 50–100 % obstructiona 17 10 18 11 20 14 52
AR Agreement rate, defined as the percentage of cases when all three observers agreed, calculated only for dichotomous data
AOCMI acute on chronic mesenteric ischemia, CMI chronic mesenteric ischemia, SMA superior mesenteric artery, CA celiac artery, IMA inferior
mesenteric artery
a Defined as hemodynamically significant obstruction
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Fig. 2 Interobserver agreement on the vascular findings in computed
tomography
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suggested) in 19 cases. In four cases, the original CT report
was essentially correct, but some of the relevant findings were
missed, abnormal intestinal findings in three cases and SMA
thrombosis in one case. In two patients, the diagnosis was
delayed for several days due to the missed CT findings. Both
patients were eventually treated with bowel resection and
endovascular therapy; one of the two survived.
Patient Management and Outcomes
Endovascular recanalization (Fig. 4c) was attempted in all 47
cases, and failed in three (11 %) patients in the AOCMI group
and two (10 %) in the CMI group. Surgical conversion (i.e.,
SMA bypass) was performed in two patients with AOCMI
(with mortality in one) and two patients with CMI. The 30-
day mortality rate was 22 % in patients with AOCMI, and one
patient (5 %) in the CMI group died exactly 30 days after the
treatment due to complicated pancreatitis. Thirteen (48 %)
patients underwent laparotomy in the AOCMI group with
bowel infarction in 12 (44 %) patients (Fig. 1). None of the
CMI patients developed intestinal infarction. In the CMI
group, short-term resolution of symptoms was reported in 15
of 16 patients; the follow-up information was unavailable in
four CMI patients referred from other hospitals. The patient
with mortality in the CMI group remained symptomatic due to
severe chronic pancreatitis.
Of the independent CT findings according to observer A,
thrombotic occlusion of the SMA and decreased bowel wall
enhancement were significantly associated with 30-day mor-
tality, while decreased bowel wall enhancement and
pneumatosis were associated with need for bowel resection
(Table 4). The other intestinal findings had no statistically
significant predictive value associated with outcome. The cor-
relations of symptom duration between CT findings (accord-
ing to observer A), laboratory values, and outcomes in
AOCMI are presented in Table 5. The duration of symptoms
had no association with the presence of a thrombotic clot in
CT. AOCMI patients with symptom duration >24 h had
Fig. 3 Interobserver agreement
on the intestinal findings in
computed tomography
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significantly higher CRP levels than those with shorter dura-
tion of symptoms (P=0.042). However, those who had symp-
toms for more than 3 days were associated with better surviv-
al, while those with less than 24-h duration of symptoms were
more prone to developing bowel gangrene, although there
were no statistically significant differences. The correlations
between bowel infraction and CT findings, laboratory values,
and outcomes within the AOCMI group are presented in
Table 6; half of the AOCMI patients with reversible bowel
ischemia and 77 % of those who developed bowel infarction
had AMI-specific findings in CT.
The long-term mortality of the study patients is presented
in Fig. 6. The mean follow-up time was 29±22 months.
Discussion
This study highlights the challenge of interpreting vascular
and intestinal CT findings in patients with atherosclerotic ob-
struction of the SMA and acute abdominal pain. Although a
variety of CT protocols was employed, a reasonable interob-
server agreement, and agreement in comparison to the DSA,
was achieved regarding the severity of SMA obstruction.
There was more disagreement on the SMA obstruction mor-
phology (calcified versus thrombotic), and the agreement on
the intestinal findings was moderate in average.
Perhaps, the most important finding of this study was that
one third of the patients with AOCMI did not show any AMI-
specific CT findings. For example, only half of AOCMI pa-
tients had a clearly visible SMA thrombosis in CT, although
one observer tended to categorize calcified lesions more often
as thrombotic than the others (Table 2). Furthermore, AMI-
specific CT findings did not predict the development of bowel
infarction within the AOCMI group because half of those with
reversible bowel ischemia had AMI-specific CT findings as
well (Table 6). All patients with AOCMI in this study had at
least some level of intestinal abnormality in their CTs accord-
ing to the experienced abdominal radiologist A who was the
most punctilious observer in detecting intestinal findings, and
there was substantial agreement among the other observers.
The most frequent findings were mesenteric fat stranding,
bowel lumen dilatation (intestinal paralysis), and bowel wall
thickening. However, those are highly unspecific findings that
are seen in many other diagnoses of the acute abdomen.11
,12
For example, bowel wall thickening is found in inflammatory,
infectious, or malignant diseases, but specificity can be
Table 3 Intestinal CT findings stratified by the three observers and the two study groups
CT finding Observer A Observer B Observer C AR
AOCMI (n=27) CMI (n=20) AOCMI (n=27) CMI (n=20) AOCMI (n=27) CMI (n=20) %
Bowel wall enhancement pattern –
Normal 12 19 17 19 15 19
Decreased or absent 5 1 9 1 8 1
Increased 5 0 1 0 3 0
Mixed: decreased and increased segments 5 0 0 0 1 0
Any abnormal enhancement 15 1 10 1 12 1 72
Bowel wall thickening 19 2 10 1 14 2 70
Luminal dilatation/paralysis 25 0 11 0 16 2 64
Mesenteric fat stranding 26 1 12 1 11 1 57
Ascites/free fluid 9 1 9 1 4 0 75
Pneumatosis/venous gas 8 0 2 0 7 0 85
Pneumoperitoneum 1 0 1 0 1 0 100
Small bowel abnormalities 25 0 12 0 12 1 –
Colon abnormalities –
Right side 20 2 11 0 14 1
Left side 2 1 1 1 2 2
Any AMI-specific findinga 17 2 22 10 19 4 55
Any abnormal finding 27 2 21 1 23 4 77
Suggested AMI diagnosis – – 20 1 22 4 89
AR Agreement rate, defined as the percentage of cases when all three observers agreed, calculated only for dichotomous data
AOCMI acute on chronic mesenteric ischemia, CMI chronic mesenteric ischemia, AMI, acute mesenteric ischemia
a Decreased bowel wall enhancement, pneumatosis, or visible superior mesenteric artery thrombosis
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suggested) in 19 cases. In four cases, the original CT report
was essentially correct, but some of the relevant findings were
missed, abnormal intestinal findings in three cases and SMA
thrombosis in one case. In two patients, the diagnosis was
delayed for several days due to the missed CT findings. Both
patients were eventually treated with bowel resection and
endovascular therapy; one of the two survived.
Patient Management and Outcomes
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day mortality rate was 22 % in patients with AOCMI, and one
patient (5 %) in the CMI group died exactly 30 days after the
treatment due to complicated pancreatitis. Thirteen (48 %)
patients underwent laparotomy in the AOCMI group with
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relations of symptom duration between CT findings (accord-
ing to observer A), laboratory values, and outcomes in
AOCMI are presented in Table 5. The duration of symptoms
had no association with the presence of a thrombotic clot in
CT. AOCMI patients with symptom duration >24 h had
Fig. 3 Interobserver agreement
on the intestinal findings in
computed tomography
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significantly higher CRP levels than those with shorter dura-
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al, while those with less than 24-h duration of symptoms were
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and outcomes within the AOCMI group are presented in
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improved by evaluating associated bowel wall enhancement
and adjacent mesenteric fat stranding.13
In the CMI group, only few patients had abnormal intesti-
nal findings, and those were mostly related to chronic ische-
mic colitis; in only one CMI patient, observer C suggested
dilatation of the small intestine. It seems that in the absence
of any pathologic intestinal finding in CT, the diagnosis of
AOCMI is unlikely. However, this conclusion is not applica-
ble to all AMI etiologies. It has been previously demonstrated
that patients with AMI due to atherosclerosis more frequently
present with abnormal intestinal findings, such as dilated
small intestine, than those with embolic etiology.14 Acute
embolic occlusion of a previously healthy SMA causes sud-
den symptoms, and the CTmay be obtained at very early stage
when the pathologic intestinal findings are still missing. In the
present study, the duration of symptoms varied from hours to
several days in patients with AOCMI. Although statistically
insignificant, an interesting finding in our study was that
AOCMI patients with symptom duration >3 days had better
survival and lower rate of bowel infarction after endovascular
therapy than those with shorter duration of symptoms
(Table 5). In slowly progressing atherosclerotic disease, the
collateral arteries are often developed and the bowel is accus-
tomed to withstanding ischemia. Therefore, patients with
Fig. 4 This 71-year old patient
had been suffering from
postprandial pain and diarrhea for
2 months. An abdominal CT had
been obtained for the intermittent
symptoms 9 days before the final
admission. The first CT showed a
significant 3-vessel disease
without abnormal intestinal
findings. Soon, the symptoms
became worse and persistent, and
the patient was admitted to our
hospital’s emergency room. CRP
was very high (400 mg/L). A new
CT showed dilated small bowel
loops (a) recognized by all three
observers. In addition, observers
A and C saw bowel wall
thickening and mesenteric fat
stranding, and increased
enhancement was noticed by
observer A. Agreed by all
observers, the SMA (b black
arrowhead) and the CA (b white
arrowhead) were significantly
obstructed due to atherosclerosis
without signs of acute
thrombosis. Laparotomy was
performed; the small bowel
appeared pale, and the bowel
turned cyanotic when lifted out of
the abdomen. There was no
irreversible bowel damage, and
subsequent angiography was
performed. A short but tight
calcified occlusion of the
proximal SMA (c black
arrowhead) was recanalized via
brachial access and treated with
stenting (d black arrowheads).
The patient recovered without
incidents
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AOCMI usually present late when the abnormal intestinal CT
findings are common, and for the same reason, CRP and
WBC count tend to be higher in AOCMI than in embolic
AMI.6 Even so, as demonstrated in this study, the bowel was
often salvageable with revascularization even despite several
days duration of symptoms and AMI-specific CT signs
(Table 6).
The etiology of AOCMI is not exclusively acute occlusion
of the SMA. In other words, AOCMI may develop due to
multiple factors including compromise of the blood vessels
(acute or chronic obstruction), hypovolemia, anemia, and
low cardiac output. The diagnosis of AMI can never be made
irrespective of the patient’s clinical presentation, especially
when the AMI-specific CT signs are absent. Persistent
abdominal pain, vomiting, and diarrhea (which represent
symptoms of intestinal paralysis or ischemic colitis) indicate
that the patient may have gone into an irreversible state of
acute intestinal ischemia, and urgent revascularization is need-
ed. The case presented in Fig. 4 is an example of AOCMI at
early stage. The intestinal signs were very subtle in the CT
and could have been easily overlooked without the history
of postprandial pain. We believe that without revasculari-
zation, this patient probably would have developed irre-
versible bowel damage, although sometimes, antibiotics,
fluid resuscitation, and correction of anemia may be
enough to reverse the acute ischemic episode. The other
case example (Fig. 5) represents late stage of AOCMI with
chronic thrombosis of the SMA. A common mistake is
Fig. 5 This 85-year old patient
had been evaluated at the
outpatient clinic for epigastric
postprandial pain and weight loss
only 11 days before the final
admission. Upper gastrointestinal
endoscopy was negative. CT
showed gallstones and significant
atherosclerosis of the SMA and
the CA. However, the vascular
findings had been neglected, and
the patient was referred for
elective cholecystectomy. At final
admission, the patient presented
with persistent abdominal pain
and bloody diarrhea. Agreed by
all observers, a new CT showed
intestinal pneumatosis with
decreased bowel wall
enhancement (a white open
arrowheads) and thrombotic
occlusion of the SMA (a black
arrowheads), which proved to be
a chronic thrombosis based on the
earlier CT (b black arrowheads).
Laparotomy was performed first
with bowel resection. Subsequent
angiography showed a proximal
stump of the occluded SMA (c,
black arrowhead), and the CA
was also occluded (c white
arrowhead; a white arrowhead).
The SMA occlusion was
recanalized via femoral access,
and two stents (d black
arrowheads) were successfully
placed. The patient made an
uneventful recovery
J Gastrointest Surg
improved by evaluating associated bowel wall enhancement
and adjacent mesenteric fat stranding.13
In the CMI group, only few patients had abnormal intesti-
nal findings, and those were mostly related to chronic ische-
mic colitis; in only one CMI patient, observer C suggested
dilatation of the small intestine. It seems that in the absence
of any pathologic intestinal finding in CT, the diagnosis of
AOCMI is unlikely. However, this conclusion is not applica-
ble to all AMI etiologies. It has been previously demonstrated
that patients with AMI due to atherosclerosis more frequently
present with abnormal intestinal findings, such as dilated
small intestine, than those with embolic etiology.14 Acute
embolic occlusion of a previously healthy SMA causes sud-
den symptoms, and the CTmay be obtained at very early stage
when the pathologic intestinal findings are still missing. In the
present study, the duration of symptoms varied from hours to
several days in patients with AOCMI. Although statistically
insignificant, an interesting finding in our study was that
AOCMI patients with symptom duration >3 days had better
survival and lower rate of bowel infarction after endovascular
therapy than those with shorter duration of symptoms
(Table 5). In slowly progressing atherosclerotic disease, the
collateral arteries are often developed and the bowel is accus-
tomed to withstanding ischemia. Therefore, patients with
Fig. 4 This 71-year old patient
had been suffering from
postprandial pain and diarrhea for
2 months. An abdominal CT had
been obtained for the intermittent
symptoms 9 days before the final
admission. The first CT showed a
significant 3-vessel disease
without abnormal intestinal
findings. Soon, the symptoms
became worse and persistent, and
the patient was admitted to our
hospital’s emergency room. CRP
was very high (400 mg/L). A new
CT showed dilated small bowel
loops (a) recognized by all three
observers. In addition, observers
A and C saw bowel wall
thickening and mesenteric fat
stranding, and increased
enhancement was noticed by
observer A. Agreed by all
observers, the SMA (b black
arrowhead) and the CA (b white
arrowhead) were significantly
obstructed due to atherosclerosis
without signs of acute
thrombosis. Laparotomy was
performed; the small bowel
appeared pale, and the bowel
turned cyanotic when lifted out of
the abdomen. There was no
irreversible bowel damage, and
subsequent angiography was
performed. A short but tight
calcified occlusion of the
proximal SMA (c black
arrowhead) was recanalized via
brachial access and treated with
stenting (d black arrowheads).
The patient recovered without
incidents
J Gastrointest Surg
AOCMI usually present late when the abnormal intestinal CT
findings are common, and for the same reason, CRP and
WBC count tend to be higher in AOCMI than in embolic
AMI.6 Even so, as demonstrated in this study, the bowel was
often salvageable with revascularization even despite several
days duration of symptoms and AMI-specific CT signs
(Table 6).
The etiology of AOCMI is not exclusively acute occlusion
of the SMA. In other words, AOCMI may develop due to
multiple factors including compromise of the blood vessels
(acute or chronic obstruction), hypovolemia, anemia, and
low cardiac output. The diagnosis of AMI can never be made
irrespective of the patient’s clinical presentation, especially
when the AMI-specific CT signs are absent. Persistent
abdominal pain, vomiting, and diarrhea (which represent
symptoms of intestinal paralysis or ischemic colitis) indicate
that the patient may have gone into an irreversible state of
acute intestinal ischemia, and urgent revascularization is need-
ed. The case presented in Fig. 4 is an example of AOCMI at
early stage. The intestinal signs were very subtle in the CT
and could have been easily overlooked without the history
of postprandial pain. We believe that without revasculari-
zation, this patient probably would have developed irre-
versible bowel damage, although sometimes, antibiotics,
fluid resuscitation, and correction of anemia may be
enough to reverse the acute ischemic episode. The other
case example (Fig. 5) represents late stage of AOCMI with
chronic thrombosis of the SMA. A common mistake is
Fig. 5 This 85-year old patient
had been evaluated at the
outpatient clinic for epigastric
postprandial pain and weight loss
only 11 days before the final
admission. Upper gastrointestinal
endoscopy was negative. CT
showed gallstones and significant
atherosclerosis of the SMA and
the CA. However, the vascular
findings had been neglected, and
the patient was referred for
elective cholecystectomy. At final
admission, the patient presented
with persistent abdominal pain
and bloody diarrhea. Agreed by
all observers, a new CT showed
intestinal pneumatosis with
decreased bowel wall
enhancement (a white open
arrowheads) and thrombotic
occlusion of the SMA (a black
arrowheads), which proved to be
a chronic thrombosis based on the
earlier CT (b black arrowheads).
Laparotomy was performed first
with bowel resection. Subsequent
angiography showed a proximal
stump of the occluded SMA (c,
black arrowhead), and the CA
was also occluded (c white
arrowhead; a white arrowhead).
The SMA occlusion was
recanalized via femoral access,
and two stents (d black
arrowheads) were successfully
placed. The patient made an
uneventful recovery
J Gastrointest Surg
thinking that Bvisible thrombosis^ in CT is a synonym for
Bacute occlusion^; SMA thrombus alone does not prove
acute intestinal ischemia, as it may very well be a chronic
thrombus.
Although diagnostic accuracy was not actually the aim of
this study, observers B and C had substantial agreement (k=
0.79) on the cases in which they would have suggested the
diagnosis of AMI (Table 3). In average, they suggested AMI
in 78 % of cases with AOCMI (true positive) and in 13 % of
cases with CMI (false positive). Similarly, the rate of fully
correct CT interpretation by the emergency room radiologists
(based on the original radiology reports) in patients with
AOCMI was 70 %. The weakness of this study, however, is
the lack of a control group with asymptomatic SMA obstruc-
tion and a non-ischemic cause of acute abdominal pain. It was
impossible to find sufficient number of such patients in a
retrospective setting. Using patients without SMA obstruction
as a control group would have constituted a problem with
blinding the radiologists from the case–control grouping,
and therefore, we used patients with CMI. The results of this
study should be interpreted considering the fact that CMI
patients are not asymptomatic, and sometimes, there is only
a Bthin red line^ between acute and chronic ischemia.
The latest research has been focusing on AMI biomarkers,
but there has not been any major breakthrough yet.8 For exam-
ple, recently, intestinal fatty acid binding protein was shown to
have similar diagnostic accuracy for AMI as the abdominal CT
interpretation in this study.15 However, most patients with AMI
in that study had already developed bowel infarction, and the
etiology of AMI was mostly non-occlusive. The problem with
biomarkers and CT findings in studies with high laparotomy
rates (laparotomy being the gold standard proof of AMI) is that
the bowel damage is already advanced when surgical resection
is needed. The AMI-specific CT findings also suggest ad-
vanced (but not necessarily irreversible) bowel ischemia. Ob-
viously, we need diagnostic tests that can detect ongoing intes-
tinal ischemia when it still can be reversed. Contrast-enhanced
CT is the only practical non-invasive diagnostic method for
AMI available 24/7 and being widely used in patients with
acute abdomen. Recently, the utility of dual-energy CT in de-
tecting early ischemic changes on the bowel wall was studied in
a swine model.16 Prospective studies are needed to evaluate,
whether diagnostic accuracy in the early detection of AMI
could be improved with these next generation CT devices, as
they are becoming available in surgical acute care units.
Conclusion
Although contrast-enhanced CT examination, even in por-
tal venous phase alone, is satisfactory in detecting vascu-
lar pathology, significant interobserver variability exists in
the interpretation of the CT images especially regarding
the intestinal findings. One third of patients who develop
AOCMI present without AMI-specific CT signs. In those
cases, any unspecific intestinal abnormality in the CT
Table 5 Correlations between
the duration of symptoms and
computed tomography (CT)
findings, laboratory findings, and
outcomes in 27 patients with
acute on chronic mesenteric
ischemia
Duration of symptoms at CT scan P
<24 h (n=6) 1–3 days (n=8) >3 days (n=13)
Delay from admission to CT (h) 1.7 5.3 14.8 0.115
Visible thrombotic clot (SMA) 2 (33) 4 (50) 5 (38) 0.779
Any AMI-specific CT finding 6 (100) 4 (50) 7 (54) 0.107
WBC count >15×109/L 6 (100) 7 (88) 11 (85) 0.999
CRP >100 mg/L 1 (17) 7 (88) 12 (92) 0.002
CRP (mg/L) 17 146 176 0.042
Bowel infarction 4 (67) 4 (50) 5 (38) 0.479
In-hospital death 2 (33) 3 (38) 1 (8) 0.243
Nominal data are presented as n (%) and nonparametric data as medians
WBC white blood cell, CRP C-reactive protein, SMA superior mesenteric artery, AMI acute mesenteric ischemia
Table 4 Univariate analysis of independent computed tomography
(CT) findings associated significantly with outcome in 47 patients with
symptomatic mesenteric atherosclerosis
Variable P OR 95 % CI
Factors associated with 30-day mortality
Decreased bowel wall enhancement 0.004 29.17 2.88–295.34
Visible thrombotic clot (SMA) 0.006 24.29 2.44–241.26
Factors associated with bowel resection
Decreased bowel wall enhancement 0.010 7.44 1.63–33.91
Pneumatosis 0.010 9.17 1.72–48.94
OR odds ratio, CI confidence interval, SMA superior mesenteric artery,
AMI acute mesenteric ischemia
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together with atherosclerotic obstruction of the mesenteric
arteries should be carefully evaluated, and when present,
the clinician and the radiologist should consider the pos-
sibility of acute intestinal ischemia.
Table 6 Correlations between bowel infarction and computed tomography (CT) findings, laboratory findings, and outcomes in 27 patients with acute






Delay from admission to CT (h) 5.5 5.3 0.756
Visible thrombotic clot (SMA) 7 (55) 4 (29) 0.252
Decreased bowel wall enhancement 7 (54) 3 (21) 0.120
Pneumatosis 6 (46) 2 (14) 0.103
Any AMI-specific CT finding 10 (77) 7 (50) 0.236
WBC count >15×109/L 12 (92) 12 (86) 0.999
CRP >100 mg/L 8 (62) 12 (86) 0.209
CRP (mg/L) 135 181 0.094
Need for surgery 12 (92)a 1 (7)b 0.000
In-hospital death 5 (38) 1 (7)c 0.077
Nominal data are presented as n (%) and nonparametric data as medians
WBC white blood cell, CRP C-reactive protein, SMA superior mesenteric artery, AMI acute mesenteric ischemia
a Including bypass with bowel resection (n=2), bowel resection alone (n=9), explorative laparotomy with unresectable bowel necrosis (n=1). One
patient was unfit for general anesthesia and died within 24 h after failure of endovascular therapy; the cause of death was determined as SMA thrombosis
and bowel infarction based on clinical and CT findings
b Explorative laparotomy with salvageable bowel
c One patient with resolution of symptoms after endovascular revascularization died 2 days after the procedure due to myocardial infarction; the bowel
ischemia had been reversed based on autopsy findings
Fig. 6 Kaplan-Meier cumulative
survival of 27 patients with acute
on chronic mesenteric ischemia
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Acute mesenteric ischemia is considered a 
rare and fatal condition. Removal of necrotic 
bowel has been the conventional treatment 
with >80% overall mortality. This study 
shows that the disease is more common 
than appendicitis or ruptured abdominal 
aortic aneurysm in patients >75 years of age. 
Endovascular therapy was attempted in ¾ of 
patients resulting in 42% overall mortality and 
only ¹⁄³ required bowel resection. Computed 
tomography was diagnostic in 86%, but the 
specific signs were often missing.
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